data_2ken_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ken _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 CA-C-O 121.577 0.574 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -80.32 119.99 23.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -90.91 131.64 36.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 141.95 51.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.84 150.64 20.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 110.106 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mm -55.0 -45.45 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.64 0.733 . . . . 0.0 109.371 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.98 -11.72 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -97.4 3.91 50.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 109.653 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLU . 77.8 mt -59.87 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.306 -0.871 . . . . 0.0 110.483 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' ILE . 11.8 m 31.26 31.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.397 0.617 . . . . 0.0 110.735 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.3 tt0 -166.13 112.78 0.88 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.321 -0.862 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 54.1 p30 -86.91 154.45 20.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 23.98 76.3 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -97.48 140.2 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -1.031 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.91 128.62 44.05 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.44 -170.71 2.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -130.68 135.16 47.56 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.76 148.12 43.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -116.57 132.5 56.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.85 165.68 29.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.045 0.926 . . . . 0.0 110.925 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -105.6 155.69 18.97 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.909 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -88.36 99.78 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.234 -0.916 . . . . 0.0 110.467 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.73 -28.71 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.077 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.27 140.52 18.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 109.24 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.577 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 1.6 pt? -120.93 150.09 41.62 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.34 0.591 . . . . 0.0 109.926 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -141.03 112.25 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.374 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 109.433 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.571 0.701 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 t -96.85 -49.44 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.592 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.42 149.42 28.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.02 142.41 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.17 -161.52 12.61 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.92 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.2 146.16 46.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.943 -0.739 . . . . 0.0 109.42 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.3 mt -108.77 124.41 50.55 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.26 96.75 2.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.8 t0 -100.48 160.85 14.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -1.159 . . . . 0.0 109.387 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 84.3 tt0 -70.36 -20.5 62.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.693 -0.63 . . . . 0.0 109.858 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.4 p -92.15 -12.12 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.16 -153.28 24.46 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.99 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 pt -136.48 159.86 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.547 -0.973 . . . . 0.0 109.918 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -159.2 146.34 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.842 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -90.31 134.9 34.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -129.5 157.27 42.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 108.649 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.2 m -132.89 132.52 42.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.47 127.91 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -85.3 145.54 27.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 110.547 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.54 -36.64 78.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -59.63 -8.89 2.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.474 -0.766 . . . . 0.0 109.899 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 -26.47 24.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 109.044 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.59 51.32 15.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.697 -0.627 . . . . 0.0 109.878 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.0 mt -105.28 148.76 36.8 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.37 161.96 42.61 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.618 2.212 . . . . 0.0 112.637 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.01 141.0 47.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.665 0.745 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.2 mp -84.31 156.67 21.81 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -99.87 129.59 45.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.388 -0.82 . . . . 0.0 109.742 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.79 137.63 57.37 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.456 0.646 . . . . 0.0 110.487 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.93 -10.68 64.63 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -94.79 151.68 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -1.135 . . . . 0.0 110.31 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -84.99 140.44 31.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -133.7 142.87 48.19 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.754 0.787 . . . . 0.0 109.773 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.09 127.79 54.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.64 118.46 35.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -114.18 145.55 41.54 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.408 0.623 . . . . 0.0 110.403 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.9 t 58.17 58.15 3.65 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.726 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.05 165.98 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.343 -0.848 . . . . 0.0 109.273 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.27 149.81 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.729 0.776 . . . . 0.0 110.012 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.02 133.89 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.754 -0.591 . . . . 0.0 109.629 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.28 148.73 16.78 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -94.63 104.64 16.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -1.146 . . . . 0.0 109.148 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 80' ' ' ARG . 84.3 t80 -99.85 106.4 18.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.789 . . . . 0.0 109.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.2 t30 42.19 -116.64 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.549 -0.72 . . . . 0.0 110.757 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.41 -17.12 23.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.085 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 mmm-85 -100.94 156.43 17.39 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.874 0.845 . . . . 0.0 110.373 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -97.79 150.83 20.83 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.68 155.5 43.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 109.17 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.85 125.19 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.372 -0.83 . . . . 0.0 108.956 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -106.38 129.25 54.41 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.741 . . . . 0.0 109.279 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.89 131.22 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.0 m-80 -136.55 -163.08 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.804 0.812 . . . . 0.0 109.821 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 89' ' ' SER . 33.9 mmtt -57.35 166.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.792 -0.567 . . . . 0.0 109.472 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 12.8 t-20 72.81 -21.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.708 -0.62 . . . . 0.0 109.547 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 87' ' ' LYS . 87.1 p -74.61 159.29 32.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.3 m -136.86 156.22 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.399 -0.813 . . . . 0.0 109.131 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.62 130.66 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -132.16 138.05 47.88 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 0.0 109.355 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -81.81 138.98 35.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.592 -0.692 . . . . 0.0 109.762 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.71 137.73 48.01 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.922 0.868 . . . . 0.0 110.147 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -86.58 8.34 22.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -117.04 91.77 37.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.329 -0.857 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -55.34 152.32 32.62 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.887 2.391 . . . . 0.0 112.136 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.6 mt -101.14 147.79 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.26 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 57.0 mp0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.855 . . . . 0.0 110.201 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.376 0.49 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.12 119.87 23.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.914 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -90.39 128.88 36.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.782 . . . . 0.0 109.753 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -128.44 145.01 51.22 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.19 143.0 28.42 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.71 0.767 . . . . 0.0 110.494 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 8' ' ' ILE . 83.1 mt -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.41 -0.806 . . . . 0.0 109.322 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.41 -10.79 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.448 -0.783 . . . . 0.0 109.918 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -97.51 6.28 48.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.584 ' O ' ' N ' ' A' ' 13' ' ' GLU . 44.8 mt -59.85 -70.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.3 m 40.5 17.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.741 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 11' ' ' ILE . 6.5 pt-20 -171.92 130.77 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.808 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.83 167.38 12.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.021 -1.049 . . . . 0.0 110.58 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.17 23.54 77.39 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.1 136.67 35.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -1.03 . . . . 0.0 110.17 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -97.33 127.44 43.3 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -162.71 -169.73 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 43.4 m-20 -140.59 137.86 33.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.568 -0.707 . . . . 0.0 109.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.67 147.45 25.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 110.391 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -101.14 140.92 34.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.53 0.681 . . . . 0.0 109.397 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 161.62 42.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.292 -0.88 . . . . 0.0 110.77 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.02 148.93 25.65 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.355 0.598 . . . . 0.0 109.645 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -87.48 94.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.278 -0.889 . . . . 0.0 110.52 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.8 mt -70.61 -31.26 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.499 -0.751 . . . . 0.0 109.324 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -148.07 129.3 14.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.064 -1.022 . . . . 0.0 109.604 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.7 tp -110.89 146.5 36.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -142.57 111.35 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.54 0.686 . . . . 0.0 109.795 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.666 . . . . 0.0 109.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.674 0.749 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -83.53 -56.79 3.54 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.666 0.746 . . . . 0.0 109.963 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -159.11 162.22 36.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.107 -0.996 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.09 159.61 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.18 -157.95 20.58 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -125.76 149.82 48.24 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.973 -0.722 . . . . 0.0 109.976 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD2' ' CD1' ' A' ' 50' ' ' PHE . 31.5 mt -109.91 124.81 52.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.17 94.35 1.9 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.58 159.99 14.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -1.011 . . . . 0.0 109.597 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.13 -17.54 63.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.819 -0.551 . . . . 0.0 109.839 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 p -92.43 -9.66 40.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.25 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.64 -148.29 19.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -138.16 160.56 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.696 -0.885 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -162.57 158.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.927 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -84.8 164.58 18.39 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.558 -0.714 . . . . 0.0 110.275 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CD1' ' CD2' ' A' ' 41' ' ' LEU . 24.8 p90 -156.06 153.65 29.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.069 -1.019 . . . . 0.0 108.549 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.516 ' OG1' ' NE2' ' A' ' 82' ' ' GLN . 69.5 m -136.36 129.57 31.51 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 HG22 HD13 ' A' ' 52' ' ' ILE . 89.3 mt -106.52 130.12 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -90.26 142.92 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 110.431 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.42 -35.04 76.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.687 -0.633 . . . . 0.0 109.456 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -58.89 -7.8 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.473 -0.767 . . . . 0.0 109.825 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.52 -23.59 34.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.869 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 51.16 44.26 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 109.887 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.57 151.6 39.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.796 -0.565 . . . . 0.0 109.716 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.54 146.89 50.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.479 2.119 . . . . 0.0 112.804 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.07 141.61 56.09 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.658 0.742 . . . . 0.0 110.491 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -81.1 139.85 35.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.0 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.32 134.08 37.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.466 -0.771 . . . . 0.0 110.17 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.78 136.57 48.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.402 0.62 . . . . 0.0 110.532 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -6.36 83.5 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.59 159.87 15.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -1.001 . . . . 0.0 110.543 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -95.7 148.93 22.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -141.23 150.07 42.18 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.005 0.907 . . . . 0.0 109.964 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.01 132.1 46.57 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 mt -112.72 112.4 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.928 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -118.64 145.46 45.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 71' ' ' SER . 7.5 t 57.33 54.91 6.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.04 165.94 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 0.0 109.304 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.859 0.838 . . . . 0.0 109.925 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -92.61 131.71 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.579 -0.7 . . . . 0.0 109.855 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.64 150.5 16.81 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.77 104.85 16.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.6 -0.941 . . . . 0.0 109.364 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 80' ' ' ARG . 42.0 t80 -97.06 104.22 16.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 109.239 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' TYR . 98.7 m-20 39.67 -111.87 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -95.13 -20.19 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.419 -0.801 . . . . 0.0 109.898 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.1 mtt180 -98.85 159.29 15.06 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.905 0.86 . . . . 0.0 110.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.3 149.97 20.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.752 . . . . 0.0 109.14 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 51' ' ' THR . 57.1 tt0 -144.03 150.96 39.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.89 124.47 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -107.43 126.36 52.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.446 -0.783 . . . . 0.0 109.567 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.22 132.82 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 89' ' ' SER . 13.5 p30 -146.06 -176.57 5.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.768 0.794 . . . . 0.0 110.014 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.528 ' C ' ' H ' ' A' ' 89' ' ' SER . 80.5 tttt -42.84 166.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 1.8 t-20 73.5 -30.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.65 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 87' ' ' LYS . 81.6 p -76.95 164.3 25.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 109.964 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 p -139.63 158.31 44.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.427 -0.796 . . . . 0.0 109.417 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.7 mt -141.89 133.73 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.499 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.37 138.71 46.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.612 0.72 . . . . 0.0 109.232 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -73.05 139.47 46.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.592 -0.692 . . . . 0.0 109.594 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 96' ' ' GLU . 89.3 mt -101.01 -13.37 18.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.9 t 51.91 4.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.758 -0.589 . . . . 0.0 109.732 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 94' ' ' LEU . 37.8 tp10 -107.59 127.29 28.07 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.617 -0.677 . . . . 0.0 109.5 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.82 141.08 29.9 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.411 2.074 . . . . 0.0 112.182 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.3 mt -112.09 135.97 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.77 -0.582 . . . . 0.0 109.456 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 -179.704 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.497 1.735 0 CA-C-O 121.495 0.54 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -79.26 116.31 19.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.313 -0.867 . . . . 0.0 109.471 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt -92.33 129.47 38.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.347 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' ' CD2' ' A' ' 20' ' ' LEU . 83.3 m -125.83 144.14 50.77 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.88 146.29 23.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.052 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.07 -42.36 89.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.176 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.55 -8.54 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.632 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -103.37 9.28 37.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -86.32 124.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.168 -0.957 . . . . 0.0 109.944 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -144.13 8.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 109.286 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -143.37 138.75 29.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.277 -0.89 . . . . 0.0 109.141 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 54.0 p30 -97.52 159.37 14.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.448 -0.783 . . . . 0.0 110.353 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.91 9.91 84.74 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.85 155.55 17.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -1.083 . . . . 0.0 109.691 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.2 134.71 50.66 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.462 0.649 . . . . 0.0 109.572 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.17 -176.78 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.905 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 7.7 t30 -122.48 142.97 50.01 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -139.12 128.2 23.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.32 -0.862 . . . . 0.0 109.686 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -112.45 132.75 54.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.39 -173.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -112.53 154.91 25.2 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.09 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -92.48 113.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -71.67 -26.77 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 0.0 110.035 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.506 ' OE1' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -172.45 167.41 5.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.98 -1.075 . . . . 0.0 109.182 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.678 ' N ' HE21 ' A' ' 63' ' ' GLN . 82.7 mt -138.29 160.87 38.36 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.428 0.632 . . . . 0.0 110.005 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.406 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 14.6 t90 -134.86 105.63 6.51 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.55 0.69 . . . . 0.0 109.414 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 37' ' ' GLN . 51.4 tp10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.291 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.515 2.798 0 CA-C-O 121.324 0.583 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -94.5 -58.36 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.034 . . . . 0.0 109.666 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.543 ' NE2' ' OE1' ' A' ' 29' ' ' GLU . 6.7 mm-40 -145.0 149.29 34.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.046 -1.034 . . . . 0.0 109.979 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.47 127.99 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.4 -159.86 9.48 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.46 149.45 52.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.733 -0.863 . . . . 0.0 109.666 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.85 126.79 53.43 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.59 100.55 2.64 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 46' ' ' GLY . 5.5 p-10 -104.96 161.79 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.297 -1.12 . . . . 0.0 109.285 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.87 -17.38 63.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.743 . . . . 0.0 109.928 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.445 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 31.7 p -94.42 -3.88 49.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' OD2' ' A' ' 43' ' ' ASP . . . 146.47 -144.42 12.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.35 166.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.678 -0.895 . . . . 0.0 110.05 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.78 162.66 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.103 -0.998 . . . . 0.0 109.846 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -97.09 149.77 21.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.0 109.729 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.36 157.46 44.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.431 -1.418 . . . . 0.0 107.801 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -130.93 134.27 46.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.582 -0.699 . . . . 0.0 109.685 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 mm -102.64 127.91 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 109.149 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -83.69 137.26 33.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 110.497 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.92 -33.74 75.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -58.77 -11.03 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.596 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.9 -22.43 27.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -0.939 . . . . 0.0 108.988 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.07 55.76 7.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.64 -0.663 . . . . 0.0 109.914 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -106.03 147.94 35.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.594 -0.691 . . . . 0.0 109.832 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.86 159.77 51.35 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.521 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.66 137.98 55.99 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.627 0.727 . . . . 0.0 109.987 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.1 mp -79.61 155.1 28.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.843 -0.536 . . . . 0.0 109.667 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 3.1 tm-20 -100.54 121.85 42.27 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.955 0.883 . . . . 0.0 109.707 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.678 HE21 ' N ' ' A' ' 27' ' ' LEU . 98.8 mt-30 -63.37 138.31 58.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 -10.93 67.76 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.92 158.82 15.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -1.182 . . . . 0.0 110.458 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 96' ' ' GLU . 47.9 p -95.45 124.87 39.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.433 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 44.4 m-85 -118.54 150.07 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.971 0.891 . . . . 0.0 109.78 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 tp -110.84 127.17 55.32 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 45.7 mt -114.36 114.96 26.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -109.93 147.27 33.74 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.458 0.647 . . . . 0.0 110.43 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.4 t 58.26 58.5 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.015 0.436 . . . . 0.0 110.772 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.4 m -109.2 160.41 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.301 -0.874 . . . . 0.0 108.886 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.77 144.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.618 0.723 . . . . 0.0 109.533 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.8 t -92.19 131.75 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.58 22.12 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.491 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 97.3 mt-10 -96.96 135.04 39.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -1.116 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -135.99 119.72 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.84 . . . . 0.0 109.621 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 51.8 48.12 23.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.7 t0 60.57 20.0 9.86 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.679 -0.638 . . . . 0.0 110.449 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -128.54 155.07 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -74.63 137.57 42.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -148.62 152.07 36.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.052 -1.03 . . . . 0.0 108.977 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.96 124.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -104.95 126.34 51.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.46 132.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.88 -170.29 1.84 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.68 0.753 . . . . 0.0 109.874 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -66.15 -42.91 88.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.766 -0.584 . . . . 0.0 110.43 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.415 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 2.0 p30 -61.15 -7.7 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -83.32 164.41 20.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -136.07 154.93 50.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.312 -0.867 . . . . 0.0 108.875 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.57 127.6 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -128.39 131.6 48.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 108.957 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 136.06 36.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLU . 9.5 mp -103.86 -3.96 24.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.479 -0.763 . . . . 0.0 109.454 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t 49.41 7.93 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 94' ' ' LEU . 31.7 tt0 -103.62 124.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 109.312 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.17 141.18 25.87 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.054 1.836 . . . . 0.0 112.1 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.43 135.68 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.468 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.492 1.429 0 CA-C-O 121.412 0.505 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -78.56 117.17 19.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.7 mt -92.52 130.47 38.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.309 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.6 m -124.56 144.69 50.0 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -96.77 151.23 19.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.0 mt -58.17 -44.01 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.405 -0.809 . . . . 0.0 109.1 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.1 -14.55 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.781 . . . . 0.0 109.46 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.0 4.7 53.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.194 -0.941 . . . . 0.0 109.364 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.3 mt -87.67 121.45 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.816 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.95 7.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -135.89 135.32 39.6 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 0.0 109.078 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -94.0 157.4 16.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 110.278 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.5 19.24 79.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -99.77 150.37 22.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.363 -1.081 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -101.56 131.35 47.78 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.0 179.6 8.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.695 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -120.24 137.21 54.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -127.82 148.45 50.45 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -135.63 134.01 38.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.26 -176.85 1.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -105.71 156.31 18.41 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.47 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -92.53 107.58 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.407 -0.808 . . . . 0.0 110.226 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.2 -27.18 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 109.906 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -171.0 161.64 6.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.564 0.697 . . . . 0.0 110.086 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -143.76 121.02 11.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' ' 37' ' ' GLN . 80.9 mm-40 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.675 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.464 0.65 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 t -100.24 -51.13 3.74 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.716 0.769 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' ' 29' ' ' GLU . 33.2 mt-30 -152.07 154.43 35.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 110.224 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.96 156.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.28 -172.09 34.07 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.233 -1.461 . . . . 0.0 109.853 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.89 144.55 47.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.756 -0.849 . . . . 0.0 109.396 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.8 mt -114.55 124.78 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.89 101.63 2.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -106.44 164.66 11.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.983 . . . . 0.0 109.312 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OE2' ' A' ' 44' ' ' GLU . 1.4 mp0 -70.53 -20.24 62.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 110.106 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 p -91.05 -9.62 45.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.952 . . . . 0.0 109.244 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.02 -145.84 14.15 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 8.0 mt -139.02 155.14 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -1.024 . . . . 0.0 109.331 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 148.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.88 . . . . 0.0 109.652 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.77 138.0 36.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 109.454 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.47 159.54 34.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.145 -0.972 . . . . 0.0 108.58 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -133.66 137.91 45.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.657 . . . . 0.0 109.708 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -104.15 126.96 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.371 0.605 . . . . 0.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -88.03 145.62 25.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 110.361 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -50.43 -29.9 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.601 -0.687 . . . . 0.0 109.35 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -13.39 10.92 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 109.881 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -113.89 44.53 1.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.309 -0.869 . . . . 0.0 109.209 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' ALA . 8.2 pt-20 -35.12 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.716 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.8 mt -109.35 153.5 42.7 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.73 162.26 32.42 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.444 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.86 135.62 54.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.512 -0.743 . . . . 0.0 110.198 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.4 mp -79.49 153.66 29.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 109.839 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -96.79 120.14 36.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.404 -0.81 . . . . 0.0 109.896 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.31 147.92 52.35 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.761 0.791 . . . . 0.0 110.194 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.53 -10.88 48.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -97.64 161.03 13.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 0.0 110.5 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -88.31 146.92 25.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.288 0.566 . . . . 0.0 109.631 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -142.11 145.94 34.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.97 0.89 . . . . 0.0 109.691 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.17 129.76 55.85 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.36 119.81 39.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.588 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.17 148.03 43.54 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m 56.49 55.75 6.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 120.945 0.402 . . . . 0.0 110.451 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.19 165.8 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.293 -0.879 . . . . 0.0 108.9 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.74 150.38 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.649 0.738 . . . . 0.0 109.444 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.85 137.01 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.788 -0.57 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.77 153.45 17.62 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -91.32 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 109.417 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' ARG . 69.5 t80 -100.57 106.55 18.06 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.761 0.791 . . . . 0.0 109.55 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 44.97 -115.4 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.524 -0.735 . . . . 0.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 63.2 t0 -97.28 -14.27 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' TYR . 75.3 ttt180 -109.01 151.5 26.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.261 -0.9 . . . . 0.0 110.23 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.11 160.22 15.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.455 HE21 HE21 ' A' ' 84' ' ' GLN . 13.2 pt20 -146.87 162.82 37.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.295 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.02 126.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 108.943 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.455 HE21 HE21 ' A' ' 82' ' ' GLN . 87.4 mt-30 -104.93 127.59 52.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.492 -0.755 . . . . 0.0 109.396 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.04 132.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.454 -0.779 . . . . 0.0 108.997 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.42 ' OD1' ' OG ' ' A' ' 89' ' ' SER . 21.7 p30 -125.0 -173.56 2.83 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.662 0.744 . . . . 0.0 109.89 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -40.39 96.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.566 -0.709 . . . . 0.0 109.962 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -68.45 -12.87 61.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' A' ' 86' ' ' ASN . 49.7 m -82.93 163.77 20.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 109.822 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -140.69 162.36 35.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.269 -0.894 . . . . 0.0 109.049 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.8 mt -138.38 130.6 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -130.02 134.65 47.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.359 -0.838 . . . . 0.0 109.019 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -74.68 135.46 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.78 129.71 41.62 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.889 0.852 . . . . 0.0 110.16 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.4 t -77.44 -6.48 53.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.767 -0.583 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -114.28 95.71 40.13 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.438 -0.789 . . . . 0.0 109.268 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.34 152.05 16.34 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.444 2.096 . . . . 0.0 112.116 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -101.43 134.14 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.783 -179.495 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.498 0.541 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -80.6 113.44 18.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.0 133.79 37.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.591 -0.693 . . . . 0.0 109.868 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -127.98 152.03 48.41 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.453 0.644 . . . . 0.0 109.548 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.38 147.08 24.55 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.707 0.765 . . . . 0.0 110.162 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.12 -44.28 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.53 -11.25 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.601 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 52.8 t0 -96.73 8.33 44.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -87.11 120.74 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.85 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.2 4.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.843 . . . . 0.0 109.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -134.8 131.54 37.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.353 -0.842 . . . . 0.0 109.122 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.26 160.19 14.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.29 18.98 79.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -103.06 156.38 17.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.504 -0.998 . . . . 0.0 109.899 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -102.81 131.97 49.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.57 176.59 12.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 109.866 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' SER . 61.7 m-20 -138.91 142.99 38.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.657 . . . . 0.0 109.648 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.5 tp -159.14 147.14 17.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.034 -1.041 . . . . 0.0 110.423 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -94.06 137.66 33.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.72 158.34 44.08 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.083 0.944 . . . . 0.0 110.661 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.74 152.72 18.84 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.304 0.573 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 59.6 t -93.23 101.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.04 -26.31 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 0.0 109.77 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -168.68 160.34 10.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -135.07 160.08 39.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.186 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -143.14 113.82 7.52 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.483 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 -179.662 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 11.4 p -88.42 -56.5 3.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.568 -0.707 . . . . 0.0 109.769 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.504 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.5 tt0 -154.55 155.24 34.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.433 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.35 149.67 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.2 -158.77 14.63 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.135 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 mt -121.45 149.08 43.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.091 -0.652 . . . . 0.0 109.555 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.3 127.84 55.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.536 0.684 . . . . 0.0 109.407 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.83 96.73 2.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -93.92 157.1 16.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.6 -18.18 64.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.675 -0.641 . . . . 0.0 109.768 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -98.88 -11.52 21.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.378 -0.826 . . . . 0.0 109.153 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -154.06 24.96 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.084 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.06 160.41 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.616 -0.932 . . . . 0.0 109.84 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -160.4 147.14 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.521 -0.737 . . . . 0.0 109.914 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.72 164.65 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.875 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.88 150.0 23.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.167 -0.958 . . . . 0.0 108.98 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -137.24 135.08 36.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.036 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.441 ' O ' ' OG ' ' A' ' 36' ' ' SER . 79.8 mt -105.62 129.09 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.617 -0.677 . . . . 0.0 109.537 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -84.04 139.7 32.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 110.504 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -60.72 -37.2 80.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.655 -0.653 . . . . 0.0 109.391 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.83 -11.07 4.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.822 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.61 -25.83 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.131 -0.98 . . . . 0.0 108.974 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 53.94 52.13 13.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.63 -0.669 . . . . 0.0 110.146 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.86 156.12 36.49 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.337 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.31 154.41 74.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.711 2.274 . . . . 0.0 112.7 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.62 142.17 46.53 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.787 0.804 . . . . 0.0 110.626 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.2 mp -81.13 151.0 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.764 -0.585 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.02 136.11 43.45 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.747 0.784 . . . . 0.0 109.945 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 24' ' ' VAL . 10.3 tm0? -72.38 134.9 45.68 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 110.682 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 -13.18 67.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.4 mp0 -97.77 157.58 15.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -1.121 . . . . 0.0 110.681 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 96' ' ' GLU . 12.1 p -100.92 141.07 34.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -134.41 157.03 47.48 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.161 0.982 . . . . 0.0 110.13 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.4 tp -105.31 134.02 49.12 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 mt -110.13 108.84 19.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 92' ' ' GLU . 65.4 mtm180 -112.81 148.2 35.34 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.595 0.712 . . . . 0.0 110.376 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.9 p 51.16 58.17 5.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 122.054 -0.404 . . . . 0.0 110.827 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.65 165.09 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.517 -0.739 . . . . 0.0 109.319 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 p -123.36 149.25 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 121.724 0.773 . . . . 0.0 109.82 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.34 135.13 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.629 -0.669 . . . . 0.0 109.867 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.62 158.24 17.27 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -100.16 93.76 5.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.949 . . . . 0.0 109.329 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.497 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.1 t80 -106.09 119.27 38.78 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.744 0.783 . . . . 0.0 109.707 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.3 m120 53.51 50.17 17.91 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.336 0.588 . . . . 0.0 110.624 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t0 64.41 -12.69 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.744 -0.598 . . . . 0.0 110.408 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' A' ' 78' ' ' ASN . 91.6 mtm-85 -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.187 -0.946 . . . . 0.0 110.351 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -76.4 146.11 38.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.602 -0.686 . . . . 0.0 109.355 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -147.14 151.29 36.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.177 -0.952 . . . . 0.0 109.382 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.32 122.45 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -102.18 128.65 48.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 t -100.1 134.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.538 -0.726 . . . . 0.0 109.08 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -131.32 -168.93 2.08 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.71 0.767 . . . . 0.0 109.952 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -62.12 -42.33 99.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.279 0.561 . . . . 0.0 109.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -65.36 -22.2 66.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -81.5 164.26 22.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -140.52 162.55 35.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.4 mt -138.84 132.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.63 -0.669 . . . . 0.0 109.653 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 89.1 mt-10 -131.35 135.96 47.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.548 -0.72 . . . . 0.0 109.218 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -81.84 135.77 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' C ' ' N ' ' A' ' 96' ' ' GLU . 4.0 mm? -109.86 0.35 18.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.64 -0.663 . . . . 0.0 109.988 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 p 49.78 14.91 0.14 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 109.733 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' SER . 24.0 mm-40 -114.07 110.17 48.81 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.281 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.36 151.26 59.72 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.712 2.274 . . . . 0.0 112.724 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -105.56 143.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.7 . . . . 0.0 109.679 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.798 0.809 . . . . 0.0 109.864 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.416 ' CG ' ' ND2' ' A' ' 19' ' ' ASN . 56.3 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 CA-C-O 121.408 0.503 . . . . 0.0 112.301 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -81.11 113.24 19.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 131.42 34.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.592 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.0 m -119.3 132.52 55.9 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -98.5 155.73 17.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 110.085 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.55 -49.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.655 0.741 . . . . 0.0 109.349 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.37 -13.89 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 49.4 t0 -93.03 -3.18 54.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLU . 97.7 mt -58.6 -73.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 110.416 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 11' ' ' ILE . 15.6 m 31.93 29.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.396 0.617 . . . . 0.0 110.923 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.2 tt0 -167.23 114.17 0.78 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.472 -0.768 . . . . 0.0 109.066 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -87.15 153.64 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.78 72.69 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -94.52 137.21 33.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.094 . . . . 0.0 109.929 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.57 125.44 38.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.04 -167.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.828 . . . . 0.0 109.792 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.416 ' ND2' ' CG ' ' A' ' 3' ' ' PRO . 60.2 m-20 -117.64 146.29 43.77 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.47 131.17 35.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 0.0 110.475 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -116.55 127.84 54.88 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.56 169.77 19.7 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -103.59 154.94 18.95 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.873 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.96 113.78 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.375 -0.828 . . . . 0.0 109.656 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -93.41 -22.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.674 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.655 ' NE2' ' HE1' ' A' ' 28' ' ' TRP . 18.2 tt0 -152.79 136.07 15.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.783 -1.198 . . . . 0.0 109.609 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 4.2 mm? -108.18 143.28 37.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.642 0.734 . . . . 0.0 109.682 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.655 ' HE1' ' NE2' ' A' ' 26' ' ' GLN . 61.6 m95 -145.0 119.78 9.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.696 0.76 . . . . 0.0 109.129 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.62 -0.675 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.467 0.651 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -93.16 -57.93 2.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 109.664 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -149.67 150.72 32.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -141.5 155.8 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.66 -171.15 35.72 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.071 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.09 146.14 40.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.91 -0.759 . . . . 0.0 109.601 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.9 mt -117.23 124.16 48.38 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.59 0.709 . . . . 0.0 109.096 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' CD1' ' A' ' 25' ' ' ILE . . . -95.28 97.4 2.12 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.6 t0 -99.04 161.23 13.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.273 -1.134 . . . . 0.0 109.304 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.8 mt-10 -66.32 -18.55 65.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.2 p -93.73 -5.1 49.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.01 -144.53 12.71 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -135.64 163.45 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.647 -0.913 . . . . 0.0 109.958 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 151.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.5 159.22 18.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -147.79 153.98 39.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.488 -1.383 . . . . 0.0 108.026 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -133.96 129.82 36.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.477 -0.764 . . . . 0.0 109.906 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 52' ' ' ILE . 89.1 mt -104.33 129.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.593 -0.692 . . . . 0.0 109.67 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -87.91 145.7 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 56' ' ' ALA . 51.8 mtmt -58.11 -38.22 76.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.496 -0.753 . . . . 0.0 109.309 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -59.51 -4.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 109.695 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -85.78 -27.91 24.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 108.879 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 55.17 52.96 10.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.627 -0.671 . . . . 0.0 110.244 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.41 147.22 35.9 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.657 -0.652 . . . . 0.0 109.853 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.1 164.39 32.27 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.705 2.27 . . . . 0.0 112.648 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.4 mt -72.99 141.19 47.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.516 -0.74 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.9 mp -84.13 145.11 28.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.75 -0.594 . . . . 0.0 109.846 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.3 137.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.317 -0.864 . . . . 0.0 109.885 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.09 137.52 40.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.702 . . . . 0.0 110.808 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.3 -7.21 72.14 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -106.11 162.21 13.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.366 -1.079 . . . . 0.0 110.689 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -100.96 142.58 32.23 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.79 152.2 51.57 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.97 0.89 . . . . 0.0 110.151 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.1 tp -109.33 131.51 54.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.28 111.14 22.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.368 -0.833 . . . . 0.0 109.158 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.478 ' O ' ' OG ' ' A' ' 71' ' ' SER . 74.8 mtm180 -109.92 149.18 30.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.611 -0.681 . . . . 0.0 110.388 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 2.8 p 52.72 57.77 6.04 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.89 167.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.423 -0.798 . . . . 0.0 109.147 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.56 152.04 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.74 0.781 . . . . 0.0 109.718 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 132.84 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.769 -0.582 . . . . 0.0 109.553 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 147.78 16.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -90.51 101.19 13.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -1.134 . . . . 0.0 109.181 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.63 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 16.0 t80 -97.79 101.12 12.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 109.132 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.63 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 13.0 p30 40.25 -117.58 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 50.1 t0 -90.81 -18.07 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 77' ' ' TYR . 64.3 ttm-85 -100.0 154.46 18.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.169 -0.957 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.79 151.17 19.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 108.78 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -145.41 151.5 38.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.987 -1.071 . . . . 0.0 109.02 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.45 121.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.934 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.62 127.79 53.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.0 133.84 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -133.76 -170.27 2.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 89' ' ' SER . 73.4 tttt -53.83 166.15 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.2 t-20 72.09 -19.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.677 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 87' ' ' LYS . 16.4 p -76.69 162.81 27.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.07 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.0 p -145.22 166.31 25.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.264 -0.897 . . . . 0.0 108.973 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 91' ' ' ILE . 96.9 mt -138.99 131.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -128.0 131.12 49.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.312 -0.867 . . . . 0.0 108.903 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.77 137.15 51.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 109.639 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.26 135.31 39.37 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.958 0.885 . . . . 0.0 110.192 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 m -82.35 -5.88 58.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -121.9 119.89 28.73 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.89 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 161.47 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.509 2.14 . . . . 0.0 112.128 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.19 152.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.715 . . . . 0.0 109.997 -179.687 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 CA-C-O 121.169 0.404 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.58 120.2 21.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.177 -0.952 . . . . 0.0 110.127 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.6 mm? -89.89 126.42 35.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.6 m -121.99 142.12 50.64 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -95.92 148.35 22.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.045 -1.034 . . . . 0.0 110.121 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.41 -43.61 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.197 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.91 -15.16 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 9.93 29.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 109.933 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.54 122.48 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.077 -1.015 . . . . 0.0 110.0 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.19 -0.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.304 -0.872 . . . . 0.0 109.749 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -131.73 134.29 45.72 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.32 -0.863 . . . . 0.0 109.081 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 57.0 p30 -90.07 159.01 17.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 109.881 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.69 79.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -98.47 147.02 25.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.343 -1.093 . . . . 0.0 109.706 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -97.82 135.13 40.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.418 -0.801 . . . . 0.0 109.592 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.432 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -157.39 169.02 25.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.111 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 71' ' ' SER . 11.3 m120 -132.41 136.96 47.12 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -159.67 178.84 9.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.021 -1.05 . . . . 0.0 110.461 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -128.39 148.45 50.7 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.46 38.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.742 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -93.2 152.5 19.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.592 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.99 99.67 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 110.333 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 mm -73.35 -25.49 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.517 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 53.2 tt0 -166.63 157.85 12.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.0 -1.063 . . . . 0.0 109.702 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -127.66 153.32 46.61 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.542 -0.724 . . . . 0.0 110.071 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.517 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 44.0 m95 -144.28 123.06 12.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.284 -0.885 . . . . 0.0 109.231 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.513 -0.742 . . . . 0.0 109.455 -179.53 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 35' ' ' ILE . 96.5 mt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 17.2 p -87.31 -58.52 2.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.7 tt0 -149.55 155.36 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.957 -1.09 . . . . 0.0 109.771 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 39' ' ' GLY . 53.9 t -137.95 160.92 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.404 ' N ' ' CG1' ' A' ' 38' ' ' VAL . . . 177.42 -162.75 30.9 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.881 -1.628 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.51 150.6 40.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.894 -0.768 . . . . 0.0 109.142 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.1 129.23 54.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.611 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.0 103.75 2.79 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -103.01 163.86 11.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.99 . . . . 0.0 109.154 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' A' ' 99' ' ' GLU . 47.2 tp10 -69.41 -19.44 63.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -92.31 -10.87 36.77 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.941 -1.1 . . . . 0.0 110.14 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -150.29 21.87 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 pt -132.94 159.12 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.581 -0.952 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.8 tt -161.36 150.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.6 164.07 22.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 108.961 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.12 154.51 31.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.563 -1.336 . . . . 0.0 108.422 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 t -139.56 133.52 30.9 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.239 -0.913 . . . . 0.0 110.251 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.42 ' O ' ' OG ' ' A' ' 36' ' ' SER . 88.8 mt -105.27 128.7 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -96.64 147.75 23.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 0.0 110.335 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -67.06 -19.31 65.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.725 . . . . 0.0 109.379 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -61.23 -33.26 73.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.842 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.34 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.047 . . . . 0.0 109.276 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.74 61.21 2.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.434 -0.791 . . . . 0.0 110.09 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.74 148.74 38.81 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.606 -0.684 . . . . 0.0 109.398 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.52 161.33 45.51 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.519 2.146 . . . . 0.0 112.189 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.19 143.63 50.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 110.364 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -85.15 148.43 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.573 -0.705 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -95.19 134.55 37.8 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.41 137.16 52.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.51 -12.84 68.81 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.26 158.39 15.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.877 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 p -94.92 143.74 26.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.32 152.55 51.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.816 0.817 . . . . 0.0 110.186 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.33 130.84 46.48 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.5 mt -109.01 105.26 14.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.513 ' NE ' ' OG ' ' A' ' 90' ' ' SER . 87.3 mtm-85 -107.68 133.04 52.67 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.594 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 1.1 m 70.81 59.37 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.116 -0.365 . . . . 0.0 110.76 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 m -112.86 160.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.346 -0.846 . . . . 0.0 109.456 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.45 151.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.499 0.666 . . . . 0.0 109.351 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.59 132.12 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.124 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.28 151.69 18.01 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.457 ' OE2' ' N ' ' A' ' 79' ' ' ASP . 10.8 tm-20 -98.76 93.15 5.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.129 -1.218 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -111.27 117.39 33.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.444 -0.785 . . . . 0.0 110.119 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 80' ' ' ARG . 20.0 t-20 55.57 54.36 8.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.818 . . . . 0.0 110.293 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' N ' ' OE2' ' A' ' 76' ' ' GLU . 91.2 m-20 56.35 -2.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.676 -0.64 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 78' ' ' ASN . 14.6 mmp_? -102.24 158.58 16.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.041 -1.037 . . . . 0.0 109.737 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.23 146.69 25.92 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.88 154.61 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.02 117.2 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.377 -0.827 . . . . 0.0 109.094 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -107.08 127.38 53.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.323 -0.861 . . . . 0.0 109.538 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.6 124.59 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -152.55 -173.71 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 109.689 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 57.0 -152.64 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.54 0.686 . . . . 0.0 110.365 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 89' ' ' SER . 92.3 m-20 -83.58 27.18 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 88' ' ' ASN . 12.1 p -47.86 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.513 ' OG ' ' NE ' ' A' ' 70' ' ' ARG . 13.6 p -139.44 161.67 36.9 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.073 -1.017 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.3 mt -140.85 132.87 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.946 . . . . 0.0 109.272 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.466 ' CB ' HH12 ' A' ' 70' ' ' ARG . 83.8 tt0 -124.73 124.99 43.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.06 140.52 43.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 109.82 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.08 142.31 29.94 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.8 p -83.85 -3.82 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.589 -0.695 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.88 133.01 21.09 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.429 -0.794 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.77 155.9 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.848 1.699 . . . . 0.0 112.04 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -108.62 133.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 84.7 tt0 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 CA-C-O 121.47 0.529 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.4 mp0 -81.36 111.54 17.82 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.348 -0.845 . . . . 0.0 109.56 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.4 mt -91.53 134.25 34.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.669 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -127.15 146.46 50.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.462 0.648 . . . . 0.0 109.381 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.35 147.71 22.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 110.072 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.36 -43.53 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.608 -0.682 . . . . 0.0 109.188 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 p -65.61 -6.3 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.475 -0.765 . . . . 0.0 109.454 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -103.98 6.82 36.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -88.08 115.76 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 109.778 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.56 5.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -125.57 122.81 37.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.788 . . . . 0.0 109.246 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 15' ' ' GLY . 2.3 t-20 -82.02 150.67 27.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.975 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.587 ' N ' ' ND2' ' A' ' 14' ' ' ASN . . . 76.93 19.33 77.71 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -96.32 144.11 26.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.481 -1.011 . . . . 0.0 110.095 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -102.28 130.23 48.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.557 -0.714 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.86 -176.26 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.848 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -122.96 146.93 47.17 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.31 133.67 24.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.0 110.514 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' CB ' ' HZ2' ' A' ' 21' ' ' LYS . 3.8 ttmp? -109.89 131.12 55.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.84 159.45 35.07 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.017 0.913 . . . . 0.0 110.883 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 17.5 ttmm -92.08 156.26 17.5 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.14 113.09 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.139 -0.976 . . . . 0.0 110.38 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 pt -90.4 -19.51 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.96 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -167.77 157.47 10.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.986 . . . . 0.0 109.707 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.468 ' N ' HE21 ' A' ' 63' ' ' GLN . 96.1 mt -135.39 159.93 40.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.595 -0.691 . . . . 0.0 109.98 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -144.72 118.14 9.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.435 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.53 -0.731 . . . . 0.0 109.664 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.679 0.752 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.8 p -85.3 -57.16 3.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.658 -0.651 . . . . 0.0 109.911 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.502 ' N ' ' OG ' ' A' ' 36' ' ' SER . 17.4 pt20 -160.48 164.8 31.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.093 -1.005 . . . . 0.0 110.316 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.2 160.34 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.91 -165.76 31.07 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.169 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.34 145.73 49.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.925 -0.75 . . . . 0.0 109.531 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.42 130.58 55.93 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.35 101.33 2.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 44.3 t0 -104.86 162.69 13.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.56 -0.965 . . . . 0.0 109.445 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 13.5 tm-20 -70.3 -18.58 63.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.69 -0.631 . . . . 0.0 109.778 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.5 p -93.9 -9.74 36.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.074 -1.016 . . . . 0.0 109.334 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.93 -146.61 15.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.92 160.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.667 -0.902 . . . . 0.0 109.888 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -158.53 145.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 109.883 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -86.37 164.36 17.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.717 . . . . 0.0 109.992 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -154.29 156.82 37.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.696 -1.253 . . . . 0.0 108.48 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -139.97 129.96 24.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 109.646 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.443 ' O ' ' OG ' ' A' ' 36' ' ' SER . 82.9 mt -106.76 131.58 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.333 0.587 . . . . 0.0 109.68 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -90.91 144.07 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 110.362 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -59.63 -31.64 69.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.711 . . . . 0.0 109.406 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.87 -13.39 6.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.53 -30.3 20.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 108.938 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 55.3 55.84 7.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.557 -0.715 . . . . 0.0 110.242 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.8 mp -108.0 154.82 40.91 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.611 -0.681 . . . . 0.0 109.398 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.7 156.56 65.23 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.766 2.31 . . . . 0.0 112.528 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.96 144.28 48.95 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.751 0.786 . . . . 0.0 110.394 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.433 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.5 mp -81.5 148.53 29.15 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.36 0.6 . . . . 0.0 109.936 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -101.35 136.03 41.86 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.802 0.81 . . . . 0.0 110.111 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.468 HE21 ' N ' ' A' ' 27' ' ' LEU . 97.5 mt-30 -71.77 134.55 46.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.523 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 93.89 -14.48 65.21 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.6 mp0 -95.43 158.41 15.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 110.65 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -90.63 141.98 28.22 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -133.82 142.83 48.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.842 0.829 . . . . 0.0 109.889 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.2 132.0 54.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.99 112.75 25.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.803 . . . . 0.0 109.312 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.495 HH21 ' HG ' ' A' ' 90' ' ' SER . 75.9 mtm180 -109.54 140.45 43.31 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.578 0.704 . . . . 0.0 110.413 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.6 t 56.94 60.04 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.932 -0.48 . . . . 0.0 110.929 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.3 168.11 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 0.0 109.228 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.08 160.33 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.426 0.632 . . . . 0.0 109.836 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 56.3 t -103.11 132.73 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.681 -0.637 . . . . 0.0 109.409 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.24 158.81 14.07 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -102.28 91.56 4.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.933 . . . . 0.0 109.392 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.46 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 88.0 t80 -101.37 119.74 39.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.818 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 80' ' ' ARG . 3.7 m120 52.68 43.08 31.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.763 -0.586 . . . . 0.0 110.657 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 68.99 -15.29 0.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.675 -0.641 . . . . 0.0 110.302 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' H ' ' C ' ' A' ' 78' ' ' ASN . 79.9 mtp85 -88.04 159.91 18.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.76 135.52 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -143.33 153.7 43.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 109.332 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -97.2 123.32 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.403 -0.811 . . . . 0.0 108.861 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -108.89 124.47 50.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 0.0 109.366 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.9 132.53 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' LYS . 5.3 p30 -145.62 -178.89 6.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 89' ' ' SER . 62.0 tttm -40.91 161.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 74.76 -27.36 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 109.795 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 87' ' ' LYS . 23.2 t -79.92 166.01 22.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.923 . . . . 0.0 110.012 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.495 ' HG ' HH21 ' A' ' 70' ' ' ARG . 35.6 t -148.11 169.93 18.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 109.334 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.2 mt -144.48 136.01 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.455 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.06 127.59 46.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.45 -0.781 . . . . 0.0 109.189 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.61 140.72 44.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.536 -0.728 . . . . 0.0 109.515 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.01 135.08 52.05 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.818 0.818 . . . . 0.0 110.175 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.2 m -85.66 9.67 15.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.23 92.47 39.93 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.455 -0.778 . . . . 0.0 109.19 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.12 153.25 21.77 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.761 2.308 . . . . 0.0 112.064 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt -100.84 139.66 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 109.577 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.79 -179.517 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.494 1.544 0 CA-C-O 121.342 0.476 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -81.89 121.99 27.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.403 HD23 HD21 ' A' ' 19' ' ' ASN . 56.9 mt -88.13 131.01 34.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.347 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.4 m -124.99 138.71 54.22 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -95.66 152.77 18.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.276 -0.89 . . . . 0.0 109.814 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.1 mt -58.29 -44.35 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.548 -0.72 . . . . 0.0 109.361 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.94 -18.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 108.937 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 t0 -87.87 3.78 47.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -85.6 120.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.047 -1.033 . . . . 0.0 109.678 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 1.2 p -138.47 -2.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.322 -0.861 . . . . 0.0 109.043 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 97.7 mt-10 -134.58 136.04 42.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.104 -0.997 . . . . 0.0 109.488 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -97.14 156.4 16.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.97 18.67 69.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 24.2 pt20 -103.36 159.49 15.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -1.032 . . . . 0.0 109.71 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.24 135.42 46.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.69 -0.631 . . . . 0.0 109.642 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.29 177.36 11.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 109.796 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 16.1 t30 -133.46 138.16 46.05 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.4 tp -154.29 147.1 24.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.793 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -104.68 140.36 38.15 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.27 161.05 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -103.82 153.92 20.18 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 t -93.14 102.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.067 -1.02 . . . . 0.0 110.597 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 pt -84.08 -23.8 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.553 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 47.5 tt0 -152.96 134.92 14.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.911 . . . . 0.0 108.918 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.3 tp -118.06 147.74 42.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.256 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.553 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 80.7 m95 -146.78 128.75 15.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 109.185 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.486 0.66 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 52' ' ' ILE . 52.3 p -88.0 -55.81 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.836 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.409 ' N ' ' OG ' ' A' ' 36' ' ' SER . 22.8 pt20 -158.23 165.87 33.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.014 . . . . 0.0 110.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.61 160.82 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.11 -166.59 34.26 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.194 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.74 146.77 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.857 . . . . 0.0 109.155 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.5 mt -109.16 125.22 51.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.84 99.43 2.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -105.52 164.52 11.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.969 . . . . 0.0 109.479 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -70.48 -18.98 62.98 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.865 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -90.08 -10.51 44.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.106 . . . . 0.0 109.827 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.06 -147.87 18.33 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 47' ' ' ILE . 96.0 mt -134.73 155.81 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.597 -0.943 . . . . 0.0 109.48 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.2 tt -154.53 148.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.795 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -88.22 154.42 20.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -146.7 154.33 41.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.603 -1.31 . . . . 0.0 108.311 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.446 ' CG2' ' OE1' ' A' ' 84' ' ' GLN . 15.3 t -135.45 132.32 37.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 36' ' ' SER . 94.9 mt -102.77 128.7 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.573 -0.704 . . . . 0.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -83.96 142.68 30.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 110.454 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -60.8 -34.74 74.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -59.33 -9.59 2.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 109.764 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.33 -25.66 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -0.971 . . . . 0.0 108.825 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 42.47 47.3 4.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 110.066 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.55 165.45 14.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.03 147.65 89.16 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.321 2.014 . . . . 0.0 112.242 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.85 142.08 49.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.089 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 8.3 mp -80.24 143.89 33.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.79 131.99 43.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 109.307 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -70.07 134.45 48.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.0 110.477 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 -13.89 66.39 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -97.4 159.51 14.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -1.159 . . . . 0.0 110.796 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.7 m -93.26 146.73 23.49 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.271 0.558 . . . . 0.0 109.798 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.3 151.02 43.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.025 0.917 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.5 tp -106.3 132.53 52.23 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 mt -109.28 106.03 15.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -105.93 140.96 38.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.353 -0.842 . . . . 0.0 110.265 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.1 t 56.86 61.96 2.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.66 . . . . 0.0 110.983 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.93 164.11 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.43 144.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.518 0.675 . . . . 0.0 109.637 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -94.09 134.27 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 151.54 18.04 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -97.4 95.86 7.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -1.155 . . . . 0.0 109.149 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.3 t80 -102.13 116.22 32.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.085 -1.009 . . . . 0.0 109.758 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.542 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 22.0 t-20 51.31 -126.7 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 110.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 56.8 t0 -95.85 -6.69 38.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 ttm180 -114.83 146.67 40.79 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.809 0.814 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.73 158.2 21.87 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -141.71 156.96 45.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 108.886 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.0 123.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.446 ' OE1' ' CG2' ' A' ' 51' ' ' THR . 92.4 mm-40 -103.26 126.94 50.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.06 130.48 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 108.871 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.96 -166.83 1.67 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.629 0.728 . . . . 0.0 109.968 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -64.28 -41.93 96.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.666 -0.646 . . . . 0.0 110.14 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 88' ' ' ASN . 2.3 p30 -65.69 -11.78 48.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.998 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.461 ' HG ' ' H ' ' A' ' 90' ' ' SER . 46.1 t -86.34 162.44 18.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.461 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.461 ' H ' ' HG ' ' A' ' 89' ' ' SER . 48.6 m -135.24 157.96 45.57 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -138.98 130.31 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.056 -1.027 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.98 129.18 48.72 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.323 -0.86 . . . . 0.0 109.156 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -77.36 138.67 39.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.95 138.01 43.94 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.855 0.836 . . . . 0.0 109.981 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -83.16 2.25 36.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.817 -0.552 . . . . 0.0 109.512 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 96' ' ' GLU . 2.7 mp0 -103.5 129.71 24.91 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.189 -0.945 . . . . 0.0 109.796 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.64 146.87 30.92 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.872 1.715 . . . . 0.0 112.289 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -110.57 135.44 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.494 -0.754 . . . . 0.0 108.987 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 109.96 -179.415 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.491 1.343 0 CA-C-O 121.567 0.569 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.65 118.16 22.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.864 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.533 ' CD2' HD21 ' A' ' 19' ' ' ASN . 47.3 mt -90.54 131.16 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.2 m -123.02 142.64 50.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.88 146.94 23.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.639 0.733 . . . . 0.0 110.402 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.2 mm -53.62 -46.02 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.8 . . . . 0.0 109.597 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.82 -11.81 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.612 -0.68 . . . . 0.0 109.89 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.72 2.74 44.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -86.98 119.02 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.819 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -151.86 9.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.816 . . . . 0.0 109.459 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -127.35 123.11 35.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.555 -0.716 . . . . 0.0 109.283 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.38 152.02 23.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.438 -0.789 . . . . 0.0 110.057 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.73 79.17 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -98.06 145.2 26.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.092 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.17 129.6 45.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.516 -0.74 . . . . 0.0 109.481 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.21 -175.88 5.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.533 HD21 ' CD2' ' A' ' 5' ' ' LEU . 27.7 t30 -127.11 141.13 51.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.683 -0.636 . . . . 0.0 109.295 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.96 154.56 49.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.479 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -135.8 135.42 39.87 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.55 -173.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.169 0.985 . . . . 0.0 110.511 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.49 155.84 27.9 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.51 106.5 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.34 -24.0 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.284 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -161.26 151.41 17.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.043 -1.036 . . . . 0.0 109.529 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.3 pt? -140.96 163.85 31.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.467 -0.771 . . . . 0.0 109.961 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -145.37 111.14 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.802 0.81 . . . . 0.0 109.5 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 35' ' ' ILE . 96.7 mt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.514 0.673 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -93.25 -47.72 6.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -155.05 156.51 36.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.37 141.1 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 50' ' ' PHE . . . -168.81 -154.09 8.73 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.291 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -136.88 153.09 50.85 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.794 -0.827 . . . . 0.0 109.322 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.02 132.12 54.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.64 0.733 . . . . 0.0 109.741 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.97 104.24 3.12 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 1.4 m-20 -103.73 162.68 12.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.654 -0.91 . . . . 0.0 109.375 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.9 mp0 -69.37 -15.35 63.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -97.0 -6.14 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.86 -147.11 17.28 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.227 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.93 162.89 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.644 -0.916 . . . . 0.0 110.069 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -159.33 150.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.971 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.86 165.64 21.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.648 -0.658 . . . . 0.0 110.023 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 18.6 p90 -158.67 148.7 19.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.156 -0.965 . . . . 0.0 108.89 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -134.6 128.72 33.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.6 mt -105.45 128.44 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 109.414 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.62 143.01 27.22 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.755 0.788 . . . . 0.0 110.373 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 56' ' ' ALA . 39.5 tptt -60.45 -30.59 69.76 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.619 -0.675 . . . . 0.0 109.403 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -58.98 -3.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.838 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -97.14 -28.19 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.172 -0.955 . . . . 0.0 109.051 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 55.2 mp0 48.97 54.7 10.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.21 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.1 mt -110.89 152.85 43.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.73 147.51 71.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.567 2.178 . . . . 0.0 112.709 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 mt -72.34 149.29 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.754 0.788 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.3 mp -86.86 144.33 27.05 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.446 0.641 . . . . 0.0 110.115 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.88 139.56 31.14 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.884 0.849 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.19 137.87 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.45 -0.781 . . . . 0.0 110.727 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.97 56.34 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -94.39 159.03 15.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 p -90.28 149.3 22.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.295 0.569 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -144.32 145.88 32.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.7 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.5 tp -113.32 130.57 56.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 1.9 mp -119.45 113.64 21.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.63 -0.669 . . . . 0.0 109.502 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -105.92 151.53 24.46 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.76 58.64 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.553 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.3 165.07 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.535 -0.728 . . . . 0.0 109.459 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.87 147.58 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.676 0.75 . . . . 0.0 109.71 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.6 t -87.93 130.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.67 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.9 147.44 16.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -96.81 103.26 15.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.451 -1.029 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' ARG . 71.2 t80 -101.58 107.62 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.737 0.78 . . . . 0.0 109.372 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.443 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 47.5 t30 39.69 -115.65 0.2 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.793 -0.567 . . . . 0.0 110.629 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 97.7 m-20 -93.61 -19.08 21.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.817 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' TYR . 84.8 mtt85 -97.41 159.54 14.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.25 -0.906 . . . . 0.0 110.353 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.88 153.19 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.619 -0.675 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -151.96 164.07 37.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 m -102.91 126.91 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 109.103 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.95 128.77 53.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.325 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.59 134.29 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' LYS . 4.2 p30 -146.34 -174.4 4.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.87 0.843 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.616 ' C ' ' H ' ' A' ' 89' ' ' SER . 1.6 pptp? -44.34 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.899 -0.5 . . . . 0.0 109.896 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 t30 67.29 -27.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.676 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 87' ' ' LYS . 12.7 p -79.98 166.9 21.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.156 -0.965 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.8 p -141.14 160.42 40.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 91' ' ' ILE . 97.4 mt -139.38 132.3 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.593 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -128.76 130.16 46.68 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.609 0.719 . . . . 0.0 109.365 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.47 144.3 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.63 -0.668 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.33 145.24 46.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.704 0.764 . . . . 0.0 110.028 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -86.27 16.8 4.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -119.39 118.43 32.42 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.655 -0.653 . . . . 0.0 109.533 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.09 157.8 42.2 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.647 2.231 . . . . 0.0 112.376 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 98' ' ' ILE . 49.3 mm -108.27 137.23 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.748 -0.595 . . . . 0.0 109.674 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.763 . . . . 0.0 109.663 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo . . . . . 0 N--CA 1.49 1.307 0 CA-C-O 121.453 0.522 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -79.73 118.62 21.7 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.591 0.71 . . . . 0.0 109.687 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.2 mt -93.73 128.06 39.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.8 t -129.6 152.69 48.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.557 0.694 . . . . 0.0 109.648 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.18 135.1 34.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.341 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -50.97 -34.37 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.758 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.82 1.46 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.854 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -122.48 6.57 9.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.21 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 13' ' ' GLU . 27.7 mt -64.19 -52.42 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 11' ' ' ILE . 12.2 m 4.29 64.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 121.395 0.617 . . . . 0.0 111.383 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 11' ' ' ILE . 38.3 tp10 -174.09 109.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.732 0.777 . . . . 0.0 109.368 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p-10 -82.57 140.52 33.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.5 77.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.05 137.27 32.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -1.16 . . . . 0.0 110.049 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -100.01 129.72 46.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.524 -0.735 . . . . 0.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.99 -175.06 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.398 -0.814 . . . . 0.0 109.932 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 88.0 m-20 -138.35 143.41 39.86 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.434 0.635 . . . . 0.0 109.629 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.2 tp -159.06 145.82 17.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.216 -0.928 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -100.0 141.81 32.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.594 -0.692 . . . . 0.0 109.152 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.73 159.07 40.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.853 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -97.8 150.42 21.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -89.31 101.9 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.551 -0.718 . . . . 0.0 110.754 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.408 HG23 HD11 ' A' ' 25' ' ' ILE . 96.7 mt -73.45 -25.61 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -170.61 162.43 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -0.989 . . . . 0.0 109.673 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.43 158.31 43.38 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.7 0.762 . . . . 0.0 110.144 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -148.61 127.94 13.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.437 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.522 -0.736 . . . . 0.0 109.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 122.024 0.916 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 6.1 p -93.2 -56.62 2.89 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.096 -1.002 . . . . 0.0 109.832 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.515 ' N ' ' OG ' ' A' ' 36' ' ' SER . 80.1 mt-30 -150.01 158.61 44.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.952 -1.093 . . . . 0.0 110.542 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.67 141.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.85 -164.57 13.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.311 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.79 143.85 47.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.854 -0.792 . . . . 0.0 109.749 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.4 mt -112.85 128.89 56.57 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.69 0.757 . . . . 0.0 109.748 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.01 99.02 2.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -99.3 156.35 17.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.126 -1.22 . . . . 0.0 109.469 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.96 -17.41 63.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.646 -0.659 . . . . 0.0 109.722 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 p -96.76 -11.74 24.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.285 -0.885 . . . . 0.0 109.076 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.84 -146.73 13.53 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.78 161.49 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.1 tt -161.97 143.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.756 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.37 148.74 22.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 110.172 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -138.6 160.03 40.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.945 -1.097 . . . . 0.0 109.207 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -134.21 133.19 40.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.339 -0.851 . . . . 0.0 109.982 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' O ' ' OG ' ' A' ' 36' ' ' SER . 87.1 mt -102.7 129.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.639 0.733 . . . . 0.0 109.656 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -87.1 140.74 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 110.46 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -54.89 -23.63 19.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.57 -0.707 . . . . 0.0 109.539 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.33 -6.97 47.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.705 . . . . 0.0 109.673 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.96 -34.32 19.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.15 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 54.53 53.03 11.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 110.123 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.19 155.46 37.73 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.06 156.03 65.01 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.774 2.316 . . . . 0.0 112.737 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.27 139.78 54.42 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.894 0.854 . . . . 0.0 110.684 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.4 mp -82.93 152.59 25.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.356 0.598 . . . . 0.0 110.113 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -104.31 133.3 49.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.727 0.775 . . . . 0.0 110.228 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -67.88 138.94 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.81 0.814 . . . . 0.0 110.622 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 -9.64 64.8 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -94.08 149.92 20.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.241 . . . . 0.0 110.471 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -89.2 147.56 24.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.45 0.643 . . . . 0.0 109.78 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -141.79 152.6 43.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.164 -0.96 . . . . 0.0 110.154 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.9 tp -106.1 133.8 50.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.38 109.65 20.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.393 -0.817 . . . . 0.0 109.648 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -113.66 142.69 45.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.708 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.0 t 57.06 58.04 4.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.115 0.483 . . . . 0.0 110.774 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.36 163.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.2 154.84 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.774 0.797 . . . . 0.0 109.953 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.5 t -95.34 130.1 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 109.851 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.54 151.05 18.96 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -91.29 96.15 10.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -1.028 . . . . 0.0 109.697 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.529 ' CD2' ' OD1' ' A' ' 78' ' ' ASN . 16.3 t80 -95.17 100.18 12.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 77' ' ' TYR . 1.5 p-10 37.48 -110.52 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -95.14 -20.93 18.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.868 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' TYR . 72.5 ttt180 -98.56 162.7 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.121 -0.987 . . . . 0.0 110.505 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -101.02 150.37 22.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.235 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -143.63 148.08 35.31 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.048 -1.032 . . . . 0.0 109.592 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.45 125.22 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.235 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.58 124.4 49.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.377 -0.827 . . . . 0.0 109.564 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.76 134.63 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -132.13 -167.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.889 0.852 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.68 -41.69 98.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.661 -0.649 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.08 -22.72 67.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -0.941 . . . . 0.0 109.605 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.7 m -80.23 163.99 23.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 p -142.62 162.08 36.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.9 mt -141.56 134.1 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.833 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -130.7 135.27 47.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -71.26 136.45 47.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.702 . . . . 0.0 109.597 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.2 mt -92.57 136.45 33.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 110.051 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.9 t -74.99 -9.02 58.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.713 . . . . 0.0 109.78 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -118.92 137.27 24.84 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.769 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.9 159.15 38.32 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.668 2.245 . . . . 0.0 112.189 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.11 131.53 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.687 . . . . 0.0 109.383 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.873 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.496 1.621 0 CA-C-O 121.399 0.5 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.02 120.25 17.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.864 . . . . 0.0 109.74 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.5 mt -97.02 129.85 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -123.31 151.31 42.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -99.84 147.6 25.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.089 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 9' ' ' VAL . 5.0 pt -58.78 -43.0 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.517 -0.739 . . . . 0.0 109.369 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.402 ' H ' HG13 ' A' ' 8' ' ' ILE . 12.0 p -67.8 -7.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.78 15.29 28.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.408 -0.808 . . . . 0.0 109.298 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.43 115.51 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.975 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.28 2.05 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -135.29 131.59 36.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.371 -0.831 . . . . 0.0 109.058 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -95.95 155.64 16.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 19.89 74.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -101.29 156.88 17.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -1.042 . . . . 0.0 109.892 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -106.15 134.2 49.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -176.85 5.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.437 -0.79 . . . . 0.0 109.811 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 70' ' ' ARG . 9.9 m120 -120.37 135.0 55.17 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -136.62 138.03 40.74 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.962 -1.086 . . . . 0.0 110.174 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 34.0 ttpt -117.68 134.33 55.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.6 23.56 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.21 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 51.6 tttp -96.53 163.35 13.07 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.05 97.17 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.321 -0.862 . . . . 0.0 110.942 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.7 pt -80.46 -27.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.877 . . . . 0.0 110.225 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -147.33 130.47 16.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -116.42 140.86 48.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.232 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -149.41 137.24 20.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.168 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.26 -0.9 . . . . 0.0 109.71 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.536 0.684 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 m -91.11 -54.1 4.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.502 -0.749 . . . . 0.0 109.607 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.98 168.74 23.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.7 t -146.91 156.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.67 -163.8 31.0 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.597 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.79 147.51 51.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.782 -0.834 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -136.56 144.76 44.36 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.602 0.715 . . . . 0.0 109.806 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.58 135.07 12.07 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' A' ' 44' ' ' GLU . 53.1 t0 -115.21 4.34 14.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.523 -0.986 . . . . 0.0 110.674 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.595 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 65.1 tt0 100.75 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.515 1.052 . . . . 0.0 108.487 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -93.48 -3.56 52.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.153 . . . . 0.0 109.562 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.47 -150.46 21.9 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.4 160.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.625 -0.927 . . . . 0.0 109.764 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tp -157.18 141.07 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.013 . . . . 0.0 109.526 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -89.93 132.23 35.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -125.1 154.31 41.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.313 -0.867 . . . . 0.0 109.192 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -132.27 133.32 43.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.69 122.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.304 -0.873 . . . . 0.0 109.79 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -80.41 149.57 30.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.43 -34.71 78.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -59.67 -20.76 58.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.99 60.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.106 -0.996 . . . . 0.0 108.746 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 44.16 45.5 6.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.585 -0.697 . . . . 0.0 109.969 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.81 150.95 37.29 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.02 160.72 47.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.595 2.197 . . . . 0.0 112.296 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.87 134.87 48.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 110.109 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.2 mp -78.05 146.09 35.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.625 -0.672 . . . . 0.0 109.541 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -86.39 131.11 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -73.12 135.83 44.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.522 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 88.73 5.02 75.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.517 ' CD ' ' HZ1' ' A' ' 93' ' ' LYS . 78.0 mm-40 -113.69 157.54 22.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.413 -1.051 . . . . 0.0 110.896 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 m -85.9 141.79 29.31 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.33 0.585 . . . . 0.0 109.629 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -138.98 145.01 39.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.298 -0.876 . . . . 0.0 109.803 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.45 128.42 55.99 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mp -115.55 116.34 27.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.625 -0.672 . . . . 0.0 109.448 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HA ' HD21 ' A' ' 19' ' ' ASN . 84.5 mtp180 -108.66 143.09 38.2 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.551 0.691 . . . . 0.0 110.432 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.9 p 60.57 57.51 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 0.0 110.656 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.4 157.82 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.175 -0.953 . . . . 0.0 108.773 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.54 134.38 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.752 . . . . 0.0 109.211 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.09 135.82 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.532 -0.73 . . . . 0.0 109.649 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.68 ' H ' HE22 ' A' ' 84' ' ' GLN . . . -108.81 146.58 16.6 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.23 103.34 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.243 . . . . 0.0 109.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 80' ' ' ARG . 64.9 t80 -97.95 96.97 8.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.223 -0.923 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.65 -119.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.645 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.21 -11.2 39.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 77' ' ' TYR . 89.1 mtm180 -111.15 161.12 16.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 110.115 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.38 153.87 18.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -140.32 153.94 46.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.146 -0.971 . . . . 0.0 109.133 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.76 113.81 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.241 -0.912 . . . . 0.0 108.582 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.68 HE22 ' H ' ' A' ' 75' ' ' GLY . 2.6 mp0 -103.05 134.98 45.58 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 0.0 109.325 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -102.92 129.42 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.513 ' H ' ' HG ' ' A' ' 89' ' ' SER . 20.9 p30 -121.36 -174.38 2.84 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.697 0.761 . . . . 0.0 110.047 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.68 -41.68 97.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.68 -0.638 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -65.59 -2.52 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.957 . . . . 0.0 109.767 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 86' ' ' ASN . 9.4 m -89.82 161.28 16.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.2 t -132.99 151.86 52.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 91' ' ' ILE . 97.2 mt -135.97 128.32 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.901 -1.125 . . . . 0.0 109.086 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -129.44 135.92 49.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.081 -1.012 . . . . 0.0 109.135 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.517 ' HZ1' ' CD ' ' A' ' 65' ' ' GLU . 63.2 tttp -79.6 129.78 34.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.33 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.3 134.74 47.01 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.927 0.87 . . . . 0.0 109.982 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -81.81 -3.14 53.22 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -91.78 123.01 64.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.876 -1.14 . . . . 0.0 109.548 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.25 141.82 23.56 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.733 1.622 . . . . 0.0 112.422 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.01 141.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.46 -0.775 . . . . 0.0 109.177 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 0.0 109.223 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 121.379 0.491 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -79.58 112.28 16.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.4 mt -89.89 129.61 36.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.0 109.691 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.6 m -123.88 139.87 53.54 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.421 0.629 . . . . 0.0 109.326 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.24 144.35 25.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.964 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 pt -52.72 -41.7 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.626 -0.671 . . . . 0.0 109.686 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.03 -11.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -96.59 6.44 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.65 119.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 109.968 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.92 6.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 96.6 mt-10 -131.71 128.01 38.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.542 -0.724 . . . . 0.0 109.369 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.597 ' ND2' ' N ' ' A' ' 15' ' ' GLY . 2.3 t-20 -88.95 150.03 23.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.848 . . . . 0.0 109.924 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.597 ' N ' ' ND2' ' A' ' 14' ' ' ASN . . . 80.34 21.82 63.98 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 13' ' ' GLU . 4.9 pt20 -103.35 153.2 20.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.575 -0.956 . . . . 0.0 109.837 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -103.9 132.25 50.34 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.507 0.67 . . . . 0.0 109.446 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.32 178.87 9.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 109.863 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -120.66 144.98 47.89 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.1 tp -136.59 133.7 36.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.512 -0.742 . . . . 0.0 110.131 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -118.31 132.03 56.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.39 -173.21 0.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.176 0.989 . . . . 0.0 110.806 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.9 ptpt -118.19 155.82 29.82 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.438 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.4 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 95.8 t -90.06 105.75 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.471 -0.768 . . . . 0.0 110.158 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.412 ' C ' HE21 ' A' ' 63' ' ' GLN . 34.5 pt -73.19 -25.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.804 -0.56 . . . . 0.0 110.045 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -159.59 148.59 17.94 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 1.6 pt? -125.34 152.01 45.3 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.13 117.7 9.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 109.606 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.623 -0.673 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.475 0.655 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 3.0 m -102.05 -46.32 4.9 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.513 0.673 . . . . 0.0 109.894 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -148.82 148.2 29.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.988 -1.07 . . . . 0.0 109.975 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.86 130.74 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.38 -166.93 15.12 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.15 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.31 150.48 50.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.866 -0.784 . . . . 0.0 109.734 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.21 125.22 53.57 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.64 8.13 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.4 p-10 -125.73 -134.69 0.26 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.714 -0.874 . . . . 0.0 109.098 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 81.7 tt0 -119.8 -18.57 8.24 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 15.7 p -93.06 -11.06 33.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.97 -1.081 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 151.65 -143.85 10.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -141.54 158.11 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -1.09 . . . . 0.0 109.432 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -148.86 145.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 109.885 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -92.01 127.36 37.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.023 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -122.87 152.76 40.44 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.3 m -131.24 133.44 45.45 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.426 0.631 . . . . 0.0 109.634 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.64 127.1 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -82.5 142.56 31.77 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.597 -0.689 . . . . 0.0 110.118 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' N ' ' OG ' ' A' ' 36' ' ' SER . 78.8 tttt -58.08 -37.32 74.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.541 -0.725 . . . . 0.0 109.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -6.11 1.23 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.828 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -88.71 -30.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.884 . . . . 0.0 109.158 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 46.33 51.95 11.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.643 -0.661 . . . . 0.0 109.889 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.4 mt -100.65 153.02 37.97 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.741 -0.599 . . . . 0.0 109.848 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.46 148.89 60.1 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.477 2.118 . . . . 0.0 112.779 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.6 140.12 51.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.512 -0.742 . . . . 0.0 110.379 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 8.3 mp -83.37 150.33 26.16 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.367 0.603 . . . . 0.0 109.964 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.2 128.2 45.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 64' ' ' GLY . 11.1 tm0? -66.71 137.99 57.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.662 -0.649 . . . . 0.0 110.712 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 86.74 -10.77 66.37 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -98.18 158.19 15.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -1.033 . . . . 0.0 110.674 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 m -91.58 145.67 24.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -141.73 148.82 39.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 109.815 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 tp -110.32 128.76 55.71 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.83 118.05 31.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.531 -0.731 . . . . 0.0 109.728 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -114.86 145.01 42.63 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.692 0.758 . . . . 0.0 110.694 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 63.22 56.57 1.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 m -110.73 161.97 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.512 -0.743 . . . . 0.0 109.381 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 148.43 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.581 0.705 . . . . 0.0 109.59 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 65.3 t -95.75 132.47 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.676 -0.64 . . . . 0.0 109.686 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.0 16.96 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -94.86 109.39 21.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.534 -0.98 . . . . 0.0 109.403 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.632 ' CB ' HE21 ' A' ' 82' ' ' GLN . 40.4 t80 -106.8 106.45 16.97 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.922 0.868 . . . . 0.0 109.483 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.4 m120 42.64 -118.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -93.07 -17.3 23.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.102 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.7 mtt-85 -100.82 159.78 14.91 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.411 -0.805 . . . . 0.0 110.329 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -104.72 153.32 21.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.632 HE21 ' CB ' ' A' ' 77' ' ' TYR . 43.5 mt-30 -147.81 159.94 43.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.38 123.55 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.72 129.35 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -104.41 131.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -127.08 -170.46 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.673 0.749 . . . . 0.0 110.066 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.53 -45.14 91.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.907 -0.496 . . . . 0.0 110.181 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.18 -11.07 7.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 109.758 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.5 p -83.23 163.91 20.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.9 p -138.44 155.67 48.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -139.66 131.77 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 0.0 109.313 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -127.47 130.57 49.47 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -70.34 135.89 49.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.705 -0.622 . . . . 0.0 109.502 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.1 mt -96.92 134.36 40.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.505 -0.747 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.5 p -85.29 -6.34 59.26 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -107.12 130.52 22.74 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.567 -0.708 . . . . 0.0 109.57 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.25 147.39 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.478 2.119 . . . . 0.0 112.242 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.508 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.5 mt -110.27 131.67 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.6 mp0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 110.011 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 N--CA 1.494 1.522 0 CA-C-O 121.416 0.507 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.03 115.43 18.7 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.12 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.9 mt -86.95 126.64 34.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.55 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.7 m -120.77 136.78 54.8 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.07 148.39 22.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.23 -43.3 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.528 0.68 . . . . 0.0 109.193 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.22 -13.39 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.429 -0.795 . . . . 0.0 109.535 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 53.2 t0 -95.58 5.52 51.29 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.159 -0.963 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 13' ' ' GLU . 3.7 mm -56.14 -72.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.142 -0.974 . . . . 0.0 109.185 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t 62.59 -32.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' A' ' 11' ' ' ILE . 52.3 tp10 -145.54 147.6 32.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.883 -1.135 . . . . 0.0 108.987 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -101.48 173.11 6.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.56 0.695 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.43 21.85 79.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 34.3 mt-30 -99.43 145.76 27.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.349 -1.089 . . . . 0.0 109.984 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.27 126.05 39.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' C ' HD21 ' A' ' 19' ' ' ASN . . . -162.28 -169.98 2.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.677 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.6 OUTLIER -126.09 144.07 50.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.69 130.81 38.7 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.715 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -116.05 130.67 56.91 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.16 -173.67 1.14 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.23 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HZ3' ' H ' ' A' ' 98' ' ' ILE . 3.3 ttmp? -114.26 148.89 36.72 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.831 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.08 123.71 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 25' ' ' ILE . 11.4 pt -88.46 -20.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.432 -0.793 . . . . 0.0 110.45 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -164.91 154.82 13.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.723 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.7 mt -124.36 152.09 43.59 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.443 0.64 . . . . 0.0 110.021 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -137.33 104.92 5.53 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.406 ' HG2' HE21 ' A' ' 37' ' ' GLN . 96.9 mt-10 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.743 -0.598 . . . . 0.0 109.695 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.1 p -90.93 -60.17 1.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.912 0.863 . . . . 0.0 110.437 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.537 ' N ' ' OG ' ' A' ' 36' ' ' SER . 81.3 mt-30 -146.67 155.34 42.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.864 -1.148 . . . . 0.0 109.964 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -135.94 161.77 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' ' CE2' ' A' ' 50' ' ' PHE . . . 178.4 -168.17 39.16 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.058 -1.544 . . . . 0.0 109.939 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.08 149.88 52.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.764 -0.845 . . . . 0.0 109.583 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.6 125.72 53.7 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.733 0.778 . . . . 0.0 108.992 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.93 101.2 2.75 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -105.05 164.02 12.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.678 -0.895 . . . . 0.0 109.293 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -71.49 -17.01 62.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.491 -0.756 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.3 p -93.81 -10.85 32.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 109.571 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.61 -149.57 21.23 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 pt -132.98 156.16 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.944 . . . . 0.0 109.701 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -152.47 145.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.865 . . . . 0.0 109.397 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.617 ' H ' HH12 ' A' ' 80' ' ' ARG . 68.3 mttm -80.44 165.35 22.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.807 . . . . 0.0 109.451 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CE2' ' C ' ' A' ' 39' ' ' GLY . 24.6 p90 -154.23 148.6 26.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.513 -1.367 . . . . 0.0 108.08 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.5 m -132.93 132.38 41.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.436 -0.79 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 52' ' ' ILE . 79.2 mt -105.7 127.56 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.491 -0.755 . . . . 0.0 109.38 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -83.76 140.3 32.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 57' ' ' GLU . 27.7 tptp -58.66 -33.01 69.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.466 -0.771 . . . . 0.0 109.226 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -64.14 -6.43 6.54 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.79 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.58 -31.84 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 108.941 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 54' ' ' LYS . 74.0 mm-40 49.51 52.9 13.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.909 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 mt -101.96 153.93 37.67 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.36 -0.837 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.71 149.65 31.67 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.145 1.896 . . . . 0.0 112.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.0 138.29 57.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 0.0 110.27 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.8 mp -82.86 145.24 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 109.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -105.21 135.36 46.71 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.835 0.826 . . . . 0.0 109.998 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -74.78 146.64 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.022 0.915 . . . . 0.0 110.006 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.72 -11.1 42.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -97.81 150.14 21.58 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.102 -1.234 . . . . 0.0 110.507 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -84.16 143.8 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.364 0.602 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -142.14 150.26 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.08 129.92 55.47 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.31 115.65 28.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.423 -0.798 . . . . 0.0 109.576 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -113.66 146.25 40.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.579 -0.701 . . . . 0.0 110.317 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.1 t 56.96 58.97 3.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.882 -0.511 . . . . 0.0 110.908 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.98 165.73 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.302 -0.873 . . . . 0.0 108.849 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.01 152.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.654 0.74 . . . . 0.0 109.591 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.15 132.08 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.649 -0.657 . . . . 0.0 109.536 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.12 156.24 15.71 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.44 118.17 36.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 109.032 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.5 t80 -135.46 117.89 15.77 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.595 ' C ' ' H ' ' A' ' 80' ' ' ARG . 9.4 m120 52.73 55.75 8.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.452 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 56.16 -4.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.68 -0.638 . . . . 0.0 110.808 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.617 HH12 ' H ' ' A' ' 49' ' ' LYS . 68.3 ttt-85 -102.02 131.91 48.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.093 -1.004 . . . . 0.0 109.598 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -78.15 146.3 35.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.488 -0.757 . . . . 0.0 109.233 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -147.32 162.6 38.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 0.0 109.613 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.94 119.77 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.442 -0.787 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -100.56 129.91 46.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 0.0 109.043 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.56 132.39 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.045 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -125.49 -170.12 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.402 -0.811 . . . . 0.0 109.81 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -67.3 -25.42 66.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.654 -0.654 . . . . 0.0 110.102 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -80.72 -9.24 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.776 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 m -88.87 164.07 15.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 0.0 109.675 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.6 m -134.93 158.0 45.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.264 -0.897 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 91' ' ' ILE . 96.7 mt -136.94 128.87 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.114 -0.991 . . . . 0.0 108.843 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.97 128.56 47.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.311 -0.868 . . . . 0.0 108.919 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.82 137.97 55.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 109.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.2 134.37 46.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.848 . . . . 0.0 109.941 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.9 p -85.5 -2.01 57.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -109.66 127.53 27.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.368 -0.833 . . . . 0.0 109.692 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.55 151.0 41.35 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.121 1.881 . . . . 0.0 112.265 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.572 ' H ' ' HZ3' ' A' ' 23' ' ' LYS . 96.6 mt -111.01 134.5 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.716 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.497 1.726 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.453 ' N ' HD21 ' A' ' 19' ' ' ASN . 85.1 mt-30 -77.84 115.78 17.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.516 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.72 127.48 35.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.9 m -121.12 137.7 54.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -95.85 151.74 19.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.944 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mm -55.96 -44.56 78.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.77 -18.24 23.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.222 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.28 -0.52 56.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.23 118.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -142.88 -2.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.926 . . . . 0.0 109.192 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.8 140.52 45.93 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.094 -1.004 . . . . 0.0 109.505 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -92.5 162.93 14.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.53 78.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -94.46 140.45 29.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -1.17 . . . . 0.0 109.682 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -96.48 128.26 43.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.626 -0.671 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.747 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.453 HD21 ' N ' ' A' ' 4' ' ' GLN . 58.9 m-20 -120.69 139.56 52.87 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -116.84 146.68 42.74 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.087 -1.008 . . . . 0.0 109.71 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -138.42 125.33 21.16 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 -175.16 1.06 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.177 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -110.54 151.76 27.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.854 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.47 111.06 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.322 -0.861 . . . . 0.0 110.84 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.7 pt -89.22 -24.38 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -156.56 147.26 21.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 109.449 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 160.61 39.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.249 -0.907 . . . . 0.0 109.37 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -141.21 109.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 109.389 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.618 -179.445 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 121.408 0.623 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.416 ' OG ' ' C ' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -85.04 -58.32 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -151.98 152.01 31.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.258 -0.901 . . . . 0.0 109.871 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.87 133.01 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.27 -156.8 8.45 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.525 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.67 153.49 50.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.87 -0.782 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.46 128.7 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.8 97.84 2.35 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 53.8 t0 -101.37 159.86 14.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -1.045 . . . . 0.0 109.421 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.3 mt-10 -68.99 -14.8 63.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.44 -0.788 . . . . 0.0 109.984 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -98.0 -7.03 30.73 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.155 -0.966 . . . . 0.0 109.577 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.61 -147.81 18.11 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.162 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.81 165.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.662 -0.905 . . . . 0.0 109.909 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.5 tt -157.5 144.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.147 -0.97 . . . . 0.0 109.91 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.88 130.22 38.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -128.45 154.99 45.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.831 -1.168 . . . . 0.0 108.599 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.6 m -131.33 130.47 42.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.59 -0.694 . . . . 0.0 109.257 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.06 129.62 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.332 -0.855 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.416 ' C ' ' OG ' ' A' ' 36' ' ' SER . 97.9 m95 -82.0 139.91 34.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 110.312 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 56' ' ' ALA . 64.5 tttm -59.63 -37.78 79.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -61.04 -2.04 0.54 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -85.07 -23.71 28.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 108.779 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 53.85 48.28 21.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 109.9 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.77 147.06 35.38 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.533 -0.729 . . . . 0.0 109.581 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 157.27 62.54 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.384 2.056 . . . . 0.0 112.648 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.74 147.39 43.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.054 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 8.7 mp -85.2 155.19 21.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.528 -0.733 . . . . 0.0 109.556 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 47.2 tp10 -100.47 136.73 39.9 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -71.34 138.6 49.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.405 -0.809 . . . . 0.0 110.488 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.16 -14.81 62.6 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.35 158.45 15.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.327 -1.102 . . . . 0.0 110.667 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -88.15 151.77 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.485 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 31.7 m-85 -142.9 143.72 32.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 109.561 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.45 129.83 56.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.04 122.74 45.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.615 -0.678 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -116.86 151.99 35.41 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.477 0.656 . . . . 0.0 110.536 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m 56.93 54.97 6.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.89 -0.506 . . . . 0.0 110.788 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.21 164.6 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.243 -0.911 . . . . 0.0 108.853 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.51 147.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.564 0.697 . . . . 0.0 109.374 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.89 131.83 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 109.383 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.93 149.94 16.95 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 78' ' ' ASN . 5.5 tm-20 -92.08 100.2 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.034 -1.274 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.8 t80 -95.18 103.61 15.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.93 . . . . 0.0 109.191 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' O ' ' OE2' ' A' ' 76' ' ' GLU . 99.3 m-20 40.25 -110.67 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 0.0 110.684 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -95.89 -19.65 19.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.099 -1.001 . . . . 0.0 110.383 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 77' ' ' TYR . 37.4 mmt180 -101.31 162.61 12.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 110.006 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.37 152.25 21.81 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.426 ' NE2' ' CD1' ' A' ' 77' ' ' TYR . 27.5 mt-30 -142.06 157.81 44.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.16 123.7 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.434 -0.791 . . . . 0.0 109.111 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -104.8 126.64 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.453 -0.779 . . . . 0.0 109.545 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.74 134.93 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.39 -0.819 . . . . 0.0 109.162 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -129.29 -168.57 1.95 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.323 -0.86 . . . . 0.0 109.896 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.63 -41.63 98.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.521 -0.737 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.91 -20.07 66.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.735 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.0 m -81.21 163.88 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.777 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.5 m -137.44 162.27 34.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.85 130.19 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.015 -1.053 . . . . 0.0 108.834 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -130.08 134.71 47.55 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.211 -0.931 . . . . 0.0 109.013 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -75.57 139.54 42.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.532 -0.73 . . . . 0.0 109.902 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.07 141.74 28.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 109.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -85.05 -8.98 58.46 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.24 134.05 20.88 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.336 -0.852 . . . . 0.0 110.033 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 154.02 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.053 1.836 . . . . 0.0 112.155 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -111.64 133.41 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 109.663 -179.496 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.496 1.618 0 CA-C-O 121.359 0.483 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.74 115.66 20.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.95 131.43 35.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -123.57 142.08 51.38 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -93.28 149.86 20.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.073 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.25 -43.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.369 -0.832 . . . . 0.0 109.078 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 p -62.99 -5.7 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -102.02 6.25 41.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.372 -0.83 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.74 112.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 109.551 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.6 m -149.74 4.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -132.91 130.47 39.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.362 -0.836 . . . . 0.0 109.078 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -88.15 160.06 17.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.193 -0.942 . . . . 0.0 110.359 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.52 20.68 72.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -94.29 138.57 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 109.996 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -94.85 126.69 40.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 109.386 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -179.41 7.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -126.3 140.36 52.58 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.36 143.73 40.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.5 135.74 54.2 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.87 -173.69 1.01 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.183 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.09 150.99 28.6 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.863 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.14 97.34 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.086 -1.009 . . . . 0.0 109.932 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 tp -66.47 -32.59 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 121.092 -1.005 . . . . 0.0 110.529 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -147.35 129.7 15.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 109.535 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.78 147.59 41.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.598 -0.689 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -143.51 115.39 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 109.396 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.459 -0.776 . . . . 0.0 109.649 -179.691 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.524 3.232 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -81.72 -57.87 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.394 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.74 165.19 33.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 0.0 110.661 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.76 154.9 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.66 -155.38 17.36 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.393 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.01 155.2 50.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.911 -0.758 . . . . 0.0 109.541 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.35 127.8 55.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.8 105.89 3.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -112.95 167.99 10.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.923 . . . . 0.0 109.484 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -73.01 -17.33 61.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.947 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.8 p -93.17 -12.1 31.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.917 -1.114 . . . . 0.0 109.644 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.69 -148.56 19.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.426 ' CD1' ' C ' ' A' ' 47' ' ' ILE . 2.3 pp -135.55 160.66 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.992 . . . . 0.0 109.55 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -153.77 147.56 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.189 -0.944 . . . . 0.0 109.76 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -81.07 163.64 23.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 109.189 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -160.6 150.94 18.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.483 -1.386 . . . . 0.0 108.265 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 t -138.42 133.1 32.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.837 . . . . 0.0 109.47 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -105.2 129.77 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.677 -0.639 . . . . 0.0 109.467 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -81.98 139.3 34.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 110.686 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.35 -32.03 72.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.416 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.09 -10.4 10.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.85 -21.88 34.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 47.74 48.89 17.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.985 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt -103.71 152.27 38.9 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.404 -0.81 . . . . 0.0 109.8 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.42 146.5 41.27 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.077 1.851 . . . . 0.0 112.589 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.47 142.78 53.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.0 mp -82.63 143.32 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.514 -0.741 . . . . 0.0 109.667 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -93.41 132.04 38.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.28 -0.888 . . . . 0.0 109.755 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -69.26 139.11 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 110.746 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -11.97 59.56 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -96.06 158.51 15.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -1.109 . . . . 0.0 110.585 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.449 ' H ' ' HG ' ' A' ' 66' ' ' SER . 8.7 p -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.489 0.661 . . . . 0.0 109.836 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.11 148.78 38.9 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.936 0.874 . . . . 0.0 109.879 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -107.16 131.41 54.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.9 mt -116.27 111.29 19.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' O ' ' OG ' ' A' ' 71' ' ' SER . 99.1 mtt180 -115.65 153.04 32.0 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.737 0.779 . . . . 0.0 110.556 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 5.2 p 50.46 56.58 7.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.867 -0.52 . . . . 0.0 110.67 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 167.26 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.98 152.72 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.6 0.714 . . . . 0.0 109.402 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.11 131.44 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.65 -0.656 . . . . 0.0 109.734 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.25 148.56 17.21 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -97.5 107.59 20.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.279 -1.13 . . . . 0.0 108.927 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ARG . 87.1 t80 -107.13 109.22 21.0 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.371 -0.83 . . . . 0.0 109.273 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.483 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 26.6 t-20 38.92 -116.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.483 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 99.4 m-20 -92.81 -20.13 21.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 77' ' ' TYR . 3.6 mpt_? -96.12 162.22 13.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.84 153.89 25.94 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -149.77 161.87 41.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.167 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.17 128.14 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.87 124.35 49.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.484 -0.76 . . . . 0.0 109.356 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.7 t -98.4 133.51 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -123.27 -169.09 1.87 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 0.0 109.655 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.45 -38.81 88.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.761 -0.587 . . . . 0.0 109.924 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.55 -12.17 56.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.983 . . . . 0.0 109.902 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.546 ' HG ' ' N ' ' A' ' 90' ' ' SER . 40.0 t -87.75 166.66 14.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 89' ' ' SER . 42.4 m -134.82 156.03 49.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.29 -0.881 . . . . 0.0 108.829 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.439 HG22 HD12 ' A' ' 91' ' ' ILE . 96.8 mt -139.12 130.88 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.094 -1.004 . . . . 0.0 108.981 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -127.22 127.91 45.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.28 -0.888 . . . . 0.0 108.917 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.58 141.92 44.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.27 142.2 37.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.52 ' HG ' ' CD ' ' A' ' 96' ' ' GLU . 94.5 p -88.2 3.18 50.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.616 -0.677 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' CD ' ' HG ' ' A' ' 95' ' ' SER . 27.6 mp0 -105.99 133.72 20.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.291 -0.881 . . . . 0.0 109.687 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.51 148.29 37.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.089 1.86 . . . . 0.0 112.157 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.53 134.11 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.9 mp0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.095 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 N--CA 1.494 1.538 0 CA-C-O 121.335 0.473 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.61 115.51 17.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.14 131.32 36.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.849 . . . . 0.0 109.438 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.3 m -124.68 141.06 52.37 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.88 151.75 19.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.3 mt -56.38 -45.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.229 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.7 -17.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.625 -0.672 . . . . 0.0 109.436 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -92.8 2.41 56.77 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -86.21 121.23 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.045 -1.034 . . . . 0.0 109.861 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -147.9 6.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -137.56 135.42 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -93.32 158.75 15.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.9 20.71 79.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.46 147.62 25.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -1.123 . . . . 0.0 110.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -97.49 126.91 43.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.94 -178.23 6.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.682 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -117.91 145.62 44.52 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.4 tp -134.24 127.86 32.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -114.88 130.21 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.11 170.78 11.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.122 0.963 . . . . 0.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -100.1 155.34 17.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.751 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.45 113.19 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.51 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -147.56 130.5 16.23 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.036 -1.04 . . . . 0.0 109.781 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.522 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 1.4 pt? -129.68 156.81 43.65 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.293 0.568 . . . . 0.0 109.812 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -144.5 110.5 5.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.575 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.423 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.5 0.667 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -82.52 -62.77 1.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.621 -0.674 . . . . 0.0 109.995 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -152.32 149.19 28.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.968 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.61 154.13 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.14 -159.63 22.68 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 tp -125.27 145.2 50.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.907 -0.76 . . . . 0.0 109.448 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.0 mt -108.48 128.68 55.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.514 -0.741 . . . . 0.0 109.201 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 97.83 2.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -103.32 164.31 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.97 . . . . 0.0 109.621 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.09 -20.22 62.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.602 -0.686 . . . . 0.0 110.104 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 p -90.12 -12.65 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.359 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.58 -148.97 20.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.02 159.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.672 -0.899 . . . . 0.0 109.666 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.42 141.69 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -88.36 144.68 26.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -141.27 158.63 43.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.73 -1.231 . . . . 0.0 108.49 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -135.03 137.57 43.09 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.514 0.674 . . . . 0.0 109.726 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.6 mt -106.33 129.68 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -86.39 142.94 28.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.376 -0.827 . . . . 0.0 110.378 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -61.93 -32.08 72.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.643 -0.66 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.5 -12.77 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.517 -0.739 . . . . 0.0 109.619 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.23 24.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.948 . . . . 0.0 108.939 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 49.13 52.91 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.815 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 mt -102.37 153.66 37.95 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.1 149.0 45.94 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 122.082 1.855 . . . . 0.0 112.72 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.54 140.89 51.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.264 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.5 mp -82.97 145.04 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.709 -0.619 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.615 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 96.1 mt-10 -101.17 139.2 37.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -76.58 138.27 40.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.644 -0.66 . . . . 0.0 110.726 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.02 -18.65 56.94 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 97.8 mt-10 -97.0 159.95 14.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.681 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -89.55 148.59 23.3 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.416 0.627 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.615 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 34.3 m-85 -141.43 143.94 34.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.713 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 tp -109.45 130.44 55.5 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -113.33 122.17 46.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.502 -0.749 . . . . 0.0 109.831 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -120.19 147.1 45.35 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.675 0.75 . . . . 0.0 110.426 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.6 t 57.11 56.86 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.097 0.475 . . . . 0.0 110.751 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.56 166.03 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.81 143.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.602 0.715 . . . . 0.0 109.666 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.83 132.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.65 -0.656 . . . . 0.0 109.655 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.29 153.1 17.77 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -95.71 110.44 22.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -1.147 . . . . 0.0 109.139 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 80' ' ' ARG . 75.4 t80 -103.84 109.73 21.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.145 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 43.75 -119.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.773 . . . . 0.0 110.438 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -94.01 -17.08 23.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.11 -0.994 . . . . 0.0 110.254 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 77' ' ' TYR . 78.4 ttt180 -102.56 144.13 31.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.38 153.27 37.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 0.0 108.955 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -143.82 152.05 40.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.991 -1.068 . . . . 0.0 109.011 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.89 122.27 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.86 128.67 53.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.448 -0.783 . . . . 0.0 109.414 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.11 133.11 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -136.94 -166.32 1.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 89' ' ' SER . 10.0 mtpm? -55.43 167.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.873 -0.517 . . . . 0.0 109.763 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 73.07 -23.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.413 -0.804 . . . . 0.0 109.614 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 87' ' ' LYS . 48.9 m -72.35 159.18 34.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.752 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.9 m -135.04 155.12 51.3 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.336 -0.852 . . . . 0.0 108.871 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -139.26 131.19 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.1 -1.0 . . . . 0.0 109.06 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -131.58 136.91 48.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 0.0 108.917 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -72.45 140.53 48.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.32 132.14 44.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.404 -0.81 . . . . 0.0 109.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -83.1 -4.77 58.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.661 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -115.53 93.66 37.42 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.78 . . . . 0.0 109.441 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.94 156.78 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.525 2.15 . . . . 0.0 112.208 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.7 147.85 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.07 -179.699 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.494 1.524 0 CA-C-O 121.412 0.505 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.42 113.79 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.517 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.32 132.18 36.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.1 m -124.46 143.49 50.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.63 -0.668 . . . . 0.0 109.27 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -94.1 148.08 22.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.7 mt -57.24 -44.74 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 109.399 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.36 -12.31 13.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.565 -0.71 . . . . 0.0 109.385 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 53.7 t0 -97.31 4.89 50.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.2 mt -88.0 121.57 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.99 6.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.208 -0.933 . . . . 0.0 109.417 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -133.49 128.99 36.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -87.81 153.61 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.148 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.88 17.01 78.04 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -96.44 150.12 20.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.425 -1.044 . . . . 0.0 110.045 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -102.33 131.26 49.05 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.4 0.619 . . . . 0.0 109.481 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.63 179.24 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -117.15 131.12 56.95 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.18 146.26 43.33 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.898 0.856 . . . . 0.0 110.352 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -136.08 131.47 34.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.54 -173.82 0.78 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.039 0.923 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -111.85 150.98 29.62 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.943 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.4 t -86.39 95.02 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.21 -26.7 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.77 . . . . 0.0 109.811 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -143.17 119.25 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.954 -1.091 . . . . 0.0 109.379 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.4 tp -109.3 143.63 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 0.0 109.18 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -140.26 107.28 5.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.61 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.677 0.751 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -97.63 -50.06 4.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -149.87 146.84 27.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 110.129 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.39 153.01 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.38 -161.58 23.87 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.275 -1.441 . . . . 0.0 109.925 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.76 146.53 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.021 -0.693 . . . . 0.0 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -112.3 127.08 55.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.53 -0.731 . . . . 0.0 109.431 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.35 100.93 2.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -101.25 162.39 12.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.359 -1.083 . . . . 0.0 109.358 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -72.26 -21.93 61.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.601 -0.687 . . . . 0.0 109.893 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.9 p -93.92 -16.12 24.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.208 -0.933 . . . . 0.0 109.136 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.21 -156.98 29.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.014 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.2 pt -137.98 163.18 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.531 -0.981 . . . . 0.0 109.93 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.2 tt -162.5 152.12 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.196 -0.94 . . . . 0.0 109.716 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -97.12 138.84 34.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -131.49 156.16 46.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.058 -1.026 . . . . 0.0 108.933 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.8 m -131.59 132.28 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.472 0.653 . . . . 0.0 109.64 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.3 mt -98.47 128.23 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 109.699 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -85.0 143.73 28.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -0.792 . . . . 0.0 110.432 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.56 -35.36 74.09 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -58.97 -9.54 1.94 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.575 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.22 -28.13 24.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 108.889 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 45.9 49.99 11.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.639 . . . . 0.0 109.865 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.0 mt -102.78 153.22 38.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.614 -0.679 . . . . 0.0 109.739 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.78 149.91 47.89 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.357 2.038 . . . . 0.0 112.642 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.91 140.4 53.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.469 -0.77 . . . . 0.0 110.335 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.3 mp -81.57 145.42 30.66 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.423 0.63 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 97.0 mt-10 -94.24 128.78 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 58.3 tt0 -68.5 135.45 51.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.592 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.1 71.59 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.0 mp0 -99.4 162.38 13.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -1.123 . . . . 0.0 110.687 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -98.04 137.13 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -133.75 153.38 51.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.133 0.968 . . . . 0.0 110.08 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 tp -111.74 131.32 55.39 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.9 mt -111.9 120.86 43.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.471 -0.768 . . . . 0.0 109.533 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' OG ' ' A' ' 71' ' ' SER . 83.0 mtp180 -117.75 151.37 37.43 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.578 0.704 . . . . 0.0 110.647 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.2 p 51.71 56.2 8.21 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.52 166.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.55 150.03 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.686 0.755 . . . . 0.0 109.888 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.45 132.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.674 . . . . 0.0 109.442 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.75 150.2 16.85 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -88.02 99.7 12.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ARG . 76.2 t80 -98.1 100.71 12.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.251 -0.906 . . . . 0.0 109.225 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 44.7 -119.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 110.7 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 34.6 p-10 -93.65 -7.58 43.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -110.57 155.27 22.56 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.89 0.852 . . . . 0.0 110.184 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -95.95 153.45 17.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 108.848 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -144.11 159.43 42.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.41 126.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -103.13 126.75 50.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.432 -0.792 . . . . 0.0 109.148 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.03 132.24 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -127.01 -168.45 1.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.692 0.758 . . . . 0.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -65.2 -41.76 94.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.762 -0.587 . . . . 0.0 110.18 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -64.48 -12.2 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.8 t -83.86 164.03 19.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.8 m -136.5 157.59 46.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.327 -0.858 . . . . 0.0 109.044 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 91' ' ' ILE . 96.3 mt -134.96 128.24 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.267 -0.896 . . . . 0.0 109.226 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -129.76 133.12 46.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -80.1 134.86 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' GLU . 4.0 mm? -107.64 -1.7 20.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.464 -0.772 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 t 47.28 15.77 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.269 -0.894 . . . . 0.0 109.97 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 94' ' ' LEU . 6.9 tp10 -114.83 93.28 33.31 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 108.936 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.8 147.39 41.3 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.683 2.255 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 mm -105.74 139.96 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.573 -0.704 . . . . 0.0 109.17 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.495 -179.555 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 CA-C-O 121.272 0.447 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.56 117.96 22.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -87.77 128.67 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.9 m -124.94 145.64 49.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -97.49 142.71 28.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 pt -52.94 -39.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 0.0 109.733 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.56 -12.19 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.504 -0.748 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -97.17 5.18 50.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.95 123.77 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.159 -0.963 . . . . 0.0 109.951 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.41 8.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -137.45 134.42 35.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 109.243 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.418 ' OD1' ' OE1' ' A' ' 76' ' ' GLU . 16.0 m120 -92.61 153.74 18.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.369 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.19 71.75 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -95.83 146.86 24.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.66 132.47 52.61 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.352 0.596 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -175.16 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 0.0 109.848 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 27.3 t30 -119.48 140.53 50.31 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -133.62 149.03 51.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.383 -0.823 . . . . 0.0 110.165 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -133.07 127.34 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.93 177.5 10.31 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.098 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -109.16 153.15 24.15 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.919 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.0 99.61 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.286 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.51 -26.09 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -158.36 147.43 19.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.361 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.3 pt? -133.54 158.78 42.27 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.51 -0.744 . . . . 0.0 109.628 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -142.41 109.32 5.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.231 -179.599 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.513 0.673 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.579 ' HG ' ' HZ1' ' A' ' 54' ' ' LYS . 4.7 t -86.25 -57.43 3.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.991 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -151.41 154.95 37.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.187 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.35 139.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.69 -156.02 10.12 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.327 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.06 152.2 51.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.832 -0.805 . . . . 0.0 109.688 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.75 131.64 54.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.33 99.15 2.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -100.34 160.78 14.06 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.452 -1.028 . . . . 0.0 109.46 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.98 -16.63 63.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 109.85 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -96.63 -11.72 24.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.213 -0.929 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.17 17.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' ILE . 2.6 pp -132.82 162.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.964 . . . . 0.0 109.635 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.2 tp -156.67 148.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.665 ' HZ3' HH11 ' A' ' 80' ' ' ARG . 63.1 mttp -81.53 164.13 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.603 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -157.01 148.07 21.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.64 -1.288 . . . . 0.0 108.543 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -136.42 131.88 34.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.216 -0.927 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.07 130.11 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.664 -0.648 . . . . 0.0 109.578 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -86.85 141.44 28.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.579 ' HZ1' ' HG ' ' A' ' 36' ' ' SER . 12.6 mmtm -56.59 -35.3 68.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.54 -0.725 . . . . 0.0 109.068 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -59.4 -4.6 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.484 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -87.35 -31.08 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 108.909 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 51.22 50.62 18.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 110.089 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.82 152.38 42.29 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.765 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.2 148.34 41.02 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.173 1.915 . . . . 0.0 112.784 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -68.32 144.65 54.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.479 -0.763 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.6 mp -80.16 145.21 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -102.35 133.91 46.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.368 -0.833 . . . . 0.0 109.48 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.71 138.42 44.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.477 -0.764 . . . . 0.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.29 -8.15 79.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -106.04 157.32 17.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.417 -1.049 . . . . 0.0 110.493 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -89.1 147.4 24.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.861 -0.525 . . . . 0.0 109.619 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -140.52 145.75 37.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.819 0.819 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -111.69 131.25 55.42 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 2.8 mp -117.75 115.85 25.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.516 -0.74 . . . . 0.0 109.51 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -109.59 149.12 30.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.52 -0.737 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.68 59.43 3.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.789 -0.569 . . . . 0.0 110.61 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.79 162.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.27 147.96 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.512 0.673 . . . . 0.0 109.473 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.36 127.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.22 156.79 15.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.508 ' OE1' ' CE2' ' A' ' 81' ' ' PHE . 49.6 tp10 -105.6 134.35 48.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -1.006 . . . . 0.0 108.816 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 79' ' ' ASP . 87.9 t80 -129.37 117.93 21.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.744 . . . . 0.0 109.077 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' TYR . 95.0 m-20 39.65 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.707 -0.62 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 77' ' ' TYR . 37.3 p-10 -125.08 -17.61 5.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.309 -0.869 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.665 HH11 ' HZ3' ' A' ' 49' ' ' LYS . 96.8 mtt180 -93.25 155.43 17.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.969 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.508 ' CE2' ' OE1' ' A' ' 76' ' ' GLU . 96.0 m-85 -101.81 149.09 24.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 0.0 108.945 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -152.35 161.16 43.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -104.46 127.75 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.29 127.01 46.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.798 . . . . 0.0 109.596 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 ' CG1' ' HG ' ' A' ' 89' ' ' SER . 21.4 t -99.59 133.15 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 109.07 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.539 ' H ' ' HG ' ' A' ' 89' ' ' SER . 78.8 m-20 -132.5 -166.16 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -62.36 -40.91 97.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -62.27 -32.31 73.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.539 ' HG ' ' H ' ' A' ' 86' ' ' ASN . 24.2 p -79.54 164.72 23.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.4 t -139.54 166.92 23.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.468 -0.77 . . . . 0.0 109.111 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -139.59 131.58 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.189 -0.944 . . . . 0.0 109.175 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -128.81 132.43 47.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.299 -0.876 . . . . 0.0 109.147 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.64 139.98 40.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.296 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -101.26 141.57 33.95 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.971 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -84.43 -1.75 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.556 -0.715 . . . . 0.0 109.681 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.04 131.4 23.19 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.433 -0.792 . . . . 0.0 109.692 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.43 152.91 49.81 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.998 1.799 . . . . 0.0 112.439 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.49 134.44 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.54 -0.725 . . . . 0.0 109.14 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.303 -0.873 . . . . 0.0 109.837 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.41 0.504 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -76.72 118.5 19.41 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.303 -0.873 . . . . 0.0 109.35 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.8 mt -93.23 128.29 39.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -127.86 150.5 49.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -97.61 146.99 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.153 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.42 -42.3 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.795 . . . . 0.0 108.956 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.41 -8.97 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.558 -0.714 . . . . 0.0 109.407 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 57.9 t0 -100.18 4.46 44.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.904 . . . . 0.0 109.176 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.56 118.95 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.55 6.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 14' ' ' ASN . 8.0 tm-20 -131.09 129.34 41.76 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.407 -0.808 . . . . 0.0 109.137 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p30 -88.04 150.63 23.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.284 -0.885 . . . . 0.0 110.289 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.85 16.33 79.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -93.07 144.46 25.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.364 -1.08 . . . . 0.0 109.938 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.82 129.69 45.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.695 . . . . 0.0 109.565 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.71 -179.42 7.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.384 -0.822 . . . . 0.0 109.876 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 71' ' ' SER . 77.2 m-20 -140.09 145.48 37.69 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.453 -0.779 . . . . 0.0 109.157 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.96 158.57 30.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -100.57 139.69 35.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.044 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.26 157.51 40.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.892 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -103.06 153.89 19.81 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.1 110.45 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.132 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 25' ' ' ILE . 15.5 pt -91.5 -21.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 110.143 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -162.76 153.03 16.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.08 -1.013 . . . . 0.0 109.422 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.489 ' N ' HE21 ' A' ' 63' ' ' GLN . 91.5 mt -132.06 157.11 45.0 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.572 0.701 . . . . 0.0 109.909 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' VAL . 46.1 m95 -144.55 118.94 9.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.218 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 0.0 109.571 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.799 0.809 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -81.69 -65.1 1.05 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.547 0.689 . . . . 0.0 109.914 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -149.55 153.24 36.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.011 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 28' ' ' TRP . 3.0 t -137.91 163.75 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.55 33.55 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.1 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -126.96 146.81 50.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.973 -0.722 . . . . 0.0 109.123 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.1 mt -109.92 129.41 55.66 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.79 101.74 2.8 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -107.01 165.0 11.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.597 -0.943 . . . . 0.0 109.458 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.96 -18.78 62.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.52 -0.738 . . . . 0.0 109.847 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 p -91.66 -11.56 36.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 109.391 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.25 -146.61 15.89 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.56 151.1 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.691 -0.888 . . . . 0.0 109.636 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tp -146.48 138.06 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.765 . . . . 0.0 109.655 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -83.28 152.52 25.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.382 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.11 154.67 41.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.574 -1.329 . . . . 0.0 107.864 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -132.19 131.06 41.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.637 -0.664 . . . . 0.0 109.743 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.71 128.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -89.41 144.02 26.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 56' ' ' ALA . 53.8 mtmt -58.22 -34.36 70.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.84 -5.7 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -89.07 -33.41 17.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 108.719 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 49.81 50.25 18.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.597 -0.689 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.85 163.11 18.2 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.551 -0.718 . . . . 0.0 109.671 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.79 150.09 84.73 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.577 2.185 . . . . 0.0 112.325 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.5 mt -72.35 142.82 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 110.308 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -84.35 149.52 25.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.668 . . . . 0.0 109.723 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 62' ' ' GLU . 57.0 mp0 -110.14 142.39 41.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.964 0.888 . . . . 0.0 109.593 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.489 HE21 ' N ' ' A' ' 27' ' ' LEU . 99.5 mt-30 -74.56 137.58 42.49 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.541 0.686 . . . . 0.0 110.794 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.49 -14.91 64.4 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.06 155.01 16.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 0.0 110.832 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.468 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 5.7 p -93.39 158.79 15.55 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' A' ' 66' ' ' SER . 90.1 m-85 -149.8 149.28 30.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.66 131.73 50.56 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.0 mt -105.43 107.5 18.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -110.15 139.39 45.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.463 0.649 . . . . 0.0 110.252 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 25.2 t 55.25 59.11 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.88 -0.512 . . . . 0.0 110.908 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.42 165.57 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.34 -0.85 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.78 153.99 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.623 0.725 . . . . 0.0 109.759 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.03 131.28 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 0.0 109.709 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.47 148.13 17.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.29 100.19 12.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -1.166 . . . . 0.0 109.229 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' ARG . 73.5 t80 -101.49 105.2 16.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.403 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 56.4 t30 40.57 -117.13 0.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.527 -0.733 . . . . 0.0 110.686 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 97.7 m-20 -92.63 -18.35 23.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -99.29 162.78 12.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 110.056 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.48 153.0 24.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.23 163.13 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 0.0 109.124 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.62 125.89 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -106.08 126.19 51.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.381 -0.824 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -97.17 135.2 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -130.95 -169.41 2.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.479 -0.763 . . . . 0.0 109.747 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.53 -39.45 94.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.649 -0.657 . . . . 0.0 110.224 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -68.0 -19.63 64.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.794 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.57 166.24 17.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -0.843 . . . . 0.0 110.019 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -145.08 164.29 31.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -0.92 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mt -149.4 139.72 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -133.61 143.24 48.5 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.468 -0.77 . . . . 0.0 109.583 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 68.1 mttm -72.81 140.68 47.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.766 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt -111.64 147.72 34.89 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.634 0.73 . . . . 0.0 109.996 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -95.75 6.07 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.0 109.783 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.56 92.08 43.09 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.427 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.09 160.46 8.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.821 2.348 . . . . 0.0 112.117 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.81 139.2 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.552 -0.717 . . . . 0.0 109.55 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 . . . . . 0 C--N 1.303 -1.456 0 O-C-N 121.405 -0.809 . . . . 0.0 109.641 -179.488 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.64 152.6 78.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.585 -0.697 . . . . 0.0 109.935 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.59 163.04 38.44 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.577 2.185 . . . . 0.0 112.143 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -80.32 119.99 23.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -90.91 131.64 36.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 141.95 51.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.84 150.64 20.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 110.106 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mm -55.0 -45.45 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.64 0.733 . . . . 0.0 109.371 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.98 -11.72 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -97.4 3.91 50.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 109.653 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLU . 77.8 mt -59.87 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.306 -0.871 . . . . 0.0 110.483 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' ILE . 11.8 m 31.26 31.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.397 0.617 . . . . 0.0 110.735 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.3 tt0 -166.13 112.78 0.88 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.321 -0.862 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 54.1 p30 -86.91 154.45 20.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 23.98 76.3 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -97.48 140.2 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -1.031 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.91 128.62 44.05 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.44 -170.71 2.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -130.68 135.16 47.56 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.76 148.12 43.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -116.57 132.5 56.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.85 165.68 29.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.045 0.926 . . . . 0.0 110.925 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -105.6 155.69 18.97 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.909 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -88.36 99.78 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.234 -0.916 . . . . 0.0 110.467 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.73 -28.71 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.077 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.27 140.52 18.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 109.24 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.577 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 1.6 pt? -120.93 150.09 41.62 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.34 0.591 . . . . 0.0 109.926 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -141.03 112.25 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.374 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -71.25 120.73 17.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 109.433 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 23.3 t-20 -91.04 139.16 31.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 109.116 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -101.47 -8.57 21.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 109.066 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.583 ' N ' ' HD1' ' A' ' 32' ' ' HIS . 1.6 m80 -79.39 145.63 33.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -69.92 -34.5 73.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.679 . . . . 0.0 110.187 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.8 m -61.03 -46.23 91.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.129 -0.982 . . . . 0.0 109.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.3 mt -108.49 135.5 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.571 0.701 . . . . 0.0 109.566 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 t -96.85 -49.44 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.592 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.42 149.42 28.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.02 142.41 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.17 -161.52 12.61 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.92 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.2 146.16 46.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.943 -0.739 . . . . 0.0 109.42 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.3 mt -108.77 124.41 50.55 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.26 96.75 2.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.8 t0 -100.48 160.85 14.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -1.159 . . . . 0.0 109.387 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 84.3 tt0 -70.36 -20.5 62.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.693 -0.63 . . . . 0.0 109.858 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.4 p -92.15 -12.12 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.16 -153.28 24.46 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.99 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 pt -136.48 159.86 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.547 -0.973 . . . . 0.0 109.918 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -159.2 146.34 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.842 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -90.31 134.9 34.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -129.5 157.27 42.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 108.649 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.2 m -132.89 132.52 42.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.47 127.91 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -85.3 145.54 27.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 110.547 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.54 -36.64 78.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -59.63 -8.89 2.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.474 -0.766 . . . . 0.0 109.899 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 -26.47 24.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 109.044 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.59 51.32 15.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.697 -0.627 . . . . 0.0 109.878 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.0 mt -105.28 148.76 36.8 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.37 161.96 42.61 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.618 2.212 . . . . 0.0 112.637 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.01 141.0 47.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.665 0.745 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.2 mp -84.31 156.67 21.81 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -99.87 129.59 45.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.388 -0.82 . . . . 0.0 109.742 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.79 137.63 57.37 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.456 0.646 . . . . 0.0 110.487 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.93 -10.68 64.63 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -94.79 151.68 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -1.135 . . . . 0.0 110.31 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -84.99 140.44 31.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -133.7 142.87 48.19 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.754 0.787 . . . . 0.0 109.773 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.09 127.79 54.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.64 118.46 35.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -114.18 145.55 41.54 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.408 0.623 . . . . 0.0 110.403 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.9 t 58.17 58.15 3.65 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.726 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.05 165.98 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.343 -0.848 . . . . 0.0 109.273 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.27 149.81 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.729 0.776 . . . . 0.0 110.012 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.02 133.89 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.754 -0.591 . . . . 0.0 109.629 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.28 148.73 16.78 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -94.63 104.64 16.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -1.146 . . . . 0.0 109.148 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 80' ' ' ARG . 84.3 t80 -99.85 106.4 18.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.789 . . . . 0.0 109.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.2 t30 42.19 -116.64 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.549 -0.72 . . . . 0.0 110.757 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.41 -17.12 23.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.085 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 mmm-85 -100.94 156.43 17.39 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.874 0.845 . . . . 0.0 110.373 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -97.79 150.83 20.83 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.68 155.5 43.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 109.17 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.85 125.19 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.372 -0.83 . . . . 0.0 108.956 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -106.38 129.25 54.41 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.741 . . . . 0.0 109.279 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.89 131.22 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.0 m-80 -136.55 -163.08 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.804 0.812 . . . . 0.0 109.821 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 89' ' ' SER . 33.9 mmtt -57.35 166.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.792 -0.567 . . . . 0.0 109.472 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 12.8 t-20 72.81 -21.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.708 -0.62 . . . . 0.0 109.547 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 87' ' ' LYS . 87.1 p -74.61 159.29 32.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.3 m -136.86 156.22 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.399 -0.813 . . . . 0.0 109.131 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.62 130.66 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -132.16 138.05 47.88 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 0.0 109.355 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -81.81 138.98 35.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.592 -0.692 . . . . 0.0 109.762 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.71 137.73 48.01 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.922 0.868 . . . . 0.0 110.147 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -86.58 8.34 22.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -117.04 91.77 37.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.329 -0.857 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -55.34 152.32 32.62 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.887 2.391 . . . . 0.0 112.136 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.6 mt -101.14 147.79 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.26 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 101' ' ' GLY . 57.0 mp0 -46.85 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.855 . . . . 0.0 110.201 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 t 53.68 9.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 108.775 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 99' ' ' GLU . . . -154.98 86.34 0.13 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -153.36 111.7 3.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -1.118 . . . . 0.0 109.104 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.503 ' CG ' ' HD1' ' A' ' 104' ' ' HIS . 17.6 pt-20 -164.78 -22.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.171 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.503 ' HD1' ' CG ' ' A' ' 103' ' ' GLU . 28.3 p-80 -145.8 151.19 37.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -162.19 84.68 0.58 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 108.846 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -90.71 124.25 34.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 53.7 t-80 45.41 -109.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.906 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 80.0 m80 -142.74 143.6 32.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -0.834 . . . . 0.0 109.586 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.668 -179.896 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.501 0.667 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.73 152.39 91.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.569 -0.707 . . . . 0.0 109.875 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.64 148.76 78.65 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.584 2.189 . . . . 0.0 112.196 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.12 119.87 23.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.914 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -90.39 128.88 36.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.782 . . . . 0.0 109.753 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -128.44 145.01 51.22 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.19 143.0 28.42 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.71 0.767 . . . . 0.0 110.494 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 8' ' ' ILE . 83.1 mt -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.41 -0.806 . . . . 0.0 109.322 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.41 -10.79 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.448 -0.783 . . . . 0.0 109.918 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -97.51 6.28 48.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.584 ' O ' ' N ' ' A' ' 13' ' ' GLU . 44.8 mt -59.85 -70.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.3 m 40.5 17.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.741 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 11' ' ' ILE . 6.5 pt-20 -171.92 130.77 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.808 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.83 167.38 12.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.021 -1.049 . . . . 0.0 110.58 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.17 23.54 77.39 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.1 136.67 35.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -1.03 . . . . 0.0 110.17 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -97.33 127.44 43.3 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -162.71 -169.73 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 43.4 m-20 -140.59 137.86 33.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.568 -0.707 . . . . 0.0 109.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.67 147.45 25.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 110.391 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -101.14 140.92 34.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.53 0.681 . . . . 0.0 109.397 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 161.62 42.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.292 -0.88 . . . . 0.0 110.77 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.02 148.93 25.65 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.355 0.598 . . . . 0.0 109.645 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -87.48 94.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.278 -0.889 . . . . 0.0 110.52 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.8 mt -70.61 -31.26 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.499 -0.751 . . . . 0.0 109.324 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -148.07 129.3 14.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.064 -1.022 . . . . 0.0 109.604 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.7 tp -110.89 146.5 36.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -142.57 111.35 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.54 0.686 . . . . 0.0 109.795 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.31 124.11 23.34 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.666 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 32' ' ' HIS . 7.1 t30 -103.99 149.63 24.97 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.6 m -139.84 54.8 1.66 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.538 ' C ' ' H ' ' A' ' 34' ' ' SER . 65.5 t-80 -104.44 10.91 35.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.167 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 66.34 -35.82 0.24 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.092 0.472 . . . . 0.0 110.074 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 32' ' ' HIS . 63.7 m -86.36 -40.57 15.3 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.154 -0.967 . . . . 0.0 108.833 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt -105.37 138.49 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.674 0.749 . . . . 0.0 109.593 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -83.53 -56.79 3.54 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.666 0.746 . . . . 0.0 109.963 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -159.11 162.22 36.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.107 -0.996 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.09 159.61 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.18 -157.95 20.58 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -125.76 149.82 48.24 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.973 -0.722 . . . . 0.0 109.976 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD2' ' CD1' ' A' ' 50' ' ' PHE . 31.5 mt -109.91 124.81 52.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.17 94.35 1.9 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.58 159.99 14.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -1.011 . . . . 0.0 109.597 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.13 -17.54 63.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.819 -0.551 . . . . 0.0 109.839 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 p -92.43 -9.66 40.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.25 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.64 -148.29 19.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -138.16 160.56 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.696 -0.885 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -162.57 158.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.927 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -84.8 164.58 18.39 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.558 -0.714 . . . . 0.0 110.275 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CD1' ' CD2' ' A' ' 41' ' ' LEU . 24.8 p90 -156.06 153.65 29.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.069 -1.019 . . . . 0.0 108.549 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.516 ' OG1' ' NE2' ' A' ' 82' ' ' GLN . 69.5 m -136.36 129.57 31.51 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 HG22 HD13 ' A' ' 52' ' ' ILE . 89.3 mt -106.52 130.12 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -90.26 142.92 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 110.431 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.42 -35.04 76.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.687 -0.633 . . . . 0.0 109.456 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -58.89 -7.8 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.473 -0.767 . . . . 0.0 109.825 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.52 -23.59 34.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.869 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 51.16 44.26 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 109.887 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.57 151.6 39.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.796 -0.565 . . . . 0.0 109.716 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.54 146.89 50.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.479 2.119 . . . . 0.0 112.804 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.07 141.61 56.09 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.658 0.742 . . . . 0.0 110.491 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -81.1 139.85 35.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.0 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.32 134.08 37.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.466 -0.771 . . . . 0.0 110.17 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.78 136.57 48.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.402 0.62 . . . . 0.0 110.532 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -6.36 83.5 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.59 159.87 15.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -1.001 . . . . 0.0 110.543 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -95.7 148.93 22.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -141.23 150.07 42.18 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.005 0.907 . . . . 0.0 109.964 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.01 132.1 46.57 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 mt -112.72 112.4 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.928 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -118.64 145.46 45.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 71' ' ' SER . 7.5 t 57.33 54.91 6.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.04 165.94 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 0.0 109.304 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.859 0.838 . . . . 0.0 109.925 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -92.61 131.71 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.579 -0.7 . . . . 0.0 109.855 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.64 150.5 16.81 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.77 104.85 16.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.6 -0.941 . . . . 0.0 109.364 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 80' ' ' ARG . 42.0 t80 -97.06 104.22 16.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 109.239 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' TYR . 98.7 m-20 39.67 -111.87 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -95.13 -20.19 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.419 -0.801 . . . . 0.0 109.898 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.1 mtt180 -98.85 159.29 15.06 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.905 0.86 . . . . 0.0 110.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.3 149.97 20.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.752 . . . . 0.0 109.14 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 51' ' ' THR . 57.1 tt0 -144.03 150.96 39.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.89 124.47 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -107.43 126.36 52.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.446 -0.783 . . . . 0.0 109.567 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.22 132.82 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 89' ' ' SER . 13.5 p30 -146.06 -176.57 5.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.768 0.794 . . . . 0.0 110.014 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.528 ' C ' ' H ' ' A' ' 89' ' ' SER . 80.5 tttt -42.84 166.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 1.8 t-20 73.5 -30.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.65 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 87' ' ' LYS . 81.6 p -76.95 164.3 25.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 109.964 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 p -139.63 158.31 44.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.427 -0.796 . . . . 0.0 109.417 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.7 mt -141.89 133.73 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.499 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.37 138.71 46.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.612 0.72 . . . . 0.0 109.232 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -73.05 139.47 46.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.592 -0.692 . . . . 0.0 109.594 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 96' ' ' GLU . 89.3 mt -101.01 -13.37 18.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.9 t 51.91 4.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.758 -0.589 . . . . 0.0 109.732 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 94' ' ' LEU . 37.8 tp10 -107.59 127.29 28.07 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.617 -0.677 . . . . 0.0 109.5 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.82 141.08 29.9 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.411 2.074 . . . . 0.0 112.182 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.3 mt -112.09 135.97 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.77 -0.582 . . . . 0.0 109.456 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -91.76 118.5 30.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.39 -5.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.71 112.5 3.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 103' ' ' GLU . 3.5 tt -95.21 110.69 22.63 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.444 -1.033 . . . . 0.0 109.513 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 102' ' ' LEU . 42.8 tp10 56.39 114.39 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.543 0.687 . . . . 0.0 110.281 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -150.52 153.2 35.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -134.74 32.49 3.27 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.622 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 53.8 t-80 47.88 -106.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.358 -0.839 . . . . 0.0 109.614 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.622 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 86.1 t60 -152.11 -8.97 0.2 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.795 . . . . 0.0 109.383 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -152.53 -44.01 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.317 -0.864 . . . . 0.0 109.273 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.544 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -86.05 152.71 56.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.41 157.63 61.03 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.679 2.253 . . . . 0.0 112.186 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -79.26 116.31 19.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.313 -0.867 . . . . 0.0 109.471 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt -92.33 129.47 38.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.347 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' ' CD2' ' A' ' 20' ' ' LEU . 83.3 m -125.83 144.14 50.77 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.88 146.29 23.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.052 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.07 -42.36 89.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.176 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.55 -8.54 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.632 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -103.37 9.28 37.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -86.32 124.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.168 -0.957 . . . . 0.0 109.944 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -144.13 8.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 109.286 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -143.37 138.75 29.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.277 -0.89 . . . . 0.0 109.141 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 54.0 p30 -97.52 159.37 14.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.448 -0.783 . . . . 0.0 110.353 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.91 9.91 84.74 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.85 155.55 17.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -1.083 . . . . 0.0 109.691 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.2 134.71 50.66 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.462 0.649 . . . . 0.0 109.572 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.17 -176.78 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.905 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 7.7 t30 -122.48 142.97 50.01 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -139.12 128.2 23.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.32 -0.862 . . . . 0.0 109.686 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -112.45 132.75 54.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.39 -173.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -112.53 154.91 25.2 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.09 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -92.48 113.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -71.67 -26.77 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 0.0 110.035 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.506 ' OE1' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -172.45 167.41 5.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.98 -1.075 . . . . 0.0 109.182 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.678 ' N ' HE21 ' A' ' 63' ' ' GLN . 82.7 mt -138.29 160.87 38.36 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.428 0.632 . . . . 0.0 110.005 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.406 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 14.6 t90 -134.86 105.63 6.51 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.55 0.69 . . . . 0.0 109.414 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 37' ' ' GLN . 51.4 tp10 -73.66 119.78 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.291 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -95.67 177.89 5.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 109.079 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.2 p -129.6 0.89 4.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.543 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 93.8 m-70 -94.98 170.51 9.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.365 -0.835 . . . . 0.0 109.85 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -88.14 -41.64 12.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.38 -0.825 . . . . 0.0 110.007 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 35' ' ' ILE . 15.7 m -75.36 65.58 1.68 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.56 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 2.6 mt 145.15 120.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 121.324 0.583 . . . . 0.0 109.655 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -94.5 -58.36 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.034 . . . . 0.0 109.666 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.543 ' NE2' ' OE1' ' A' ' 29' ' ' GLU . 6.7 mm-40 -145.0 149.29 34.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.046 -1.034 . . . . 0.0 109.979 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.47 127.99 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.4 -159.86 9.48 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.46 149.45 52.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.733 -0.863 . . . . 0.0 109.666 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.85 126.79 53.43 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.59 100.55 2.64 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 46' ' ' GLY . 5.5 p-10 -104.96 161.79 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.297 -1.12 . . . . 0.0 109.285 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.87 -17.38 63.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.743 . . . . 0.0 109.928 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.445 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 31.7 p -94.42 -3.88 49.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' OD2' ' A' ' 43' ' ' ASP . . . 146.47 -144.42 12.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.35 166.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.678 -0.895 . . . . 0.0 110.05 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.78 162.66 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.103 -0.998 . . . . 0.0 109.846 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -97.09 149.77 21.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.0 109.729 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.36 157.46 44.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.431 -1.418 . . . . 0.0 107.801 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -130.93 134.27 46.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.582 -0.699 . . . . 0.0 109.685 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 mm -102.64 127.91 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 109.149 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -83.69 137.26 33.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 110.497 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.92 -33.74 75.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -58.77 -11.03 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.596 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.9 -22.43 27.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -0.939 . . . . 0.0 108.988 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.07 55.76 7.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.64 -0.663 . . . . 0.0 109.914 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -106.03 147.94 35.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.594 -0.691 . . . . 0.0 109.832 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.86 159.77 51.35 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.521 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.66 137.98 55.99 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.627 0.727 . . . . 0.0 109.987 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.1 mp -79.61 155.1 28.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.843 -0.536 . . . . 0.0 109.667 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 3.1 tm-20 -100.54 121.85 42.27 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.955 0.883 . . . . 0.0 109.707 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.678 HE21 ' N ' ' A' ' 27' ' ' LEU . 98.8 mt-30 -63.37 138.31 58.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 -10.93 67.76 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.92 158.82 15.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -1.182 . . . . 0.0 110.458 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 96' ' ' GLU . 47.9 p -95.45 124.87 39.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 44.4 m-85 -118.54 150.07 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.971 0.891 . . . . 0.0 109.78 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 tp -110.84 127.17 55.32 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 45.7 mt -114.36 114.96 26.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -109.93 147.27 33.74 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.458 0.647 . . . . 0.0 110.43 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.4 t 58.26 58.5 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.015 0.436 . . . . 0.0 110.772 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.4 m -109.2 160.41 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.301 -0.874 . . . . 0.0 108.886 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.77 144.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.618 0.723 . . . . 0.0 109.533 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.8 t -92.19 131.75 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.58 22.12 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.491 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 97.3 mt-10 -96.96 135.04 39.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -1.116 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -135.99 119.72 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.84 . . . . 0.0 109.621 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 51.8 48.12 23.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.7 t0 60.57 20.0 9.86 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.679 -0.638 . . . . 0.0 110.449 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -128.54 155.07 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -74.63 137.57 42.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -148.62 152.07 36.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.052 -1.03 . . . . 0.0 108.977 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.96 124.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -104.95 126.34 51.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.46 132.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.88 -170.29 1.84 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.68 0.753 . . . . 0.0 109.874 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -66.15 -42.91 88.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.766 -0.584 . . . . 0.0 110.43 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.415 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 2.0 p30 -61.15 -7.7 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -83.32 164.41 20.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -136.07 154.93 50.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.312 -0.867 . . . . 0.0 108.875 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.57 127.6 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -128.39 131.6 48.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 108.957 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 136.06 36.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLU . 9.5 mp -103.86 -3.96 24.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.479 -0.763 . . . . 0.0 109.454 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t 49.41 7.93 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 94' ' ' LEU . 31.7 tt0 -103.62 124.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 109.312 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.17 141.18 25.87 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.054 1.836 . . . . 0.0 112.1 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.43 135.68 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 102' ' ' LEU . 36.5 tt0 -98.57 121.6 40.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.54 48.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.35 -143.62 11.77 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.404 ' O ' ' OE2' ' A' ' 99' ' ' GLU . 69.2 mt -102.48 -65.31 1.0 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -1.139 . . . . 0.0 109.343 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.16 142.11 49.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 110.581 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' A' ' 104' ' ' HIS . 60.3 t-80 -145.83 24.17 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 51.5 91.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 109.505 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.27 137.51 46.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -142.82 144.99 32.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -144.95 139.24 27.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.165 -179.723 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.6 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.492 0.663 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.43 58.55 0.26 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.411 -0.805 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 154.64 63.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.787 2.325 . . . . 0.0 112.047 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -78.56 117.17 19.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.7 mt -92.52 130.47 38.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.309 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.6 m -124.56 144.69 50.0 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -96.77 151.23 19.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.0 mt -58.17 -44.01 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.405 -0.809 . . . . 0.0 109.1 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.1 -14.55 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.781 . . . . 0.0 109.46 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.0 4.7 53.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.194 -0.941 . . . . 0.0 109.364 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.3 mt -87.67 121.45 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.816 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.95 7.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -135.89 135.32 39.6 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 0.0 109.078 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -94.0 157.4 16.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 110.278 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.5 19.24 79.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -99.77 150.37 22.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.363 -1.081 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -101.56 131.35 47.78 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.0 179.6 8.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.695 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -120.24 137.21 54.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -127.82 148.45 50.45 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -135.63 134.01 38.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.26 -176.85 1.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -105.71 156.31 18.41 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.47 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -92.53 107.58 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.407 -0.808 . . . . 0.0 110.226 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.2 -27.18 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 109.906 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -171.0 161.64 6.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.564 0.697 . . . . 0.0 110.086 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -143.76 121.02 11.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' ' 37' ' ' GLN . 80.9 mm-40 -82.18 135.94 35.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.675 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.557 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -94.49 148.95 21.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 108.784 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.3 p -104.86 -10.73 17.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.248 -0.907 . . . . 0.0 109.139 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -72.3 141.32 48.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.245 -0.909 . . . . 0.0 109.7 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -33.47 75.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.292 -0.88 . . . . 0.0 109.971 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -64.33 -77.44 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.4 mt -67.29 147.1 12.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 13.8 t -100.24 -51.13 3.74 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.716 0.769 . . . . 0.0 109.691 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' ' 29' ' ' GLU . 33.2 mt-30 -152.07 154.43 35.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 110.224 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.96 156.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.28 -172.09 34.07 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.233 -1.461 . . . . 0.0 109.853 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.89 144.55 47.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.756 -0.849 . . . . 0.0 109.396 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.8 mt -114.55 124.78 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.89 101.63 2.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -106.44 164.66 11.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.983 . . . . 0.0 109.312 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OE2' ' A' ' 44' ' ' GLU . 1.4 mp0 -70.53 -20.24 62.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 110.106 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 p -91.05 -9.62 45.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.952 . . . . 0.0 109.244 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.02 -145.84 14.15 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 8.0 mt -139.02 155.14 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -1.024 . . . . 0.0 109.331 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 148.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.88 . . . . 0.0 109.652 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.77 138.0 36.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 109.454 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.47 159.54 34.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.145 -0.972 . . . . 0.0 108.58 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -133.66 137.91 45.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.657 . . . . 0.0 109.708 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -104.15 126.96 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.371 0.605 . . . . 0.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -88.03 145.62 25.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 110.361 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -50.43 -29.9 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.601 -0.687 . . . . 0.0 109.35 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -13.39 10.92 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 109.881 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -113.89 44.53 1.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.309 -0.869 . . . . 0.0 109.209 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' ALA . 8.2 pt-20 -35.12 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.716 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.8 mt -109.35 153.5 42.7 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.73 162.26 32.42 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.444 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.86 135.62 54.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.512 -0.743 . . . . 0.0 110.198 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.4 mp -79.49 153.66 29.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 109.839 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -96.79 120.14 36.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.404 -0.81 . . . . 0.0 109.896 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.31 147.92 52.35 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.761 0.791 . . . . 0.0 110.194 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.53 -10.88 48.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -97.64 161.03 13.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 0.0 110.5 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -88.31 146.92 25.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.288 0.566 . . . . 0.0 109.631 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -142.11 145.94 34.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.97 0.89 . . . . 0.0 109.691 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.17 129.76 55.85 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.36 119.81 39.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.588 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.17 148.03 43.54 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m 56.49 55.75 6.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 120.945 0.402 . . . . 0.0 110.451 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.19 165.8 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.293 -0.879 . . . . 0.0 108.9 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.74 150.38 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.649 0.738 . . . . 0.0 109.444 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.85 137.01 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.788 -0.57 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.77 153.45 17.62 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -91.32 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 109.417 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' ARG . 69.5 t80 -100.57 106.55 18.06 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.761 0.791 . . . . 0.0 109.55 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 44.97 -115.4 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.524 -0.735 . . . . 0.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 63.2 t0 -97.28 -14.27 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' TYR . 75.3 ttt180 -109.01 151.5 26.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.261 -0.9 . . . . 0.0 110.23 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.11 160.22 15.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.455 HE21 HE21 ' A' ' 84' ' ' GLN . 13.2 pt20 -146.87 162.82 37.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.295 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.02 126.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 108.943 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.455 HE21 HE21 ' A' ' 82' ' ' GLN . 87.4 mt-30 -104.93 127.59 52.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.492 -0.755 . . . . 0.0 109.396 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.04 132.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.454 -0.779 . . . . 0.0 108.997 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.42 ' OD1' ' OG ' ' A' ' 89' ' ' SER . 21.7 p30 -125.0 -173.56 2.83 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.662 0.744 . . . . 0.0 109.89 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -40.39 96.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.566 -0.709 . . . . 0.0 109.962 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -68.45 -12.87 61.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' A' ' 86' ' ' ASN . 49.7 m -82.93 163.77 20.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 109.822 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -140.69 162.36 35.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.269 -0.894 . . . . 0.0 109.049 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.8 mt -138.38 130.6 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -130.02 134.65 47.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.359 -0.838 . . . . 0.0 109.019 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -74.68 135.46 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.78 129.71 41.62 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.889 0.852 . . . . 0.0 110.16 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.4 t -77.44 -6.48 53.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.767 -0.583 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -114.28 95.71 40.13 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.438 -0.789 . . . . 0.0 109.268 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.34 152.05 16.34 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.444 2.096 . . . . 0.0 112.116 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -101.43 134.14 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -85.34 132.49 34.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.783 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.66 75.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.76 -106.65 0.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 102' ' ' LEU . 10.0 mp -94.37 109.2 21.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.24 . . . . 0.0 109.413 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -68.9 -37.16 78.79 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.348 0.594 . . . . 0.0 109.693 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.506 ' N ' ' HD1' ' A' ' 104' ' ' HIS . 6.3 p-80 -153.0 152.44 31.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 108.842 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.744 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.457 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 86.4 t60 45.62 -101.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.886 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 108' ' ' HIS . 56.3 t-80 47.05 -115.87 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.533 ' H ' ' CG ' ' A' ' 107' ' ' HIS . 60.6 t-80 -66.01 -42.65 89.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.29 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -164.72 59.16 0.66 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.615 -0.678 . . . . 0.0 109.466 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.42 156.94 57.68 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.62 2.214 . . . . 0.0 112.062 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -80.6 113.44 18.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.0 133.79 37.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.591 -0.693 . . . . 0.0 109.868 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -127.98 152.03 48.41 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.453 0.644 . . . . 0.0 109.548 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.38 147.08 24.55 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.707 0.765 . . . . 0.0 110.162 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.12 -44.28 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.53 -11.25 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.601 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 52.8 t0 -96.73 8.33 44.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -87.11 120.74 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.85 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.2 4.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.843 . . . . 0.0 109.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -134.8 131.54 37.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.353 -0.842 . . . . 0.0 109.122 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.26 160.19 14.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.29 18.98 79.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -103.06 156.38 17.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.504 -0.998 . . . . 0.0 109.899 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -102.81 131.97 49.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.57 176.59 12.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 109.866 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' SER . 61.7 m-20 -138.91 142.99 38.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.657 . . . . 0.0 109.648 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.5 tp -159.14 147.14 17.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.034 -1.041 . . . . 0.0 110.423 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -94.06 137.66 33.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.72 158.34 44.08 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.083 0.944 . . . . 0.0 110.661 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.74 152.72 18.84 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.304 0.573 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 59.6 t -93.23 101.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.04 -26.31 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 0.0 109.77 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -168.68 160.34 10.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -135.07 160.08 39.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.186 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -143.14 113.82 7.52 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.483 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.77 130.26 41.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -115.83 126.68 54.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 33' ' ' GLU . 1.9 m -109.48 13.86 23.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.581 -0.699 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.636 ' HD1' ' HG ' ' A' ' 34' ' ' SER . 61.9 t-80 -67.29 7.26 0.45 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.385 -0.822 . . . . 0.0 109.297 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 31' ' ' THR . 76.4 tt0 65.33 -55.81 0.32 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.184 0.516 . . . . 0.0 110.091 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.636 ' HG ' ' HD1' ' A' ' 32' ' ' HIS . 78.1 p -59.66 -41.94 91.72 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.126 -0.984 . . . . 0.0 108.919 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.1 mt -103.79 136.46 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 109.449 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 11.4 p -88.42 -56.5 3.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.568 -0.707 . . . . 0.0 109.769 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.504 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.5 tt0 -154.55 155.24 34.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.433 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.35 149.67 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.2 -158.77 14.63 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.135 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 mt -121.45 149.08 43.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.091 -0.652 . . . . 0.0 109.555 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.3 127.84 55.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.536 0.684 . . . . 0.0 109.407 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.83 96.73 2.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -93.92 157.1 16.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.6 -18.18 64.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.675 -0.641 . . . . 0.0 109.768 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -98.88 -11.52 21.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.378 -0.826 . . . . 0.0 109.153 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -154.06 24.96 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.084 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.06 160.41 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.616 -0.932 . . . . 0.0 109.84 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -160.4 147.14 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.521 -0.737 . . . . 0.0 109.914 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.72 164.65 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.875 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.88 150.0 23.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.167 -0.958 . . . . 0.0 108.98 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -137.24 135.08 36.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.036 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.441 ' O ' ' OG ' ' A' ' 36' ' ' SER . 79.8 mt -105.62 129.09 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.617 -0.677 . . . . 0.0 109.537 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -84.04 139.7 32.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 110.504 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -60.72 -37.2 80.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.655 -0.653 . . . . 0.0 109.391 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.83 -11.07 4.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.822 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.61 -25.83 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.131 -0.98 . . . . 0.0 108.974 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 53.94 52.13 13.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.63 -0.669 . . . . 0.0 110.146 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.86 156.12 36.49 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.337 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.31 154.41 74.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.711 2.274 . . . . 0.0 112.7 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.62 142.17 46.53 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.787 0.804 . . . . 0.0 110.626 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.2 mp -81.13 151.0 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.764 -0.585 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.02 136.11 43.45 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.747 0.784 . . . . 0.0 109.945 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 24' ' ' VAL . 10.3 tm0? -72.38 134.9 45.68 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 110.682 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 -13.18 67.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.4 mp0 -97.77 157.58 15.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -1.121 . . . . 0.0 110.681 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 96' ' ' GLU . 12.1 p -100.92 141.07 34.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -134.41 157.03 47.48 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.161 0.982 . . . . 0.0 110.13 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.4 tp -105.31 134.02 49.12 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 mt -110.13 108.84 19.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 92' ' ' GLU . 65.4 mtm180 -112.81 148.2 35.34 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.595 0.712 . . . . 0.0 110.376 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.9 p 51.16 58.17 5.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 122.054 -0.404 . . . . 0.0 110.827 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.65 165.09 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.517 -0.739 . . . . 0.0 109.319 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 p -123.36 149.25 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 121.724 0.773 . . . . 0.0 109.82 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.34 135.13 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.629 -0.669 . . . . 0.0 109.867 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.62 158.24 17.27 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -100.16 93.76 5.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.949 . . . . 0.0 109.329 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.497 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.1 t80 -106.09 119.27 38.78 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.744 0.783 . . . . 0.0 109.707 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.3 m120 53.51 50.17 17.91 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.336 0.588 . . . . 0.0 110.624 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t0 64.41 -12.69 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.744 -0.598 . . . . 0.0 110.408 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' A' ' 78' ' ' ASN . 91.6 mtm-85 -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.187 -0.946 . . . . 0.0 110.351 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -76.4 146.11 38.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.602 -0.686 . . . . 0.0 109.355 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -147.14 151.29 36.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.177 -0.952 . . . . 0.0 109.382 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.32 122.45 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -102.18 128.65 48.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 t -100.1 134.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.538 -0.726 . . . . 0.0 109.08 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -131.32 -168.93 2.08 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.71 0.767 . . . . 0.0 109.952 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -62.12 -42.33 99.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.279 0.561 . . . . 0.0 109.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -65.36 -22.2 66.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -81.5 164.26 22.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -140.52 162.55 35.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.4 mt -138.84 132.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.63 -0.669 . . . . 0.0 109.653 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 89.1 mt-10 -131.35 135.96 47.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.548 -0.72 . . . . 0.0 109.218 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -81.84 135.77 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' C ' ' N ' ' A' ' 96' ' ' GLU . 4.0 mm? -109.86 0.35 18.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.64 -0.663 . . . . 0.0 109.988 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 p 49.78 14.91 0.14 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 109.733 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' SER . 24.0 mm-40 -114.07 110.17 48.81 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.281 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.36 151.26 59.72 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.712 2.274 . . . . 0.0 112.724 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -105.56 143.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.7 . . . . 0.0 109.679 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -89.49 123.53 33.68 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.798 0.809 . . . . 0.0 109.864 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.2 m -91.11 39.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.34 21.34 64.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.7 tp -82.85 102.25 11.51 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.338 -1.096 . . . . 0.0 109.774 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -170.71 -29.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.426 0.632 . . . . 0.0 109.35 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.43 17.68 3.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -59.55 -45.22 92.44 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -69.39 139.67 54.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -128.58 65.78 1.41 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.778 -0.576 . . . . 0.0 109.666 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 74.1 m80 46.37 -165.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.791 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.296 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -73.86 152.37 88.94 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.416 ' CG ' ' ND2' ' A' ' 19' ' ' ASN . 56.3 Cg_endo -69.67 169.68 18.24 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.69 2.26 . . . . 0.0 112.301 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -81.11 113.24 19.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 131.42 34.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.592 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.0 m -119.3 132.52 55.9 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -98.5 155.73 17.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 110.085 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.55 -49.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.655 0.741 . . . . 0.0 109.349 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.37 -13.89 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 49.4 t0 -93.03 -3.18 54.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLU . 97.7 mt -58.6 -73.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 110.416 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 11' ' ' ILE . 15.6 m 31.93 29.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.396 0.617 . . . . 0.0 110.923 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.2 tt0 -167.23 114.17 0.78 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.472 -0.768 . . . . 0.0 109.066 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -87.15 153.64 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.78 72.69 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -94.52 137.21 33.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.094 . . . . 0.0 109.929 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.57 125.44 38.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.04 -167.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.828 . . . . 0.0 109.792 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.416 ' ND2' ' CG ' ' A' ' 3' ' ' PRO . 60.2 m-20 -117.64 146.29 43.77 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.47 131.17 35.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 0.0 110.475 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -116.55 127.84 54.88 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.56 169.77 19.7 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -103.59 154.94 18.95 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.873 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.96 113.78 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.375 -0.828 . . . . 0.0 109.656 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -93.41 -22.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.674 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.655 ' NE2' ' HE1' ' A' ' 28' ' ' TRP . 18.2 tt0 -152.79 136.07 15.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.783 -1.198 . . . . 0.0 109.609 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 4.2 mm? -108.18 143.28 37.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.642 0.734 . . . . 0.0 109.682 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.655 ' HE1' ' NE2' ' A' ' 26' ' ' GLN . 61.6 m95 -145.0 119.78 9.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.696 0.76 . . . . 0.0 109.129 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.4 pm0 -89.3 144.08 26.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.62 -0.675 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.636 HD21 ' N ' ' A' ' 31' ' ' THR . 0.6 OUTLIER -144.84 127.46 16.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.195 -0.941 . . . . 0.0 108.995 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.636 ' N ' HD21 ' A' ' 30' ' ' ASN . 0.1 OUTLIER -145.23 18.85 1.57 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.127 -0.983 . . . . 0.0 108.694 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.455 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 97.0 m-70 -68.39 -43.54 77.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.573 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -120.21 -134.05 0.31 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.745 -0.597 . . . . 0.0 109.43 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.9 p -84.71 -2.57 57.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 108.826 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 30' ' ' ASN . 45.4 mt -72.8 128.49 35.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 109.605 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -93.16 -57.93 2.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 109.664 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -149.67 150.72 32.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -141.5 155.8 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.66 -171.15 35.72 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.071 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.09 146.14 40.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.91 -0.759 . . . . 0.0 109.601 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.9 mt -117.23 124.16 48.38 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.59 0.709 . . . . 0.0 109.096 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' CD1' ' A' ' 25' ' ' ILE . . . -95.28 97.4 2.12 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.6 t0 -99.04 161.23 13.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.273 -1.134 . . . . 0.0 109.304 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.8 mt-10 -66.32 -18.55 65.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.2 p -93.73 -5.1 49.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.01 -144.53 12.71 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -135.64 163.45 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.647 -0.913 . . . . 0.0 109.958 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 151.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.5 159.22 18.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -147.79 153.98 39.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.488 -1.383 . . . . 0.0 108.026 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -133.96 129.82 36.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.477 -0.764 . . . . 0.0 109.906 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 52' ' ' ILE . 89.1 mt -104.33 129.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.593 -0.692 . . . . 0.0 109.67 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -87.91 145.7 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 56' ' ' ALA . 51.8 mtmt -58.11 -38.22 76.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.496 -0.753 . . . . 0.0 109.309 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -59.51 -4.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 109.695 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -85.78 -27.91 24.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 108.879 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 55.17 52.96 10.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.627 -0.671 . . . . 0.0 110.244 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.41 147.22 35.9 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.657 -0.652 . . . . 0.0 109.853 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.1 164.39 32.27 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.705 2.27 . . . . 0.0 112.648 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.4 mt -72.99 141.19 47.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.516 -0.74 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.9 mp -84.13 145.11 28.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.75 -0.594 . . . . 0.0 109.846 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.3 137.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.317 -0.864 . . . . 0.0 109.885 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.09 137.52 40.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.702 . . . . 0.0 110.808 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.3 -7.21 72.14 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -106.11 162.21 13.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.366 -1.079 . . . . 0.0 110.689 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -100.96 142.58 32.23 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.79 152.2 51.57 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.97 0.89 . . . . 0.0 110.151 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.1 tp -109.33 131.51 54.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.28 111.14 22.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.368 -0.833 . . . . 0.0 109.158 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.478 ' O ' ' OG ' ' A' ' 71' ' ' SER . 74.8 mtm180 -109.92 149.18 30.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.611 -0.681 . . . . 0.0 110.388 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 2.8 p 52.72 57.77 6.04 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.89 167.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.423 -0.798 . . . . 0.0 109.147 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.56 152.04 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.74 0.781 . . . . 0.0 109.718 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 132.84 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.769 -0.582 . . . . 0.0 109.553 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 147.78 16.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -90.51 101.19 13.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -1.134 . . . . 0.0 109.181 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.63 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 16.0 t80 -97.79 101.12 12.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 109.132 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.63 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 13.0 p30 40.25 -117.58 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 50.1 t0 -90.81 -18.07 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 77' ' ' TYR . 64.3 ttm-85 -100.0 154.46 18.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.169 -0.957 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.79 151.17 19.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 108.78 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -145.41 151.5 38.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.987 -1.071 . . . . 0.0 109.02 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.45 121.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.934 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.62 127.79 53.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.0 133.84 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -133.76 -170.27 2.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 89' ' ' SER . 73.4 tttt -53.83 166.15 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.2 t-20 72.09 -19.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.677 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 87' ' ' LYS . 16.4 p -76.69 162.81 27.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.07 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.0 p -145.22 166.31 25.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.264 -0.897 . . . . 0.0 108.973 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 91' ' ' ILE . 96.9 mt -138.99 131.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -128.0 131.12 49.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.312 -0.867 . . . . 0.0 108.903 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.77 137.15 51.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 109.639 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.26 135.31 39.37 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.958 0.885 . . . . 0.0 110.192 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 m -82.35 -5.88 58.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -121.9 119.89 28.73 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.89 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 161.47 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.509 2.14 . . . . 0.0 112.128 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.19 152.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 101' ' ' GLY . 96.7 mt-10 -47.23 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.715 . . . . 0.0 109.997 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 t 60.56 -72.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 99' ' ' GLU . . . -77.31 -80.35 0.66 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.452 ' CG ' ' H ' ' A' ' 103' ' ' GLU . 3.8 tp -151.9 -145.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -1.231 . . . . 0.0 109.983 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 102' ' ' LEU . 48.5 tp10 -97.57 107.91 20.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.742 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.0 m80 44.93 -163.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.905 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -65.4 -38.07 88.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 109.326 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 49.31 90.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.422 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.23 144.76 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.45 -43.71 89.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 56.1 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -53.27 152.78 7.7 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.545 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.18 177.01 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.58 2.187 . . . . 0.0 111.993 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.58 120.2 21.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.177 -0.952 . . . . 0.0 110.127 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.6 mm? -89.89 126.42 35.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.6 m -121.99 142.12 50.64 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -95.92 148.35 22.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.045 -1.034 . . . . 0.0 110.121 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.41 -43.61 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.197 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.91 -15.16 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 9.93 29.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 109.933 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.54 122.48 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.077 -1.015 . . . . 0.0 110.0 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.19 -0.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.304 -0.872 . . . . 0.0 109.749 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -131.73 134.29 45.72 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.32 -0.863 . . . . 0.0 109.081 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 57.0 p30 -90.07 159.01 17.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 109.881 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.69 79.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -98.47 147.02 25.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.343 -1.093 . . . . 0.0 109.706 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -97.82 135.13 40.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.418 -0.801 . . . . 0.0 109.592 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.432 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -157.39 169.02 25.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.111 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 71' ' ' SER . 11.3 m120 -132.41 136.96 47.12 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -159.67 178.84 9.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.021 -1.05 . . . . 0.0 110.461 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -128.39 148.45 50.7 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.46 38.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.742 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -93.2 152.5 19.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.592 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.99 99.67 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 110.333 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 mm -73.35 -25.49 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.517 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 53.2 tt0 -166.63 157.85 12.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.0 -1.063 . . . . 0.0 109.702 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -127.66 153.32 46.61 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.542 -0.724 . . . . 0.0 110.071 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.517 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 44.0 m95 -144.28 123.06 12.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.284 -0.885 . . . . 0.0 109.231 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -68.38 140.26 55.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.513 -0.742 . . . . 0.0 109.455 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 10.8 p-10 -59.11 140.06 56.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.056 -1.028 . . . . 0.0 109.477 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.0 p -97.96 -0.88 43.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.0 108.856 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.536 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 99.4 m-70 -143.02 152.84 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' A' ' 34' ' ' SER . 17.2 pt-20 -57.64 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.486 -0.759 . . . . 0.0 110.172 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 33' ' ' GLU . 1.9 p 71.2 -55.15 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.469 -0.769 . . . . 0.0 110.034 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.5 mt -87.27 135.75 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.972 -1.08 . . . . 0.0 109.302 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 17.2 p -87.31 -58.52 2.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.7 tt0 -149.55 155.36 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.957 -1.09 . . . . 0.0 109.771 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 39' ' ' GLY . 53.9 t -137.95 160.92 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' N ' ' CG1' ' A' ' 38' ' ' VAL . . . 177.42 -162.75 30.9 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.881 -1.628 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.51 150.6 40.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.894 -0.768 . . . . 0.0 109.142 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.1 129.23 54.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.611 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.0 103.75 2.79 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -103.01 163.86 11.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.99 . . . . 0.0 109.154 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' A' ' 99' ' ' GLU . 47.2 tp10 -69.41 -19.44 63.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -92.31 -10.87 36.77 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.941 -1.1 . . . . 0.0 110.14 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -150.29 21.87 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 pt -132.94 159.12 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.581 -0.952 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.8 tt -161.36 150.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.6 164.07 22.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 108.961 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.12 154.51 31.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.563 -1.336 . . . . 0.0 108.422 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 t -139.56 133.52 30.9 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.239 -0.913 . . . . 0.0 110.251 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.42 ' O ' ' OG ' ' A' ' 36' ' ' SER . 88.8 mt -105.27 128.7 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -96.64 147.75 23.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 0.0 110.335 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -67.06 -19.31 65.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.725 . . . . 0.0 109.379 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -61.23 -33.26 73.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.842 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.34 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.047 . . . . 0.0 109.276 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.74 61.21 2.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.434 -0.791 . . . . 0.0 110.09 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.74 148.74 38.81 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.606 -0.684 . . . . 0.0 109.398 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.52 161.33 45.51 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.519 2.146 . . . . 0.0 112.189 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.19 143.63 50.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 110.364 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -85.15 148.43 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.573 -0.705 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -95.19 134.55 37.8 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.41 137.16 52.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.51 -12.84 68.81 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.26 158.39 15.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.877 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 p -94.92 143.74 26.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.32 152.55 51.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.816 0.817 . . . . 0.0 110.186 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.33 130.84 46.48 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.5 mt -109.01 105.26 14.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.513 ' NE ' ' OG ' ' A' ' 90' ' ' SER . 87.3 mtm-85 -107.68 133.04 52.67 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.594 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 1.1 m 70.81 59.37 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.116 -0.365 . . . . 0.0 110.76 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 m -112.86 160.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.346 -0.846 . . . . 0.0 109.456 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.45 151.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.499 0.666 . . . . 0.0 109.351 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.59 132.12 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.124 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.28 151.69 18.01 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' OE2' ' N ' ' A' ' 79' ' ' ASP . 10.8 tm-20 -98.76 93.15 5.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.129 -1.218 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -111.27 117.39 33.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.444 -0.785 . . . . 0.0 110.119 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 80' ' ' ARG . 20.0 t-20 55.57 54.36 8.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.818 . . . . 0.0 110.293 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' N ' ' OE2' ' A' ' 76' ' ' GLU . 91.2 m-20 56.35 -2.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.676 -0.64 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 78' ' ' ASN . 14.6 mmp_? -102.24 158.58 16.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.041 -1.037 . . . . 0.0 109.737 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.23 146.69 25.92 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.88 154.61 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.02 117.2 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.377 -0.827 . . . . 0.0 109.094 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -107.08 127.38 53.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.323 -0.861 . . . . 0.0 109.538 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.6 124.59 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -152.55 -173.71 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 109.689 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 57.0 -152.64 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.54 0.686 . . . . 0.0 110.365 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 89' ' ' SER . 92.3 m-20 -83.58 27.18 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 88' ' ' ASN . 12.1 p -47.86 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.513 ' OG ' ' NE ' ' A' ' 70' ' ' ARG . 13.6 p -139.44 161.67 36.9 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.073 -1.017 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.3 mt -140.85 132.87 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.946 . . . . 0.0 109.272 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.466 ' CB ' HH12 ' A' ' 70' ' ' ARG . 83.8 tt0 -124.73 124.99 43.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.06 140.52 43.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 109.82 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.08 142.31 29.94 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.8 p -83.85 -3.82 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.589 -0.695 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.88 133.01 21.09 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.429 -0.794 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.77 155.9 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.848 1.699 . . . . 0.0 112.04 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -108.62 133.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 84.7 tt0 -88.79 124.0 33.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.87 -7.73 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.51 119.61 5.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -98.92 110.78 23.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -1.018 . . . . 0.0 108.75 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.08 140.92 57.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.679 -0.638 . . . . 0.0 110.265 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -59.38 -85.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.302 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -158.06 157.09 32.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.278 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -96.69 20.63 10.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -0.874 . . . . 0.0 108.983 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -59.94 -41.48 91.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.578 -0.701 . . . . 0.0 109.811 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -67.6 127.69 33.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.573 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 78.3 m80 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.357 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 46.08 57.21 16.39 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.764 -0.585 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.19 159.15 52.94 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 112.262 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.4 mp0 -81.36 111.54 17.82 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.348 -0.845 . . . . 0.0 109.56 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.4 mt -91.53 134.25 34.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.669 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -127.15 146.46 50.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.462 0.648 . . . . 0.0 109.381 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.35 147.71 22.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 110.072 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.36 -43.53 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.608 -0.682 . . . . 0.0 109.188 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 p -65.61 -6.3 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.475 -0.765 . . . . 0.0 109.454 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -103.98 6.82 36.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -88.08 115.76 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 109.778 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.56 5.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -125.57 122.81 37.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.788 . . . . 0.0 109.246 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 15' ' ' GLY . 2.3 t-20 -82.02 150.67 27.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.975 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.587 ' N ' ' ND2' ' A' ' 14' ' ' ASN . . . 76.93 19.33 77.71 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -96.32 144.11 26.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.481 -1.011 . . . . 0.0 110.095 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -102.28 130.23 48.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.557 -0.714 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.86 -176.26 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.848 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -122.96 146.93 47.17 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.31 133.67 24.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.0 110.514 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' CB ' ' HZ2' ' A' ' 21' ' ' LYS . 3.8 ttmp? -109.89 131.12 55.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.84 159.45 35.07 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.017 0.913 . . . . 0.0 110.883 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 17.5 ttmm -92.08 156.26 17.5 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.14 113.09 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.139 -0.976 . . . . 0.0 110.38 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 pt -90.4 -19.51 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.96 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -167.77 157.47 10.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.986 . . . . 0.0 109.707 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.468 ' N ' HE21 ' A' ' 63' ' ' GLN . 96.1 mt -135.39 159.93 40.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.595 -0.691 . . . . 0.0 109.98 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -144.72 118.14 9.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.435 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -72.86 132.76 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.53 -0.731 . . . . 0.0 109.664 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.438 HD21 ' CG2' ' A' ' 35' ' ' ILE . 53.2 t30 -120.03 125.73 49.05 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 108.943 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.572 ' C ' ' H ' ' A' ' 33' ' ' GLU . 20.1 p -106.12 21.95 16.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.456 -0.777 . . . . 0.0 109.242 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 t-80 -68.98 13.68 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.491 -0.756 . . . . 0.0 109.384 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' H ' ' C ' ' A' ' 31' ' ' THR . 95.6 mt-10 58.58 -68.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.076 0.465 . . . . 0.0 110.337 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' HIS . 48.9 m -51.56 -39.44 57.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 0.0 108.945 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.438 ' CG2' HD21 ' A' ' 30' ' ' ASN . 96.6 mt -105.37 140.94 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.679 0.752 . . . . 0.0 109.414 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.8 p -85.3 -57.16 3.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.658 -0.651 . . . . 0.0 109.911 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.502 ' N ' ' OG ' ' A' ' 36' ' ' SER . 17.4 pt20 -160.48 164.8 31.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.093 -1.005 . . . . 0.0 110.316 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.2 160.34 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.91 -165.76 31.07 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.169 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.34 145.73 49.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.925 -0.75 . . . . 0.0 109.531 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.42 130.58 55.93 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.35 101.33 2.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 44.3 t0 -104.86 162.69 13.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.56 -0.965 . . . . 0.0 109.445 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 13.5 tm-20 -70.3 -18.58 63.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.69 -0.631 . . . . 0.0 109.778 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.5 p -93.9 -9.74 36.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.074 -1.016 . . . . 0.0 109.334 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.93 -146.61 15.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.92 160.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.667 -0.902 . . . . 0.0 109.888 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -158.53 145.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 109.883 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -86.37 164.36 17.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.717 . . . . 0.0 109.992 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -154.29 156.82 37.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.696 -1.253 . . . . 0.0 108.48 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -139.97 129.96 24.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 109.646 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.443 ' O ' ' OG ' ' A' ' 36' ' ' SER . 82.9 mt -106.76 131.58 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.333 0.587 . . . . 0.0 109.68 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -90.91 144.07 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 110.362 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -59.63 -31.64 69.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.711 . . . . 0.0 109.406 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.87 -13.39 6.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.53 -30.3 20.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 108.938 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 55.3 55.84 7.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.557 -0.715 . . . . 0.0 110.242 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.8 mp -108.0 154.82 40.91 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.611 -0.681 . . . . 0.0 109.398 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.7 156.56 65.23 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.766 2.31 . . . . 0.0 112.528 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.96 144.28 48.95 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.751 0.786 . . . . 0.0 110.394 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.433 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.5 mp -81.5 148.53 29.15 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.36 0.6 . . . . 0.0 109.936 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -101.35 136.03 41.86 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.802 0.81 . . . . 0.0 110.111 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.468 HE21 ' N ' ' A' ' 27' ' ' LEU . 97.5 mt-30 -71.77 134.55 46.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.523 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 93.89 -14.48 65.21 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.6 mp0 -95.43 158.41 15.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 110.65 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -90.63 141.98 28.22 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -133.82 142.83 48.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.842 0.829 . . . . 0.0 109.889 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.2 132.0 54.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.99 112.75 25.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.803 . . . . 0.0 109.312 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.495 HH21 ' HG ' ' A' ' 90' ' ' SER . 75.9 mtm180 -109.54 140.45 43.31 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.578 0.704 . . . . 0.0 110.413 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.6 t 56.94 60.04 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.932 -0.48 . . . . 0.0 110.929 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.3 168.11 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 0.0 109.228 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.08 160.33 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.426 0.632 . . . . 0.0 109.836 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 56.3 t -103.11 132.73 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.681 -0.637 . . . . 0.0 109.409 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.24 158.81 14.07 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -102.28 91.56 4.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.933 . . . . 0.0 109.392 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.46 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 88.0 t80 -101.37 119.74 39.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.818 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 80' ' ' ARG . 3.7 m120 52.68 43.08 31.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.763 -0.586 . . . . 0.0 110.657 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 68.99 -15.29 0.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.675 -0.641 . . . . 0.0 110.302 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' H ' ' C ' ' A' ' 78' ' ' ASN . 79.9 mtp85 -88.04 159.91 18.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.76 135.52 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -143.33 153.7 43.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 109.332 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -97.2 123.32 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.403 -0.811 . . . . 0.0 108.861 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -108.89 124.47 50.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 0.0 109.366 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.9 132.53 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' LYS . 5.3 p30 -145.62 -178.89 6.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 89' ' ' SER . 62.0 tttm -40.91 161.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 74.76 -27.36 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 109.795 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 87' ' ' LYS . 23.2 t -79.92 166.01 22.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.923 . . . . 0.0 110.012 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.495 ' HG ' HH21 ' A' ' 70' ' ' ARG . 35.6 t -148.11 169.93 18.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 109.334 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.2 mt -144.48 136.01 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.455 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.06 127.59 46.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.45 -0.781 . . . . 0.0 109.189 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.61 140.72 44.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.536 -0.728 . . . . 0.0 109.515 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.01 135.08 52.05 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.818 0.818 . . . . 0.0 110.175 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.2 m -85.66 9.67 15.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.23 92.47 39.93 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.455 -0.778 . . . . 0.0 109.19 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.12 153.25 21.77 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.761 2.308 . . . . 0.0 112.064 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt -100.84 139.66 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 109.577 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.67 129.55 35.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.79 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.94 -12.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.04 -158.03 24.64 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 tp 43.22 74.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.54 -0.976 . . . . 0.0 109.621 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.83 -11.04 43.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.72 -0.613 . . . . 0.0 109.937 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 106' ' ' HIS . 98.1 m-70 -63.79 -44.82 92.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.274 -0.892 . . . . 0.0 109.003 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 51.6 t-80 47.18 14.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 104' ' ' HIS . 12.6 t-80 -75.91 68.21 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -87.2 -9.13 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.66 -0.65 . . . . 0.0 109.856 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -79.99 -13.2 59.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.443 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.827 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.321 0.581 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 52.49 59.56 14.06 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.302 -0.874 . . . . 0.0 109.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.56 156.23 61.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.609 2.206 . . . . 0.0 112.121 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -81.89 121.99 27.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.403 HD23 HD21 ' A' ' 19' ' ' ASN . 56.9 mt -88.13 131.01 34.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.347 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.4 m -124.99 138.71 54.22 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -95.66 152.77 18.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.276 -0.89 . . . . 0.0 109.814 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.1 mt -58.29 -44.35 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.548 -0.72 . . . . 0.0 109.361 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.94 -18.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 108.937 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 63.1 t0 -87.87 3.78 47.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -85.6 120.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.047 -1.033 . . . . 0.0 109.678 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 1.2 p -138.47 -2.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.322 -0.861 . . . . 0.0 109.043 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 97.7 mt-10 -134.58 136.04 42.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.104 -0.997 . . . . 0.0 109.488 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -97.14 156.4 16.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.97 18.67 69.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 24.2 pt20 -103.36 159.49 15.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -1.032 . . . . 0.0 109.71 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.24 135.42 46.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.69 -0.631 . . . . 0.0 109.642 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.29 177.36 11.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 109.796 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 16.1 t30 -133.46 138.16 46.05 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.4 tp -154.29 147.1 24.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.793 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -104.68 140.36 38.15 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.27 161.05 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -103.82 153.92 20.18 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 t -93.14 102.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.067 -1.02 . . . . 0.0 110.597 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 pt -84.08 -23.8 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.553 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 47.5 tt0 -152.96 134.92 14.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.911 . . . . 0.0 108.918 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.3 tp -118.06 147.74 42.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.256 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.553 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 80.7 m95 -146.78 128.75 15.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 109.185 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -85.62 140.45 30.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.39 128.76 47.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 108.871 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -99.95 -5.09 28.8 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.225 -0.922 . . . . 0.0 109.081 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 33' ' ' GLU . 75.7 t60 -80.47 127.98 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.759 . . . . 0.0 109.252 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' O ' ' CD2' ' A' ' 32' ' ' HIS . 75.6 tt0 -51.76 167.6 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER 76.28 -47.16 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.546 -0.722 . . . . 0.0 109.414 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -97.12 134.4 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 52' ' ' ILE . 52.3 p -88.0 -55.81 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.836 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.409 ' N ' ' OG ' ' A' ' 36' ' ' SER . 22.8 pt20 -158.23 165.87 33.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.014 . . . . 0.0 110.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.61 160.82 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.11 -166.59 34.26 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.194 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.74 146.77 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.857 . . . . 0.0 109.155 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.5 mt -109.16 125.22 51.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.84 99.43 2.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -105.52 164.52 11.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.969 . . . . 0.0 109.479 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -70.48 -18.98 62.98 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.865 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -90.08 -10.51 44.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.106 . . . . 0.0 109.827 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.06 -147.87 18.33 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 47' ' ' ILE . 96.0 mt -134.73 155.81 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.597 -0.943 . . . . 0.0 109.48 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.2 tt -154.53 148.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.795 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -88.22 154.42 20.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -146.7 154.33 41.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.603 -1.31 . . . . 0.0 108.311 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.446 ' CG2' ' OE1' ' A' ' 84' ' ' GLN . 15.3 t -135.45 132.32 37.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 36' ' ' SER . 94.9 mt -102.77 128.7 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.573 -0.704 . . . . 0.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -83.96 142.68 30.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 110.454 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -60.8 -34.74 74.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -59.33 -9.59 2.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 109.764 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.33 -25.66 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -0.971 . . . . 0.0 108.825 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 42.47 47.3 4.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 110.066 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.55 165.45 14.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.03 147.65 89.16 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.321 2.014 . . . . 0.0 112.242 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.85 142.08 49.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.089 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 8.3 mp -80.24 143.89 33.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.79 131.99 43.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 109.307 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -70.07 134.45 48.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.0 110.477 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 -13.89 66.39 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -97.4 159.51 14.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -1.159 . . . . 0.0 110.796 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.7 m -93.26 146.73 23.49 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.271 0.558 . . . . 0.0 109.798 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.3 151.02 43.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.025 0.917 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.5 tp -106.3 132.53 52.23 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 mt -109.28 106.03 15.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -105.93 140.96 38.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.353 -0.842 . . . . 0.0 110.265 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.1 t 56.86 61.96 2.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.66 . . . . 0.0 110.983 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.93 164.11 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.43 144.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.518 0.675 . . . . 0.0 109.637 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -94.09 134.27 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 151.54 18.04 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -97.4 95.86 7.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -1.155 . . . . 0.0 109.149 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.3 t80 -102.13 116.22 32.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.085 -1.009 . . . . 0.0 109.758 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.542 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 22.0 t-20 51.31 -126.7 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 110.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 56.8 t0 -95.85 -6.69 38.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 ttm180 -114.83 146.67 40.79 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.809 0.814 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.73 158.2 21.87 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -141.71 156.96 45.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 108.886 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.0 123.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.446 ' OE1' ' CG2' ' A' ' 51' ' ' THR . 92.4 mm-40 -103.26 126.94 50.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.06 130.48 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 108.871 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.96 -166.83 1.67 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.629 0.728 . . . . 0.0 109.968 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -64.28 -41.93 96.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.666 -0.646 . . . . 0.0 110.14 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.42 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 2.3 p30 -65.69 -11.78 48.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.998 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.461 ' HG ' ' H ' ' A' ' 90' ' ' SER . 46.1 t -86.34 162.44 18.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.461 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.461 ' H ' ' HG ' ' A' ' 89' ' ' SER . 48.6 m -135.24 157.96 45.57 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -138.98 130.31 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.056 -1.027 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.98 129.18 48.72 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.323 -0.86 . . . . 0.0 109.156 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -77.36 138.67 39.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.95 138.01 43.94 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.855 0.836 . . . . 0.0 109.981 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -83.16 2.25 36.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.817 -0.552 . . . . 0.0 109.512 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 96' ' ' GLU . 2.7 mp0 -103.5 129.71 24.91 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.189 -0.945 . . . . 0.0 109.796 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.64 146.87 30.92 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.872 1.715 . . . . 0.0 112.289 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -110.57 135.44 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.494 -0.754 . . . . 0.0 108.987 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -88.0 122.39 31.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 109.96 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.72 -4.16 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.43 122.64 4.95 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.5 mt -97.91 111.44 23.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -1.114 . . . . 0.0 109.088 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -76.82 -4.28 42.76 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.404 0.621 . . . . 0.0 109.668 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -148.7 164.86 33.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 108.852 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -123.78 163.95 20.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.521 -0.737 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -74.06 154.87 39.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.299 -0.876 . . . . 0.0 109.599 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -68.68 127.96 34.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.807 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -94.1 126.04 39.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 109.468 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.639 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.535 0.683 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 57.29 60.23 7.0 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.706 -0.621 . . . . 0.0 110.082 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 159.71 50.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.627 2.218 . . . . 0.0 112.206 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.65 118.16 22.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.864 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.533 ' CD2' HD21 ' A' ' 19' ' ' ASN . 47.3 mt -90.54 131.16 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.2 m -123.02 142.64 50.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.88 146.94 23.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.639 0.733 . . . . 0.0 110.402 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.2 mm -53.62 -46.02 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.8 . . . . 0.0 109.597 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.82 -11.81 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.612 -0.68 . . . . 0.0 109.89 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.72 2.74 44.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -86.98 119.02 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.819 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -151.86 9.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.816 . . . . 0.0 109.459 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -127.35 123.11 35.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.555 -0.716 . . . . 0.0 109.283 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.38 152.02 23.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.438 -0.789 . . . . 0.0 110.057 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.73 79.17 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -98.06 145.2 26.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.092 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.17 129.6 45.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.516 -0.74 . . . . 0.0 109.481 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.21 -175.88 5.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.533 HD21 ' CD2' ' A' ' 5' ' ' LEU . 27.7 t30 -127.11 141.13 51.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.683 -0.636 . . . . 0.0 109.295 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.96 154.56 49.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.479 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -135.8 135.42 39.87 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.55 -173.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.169 0.985 . . . . 0.0 110.511 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.49 155.84 27.9 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.51 106.5 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.34 -24.0 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.284 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -161.26 151.41 17.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.043 -1.036 . . . . 0.0 109.529 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.3 pt? -140.96 163.85 31.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.467 -0.771 . . . . 0.0 109.961 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -145.37 111.14 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.802 0.81 . . . . 0.0 109.5 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.01 124.85 26.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -127.58 141.21 51.7 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -0.796 . . . . 0.0 108.886 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -116.13 29.93 7.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -66.05 6.32 0.4 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.539 ' H ' ' C ' ' A' ' 31' ' ' THR . 74.0 tt0 68.23 -54.9 0.52 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.178 0.513 . . . . 0.0 109.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -60.5 -44.54 95.89 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.122 -0.987 . . . . 0.0 108.748 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.558 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.7 mt -110.94 142.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.514 0.673 . . . . 0.0 109.425 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.543 ' C ' HD22 ' A' ' 30' ' ' ASN . 46.9 t -93.25 -47.72 6.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -155.05 156.51 36.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.37 141.1 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 50' ' ' PHE . . . -168.81 -154.09 8.73 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.291 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -136.88 153.09 50.85 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.794 -0.827 . . . . 0.0 109.322 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.02 132.12 54.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.64 0.733 . . . . 0.0 109.741 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.97 104.24 3.12 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 1.4 m-20 -103.73 162.68 12.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.654 -0.91 . . . . 0.0 109.375 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.9 mp0 -69.37 -15.35 63.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -97.0 -6.14 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.86 -147.11 17.28 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.227 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.93 162.89 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.644 -0.916 . . . . 0.0 110.069 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -159.33 150.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.971 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.86 165.64 21.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.648 -0.658 . . . . 0.0 110.023 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 18.6 p90 -158.67 148.7 19.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.156 -0.965 . . . . 0.0 108.89 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -134.6 128.72 33.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.6 mt -105.45 128.44 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 109.414 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.62 143.01 27.22 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.755 0.788 . . . . 0.0 110.373 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 56' ' ' ALA . 39.5 tptt -60.45 -30.59 69.76 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.619 -0.675 . . . . 0.0 109.403 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -58.98 -3.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.838 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -97.14 -28.19 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.172 -0.955 . . . . 0.0 109.051 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 55.2 mp0 48.97 54.7 10.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.21 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.1 mt -110.89 152.85 43.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.73 147.51 71.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.567 2.178 . . . . 0.0 112.709 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 mt -72.34 149.29 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.754 0.788 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.3 mp -86.86 144.33 27.05 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.446 0.641 . . . . 0.0 110.115 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.88 139.56 31.14 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.884 0.849 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.19 137.87 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.45 -0.781 . . . . 0.0 110.727 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.97 56.34 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -94.39 159.03 15.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 p -90.28 149.3 22.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.295 0.569 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -144.32 145.88 32.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.7 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.5 tp -113.32 130.57 56.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 1.9 mp -119.45 113.64 21.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.63 -0.669 . . . . 0.0 109.502 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -105.92 151.53 24.46 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.76 58.64 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.553 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.3 165.07 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.535 -0.728 . . . . 0.0 109.459 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.87 147.58 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.676 0.75 . . . . 0.0 109.71 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.6 t -87.93 130.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.67 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.9 147.44 16.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -96.81 103.26 15.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.451 -1.029 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' ARG . 71.2 t80 -101.58 107.62 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.737 0.78 . . . . 0.0 109.372 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.443 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 47.5 t30 39.69 -115.65 0.2 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.793 -0.567 . . . . 0.0 110.629 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 97.7 m-20 -93.61 -19.08 21.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.817 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' TYR . 84.8 mtt85 -97.41 159.54 14.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.25 -0.906 . . . . 0.0 110.353 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.88 153.19 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.619 -0.675 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -151.96 164.07 37.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 m -102.91 126.91 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 109.103 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.95 128.77 53.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.325 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.59 134.29 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' LYS . 4.2 p30 -146.34 -174.4 4.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.87 0.843 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.616 ' C ' ' H ' ' A' ' 89' ' ' SER . 1.6 pptp? -44.34 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.899 -0.5 . . . . 0.0 109.896 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 t30 67.29 -27.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.676 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 87' ' ' LYS . 12.7 p -79.98 166.9 21.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.156 -0.965 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.8 p -141.14 160.42 40.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 91' ' ' ILE . 97.4 mt -139.38 132.3 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.593 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -128.76 130.16 46.68 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.609 0.719 . . . . 0.0 109.365 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.47 144.3 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.63 -0.668 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.33 145.24 46.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.704 0.764 . . . . 0.0 110.028 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -86.27 16.8 4.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -119.39 118.43 32.42 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.655 -0.653 . . . . 0.0 109.533 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.09 157.8 42.2 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.647 2.231 . . . . 0.0 112.376 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 98' ' ' ILE . 49.3 mm -108.27 137.23 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.748 -0.595 . . . . 0.0 109.674 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.03 122.09 38.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.763 . . . . 0.0 109.663 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.62 80.61 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -119.31 19.32 9.98 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' HIS . 5.5 tp -62.18 -39.37 92.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.408 -1.054 . . . . 0.0 109.706 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.64 -13.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.717 -0.614 . . . . 0.0 110.015 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 102' ' ' LEU . 79.5 m80 -88.86 127.85 35.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 108.868 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 106' ' ' HIS . 46.6 p-80 -148.22 40.09 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 85.7 t60 48.24 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.437 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -147.43 -55.12 0.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.51 -0.744 . . . . 0.0 109.441 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -154.54 139.83 17.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.583 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 63.4 m170 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.617 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' C ' ' A' ' 2' ' ' GLU . 38.3 ttm . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 2.7 mp0 -32.08 96.1 0.09 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 CA-C-O 121.137 0.494 . . . . 0.0 110.369 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 1' ' ' MET . 41.7 Cg_exo -55.26 141.11 81.53 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.43 2.086 . . . . 0.0 112.001 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -79.73 118.62 21.7 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.591 0.71 . . . . 0.0 109.687 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.2 mt -93.73 128.06 39.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.8 t -129.6 152.69 48.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.557 0.694 . . . . 0.0 109.648 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.18 135.1 34.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.341 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -50.97 -34.37 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.758 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.82 1.46 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.854 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -122.48 6.57 9.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.21 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 13' ' ' GLU . 27.7 mt -64.19 -52.42 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 11' ' ' ILE . 12.2 m 4.29 64.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 121.395 0.617 . . . . 0.0 111.383 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 11' ' ' ILE . 38.3 tp10 -174.09 109.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.732 0.777 . . . . 0.0 109.368 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p-10 -82.57 140.52 33.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.5 77.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.05 137.27 32.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -1.16 . . . . 0.0 110.049 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -100.01 129.72 46.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.524 -0.735 . . . . 0.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.99 -175.06 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.398 -0.814 . . . . 0.0 109.932 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 88.0 m-20 -138.35 143.41 39.86 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.434 0.635 . . . . 0.0 109.629 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.2 tp -159.06 145.82 17.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.216 -0.928 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -100.0 141.81 32.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.594 -0.692 . . . . 0.0 109.152 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.73 159.07 40.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.853 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -97.8 150.42 21.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -89.31 101.9 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.551 -0.718 . . . . 0.0 110.754 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG23 HD11 ' A' ' 25' ' ' ILE . 96.7 mt -73.45 -25.61 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -170.61 162.43 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -0.989 . . . . 0.0 109.673 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.43 158.31 43.38 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.7 0.762 . . . . 0.0 110.144 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -148.61 127.94 13.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.437 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -95.17 131.39 41.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.522 -0.736 . . . . 0.0 109.918 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 3.3 p-10 -95.3 163.69 13.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.404 -0.81 . . . . 0.0 109.056 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.33 5.09 29.3 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 98.4 m-70 -96.25 139.4 32.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.86 -27.39 64.79 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.623 -0.673 . . . . 0.0 110.194 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 47.2 t -60.06 -46.22 90.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.205 -0.935 . . . . 0.0 108.807 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.595 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.8 mt -109.96 141.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.024 0.916 . . . . 0.0 109.75 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 6.1 p -93.2 -56.62 2.89 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.096 -1.002 . . . . 0.0 109.832 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.515 ' N ' ' OG ' ' A' ' 36' ' ' SER . 80.1 mt-30 -150.01 158.61 44.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.952 -1.093 . . . . 0.0 110.542 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.67 141.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.85 -164.57 13.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.311 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.79 143.85 47.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.854 -0.792 . . . . 0.0 109.749 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.4 mt -112.85 128.89 56.57 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.69 0.757 . . . . 0.0 109.748 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.01 99.02 2.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -99.3 156.35 17.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.126 -1.22 . . . . 0.0 109.469 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.96 -17.41 63.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.646 -0.659 . . . . 0.0 109.722 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 p -96.76 -11.74 24.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.285 -0.885 . . . . 0.0 109.076 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.84 -146.73 13.53 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.78 161.49 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.1 tt -161.97 143.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.756 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.37 148.74 22.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 110.172 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -138.6 160.03 40.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.945 -1.097 . . . . 0.0 109.207 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -134.21 133.19 40.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.339 -0.851 . . . . 0.0 109.982 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' O ' ' OG ' ' A' ' 36' ' ' SER . 87.1 mt -102.7 129.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.639 0.733 . . . . 0.0 109.656 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CE3' ' O ' ' A' ' 34' ' ' SER . 74.5 m95 -87.1 140.74 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 110.46 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -54.89 -23.63 19.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.57 -0.707 . . . . 0.0 109.539 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.33 -6.97 47.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.705 . . . . 0.0 109.673 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.96 -34.32 19.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.15 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 54.53 53.03 11.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 110.123 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.19 155.46 37.73 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.06 156.03 65.01 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.774 2.316 . . . . 0.0 112.737 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.27 139.78 54.42 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.894 0.854 . . . . 0.0 110.684 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.4 mp -82.93 152.59 25.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.356 0.598 . . . . 0.0 110.113 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -104.31 133.3 49.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.727 0.775 . . . . 0.0 110.228 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -67.88 138.94 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.81 0.814 . . . . 0.0 110.622 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 -9.64 64.8 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -94.08 149.92 20.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.241 . . . . 0.0 110.471 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -89.2 147.56 24.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.45 0.643 . . . . 0.0 109.78 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -141.79 152.6 43.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.164 -0.96 . . . . 0.0 110.154 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.9 tp -106.1 133.8 50.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.38 109.65 20.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.393 -0.817 . . . . 0.0 109.648 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -113.66 142.69 45.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.708 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.0 t 57.06 58.04 4.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.115 0.483 . . . . 0.0 110.774 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.36 163.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.2 154.84 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.774 0.797 . . . . 0.0 109.953 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.5 t -95.34 130.1 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 109.851 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.54 151.05 18.96 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -91.29 96.15 10.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -1.028 . . . . 0.0 109.697 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.529 ' CD2' ' OD1' ' A' ' 78' ' ' ASN . 16.3 t80 -95.17 100.18 12.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 77' ' ' TYR . 1.5 p-10 37.48 -110.52 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -95.14 -20.93 18.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.868 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' TYR . 72.5 ttt180 -98.56 162.7 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.121 -0.987 . . . . 0.0 110.505 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -101.02 150.37 22.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.235 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -143.63 148.08 35.31 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.048 -1.032 . . . . 0.0 109.592 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.45 125.22 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.235 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.58 124.4 49.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.377 -0.827 . . . . 0.0 109.564 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.76 134.63 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -132.13 -167.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.889 0.852 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.68 -41.69 98.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.661 -0.649 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.08 -22.72 67.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -0.941 . . . . 0.0 109.605 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.7 m -80.23 163.99 23.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 p -142.62 162.08 36.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.9 mt -141.56 134.1 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.833 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -130.7 135.27 47.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -71.26 136.45 47.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.702 . . . . 0.0 109.597 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.2 mt -92.57 136.45 33.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 110.051 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.9 t -74.99 -9.02 58.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.713 . . . . 0.0 109.78 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -118.92 137.27 24.84 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.769 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.9 159.15 38.32 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.668 2.245 . . . . 0.0 112.189 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.11 131.53 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.687 . . . . 0.0 109.383 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.15 123.58 45.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.873 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.58 -15.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.85 77.59 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.24 -42.95 99.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -1.039 . . . . 0.0 109.82 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 48.88 65.87 1.25 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.642 0.734 . . . . 0.0 110.334 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.16 -59.67 4.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -0.807 . . . . 0.0 109.001 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -173.32 76.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.228 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -157.24 119.17 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -93.21 -10.88 34.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.541 -0.725 . . . . 0.0 109.888 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -65.28 -40.53 94.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 56.1 t-80 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 2' ' ' GLU . 74.5 mtm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 1' ' ' MET . 46.2 mm-40 59.52 146.72 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.625 . . . . 0.0 110.157 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.64 157.97 58.76 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.391 2.061 . . . . 0.0 112.334 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.02 120.25 17.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.864 . . . . 0.0 109.74 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.5 mt -97.02 129.85 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -123.31 151.31 42.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -99.84 147.6 25.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.089 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 9' ' ' VAL . 5.0 pt -58.78 -43.0 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.517 -0.739 . . . . 0.0 109.369 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.402 ' H ' HG13 ' A' ' 8' ' ' ILE . 12.0 p -67.8 -7.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.78 15.29 28.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.408 -0.808 . . . . 0.0 109.298 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.43 115.51 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.975 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.28 2.05 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -135.29 131.59 36.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.371 -0.831 . . . . 0.0 109.058 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -95.95 155.64 16.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 19.89 74.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -101.29 156.88 17.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -1.042 . . . . 0.0 109.892 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -106.15 134.2 49.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -176.85 5.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.437 -0.79 . . . . 0.0 109.811 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 70' ' ' ARG . 9.9 m120 -120.37 135.0 55.17 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -136.62 138.03 40.74 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.962 -1.086 . . . . 0.0 110.174 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 34.0 ttpt -117.68 134.33 55.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.6 23.56 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.21 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 51.6 tttp -96.53 163.35 13.07 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.05 97.17 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.321 -0.862 . . . . 0.0 110.942 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.7 pt -80.46 -27.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.877 . . . . 0.0 110.225 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -147.33 130.47 16.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -116.42 140.86 48.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.232 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -149.41 137.24 20.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.168 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -88.87 142.38 27.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.26 -0.9 . . . . 0.0 109.71 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.713 HD21 ' H ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -100.57 142.72 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.258 -0.901 . . . . 0.0 109.012 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.713 ' H ' HD21 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -118.01 19.74 13.53 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.445 -0.785 . . . . 0.0 109.037 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.52 ' C ' ' H ' ' A' ' 34' ' ' SER . 9.6 t60 -75.13 0.9 14.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' O ' ' CE ' ' A' ' 54' ' ' LYS . 74.1 tt0 66.65 -36.32 0.26 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.107 0.48 . . . . 0.0 110.013 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.52 ' H ' ' C ' ' A' ' 32' ' ' HIS . 89.1 p -87.84 -6.13 58.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.845 -1.16 . . . . 0.0 108.863 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -124.36 149.7 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.536 0.684 . . . . 0.0 109.991 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 m -91.11 -54.1 4.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.502 -0.749 . . . . 0.0 109.607 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.98 168.74 23.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.7 t -146.91 156.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.67 -163.8 31.0 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.597 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.79 147.51 51.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.782 -0.834 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -136.56 144.76 44.36 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.602 0.715 . . . . 0.0 109.806 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.58 135.07 12.07 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' A' ' 44' ' ' GLU . 53.1 t0 -115.21 4.34 14.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.523 -0.986 . . . . 0.0 110.674 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.595 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 65.1 tt0 100.75 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.515 1.052 . . . . 0.0 108.487 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -93.48 -3.56 52.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.153 . . . . 0.0 109.562 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.47 -150.46 21.9 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.4 160.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.625 -0.927 . . . . 0.0 109.764 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tp -157.18 141.07 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.013 . . . . 0.0 109.526 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -89.93 132.23 35.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -125.1 154.31 41.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.313 -0.867 . . . . 0.0 109.192 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -132.27 133.32 43.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.69 122.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.304 -0.873 . . . . 0.0 109.79 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -80.41 149.57 30.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' CE ' ' O ' ' A' ' 33' ' ' GLU . 67.8 mttm -64.43 -34.71 78.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 109.71 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -59.67 -20.76 58.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.99 60.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.106 -0.996 . . . . 0.0 108.746 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 44.16 45.5 6.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.585 -0.697 . . . . 0.0 109.969 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.81 150.95 37.29 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.02 160.72 47.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.595 2.197 . . . . 0.0 112.296 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.87 134.87 48.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 110.109 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.2 mp -78.05 146.09 35.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.625 -0.672 . . . . 0.0 109.541 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -86.39 131.11 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -73.12 135.83 44.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.522 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 88.73 5.02 75.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.517 ' CD ' ' HZ1' ' A' ' 93' ' ' LYS . 78.0 mm-40 -113.69 157.54 22.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.413 -1.051 . . . . 0.0 110.896 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 m -85.9 141.79 29.31 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.33 0.585 . . . . 0.0 109.629 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -138.98 145.01 39.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.298 -0.876 . . . . 0.0 109.803 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.45 128.42 55.99 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mp -115.55 116.34 27.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.625 -0.672 . . . . 0.0 109.448 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HA ' HD21 ' A' ' 19' ' ' ASN . 84.5 mtp180 -108.66 143.09 38.2 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.551 0.691 . . . . 0.0 110.432 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.9 p 60.57 57.51 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 0.0 110.656 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.4 157.82 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.175 -0.953 . . . . 0.0 108.773 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.54 134.38 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.752 . . . . 0.0 109.211 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.09 135.82 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.532 -0.73 . . . . 0.0 109.649 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.68 ' H ' HE22 ' A' ' 84' ' ' GLN . . . -108.81 146.58 16.6 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.23 103.34 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.243 . . . . 0.0 109.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 80' ' ' ARG . 64.9 t80 -97.95 96.97 8.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.223 -0.923 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.65 -119.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.645 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.21 -11.2 39.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 77' ' ' TYR . 89.1 mtm180 -111.15 161.12 16.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 110.115 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.38 153.87 18.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -140.32 153.94 46.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.146 -0.971 . . . . 0.0 109.133 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.76 113.81 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.241 -0.912 . . . . 0.0 108.582 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.68 HE22 ' H ' ' A' ' 75' ' ' GLY . 2.6 mp0 -103.05 134.98 45.58 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 0.0 109.325 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -102.92 129.42 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.513 ' H ' ' HG ' ' A' ' 89' ' ' SER . 20.9 p30 -121.36 -174.38 2.84 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.697 0.761 . . . . 0.0 110.047 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.68 -41.68 97.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.68 -0.638 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -65.59 -2.52 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.957 . . . . 0.0 109.767 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 86' ' ' ASN . 9.4 m -89.82 161.28 16.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.2 t -132.99 151.86 52.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 91' ' ' ILE . 97.2 mt -135.97 128.32 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.901 -1.125 . . . . 0.0 109.086 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -129.44 135.92 49.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.081 -1.012 . . . . 0.0 109.135 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.517 ' HZ1' ' CD ' ' A' ' 65' ' ' GLU . 63.2 tttp -79.6 129.78 34.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.33 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.3 134.74 47.01 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.927 0.87 . . . . 0.0 109.982 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -81.81 -3.14 53.22 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -91.78 123.01 64.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.876 -1.14 . . . . 0.0 109.548 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.25 141.82 23.56 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.733 1.622 . . . . 0.0 112.422 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.01 141.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.46 -0.775 . . . . 0.0 109.177 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -48.38 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 0.0 109.223 -179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 99' ' ' GLU . 19.7 m 33.14 38.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.694 0.759 . . . . 0.0 110.287 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 99' ' ' GLU . . . 82.22 78.08 1.03 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 104' ' ' HIS . 4.1 tt -107.35 111.03 23.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.316 -1.108 . . . . 0.0 109.188 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 105' ' ' HIS . 44.8 tt0 40.5 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.745 -0.597 . . . . 0.0 110.688 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 102' ' ' LEU . 43.0 t-80 49.85 13.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 108.91 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 103' ' ' GLU . 30.9 m170 -59.91 -40.95 90.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -138.3 142.36 39.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.14 -43.55 91.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.859 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -150.93 -17.09 0.22 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.0 109.129 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.309 179.961 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.613 0.72 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.62 59.2 1.19 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.728 -0.608 . . . . 0.0 109.995 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.62 158.14 51.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.493 2.128 . . . . 0.0 112.24 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -79.58 112.28 16.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.4 mt -89.89 129.61 36.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.0 109.691 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.6 m -123.88 139.87 53.54 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.421 0.629 . . . . 0.0 109.326 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.24 144.35 25.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.964 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 pt -52.72 -41.7 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.626 -0.671 . . . . 0.0 109.686 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.03 -11.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -96.59 6.44 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.65 119.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 109.968 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.92 6.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 96.6 mt-10 -131.71 128.01 38.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.542 -0.724 . . . . 0.0 109.369 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.597 ' ND2' ' N ' ' A' ' 15' ' ' GLY . 2.3 t-20 -88.95 150.03 23.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.848 . . . . 0.0 109.924 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.597 ' N ' ' ND2' ' A' ' 14' ' ' ASN . . . 80.34 21.82 63.98 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 13' ' ' GLU . 4.9 pt20 -103.35 153.2 20.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.575 -0.956 . . . . 0.0 109.837 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -103.9 132.25 50.34 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.507 0.67 . . . . 0.0 109.446 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.32 178.87 9.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 109.863 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -120.66 144.98 47.89 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.1 tp -136.59 133.7 36.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.512 -0.742 . . . . 0.0 110.131 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -118.31 132.03 56.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.39 -173.21 0.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.176 0.989 . . . . 0.0 110.806 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.9 ptpt -118.19 155.82 29.82 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.438 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 95.8 t -90.06 105.75 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.471 -0.768 . . . . 0.0 110.158 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' C ' HE21 ' A' ' 63' ' ' GLN . 34.5 pt -73.19 -25.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.804 -0.56 . . . . 0.0 110.045 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -159.59 148.59 17.94 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 1.6 pt? -125.34 152.01 45.3 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.13 117.7 9.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 109.606 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 56.4 mp0 -94.75 125.45 39.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.623 -0.673 . . . . 0.0 109.386 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -149.18 170.51 18.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 t -150.66 46.78 0.87 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 109.112 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -54.27 -37.36 64.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -167.26 -99.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.3 p -87.38 -6.37 58.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.191 -0.943 . . . . 0.0 108.935 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.4 mt -80.56 131.71 33.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 3.0 m -102.05 -46.32 4.9 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.513 0.673 . . . . 0.0 109.894 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -148.82 148.2 29.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.988 -1.07 . . . . 0.0 109.975 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.86 130.74 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.38 -166.93 15.12 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.15 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.31 150.48 50.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.866 -0.784 . . . . 0.0 109.734 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.21 125.22 53.57 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.64 8.13 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.4 p-10 -125.73 -134.69 0.26 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.714 -0.874 . . . . 0.0 109.098 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 81.7 tt0 -119.8 -18.57 8.24 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 15.7 p -93.06 -11.06 33.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.97 -1.081 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 151.65 -143.85 10.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -141.54 158.11 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -1.09 . . . . 0.0 109.432 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -148.86 145.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 109.885 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -92.01 127.36 37.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.023 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -122.87 152.76 40.44 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.3 m -131.24 133.44 45.45 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.426 0.631 . . . . 0.0 109.634 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.64 127.1 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -82.5 142.56 31.77 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.597 -0.689 . . . . 0.0 110.118 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' N ' ' OG ' ' A' ' 36' ' ' SER . 78.8 tttt -58.08 -37.32 74.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.541 -0.725 . . . . 0.0 109.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -6.11 1.23 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.828 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -88.71 -30.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.884 . . . . 0.0 109.158 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 46.33 51.95 11.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.643 -0.661 . . . . 0.0 109.889 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.4 mt -100.65 153.02 37.97 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.741 -0.599 . . . . 0.0 109.848 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.46 148.89 60.1 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.477 2.118 . . . . 0.0 112.779 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.6 140.12 51.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.512 -0.742 . . . . 0.0 110.379 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 8.3 mp -83.37 150.33 26.16 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.367 0.603 . . . . 0.0 109.964 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.2 128.2 45.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 64' ' ' GLY . 11.1 tm0? -66.71 137.99 57.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.662 -0.649 . . . . 0.0 110.712 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 86.74 -10.77 66.37 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -98.18 158.19 15.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -1.033 . . . . 0.0 110.674 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 m -91.58 145.67 24.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -141.73 148.82 39.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 109.815 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 tp -110.32 128.76 55.71 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.83 118.05 31.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.531 -0.731 . . . . 0.0 109.728 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -114.86 145.01 42.63 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.692 0.758 . . . . 0.0 110.694 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 63.22 56.57 1.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 m -110.73 161.97 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.512 -0.743 . . . . 0.0 109.381 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 148.43 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.581 0.705 . . . . 0.0 109.59 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 65.3 t -95.75 132.47 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.676 -0.64 . . . . 0.0 109.686 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.0 16.96 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -94.86 109.39 21.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.534 -0.98 . . . . 0.0 109.403 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.632 ' CB ' HE21 ' A' ' 82' ' ' GLN . 40.4 t80 -106.8 106.45 16.97 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.922 0.868 . . . . 0.0 109.483 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.4 m120 42.64 -118.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -93.07 -17.3 23.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.102 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.7 mtt-85 -100.82 159.78 14.91 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.411 -0.805 . . . . 0.0 110.329 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -104.72 153.32 21.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.632 HE21 ' CB ' ' A' ' 77' ' ' TYR . 43.5 mt-30 -147.81 159.94 43.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.38 123.55 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.72 129.35 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -104.41 131.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -127.08 -170.46 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.673 0.749 . . . . 0.0 110.066 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.53 -45.14 91.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.907 -0.496 . . . . 0.0 110.181 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.18 -11.07 7.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 109.758 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.5 p -83.23 163.91 20.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.9 p -138.44 155.67 48.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -139.66 131.77 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 0.0 109.313 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -127.47 130.57 49.47 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -70.34 135.89 49.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.705 -0.622 . . . . 0.0 109.502 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.1 mt -96.92 134.36 40.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.505 -0.747 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.5 p -85.29 -6.34 59.26 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -107.12 130.52 22.74 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.567 -0.708 . . . . 0.0 109.57 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.25 147.39 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.478 2.119 . . . . 0.0 112.242 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.508 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.5 mt -110.27 131.67 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.6 mp0 -97.54 123.24 41.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.57 -3.38 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.65 144.47 3.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.36 -0.83 57.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -1.024 . . . . 0.0 109.177 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 51.13 -167.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -93.82 118.69 31.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -148.73 23.39 0.99 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.39 -0.819 . . . . 0.0 108.941 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.658 ' CD2' ' H ' ' A' ' 107' ' ' HIS . 84.7 t60 51.11 -117.17 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.718 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.658 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 50.3 t-80 -87.75 155.32 19.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.959 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -155.3 153.78 31.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.605 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.189 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -140.1 74.16 31.14 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.67 148.57 92.73 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.886 2.391 . . . . 0.0 112.017 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.03 115.43 18.7 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.12 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.9 mt -86.95 126.64 34.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.55 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.7 m -120.77 136.78 54.8 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.07 148.39 22.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.23 -43.3 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.528 0.68 . . . . 0.0 109.193 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.22 -13.39 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.429 -0.795 . . . . 0.0 109.535 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 53.2 t0 -95.58 5.52 51.29 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.159 -0.963 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 13' ' ' GLU . 3.7 mm -56.14 -72.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.142 -0.974 . . . . 0.0 109.185 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t 62.59 -32.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' A' ' 11' ' ' ILE . 52.3 tp10 -145.54 147.6 32.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.883 -1.135 . . . . 0.0 108.987 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -101.48 173.11 6.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.56 0.695 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.43 21.85 79.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 34.3 mt-30 -99.43 145.76 27.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.349 -1.089 . . . . 0.0 109.984 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.27 126.05 39.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' C ' HD21 ' A' ' 19' ' ' ASN . . . -162.28 -169.98 2.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.677 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.6 OUTLIER -126.09 144.07 50.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.69 130.81 38.7 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.715 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -116.05 130.67 56.91 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.16 -173.67 1.14 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.23 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HZ3' ' H ' ' A' ' 98' ' ' ILE . 3.3 ttmp? -114.26 148.89 36.72 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.831 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.08 123.71 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 25' ' ' ILE . 11.4 pt -88.46 -20.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.432 -0.793 . . . . 0.0 110.45 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -164.91 154.82 13.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.723 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.7 mt -124.36 152.09 43.59 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.443 0.64 . . . . 0.0 110.021 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -137.33 104.92 5.53 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.406 ' HG2' HE21 ' A' ' 37' ' ' GLN . 96.9 mt-10 -87.71 131.91 34.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.743 -0.598 . . . . 0.0 109.695 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.558 HD22 ' C ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -111.71 -31.88 6.83 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m 63.27 6.73 2.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.504 -0.748 . . . . 0.0 109.32 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 35' ' ' ILE . 32.6 m-70 -74.19 150.53 40.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.99 -41.31 91.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 t -67.39 -54.06 23.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.096 -1.002 . . . . 0.0 109.624 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.537 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 69.8 mt -107.42 137.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.558 ' C ' HD22 ' A' ' 30' ' ' ASN . 9.1 p -90.93 -60.17 1.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.912 0.863 . . . . 0.0 110.437 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.537 ' N ' ' OG ' ' A' ' 36' ' ' SER . 81.3 mt-30 -146.67 155.34 42.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.864 -1.148 . . . . 0.0 109.964 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -135.94 161.77 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' ' CE2' ' A' ' 50' ' ' PHE . . . 178.4 -168.17 39.16 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.058 -1.544 . . . . 0.0 109.939 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.08 149.88 52.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.764 -0.845 . . . . 0.0 109.583 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.6 125.72 53.7 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.733 0.778 . . . . 0.0 108.992 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.93 101.2 2.75 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -105.05 164.02 12.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.678 -0.895 . . . . 0.0 109.293 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -71.49 -17.01 62.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.491 -0.756 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.3 p -93.81 -10.85 32.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 109.571 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.61 -149.57 21.23 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 pt -132.98 156.16 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.944 . . . . 0.0 109.701 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -152.47 145.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.865 . . . . 0.0 109.397 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.617 ' H ' HH12 ' A' ' 80' ' ' ARG . 68.3 mttm -80.44 165.35 22.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.807 . . . . 0.0 109.451 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CE2' ' C ' ' A' ' 39' ' ' GLY . 24.6 p90 -154.23 148.6 26.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.513 -1.367 . . . . 0.0 108.08 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.5 m -132.93 132.38 41.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.436 -0.79 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 52' ' ' ILE . 79.2 mt -105.7 127.56 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.491 -0.755 . . . . 0.0 109.38 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -83.76 140.3 32.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 57' ' ' GLU . 27.7 tptp -58.66 -33.01 69.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.466 -0.771 . . . . 0.0 109.226 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -64.14 -6.43 6.54 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.79 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.58 -31.84 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 108.941 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 54' ' ' LYS . 74.0 mm-40 49.51 52.9 13.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.909 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 mt -101.96 153.93 37.67 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.36 -0.837 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.71 149.65 31.67 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.145 1.896 . . . . 0.0 112.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.0 138.29 57.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 0.0 110.27 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.8 mp -82.86 145.24 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 109.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -105.21 135.36 46.71 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.835 0.826 . . . . 0.0 109.998 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -74.78 146.64 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.022 0.915 . . . . 0.0 110.006 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.72 -11.1 42.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -97.81 150.14 21.58 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.102 -1.234 . . . . 0.0 110.507 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -84.16 143.8 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.364 0.602 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -142.14 150.26 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.08 129.92 55.47 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.31 115.65 28.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.423 -0.798 . . . . 0.0 109.576 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -113.66 146.25 40.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.579 -0.701 . . . . 0.0 110.317 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.1 t 56.96 58.97 3.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.882 -0.511 . . . . 0.0 110.908 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.98 165.73 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.302 -0.873 . . . . 0.0 108.849 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.01 152.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.654 0.74 . . . . 0.0 109.591 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.15 132.08 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.649 -0.657 . . . . 0.0 109.536 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.12 156.24 15.71 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.44 118.17 36.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 109.032 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.5 t80 -135.46 117.89 15.77 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.595 ' C ' ' H ' ' A' ' 80' ' ' ARG . 9.4 m120 52.73 55.75 8.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.452 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 56.16 -4.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.68 -0.638 . . . . 0.0 110.808 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.617 HH12 ' H ' ' A' ' 49' ' ' LYS . 68.3 ttt-85 -102.02 131.91 48.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.093 -1.004 . . . . 0.0 109.598 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -78.15 146.3 35.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.488 -0.757 . . . . 0.0 109.233 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -147.32 162.6 38.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 0.0 109.613 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.94 119.77 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.442 -0.787 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -100.56 129.91 46.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 0.0 109.043 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.56 132.39 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.045 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -125.49 -170.12 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.402 -0.811 . . . . 0.0 109.81 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -67.3 -25.42 66.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.654 -0.654 . . . . 0.0 110.102 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -80.72 -9.24 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.776 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 m -88.87 164.07 15.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 0.0 109.675 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.6 m -134.93 158.0 45.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.264 -0.897 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 91' ' ' ILE . 96.7 mt -136.94 128.87 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.114 -0.991 . . . . 0.0 108.843 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.97 128.56 47.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.311 -0.868 . . . . 0.0 108.919 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.82 137.97 55.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 109.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.2 134.37 46.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.848 . . . . 0.0 109.941 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.9 p -85.5 -2.01 57.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -109.66 127.53 27.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.368 -0.833 . . . . 0.0 109.692 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.55 151.0 41.35 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.121 1.881 . . . . 0.0 112.265 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.572 ' H ' ' HZ3' ' A' ' 23' ' ' LYS . 96.6 mt -111.01 134.5 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -105.8 122.77 46.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.6 m -106.61 -6.56 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' LEU . . . -94.82 -164.94 35.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 102' ' ' LEU . 10.0 mp 41.61 67.47 0.55 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.478 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' HIS . 73.7 mm-40 -74.57 131.95 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.416 0.627 . . . . 0.0 110.323 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 49.19 -90.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 0.0 109.526 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' GLU . 80.3 m80 -137.92 -172.46 3.26 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.033 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -66.48 136.1 55.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.546 ' H ' ' CD2' ' A' ' 107' ' ' HIS . 7.1 p80 -80.06 145.11 32.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.4 -0.813 . . . . 0.0 110.051 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -81.03 145.09 31.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.697 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 tpp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.316 0.579 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.28 157.12 75.84 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.149 -0.969 . . . . 0.0 109.685 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 143.88 21.7 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.055 1.837 . . . . 0.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.453 ' N ' HD21 ' A' ' 19' ' ' ASN . 85.1 mt-30 -77.84 115.78 17.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.516 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.72 127.48 35.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.9 m -121.12 137.7 54.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -95.85 151.74 19.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.944 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mm -55.96 -44.56 78.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.77 -18.24 23.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.222 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.28 -0.52 56.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.23 118.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -142.88 -2.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.926 . . . . 0.0 109.192 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.8 140.52 45.93 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.094 -1.004 . . . . 0.0 109.505 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -92.5 162.93 14.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.53 78.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -94.46 140.45 29.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -1.17 . . . . 0.0 109.682 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -96.48 128.26 43.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.626 -0.671 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.747 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.453 HD21 ' N ' ' A' ' 4' ' ' GLN . 58.9 m-20 -120.69 139.56 52.87 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -116.84 146.68 42.74 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.087 -1.008 . . . . 0.0 109.71 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -138.42 125.33 21.16 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 -175.16 1.06 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.177 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -110.54 151.76 27.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.854 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.47 111.06 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.322 -0.861 . . . . 0.0 110.84 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.7 pt -89.22 -24.38 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -156.56 147.26 21.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 109.449 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 160.61 39.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.249 -0.907 . . . . 0.0 109.37 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -141.21 109.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 109.389 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.87 129.14 39.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.618 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -105.17 153.97 20.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.296 -0.877 . . . . 0.0 109.151 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.2 p -144.84 58.67 1.3 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 34' ' ' SER . 76.3 t60 -124.49 17.73 8.89 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 55.52 2.93 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.776 -0.578 . . . . 0.0 110.66 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 32' ' ' HIS . 39.2 t -110.44 -49.02 3.09 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -108.16 140.73 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.684 -0.635 . . . . 0.0 109.524 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.416 ' OG ' ' C ' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -85.04 -58.32 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -151.98 152.01 31.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.258 -0.901 . . . . 0.0 109.871 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.87 133.01 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.27 -156.8 8.45 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.525 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.67 153.49 50.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.87 -0.782 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.46 128.7 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.8 97.84 2.35 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 53.8 t0 -101.37 159.86 14.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -1.045 . . . . 0.0 109.421 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.3 mt-10 -68.99 -14.8 63.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.44 -0.788 . . . . 0.0 109.984 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -98.0 -7.03 30.73 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.155 -0.966 . . . . 0.0 109.577 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.61 -147.81 18.11 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.162 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.81 165.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.662 -0.905 . . . . 0.0 109.909 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.5 tt -157.5 144.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.147 -0.97 . . . . 0.0 109.91 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.88 130.22 38.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -128.45 154.99 45.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.831 -1.168 . . . . 0.0 108.599 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.6 m -131.33 130.47 42.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.59 -0.694 . . . . 0.0 109.257 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.06 129.62 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.332 -0.855 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.416 ' C ' ' OG ' ' A' ' 36' ' ' SER . 97.9 m95 -82.0 139.91 34.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 110.312 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 56' ' ' ALA . 64.5 tttm -59.63 -37.78 79.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -61.04 -2.04 0.54 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -85.07 -23.71 28.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 108.779 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 53.85 48.28 21.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 109.9 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.77 147.06 35.38 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.533 -0.729 . . . . 0.0 109.581 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 157.27 62.54 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.384 2.056 . . . . 0.0 112.648 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.74 147.39 43.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.054 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 8.7 mp -85.2 155.19 21.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.528 -0.733 . . . . 0.0 109.556 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 47.2 tp10 -100.47 136.73 39.9 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -71.34 138.6 49.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.405 -0.809 . . . . 0.0 110.488 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.16 -14.81 62.6 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.35 158.45 15.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.327 -1.102 . . . . 0.0 110.667 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -88.15 151.77 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.485 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 31.7 m-85 -142.9 143.72 32.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 109.561 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.45 129.83 56.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.04 122.74 45.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.615 -0.678 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -116.86 151.99 35.41 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.477 0.656 . . . . 0.0 110.536 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m 56.93 54.97 6.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.89 -0.506 . . . . 0.0 110.788 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.21 164.6 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.243 -0.911 . . . . 0.0 108.853 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.51 147.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.564 0.697 . . . . 0.0 109.374 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.89 131.83 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 109.383 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.93 149.94 16.95 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 78' ' ' ASN . 5.5 tm-20 -92.08 100.2 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.034 -1.274 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.8 t80 -95.18 103.61 15.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.93 . . . . 0.0 109.191 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' O ' ' OE2' ' A' ' 76' ' ' GLU . 99.3 m-20 40.25 -110.67 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 0.0 110.684 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -95.89 -19.65 19.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.099 -1.001 . . . . 0.0 110.383 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 77' ' ' TYR . 37.4 mmt180 -101.31 162.61 12.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 110.006 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.37 152.25 21.81 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.426 ' NE2' ' CD1' ' A' ' 77' ' ' TYR . 27.5 mt-30 -142.06 157.81 44.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.16 123.7 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.434 -0.791 . . . . 0.0 109.111 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -104.8 126.64 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.453 -0.779 . . . . 0.0 109.545 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.74 134.93 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.39 -0.819 . . . . 0.0 109.162 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -129.29 -168.57 1.95 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.323 -0.86 . . . . 0.0 109.896 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.63 -41.63 98.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.521 -0.737 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.91 -20.07 66.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.735 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.0 m -81.21 163.88 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.777 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.5 m -137.44 162.27 34.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.85 130.19 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.015 -1.053 . . . . 0.0 108.834 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -130.08 134.71 47.55 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.211 -0.931 . . . . 0.0 109.013 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -75.57 139.54 42.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.532 -0.73 . . . . 0.0 109.902 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.07 141.74 28.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 109.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -85.05 -8.98 58.46 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.24 134.05 20.88 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.336 -0.852 . . . . 0.0 110.033 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 154.02 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.053 1.836 . . . . 0.0 112.155 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -111.64 133.41 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -87.65 123.0 32.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 109.663 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.65 -15.77 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.78 122.11 6.14 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.0 107.47 19.05 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.318 -1.107 . . . . 0.0 109.209 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.25 -3.66 40.91 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.72 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.3 m80 48.54 43.16 19.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.174 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.526 ' HD1' ' HD1' ' A' ' 106' ' ' HIS . 59.1 t-80 -59.94 -44.57 94.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.503 -0.748 . . . . 0.0 109.409 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.526 ' HD1' ' HD1' ' A' ' 105' ' ' HIS . 46.7 p-80 -150.81 163.44 38.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 109.341 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -138.15 45.92 2.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.385 -0.822 . . . . 0.0 109.34 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.87 -42.47 97.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.136 -0.977 . . . . 0.0 109.206 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.593 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -59.71 153.34 52.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.18 155.74 66.92 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.653 2.235 . . . . 0.0 112.093 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.74 115.66 20.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.95 131.43 35.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -123.57 142.08 51.38 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -93.28 149.86 20.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.073 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.25 -43.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.369 -0.832 . . . . 0.0 109.078 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 p -62.99 -5.7 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -102.02 6.25 41.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.372 -0.83 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.74 112.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 109.551 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.6 m -149.74 4.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -132.91 130.47 39.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.362 -0.836 . . . . 0.0 109.078 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -88.15 160.06 17.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.193 -0.942 . . . . 0.0 110.359 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.52 20.68 72.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -94.29 138.57 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 109.996 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -94.85 126.69 40.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 109.386 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -179.41 7.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -126.3 140.36 52.58 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.36 143.73 40.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.5 135.74 54.2 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.87 -173.69 1.01 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.183 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.09 150.99 28.6 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.863 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.14 97.34 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.086 -1.009 . . . . 0.0 109.932 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 tp -66.47 -32.59 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 121.092 -1.005 . . . . 0.0 110.529 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -147.35 129.7 15.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 109.535 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.78 147.59 41.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.598 -0.689 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -143.51 115.39 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 109.396 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.54 131.62 44.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.459 -0.776 . . . . 0.0 109.649 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.421 HD21 ' HB ' ' A' ' 35' ' ' ILE . 57.0 t30 -115.19 120.27 39.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.417 -0.802 . . . . 0.0 109.168 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 33' ' ' GLU . 69.3 p -110.99 8.25 21.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.486 -0.759 . . . . 0.0 109.1 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 25.1 m-70 -58.87 -0.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tm-20 79.21 -51.49 0.43 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 35' ' ' ILE . 83.7 p -83.6 87.72 7.03 Favored 'General case' 0 C--O 1.201 -1.474 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.585 ' CB ' ' O ' ' A' ' 34' ' ' SER . 26.2 mt 124.87 137.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 C-N-CA 123.731 0.813 . . . . 0.0 109.218 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -81.72 -57.87 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.394 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.74 165.19 33.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 0.0 110.661 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.76 154.9 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.66 -155.38 17.36 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.393 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.01 155.2 50.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.911 -0.758 . . . . 0.0 109.541 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.35 127.8 55.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.8 105.89 3.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -112.95 167.99 10.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.923 . . . . 0.0 109.484 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -73.01 -17.33 61.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.947 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.8 p -93.17 -12.1 31.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.917 -1.114 . . . . 0.0 109.644 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.69 -148.56 19.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.426 ' C ' ' CD1' ' A' ' 47' ' ' ILE . 2.3 pp -135.55 160.66 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.992 . . . . 0.0 109.55 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -153.77 147.56 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.189 -0.944 . . . . 0.0 109.76 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -81.07 163.64 23.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 109.189 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -160.6 150.94 18.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.483 -1.386 . . . . 0.0 108.265 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 t -138.42 133.1 32.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.837 . . . . 0.0 109.47 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -105.2 129.77 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.677 -0.639 . . . . 0.0 109.467 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -81.98 139.3 34.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 110.686 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.35 -32.03 72.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.416 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.09 -10.4 10.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.85 -21.88 34.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 47.74 48.89 17.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.985 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt -103.71 152.27 38.9 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.404 -0.81 . . . . 0.0 109.8 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.42 146.5 41.27 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.077 1.851 . . . . 0.0 112.589 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.47 142.78 53.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.0 mp -82.63 143.32 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.514 -0.741 . . . . 0.0 109.667 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -93.41 132.04 38.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.28 -0.888 . . . . 0.0 109.755 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -69.26 139.11 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 110.746 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -11.97 59.56 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -96.06 158.51 15.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -1.109 . . . . 0.0 110.585 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.449 ' H ' ' HG ' ' A' ' 66' ' ' SER . 8.7 p -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.489 0.661 . . . . 0.0 109.836 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.11 148.78 38.9 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.936 0.874 . . . . 0.0 109.879 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -107.16 131.41 54.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.9 mt -116.27 111.29 19.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' O ' ' OG ' ' A' ' 71' ' ' SER . 99.1 mtt180 -115.65 153.04 32.0 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.737 0.779 . . . . 0.0 110.556 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 5.2 p 50.46 56.58 7.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.867 -0.52 . . . . 0.0 110.67 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 167.26 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.98 152.72 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.6 0.714 . . . . 0.0 109.402 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.11 131.44 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.65 -0.656 . . . . 0.0 109.734 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.25 148.56 17.21 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -97.5 107.59 20.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.279 -1.13 . . . . 0.0 108.927 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ARG . 87.1 t80 -107.13 109.22 21.0 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.371 -0.83 . . . . 0.0 109.273 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.483 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 26.6 t-20 38.92 -116.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.483 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 99.4 m-20 -92.81 -20.13 21.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 77' ' ' TYR . 3.6 mpt_? -96.12 162.22 13.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.84 153.89 25.94 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -149.77 161.87 41.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.167 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.17 128.14 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.87 124.35 49.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.484 -0.76 . . . . 0.0 109.356 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.7 t -98.4 133.51 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -123.27 -169.09 1.87 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 0.0 109.655 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.45 -38.81 88.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.761 -0.587 . . . . 0.0 109.924 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.55 -12.17 56.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.983 . . . . 0.0 109.902 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.546 ' HG ' ' N ' ' A' ' 90' ' ' SER . 40.0 t -87.75 166.66 14.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 89' ' ' SER . 42.4 m -134.82 156.03 49.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.29 -0.881 . . . . 0.0 108.829 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 91' ' ' ILE . 96.8 mt -139.12 130.88 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.094 -1.004 . . . . 0.0 108.981 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -127.22 127.91 45.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.28 -0.888 . . . . 0.0 108.917 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.58 141.92 44.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.27 142.2 37.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.52 ' HG ' ' CD ' ' A' ' 96' ' ' GLU . 94.5 p -88.2 3.18 50.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.616 -0.677 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' CD ' ' HG ' ' A' ' 95' ' ' SER . 27.6 mp0 -105.99 133.72 20.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.291 -0.881 . . . . 0.0 109.687 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.51 148.29 37.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.089 1.86 . . . . 0.0 112.157 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.53 134.11 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.9 mp0 -88.79 120.93 30.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.095 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 t -91.52 80.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.58 87.92 0.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 102' ' ' LEU . 3.7 mm? 44.36 -98.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.525 -0.985 . . . . 0.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' HIS . 97.4 mt-10 -142.9 -67.27 0.37 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.465 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.8 t60 60.04 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' GLU . 97.8 m-70 -87.37 123.12 31.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -100.65 130.61 46.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.483 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 52.3 p-80 -59.85 -43.98 94.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.926 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.483 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 58.7 t-80 -149.24 156.61 42.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.736 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.492 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 36.7 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.068 -0.967 . . . . 0.0 109.709 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.401 0.62 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -166.15 57.78 0.47 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.214 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 161.09 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.749 2.3 . . . . 0.0 112.154 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.61 115.51 17.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.14 131.32 36.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.849 . . . . 0.0 109.438 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.3 m -124.68 141.06 52.37 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.88 151.75 19.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.3 mt -56.38 -45.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.229 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.7 -17.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.625 -0.672 . . . . 0.0 109.436 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -92.8 2.41 56.77 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -86.21 121.23 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.045 -1.034 . . . . 0.0 109.861 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -147.9 6.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -137.56 135.42 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -93.32 158.75 15.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.9 20.71 79.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.46 147.62 25.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -1.123 . . . . 0.0 110.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -97.49 126.91 43.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.94 -178.23 6.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.682 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -117.91 145.62 44.52 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.4 tp -134.24 127.86 32.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -114.88 130.21 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.11 170.78 11.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.122 0.963 . . . . 0.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -100.1 155.34 17.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.751 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.45 113.19 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.51 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -147.56 130.5 16.23 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.036 -1.04 . . . . 0.0 109.781 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 1.4 pt? -129.68 156.81 43.65 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.293 0.568 . . . . 0.0 109.812 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -144.5 110.5 5.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.98 117.8 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.52 137.76 40.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.269 -0.895 . . . . 0.0 109.176 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' GLU . 61.6 p -122.43 7.66 9.58 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.537 -0.727 . . . . 0.0 109.113 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -66.15 2.2 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 31' ' ' THR . 23.3 tp10 70.22 -47.57 0.63 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.706 -0.621 . . . . 0.0 110.023 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 t -60.05 -46.33 89.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.979 -1.076 . . . . 0.0 109.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt -107.8 135.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.435 -0.79 . . . . 0.0 109.485 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -82.52 -62.77 1.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.621 -0.674 . . . . 0.0 109.995 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -152.32 149.19 28.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.968 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.61 154.13 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.14 -159.63 22.68 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 tp -125.27 145.2 50.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.907 -0.76 . . . . 0.0 109.448 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.0 mt -108.48 128.68 55.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.514 -0.741 . . . . 0.0 109.201 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 97.83 2.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -103.32 164.31 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.97 . . . . 0.0 109.621 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.09 -20.22 62.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.602 -0.686 . . . . 0.0 110.104 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 p -90.12 -12.65 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.359 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.58 -148.97 20.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.02 159.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.672 -0.899 . . . . 0.0 109.666 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.42 141.69 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -88.36 144.68 26.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -141.27 158.63 43.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.73 -1.231 . . . . 0.0 108.49 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -135.03 137.57 43.09 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.514 0.674 . . . . 0.0 109.726 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.6 mt -106.33 129.68 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -86.39 142.94 28.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.376 -0.827 . . . . 0.0 110.378 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -61.93 -32.08 72.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.643 -0.66 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.5 -12.77 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.517 -0.739 . . . . 0.0 109.619 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.23 24.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.948 . . . . 0.0 108.939 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 49.13 52.91 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.815 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 mt -102.37 153.66 37.95 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.1 149.0 45.94 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 122.082 1.855 . . . . 0.0 112.72 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.54 140.89 51.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.264 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.5 mp -82.97 145.04 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.709 -0.619 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.615 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 96.1 mt-10 -101.17 139.2 37.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -76.58 138.27 40.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.644 -0.66 . . . . 0.0 110.726 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.02 -18.65 56.94 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 97.8 mt-10 -97.0 159.95 14.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.681 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -89.55 148.59 23.3 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.416 0.627 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.615 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 34.3 m-85 -141.43 143.94 34.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.713 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 tp -109.45 130.44 55.5 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -113.33 122.17 46.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.502 -0.749 . . . . 0.0 109.831 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -120.19 147.1 45.35 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.675 0.75 . . . . 0.0 110.426 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.6 t 57.11 56.86 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.097 0.475 . . . . 0.0 110.751 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.56 166.03 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.81 143.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.602 0.715 . . . . 0.0 109.666 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.83 132.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.65 -0.656 . . . . 0.0 109.655 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.29 153.1 17.77 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -95.71 110.44 22.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -1.147 . . . . 0.0 109.139 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 80' ' ' ARG . 75.4 t80 -103.84 109.73 21.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.145 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 43.75 -119.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.773 . . . . 0.0 110.438 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -94.01 -17.08 23.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.11 -0.994 . . . . 0.0 110.254 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 77' ' ' TYR . 78.4 ttt180 -102.56 144.13 31.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.38 153.27 37.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 0.0 108.955 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -143.82 152.05 40.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.991 -1.068 . . . . 0.0 109.011 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.89 122.27 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.86 128.67 53.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.448 -0.783 . . . . 0.0 109.414 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.11 133.11 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -136.94 -166.32 1.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 89' ' ' SER . 10.0 mtpm? -55.43 167.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.873 -0.517 . . . . 0.0 109.763 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 73.07 -23.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.413 -0.804 . . . . 0.0 109.614 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 87' ' ' LYS . 48.9 m -72.35 159.18 34.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.752 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.9 m -135.04 155.12 51.3 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.336 -0.852 . . . . 0.0 108.871 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -139.26 131.19 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.1 -1.0 . . . . 0.0 109.06 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -131.58 136.91 48.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 0.0 108.917 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -72.45 140.53 48.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.32 132.14 44.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.404 -0.81 . . . . 0.0 109.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -83.1 -4.77 58.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.661 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -115.53 93.66 37.42 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.78 . . . . 0.0 109.441 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.94 156.78 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.525 2.15 . . . . 0.0 112.208 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.7 147.85 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.05 -82.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.07 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t 61.09 60.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.33 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.54 32.38 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.8 tp -99.26 107.97 20.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 104' ' ' HIS . 74.2 tt0 -153.92 1.62 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 103' ' ' GLU . 96.5 m-70 53.09 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 109.357 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -136.06 135.88 39.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 109.206 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.424 ' HD1' ' H ' ' A' ' 106' ' ' HIS . 39.6 p-80 -77.77 146.35 35.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.677 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' HIS . 95.9 m-70 -75.73 144.75 41.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 107' ' ' HIS . 79.3 m80 49.42 -177.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.461 -0.775 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.697 -179.832 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mmm . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -165.0 58.19 0.57 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.4 156.06 62.48 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.673 2.249 . . . . 0.0 112.119 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.42 113.79 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.517 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.32 132.18 36.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.1 m -124.46 143.49 50.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.63 -0.668 . . . . 0.0 109.27 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -94.1 148.08 22.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.7 mt -57.24 -44.74 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 109.399 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.36 -12.31 13.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.565 -0.71 . . . . 0.0 109.385 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 53.7 t0 -97.31 4.89 50.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.2 mt -88.0 121.57 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.99 6.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.208 -0.933 . . . . 0.0 109.417 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -133.49 128.99 36.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -87.81 153.61 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.148 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.88 17.01 78.04 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -96.44 150.12 20.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.425 -1.044 . . . . 0.0 110.045 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -102.33 131.26 49.05 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.4 0.619 . . . . 0.0 109.481 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.63 179.24 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -117.15 131.12 56.95 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.18 146.26 43.33 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.898 0.856 . . . . 0.0 110.352 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -136.08 131.47 34.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.54 -173.82 0.78 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.039 0.923 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -111.85 150.98 29.62 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.943 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.4 t -86.39 95.02 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.21 -26.7 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.77 . . . . 0.0 109.811 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -143.17 119.25 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.954 -1.091 . . . . 0.0 109.379 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.4 tp -109.3 143.63 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 0.0 109.18 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -140.26 107.28 5.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.61 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -73.01 116.93 14.12 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' ND1' ' A' ' 32' ' ' HIS . 48.9 t-20 -102.8 134.23 46.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.259 -0.901 . . . . 0.0 109.175 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.2 OUTLIER -103.17 11.26 37.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 108.905 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.465 ' ND1' ' OD1' ' A' ' 30' ' ' ASN . 24.3 m80 -79.4 147.4 32.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.34 -41.2 73.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.32 -0.862 . . . . 0.0 110.068 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 t -63.65 -51.47 65.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.313 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 32' ' ' HIS . 93.8 mt -106.58 133.7 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.677 0.751 . . . . 0.0 109.446 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -97.63 -50.06 4.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -149.87 146.84 27.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 110.129 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.39 153.01 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.38 -161.58 23.87 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.275 -1.441 . . . . 0.0 109.925 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.76 146.53 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.021 -0.693 . . . . 0.0 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -112.3 127.08 55.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.53 -0.731 . . . . 0.0 109.431 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.35 100.93 2.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -101.25 162.39 12.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.359 -1.083 . . . . 0.0 109.358 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -72.26 -21.93 61.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.601 -0.687 . . . . 0.0 109.893 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.9 p -93.92 -16.12 24.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.208 -0.933 . . . . 0.0 109.136 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.21 -156.98 29.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.014 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.2 pt -137.98 163.18 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.531 -0.981 . . . . 0.0 109.93 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.2 tt -162.5 152.12 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.196 -0.94 . . . . 0.0 109.716 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -97.12 138.84 34.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -131.49 156.16 46.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.058 -1.026 . . . . 0.0 108.933 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.8 m -131.59 132.28 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.472 0.653 . . . . 0.0 109.64 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.3 mt -98.47 128.23 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 109.699 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -85.0 143.73 28.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -0.792 . . . . 0.0 110.432 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.56 -35.36 74.09 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -58.97 -9.54 1.94 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.575 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.22 -28.13 24.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 108.889 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 45.9 49.99 11.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.639 . . . . 0.0 109.865 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.0 mt -102.78 153.22 38.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.614 -0.679 . . . . 0.0 109.739 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.78 149.91 47.89 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.357 2.038 . . . . 0.0 112.642 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.91 140.4 53.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.469 -0.77 . . . . 0.0 110.335 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.3 mp -81.57 145.42 30.66 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.423 0.63 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 97.0 mt-10 -94.24 128.78 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 58.3 tt0 -68.5 135.45 51.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.592 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.1 71.59 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.0 mp0 -99.4 162.38 13.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -1.123 . . . . 0.0 110.687 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -98.04 137.13 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -133.75 153.38 51.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.133 0.968 . . . . 0.0 110.08 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 tp -111.74 131.32 55.39 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.9 mt -111.9 120.86 43.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.471 -0.768 . . . . 0.0 109.533 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' OG ' ' A' ' 71' ' ' SER . 83.0 mtp180 -117.75 151.37 37.43 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.578 0.704 . . . . 0.0 110.647 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.2 p 51.71 56.2 8.21 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.52 166.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.55 150.03 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.686 0.755 . . . . 0.0 109.888 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.45 132.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.674 . . . . 0.0 109.442 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.75 150.2 16.85 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -88.02 99.7 12.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ARG . 76.2 t80 -98.1 100.71 12.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.251 -0.906 . . . . 0.0 109.225 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 44.7 -119.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 110.7 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 34.6 p-10 -93.65 -7.58 43.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -110.57 155.27 22.56 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.89 0.852 . . . . 0.0 110.184 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -95.95 153.45 17.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 108.848 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -144.11 159.43 42.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.41 126.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -103.13 126.75 50.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.432 -0.792 . . . . 0.0 109.148 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.03 132.24 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -127.01 -168.45 1.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.692 0.758 . . . . 0.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -65.2 -41.76 94.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.762 -0.587 . . . . 0.0 110.18 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -64.48 -12.2 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.8 t -83.86 164.03 19.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.8 m -136.5 157.59 46.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.327 -0.858 . . . . 0.0 109.044 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 91' ' ' ILE . 96.3 mt -134.96 128.24 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.267 -0.896 . . . . 0.0 109.226 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -129.76 133.12 46.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -80.1 134.86 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' GLU . 4.0 mm? -107.64 -1.7 20.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.464 -0.772 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 t 47.28 15.77 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.269 -0.894 . . . . 0.0 109.97 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 94' ' ' LEU . 6.9 tp10 -114.83 93.28 33.31 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 108.936 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.8 147.39 41.3 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.683 2.255 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 mm -105.74 139.96 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.573 -0.704 . . . . 0.0 109.17 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -93.79 122.43 36.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.495 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.2 m -101.83 -5.48 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 103' ' ' GLU . . . 156.03 -94.26 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 103' ' ' GLU . 73.4 mt 56.04 5.48 0.17 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.481 -1.011 . . . . 0.0 109.312 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 101' ' ' GLY . 97.8 mt-10 44.21 -170.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.735 0.778 . . . . 0.0 110.751 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -152.97 127.5 9.35 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -154.6 24.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 108.875 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 47.2 77.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.475 -0.766 . . . . 0.0 109.293 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.49 139.64 38.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.61 -0.681 . . . . 0.0 110.037 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -73.2 139.02 45.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.677 -179.86 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -91.08 156.44 44.04 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.368 -0.833 . . . . 0.0 109.575 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.97 157.29 62.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.571 2.181 . . . . 0.0 111.971 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.56 117.96 22.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -87.77 128.67 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.9 m -124.94 145.64 49.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -97.49 142.71 28.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 pt -52.94 -39.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 0.0 109.733 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.56 -12.19 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.504 -0.748 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -97.17 5.18 50.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.95 123.77 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.159 -0.963 . . . . 0.0 109.951 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.41 8.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -137.45 134.42 35.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 109.243 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.418 ' OD1' ' OE1' ' A' ' 76' ' ' GLU . 16.0 m120 -92.61 153.74 18.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.369 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.19 71.75 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -95.83 146.86 24.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.66 132.47 52.61 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.352 0.596 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -175.16 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 0.0 109.848 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 27.3 t30 -119.48 140.53 50.31 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -133.62 149.03 51.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.383 -0.823 . . . . 0.0 110.165 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -133.07 127.34 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.93 177.5 10.31 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.098 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -109.16 153.15 24.15 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.919 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.0 99.61 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.286 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.51 -26.09 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -158.36 147.43 19.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.361 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.3 pt? -133.54 158.78 42.27 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.51 -0.744 . . . . 0.0 109.628 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -142.41 109.32 5.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -68.29 123.63 21.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.231 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 35' ' ' ILE . 4.4 t30 -134.8 123.37 23.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.406 -0.809 . . . . 0.0 109.261 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -136.71 24.18 3.12 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.368 -0.833 . . . . 0.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.46 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.441 -0.787 . . . . 0.0 109.837 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -73.66 -110.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 109.443 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -116.02 10.85 15.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 30' ' ' ASN . 89.8 mt -81.13 133.15 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.579 ' HG ' ' HZ1' ' A' ' 54' ' ' LYS . 4.7 t -86.25 -57.43 3.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.991 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -151.41 154.95 37.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.187 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.35 139.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.69 -156.02 10.12 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.327 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.06 152.2 51.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.832 -0.805 . . . . 0.0 109.688 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.75 131.64 54.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.33 99.15 2.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -100.34 160.78 14.06 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.452 -1.028 . . . . 0.0 109.46 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.98 -16.63 63.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 109.85 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -96.63 -11.72 24.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.213 -0.929 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.17 17.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' ILE . 2.6 pp -132.82 162.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.964 . . . . 0.0 109.635 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.2 tp -156.67 148.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.665 ' HZ3' HH11 ' A' ' 80' ' ' ARG . 63.1 mttp -81.53 164.13 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.603 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -157.01 148.07 21.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.64 -1.288 . . . . 0.0 108.543 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -136.42 131.88 34.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.216 -0.927 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.07 130.11 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.664 -0.648 . . . . 0.0 109.578 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -86.85 141.44 28.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.579 ' HZ1' ' HG ' ' A' ' 36' ' ' SER . 12.6 mmtm -56.59 -35.3 68.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.54 -0.725 . . . . 0.0 109.068 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -59.4 -4.6 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.484 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -87.35 -31.08 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 108.909 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 51.22 50.62 18.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 110.089 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.82 152.38 42.29 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.765 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.2 148.34 41.02 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.173 1.915 . . . . 0.0 112.784 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -68.32 144.65 54.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.479 -0.763 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.6 mp -80.16 145.21 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -102.35 133.91 46.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.368 -0.833 . . . . 0.0 109.48 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.71 138.42 44.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.477 -0.764 . . . . 0.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.29 -8.15 79.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -106.04 157.32 17.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.417 -1.049 . . . . 0.0 110.493 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -89.1 147.4 24.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.861 -0.525 . . . . 0.0 109.619 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -140.52 145.75 37.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.819 0.819 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -111.69 131.25 55.42 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 2.8 mp -117.75 115.85 25.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.516 -0.74 . . . . 0.0 109.51 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -109.59 149.12 30.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.52 -0.737 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.68 59.43 3.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.789 -0.569 . . . . 0.0 110.61 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.79 162.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.27 147.96 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.512 0.673 . . . . 0.0 109.473 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.36 127.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.22 156.79 15.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.508 ' OE1' ' CE2' ' A' ' 81' ' ' PHE . 49.6 tp10 -105.6 134.35 48.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -1.006 . . . . 0.0 108.816 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 79' ' ' ASP . 87.9 t80 -129.37 117.93 21.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.744 . . . . 0.0 109.077 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' TYR . 95.0 m-20 39.65 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.707 -0.62 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 77' ' ' TYR . 37.3 p-10 -125.08 -17.61 5.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.309 -0.869 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.665 HH11 ' HZ3' ' A' ' 49' ' ' LYS . 96.8 mtt180 -93.25 155.43 17.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.969 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.508 ' CE2' ' OE1' ' A' ' 76' ' ' GLU . 96.0 m-85 -101.81 149.09 24.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 0.0 108.945 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -152.35 161.16 43.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -104.46 127.75 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.29 127.01 46.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.798 . . . . 0.0 109.596 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 ' CG1' ' HG ' ' A' ' 89' ' ' SER . 21.4 t -99.59 133.15 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 109.07 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.539 ' H ' ' HG ' ' A' ' 89' ' ' SER . 78.8 m-20 -132.5 -166.16 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -62.36 -40.91 97.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -62.27 -32.31 73.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.539 ' HG ' ' H ' ' A' ' 86' ' ' ASN . 24.2 p -79.54 164.72 23.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.4 t -139.54 166.92 23.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.468 -0.77 . . . . 0.0 109.111 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -139.59 131.58 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.189 -0.944 . . . . 0.0 109.175 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -128.81 132.43 47.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.299 -0.876 . . . . 0.0 109.147 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.64 139.98 40.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.296 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -101.26 141.57 33.95 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.971 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -84.43 -1.75 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.556 -0.715 . . . . 0.0 109.681 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.04 131.4 23.19 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.433 -0.792 . . . . 0.0 109.692 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.43 152.91 49.81 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.998 1.799 . . . . 0.0 112.439 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.49 134.44 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.54 -0.725 . . . . 0.0 109.14 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -93.8 118.52 31.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.303 -0.873 . . . . 0.0 109.837 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.85 -31.2 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.3 104.23 0.66 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt 43.39 72.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.596 -0.943 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.03 128.37 35.81 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.452 0.644 . . . . 0.0 110.39 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 105' ' ' HIS . 45.5 t-80 -155.52 173.95 15.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 104' ' ' HIS . 97.9 m-70 -57.54 -157.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 109.515 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -76.28 -9.51 58.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.27 125.1 21.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -149.0 139.06 22.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.176 -0.952 . . . . 0.0 109.511 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.549 ' H ' ' CD2' ' A' ' 109' ' ' HIS . 6.3 p80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mmm . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.57 0.7 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 2.4 mt-10 -82.61 -49.4 0.81 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.279 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 74.4 Cg_endo -77.58 162.43 30.33 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.123 1.882 . . . . 0.0 112.28 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -76.72 118.5 19.41 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.303 -0.873 . . . . 0.0 109.35 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.8 mt -93.23 128.29 39.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -127.86 150.5 49.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -97.61 146.99 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.153 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.42 -42.3 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.795 . . . . 0.0 108.956 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.41 -8.97 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.558 -0.714 . . . . 0.0 109.407 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 57.9 t0 -100.18 4.46 44.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.904 . . . . 0.0 109.176 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.56 118.95 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.55 6.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 14' ' ' ASN . 8.0 tm-20 -131.09 129.34 41.76 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.407 -0.808 . . . . 0.0 109.137 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p30 -88.04 150.63 23.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.284 -0.885 . . . . 0.0 110.289 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.85 16.33 79.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -93.07 144.46 25.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.364 -1.08 . . . . 0.0 109.938 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.82 129.69 45.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.695 . . . . 0.0 109.565 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.71 -179.42 7.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.384 -0.822 . . . . 0.0 109.876 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 71' ' ' SER . 77.2 m-20 -140.09 145.48 37.69 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.453 -0.779 . . . . 0.0 109.157 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.96 158.57 30.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -100.57 139.69 35.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.044 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.26 157.51 40.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.892 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -103.06 153.89 19.81 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.1 110.45 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.132 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 25' ' ' ILE . 15.5 pt -91.5 -21.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 110.143 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -162.76 153.03 16.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.08 -1.013 . . . . 0.0 109.422 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.489 ' N ' HE21 ' A' ' 63' ' ' GLN . 91.5 mt -132.06 157.11 45.0 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.572 0.701 . . . . 0.0 109.909 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' VAL . 46.1 m95 -144.55 118.94 9.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.218 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 128.17 34.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.6 141.68 35.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.317 -0.864 . . . . 0.0 109.122 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.641 ' C ' ' H ' ' A' ' 33' ' ' GLU . 70.8 p -120.83 11.59 11.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.461 -0.775 . . . . 0.0 109.142 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -62.62 10.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.509 -0.744 . . . . 0.0 109.377 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.641 ' H ' ' C ' ' A' ' 31' ' ' THR . 96.8 mt-10 56.44 16.1 2.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 110.703 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 t -131.74 -32.71 1.45 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.384 -0.823 . . . . 0.0 108.935 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.41 138.62 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.799 0.809 . . . . 0.0 109.432 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -81.69 -65.1 1.05 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.547 0.689 . . . . 0.0 109.914 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -149.55 153.24 36.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.011 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 28' ' ' TRP . 3.0 t -137.91 163.75 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.55 33.55 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.1 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -126.96 146.81 50.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.973 -0.722 . . . . 0.0 109.123 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.1 mt -109.92 129.41 55.66 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.79 101.74 2.8 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -107.01 165.0 11.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.597 -0.943 . . . . 0.0 109.458 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.96 -18.78 62.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.52 -0.738 . . . . 0.0 109.847 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 p -91.66 -11.56 36.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 109.391 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.25 -146.61 15.89 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.56 151.1 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.691 -0.888 . . . . 0.0 109.636 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tp -146.48 138.06 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.765 . . . . 0.0 109.655 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -83.28 152.52 25.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.382 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.11 154.67 41.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.574 -1.329 . . . . 0.0 107.864 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -132.19 131.06 41.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.637 -0.664 . . . . 0.0 109.743 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.71 128.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -89.41 144.02 26.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HZ2' ' C ' ' A' ' 33' ' ' GLU . 53.8 mtmt -58.22 -34.36 70.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.84 -5.7 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -89.07 -33.41 17.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 108.719 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 49.81 50.25 18.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.597 -0.689 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.85 163.11 18.2 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.551 -0.718 . . . . 0.0 109.671 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.79 150.09 84.73 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.577 2.185 . . . . 0.0 112.325 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.5 mt -72.35 142.82 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 110.308 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -84.35 149.52 25.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.668 . . . . 0.0 109.723 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 57.0 mp0 -110.14 142.39 41.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.964 0.888 . . . . 0.0 109.593 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.489 HE21 ' N ' ' A' ' 27' ' ' LEU . 99.5 mt-30 -74.56 137.58 42.49 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.541 0.686 . . . . 0.0 110.794 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.49 -14.91 64.4 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.06 155.01 16.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 0.0 110.832 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.468 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 5.7 p -93.39 158.79 15.55 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' A' ' 66' ' ' SER . 90.1 m-85 -149.8 149.28 30.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.66 131.73 50.56 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.0 mt -105.43 107.5 18.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -110.15 139.39 45.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.463 0.649 . . . . 0.0 110.252 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 25.2 t 55.25 59.11 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.88 -0.512 . . . . 0.0 110.908 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.42 165.57 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.34 -0.85 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.78 153.99 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.623 0.725 . . . . 0.0 109.759 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.03 131.28 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 0.0 109.709 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.47 148.13 17.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.29 100.19 12.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -1.166 . . . . 0.0 109.229 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' ARG . 73.5 t80 -101.49 105.2 16.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.403 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 56.4 t30 40.57 -117.13 0.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.527 -0.733 . . . . 0.0 110.686 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 97.7 m-20 -92.63 -18.35 23.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -99.29 162.78 12.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 110.056 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.48 153.0 24.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.23 163.13 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 0.0 109.124 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.62 125.89 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -106.08 126.19 51.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.381 -0.824 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -97.17 135.2 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -130.95 -169.41 2.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.479 -0.763 . . . . 0.0 109.747 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.53 -39.45 94.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.649 -0.657 . . . . 0.0 110.224 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -68.0 -19.63 64.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.794 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.57 166.24 17.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -0.843 . . . . 0.0 110.019 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -145.08 164.29 31.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -0.92 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mt -149.4 139.72 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -133.61 143.24 48.5 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.468 -0.77 . . . . 0.0 109.583 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 68.1 mttm -72.81 140.68 47.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.766 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt -111.64 147.72 34.89 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.634 0.73 . . . . 0.0 109.996 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -95.75 6.07 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.0 109.783 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.56 92.08 43.09 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.427 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.09 160.46 8.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.821 2.348 . . . . 0.0 112.117 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.81 139.2 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.552 -0.717 . . . . 0.0 109.55 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 101' ' ' GLY . 48.7 tp10 -71.19 126.58 29.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -0.809 . . . . 0.0 109.641 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.2 2.45 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.424 ' O ' ' OE2' ' A' ' 99' ' ' GLU . . . -151.14 106.22 0.3 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.43 102.23 14.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.333 -1.098 . . . . 0.0 109.239 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 103' ' ' GLU . 57.2 mp0 -46.54 98.68 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.493 0.663 . . . . 0.0 110.583 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -65.89 -41.88 90.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.817 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 107' ' ' HIS . 81.7 t60 -150.11 -56.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.422 -0.799 . . . . 0.0 109.113 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 46.02 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.43 -0.794 . . . . 0.0 109.845 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' HIS . 85.1 t60 -153.08 69.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.196 -0.94 . . . . 0.0 109.36 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.667 ' HD1' ' HD1' ' A' ' 109' ' ' HIS . 54.1 t-80 -66.3 -43.43 86.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.489 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.667 ' HD1' ' HD1' ' A' ' 108' ' ' HIS . 48.5 p-80 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.18 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 CA-C-O 121.577 0.574 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -80.32 119.99 23.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -90.91 131.64 36.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 141.95 51.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.84 150.64 20.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 110.106 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mm -55.0 -45.45 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.64 0.733 . . . . 0.0 109.371 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.98 -11.72 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -97.4 3.91 50.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 109.653 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLU . 77.8 mt -59.87 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.306 -0.871 . . . . 0.0 110.483 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' ILE . 11.8 m 31.26 31.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.397 0.617 . . . . 0.0 110.735 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.3 tt0 -166.13 112.78 0.88 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.321 -0.862 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 54.1 p30 -86.91 154.45 20.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 23.98 76.3 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -97.48 140.2 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -1.031 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.91 128.62 44.05 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.44 -170.71 2.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -130.68 135.16 47.56 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.76 148.12 43.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -116.57 132.5 56.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.85 165.68 29.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.045 0.926 . . . . 0.0 110.925 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -105.6 155.69 18.97 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.909 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -88.36 99.78 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.234 -0.916 . . . . 0.0 110.467 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.518 HD11 ' CA ' ' A' ' 42' ' ' GLY . 54.5 mt -69.73 -28.71 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.077 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.27 140.52 18.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 109.24 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.954 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.6 pt? -120.93 150.09 41.62 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.34 0.591 . . . . 0.0 109.926 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -141.03 112.25 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.374 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 109.433 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.571 0.701 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 t -96.85 -49.44 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.592 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.42 149.42 28.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.02 142.41 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.693 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -163.17 -161.52 12.61 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.92 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.693 HD12 ' C ' ' A' ' 39' ' ' GLY . 9.5 mp -120.2 146.16 46.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.943 -0.739 . . . . 0.0 109.42 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.3 mt -108.77 124.41 50.55 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.518 ' CA ' HD11 ' A' ' 25' ' ' ILE . . . -95.26 96.75 2.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.8 t0 -100.48 160.85 14.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -1.159 . . . . 0.0 109.387 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 84.3 tt0 -70.36 -20.5 62.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.693 -0.63 . . . . 0.0 109.858 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.4 p -92.15 -12.12 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.16 -153.28 24.46 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.99 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 pt -136.48 159.86 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.547 -0.973 . . . . 0.0 109.918 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -159.2 146.34 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.842 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -90.31 134.9 34.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -129.5 157.27 42.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 108.649 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.2 m -132.89 132.52 42.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.47 127.91 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -85.3 145.54 27.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 110.547 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.54 -36.64 78.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -59.63 -8.89 2.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.474 -0.766 . . . . 0.0 109.899 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 -26.47 24.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 109.044 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.59 51.32 15.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.697 -0.627 . . . . 0.0 109.878 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.0 mt -105.28 148.76 36.8 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.37 161.96 42.61 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.618 2.212 . . . . 0.0 112.637 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.01 141.0 47.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.665 0.745 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.2 mp -84.31 156.67 21.81 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.442 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 42.7 tt0 -99.87 129.59 45.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.388 -0.82 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.448 ' OE1' HD22 ' A' ' 27' ' ' LEU . 58.9 tt0 -65.79 137.63 57.37 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.456 0.646 . . . . 0.0 110.487 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.93 -10.68 64.63 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -94.79 151.68 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -1.135 . . . . 0.0 110.31 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -84.99 140.44 31.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.442 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 33.1 m-85 -133.7 142.87 48.19 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.754 0.787 . . . . 0.0 109.773 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.09 127.79 54.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.64 118.46 35.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -114.18 145.55 41.54 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.408 0.623 . . . . 0.0 110.403 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t 58.17 58.15 3.65 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.726 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.05 165.98 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.343 -0.848 . . . . 0.0 109.273 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.27 149.81 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.729 0.776 . . . . 0.0 110.012 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.02 133.89 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.754 -0.591 . . . . 0.0 109.629 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.28 148.73 16.78 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -94.63 104.64 16.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -1.146 . . . . 0.0 109.148 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 80' ' ' ARG . 84.3 t80 -99.85 106.4 18.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.789 . . . . 0.0 109.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.2 t30 42.19 -116.64 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.549 -0.72 . . . . 0.0 110.757 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.41 -17.12 23.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.085 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 mmm-85 -100.94 156.43 17.39 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.874 0.845 . . . . 0.0 110.373 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -97.79 150.83 20.83 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -145.68 155.5 43.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 109.17 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.85 125.19 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.372 -0.83 . . . . 0.0 108.956 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -106.38 129.25 54.41 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.741 . . . . 0.0 109.279 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.89 131.22 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -136.55 -163.08 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.804 0.812 . . . . 0.0 109.821 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 89' ' ' SER . 33.9 mmtt -57.35 166.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.792 -0.567 . . . . 0.0 109.472 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 12.8 t-20 72.81 -21.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.708 -0.62 . . . . 0.0 109.547 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 87' ' ' LYS . 87.1 p -74.61 159.29 32.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.3 m -136.86 156.22 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.399 -0.813 . . . . 0.0 109.131 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.62 130.66 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -132.16 138.05 47.88 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 0.0 109.355 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' C ' HD22 ' A' ' 94' ' ' LEU . 50.7 mtmt -81.81 138.98 35.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.592 -0.692 . . . . 0.0 109.762 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.1 mm? -110.71 137.73 48.01 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.922 0.868 . . . . 0.0 110.147 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -86.58 8.34 22.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -117.04 91.77 37.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.329 -0.857 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -55.34 152.32 32.62 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.887 2.391 . . . . 0.0 112.136 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.6 mt -101.14 147.79 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.26 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 57.0 mp0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.855 . . . . 0.0 110.201 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.408 ' HB2' HD22 ' A' ' 19' ' ' ASN . 43.6 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.376 0.49 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.12 119.87 23.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.914 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -90.39 128.88 36.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.782 . . . . 0.0 109.753 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -128.44 145.01 51.22 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.19 143.0 28.42 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.71 0.767 . . . . 0.0 110.494 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.4 HD13 ' CG2' ' A' ' 48' ' ' ILE . 83.1 mt -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.41 -0.806 . . . . 0.0 109.322 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.41 -10.79 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.448 -0.783 . . . . 0.0 109.918 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -97.51 6.28 48.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 13' ' ' GLU . 44.8 mt -59.85 -70.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.3 m 40.5 17.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.741 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.639 ' H ' HG22 ' A' ' 11' ' ' ILE . 6.5 pt-20 -171.92 130.77 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.808 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.83 167.38 12.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.021 -1.049 . . . . 0.0 110.58 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.17 23.54 77.39 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.1 136.67 35.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -1.03 . . . . 0.0 110.17 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -97.33 127.44 43.3 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -162.71 -169.73 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 43.4 m-20 -140.59 137.86 33.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.568 -0.707 . . . . 0.0 109.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.67 147.45 25.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 110.391 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -101.14 140.92 34.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.53 0.681 . . . . 0.0 109.397 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 161.62 42.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.292 -0.88 . . . . 0.0 110.77 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.02 148.93 25.65 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.355 0.598 . . . . 0.0 109.645 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -87.48 94.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.278 -0.889 . . . . 0.0 110.52 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.511 HD11 ' CA ' ' A' ' 42' ' ' GLY . 52.8 mt -70.61 -31.26 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.499 -0.751 . . . . 0.0 109.324 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -148.07 129.3 14.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.064 -1.022 . . . . 0.0 109.604 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.7 tp -110.89 146.5 36.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -142.57 111.35 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.54 0.686 . . . . 0.0 109.795 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.666 . . . . 0.0 109.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.674 0.749 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -83.53 -56.79 3.54 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.666 0.746 . . . . 0.0 109.963 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -159.11 162.22 36.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.107 -0.996 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.09 159.61 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.18 -157.95 20.58 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -125.76 149.82 48.24 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.973 -0.722 . . . . 0.0 109.976 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.636 HD21 ' CD1' ' A' ' 50' ' ' PHE . 31.5 mt -109.91 124.81 52.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' HD11 ' A' ' 25' ' ' ILE . . . -92.17 94.35 1.9 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.58 159.99 14.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -1.011 . . . . 0.0 109.597 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.13 -17.54 63.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.819 -0.551 . . . . 0.0 109.839 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 p -92.43 -9.66 40.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.25 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.64 -148.29 19.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -138.16 160.56 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.696 -0.885 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.4 ' CG2' HD13 ' A' ' 8' ' ' ILE . 20.0 tt -162.57 158.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.927 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -84.8 164.58 18.39 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.558 -0.714 . . . . 0.0 110.275 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.636 ' CD1' HD21 ' A' ' 41' ' ' LEU . 24.8 p90 -156.06 153.65 29.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.069 -1.019 . . . . 0.0 108.549 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.5 m -136.36 129.57 31.51 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.3 mt -106.52 130.12 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -90.26 142.92 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 110.431 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.42 -35.04 76.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.687 -0.633 . . . . 0.0 109.456 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -58.89 -7.8 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.473 -0.767 . . . . 0.0 109.825 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.52 -23.59 34.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.869 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 51.16 44.26 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 109.887 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.57 151.6 39.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.796 -0.565 . . . . 0.0 109.716 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.54 146.89 50.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.479 2.119 . . . . 0.0 112.804 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.07 141.61 56.09 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.658 0.742 . . . . 0.0 110.491 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -81.1 139.85 35.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.0 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.32 134.08 37.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.466 -0.771 . . . . 0.0 110.17 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.78 136.57 48.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.402 0.62 . . . . 0.0 110.532 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -6.36 83.5 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.59 159.87 15.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -1.001 . . . . 0.0 110.543 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -95.7 148.93 22.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -141.23 150.07 42.18 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.005 0.907 . . . . 0.0 109.964 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.525 HD21 ' HE ' ' A' ' 70' ' ' ARG . 37.0 tp -101.01 132.1 46.57 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 mt -112.72 112.4 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.928 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.525 ' HE ' HD21 ' A' ' 68' ' ' LEU . 94.0 mtt180 -118.64 145.46 45.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 54.91 6.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.04 165.94 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 0.0 109.304 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.859 0.838 . . . . 0.0 109.925 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -92.61 131.71 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.579 -0.7 . . . . 0.0 109.855 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.64 150.5 16.81 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.77 104.85 16.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.6 -0.941 . . . . 0.0 109.364 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 80' ' ' ARG . 42.0 t80 -97.06 104.22 16.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 109.239 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' TYR . 98.7 m-20 39.67 -111.87 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -95.13 -20.19 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.419 -0.801 . . . . 0.0 109.898 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.1 mtt180 -98.85 159.29 15.06 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.905 0.86 . . . . 0.0 110.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.3 149.97 20.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.752 . . . . 0.0 109.14 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.418 ' NE2' ' CD2' ' A' ' 77' ' ' TYR . 6.9 tt0 -144.03 150.96 39.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.89 124.47 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -107.43 126.36 52.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.446 -0.783 . . . . 0.0 109.567 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.22 132.82 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 87' ' ' LYS . 13.5 p30 -146.06 -176.57 5.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.768 0.794 . . . . 0.0 110.014 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' SER . 80.5 tttt -42.84 166.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 1.8 t-20 73.5 -30.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.65 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 87' ' ' LYS . 81.6 p -76.95 164.3 25.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 109.964 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 p -139.63 158.31 44.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.427 -0.796 . . . . 0.0 109.417 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.7 mt -141.89 133.73 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.499 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.37 138.71 46.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.612 0.72 . . . . 0.0 109.232 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 95' ' ' SER . 88.2 tttt -73.05 139.47 46.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.592 -0.692 . . . . 0.0 109.594 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 96' ' ' GLU . 89.3 mt -101.01 -13.37 18.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.443 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 35.9 t 51.91 4.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.758 -0.589 . . . . 0.0 109.732 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 94' ' ' LEU . 37.8 tp10 -107.59 127.29 28.07 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.617 -0.677 . . . . 0.0 109.5 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.82 141.08 29.9 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.411 2.074 . . . . 0.0 112.182 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.3 mt -112.09 135.97 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.77 -0.582 . . . . 0.0 109.456 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 -179.704 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.497 1.735 0 CA-C-O 121.495 0.54 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -79.26 116.31 19.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.313 -0.867 . . . . 0.0 109.471 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt -92.33 129.47 38.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.347 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' ' CD2' ' A' ' 20' ' ' LEU . 83.3 m -125.83 144.14 50.77 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.88 146.29 23.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.052 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.07 -42.36 89.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.176 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.55 -8.54 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.632 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -103.37 9.28 37.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -86.32 124.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.168 -0.957 . . . . 0.0 109.944 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -144.13 8.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 109.286 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -143.37 138.75 29.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.277 -0.89 . . . . 0.0 109.141 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 54.0 p30 -97.52 159.37 14.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.448 -0.783 . . . . 0.0 110.353 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.91 9.91 84.74 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.85 155.55 17.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -1.083 . . . . 0.0 109.691 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.2 134.71 50.66 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.462 0.649 . . . . 0.0 109.572 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -160.17 -176.78 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.905 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 7.7 t30 -122.48 142.97 50.01 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -139.12 128.2 23.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.32 -0.862 . . . . 0.0 109.686 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.667 ' N ' HD13 ' A' ' 20' ' ' LEU . 37.1 ttmt -112.45 132.75 54.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.39 -173.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -112.53 154.91 25.2 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.09 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -92.48 113.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -71.67 -26.77 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 0.0 110.035 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.512 ' NE2' ' OE1' ' A' ' 63' ' ' GLN . 1.3 mm-40 -172.45 167.41 5.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.98 -1.075 . . . . 0.0 109.182 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.7 mt -138.29 160.87 38.36 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.428 0.632 . . . . 0.0 110.005 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.406 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 14.6 t90 -134.86 105.63 6.51 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.55 0.69 . . . . 0.0 109.414 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 37' ' ' GLN . 51.4 tp10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.291 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.515 2.798 0 CA-C-O 121.324 0.583 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -94.5 -58.36 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.034 . . . . 0.0 109.666 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.543 ' NE2' ' OE1' ' A' ' 29' ' ' GLU . 6.7 mm-40 -145.0 149.29 34.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.046 -1.034 . . . . 0.0 109.979 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.47 127.99 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.4 -159.86 9.48 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.46 149.45 52.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.733 -0.863 . . . . 0.0 109.666 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.85 126.79 53.43 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.59 100.55 2.64 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 46' ' ' GLY . 5.5 p-10 -104.96 161.79 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.297 -1.12 . . . . 0.0 109.285 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.87 -17.38 63.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.743 . . . . 0.0 109.928 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.7 p -94.42 -3.88 49.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' OD2' ' A' ' 43' ' ' ASP . . . 146.47 -144.42 12.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.35 166.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.678 -0.895 . . . . 0.0 110.05 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.78 162.66 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.103 -0.998 . . . . 0.0 109.846 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -97.09 149.77 21.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.0 109.729 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.36 157.46 44.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.431 -1.418 . . . . 0.0 107.801 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -130.93 134.27 46.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.582 -0.699 . . . . 0.0 109.685 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 mm -102.64 127.91 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 109.149 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -83.69 137.26 33.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 110.497 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.92 -33.74 75.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -58.77 -11.03 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.596 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.9 -22.43 27.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -0.939 . . . . 0.0 108.988 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.07 55.76 7.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.64 -0.663 . . . . 0.0 109.914 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -106.03 147.94 35.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.594 -0.691 . . . . 0.0 109.832 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.86 159.77 51.35 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.521 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.66 137.98 55.99 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.627 0.727 . . . . 0.0 109.987 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.1 mp -79.61 155.1 28.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.843 -0.536 . . . . 0.0 109.667 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 3.1 tm-20 -100.54 121.85 42.27 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.955 0.883 . . . . 0.0 109.707 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.512 ' OE1' ' NE2' ' A' ' 26' ' ' GLN . 25.6 mt-30 -63.37 138.31 58.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 -10.93 67.76 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.92 158.82 15.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -1.182 . . . . 0.0 110.458 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 p -95.45 124.87 39.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.433 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 44.4 m-85 -118.54 150.07 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.971 0.891 . . . . 0.0 109.78 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.535 HD21 ' HE ' ' A' ' 70' ' ' ARG . 28.8 tp -110.84 127.17 55.32 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 45.7 mt -114.36 114.96 26.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.535 ' HE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -109.93 147.27 33.74 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.458 0.647 . . . . 0.0 110.43 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 t 58.26 58.5 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.015 0.436 . . . . 0.0 110.772 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' ALA . 16.4 m -109.2 160.41 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.301 -0.874 . . . . 0.0 108.886 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.77 144.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.618 0.723 . . . . 0.0 109.533 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.8 t -92.19 131.75 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.58 22.12 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.491 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 97.3 mt-10 -96.96 135.04 39.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -1.116 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -135.99 119.72 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.84 . . . . 0.0 109.621 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 51.8 48.12 23.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.7 t0 60.57 20.0 9.86 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.679 -0.638 . . . . 0.0 110.449 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -128.54 155.07 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -74.63 137.57 42.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -148.62 152.07 36.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.052 -1.03 . . . . 0.0 108.977 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.96 124.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.95 126.34 51.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.46 132.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.88 -170.29 1.84 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.68 0.753 . . . . 0.0 109.874 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -66.15 -42.91 88.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.766 -0.584 . . . . 0.0 110.43 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -61.15 -7.7 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -83.32 164.41 20.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -136.07 154.93 50.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.312 -0.867 . . . . 0.0 108.875 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.57 127.6 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -128.39 131.6 48.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 108.957 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 136.06 36.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLU . 9.5 mp -103.86 -3.96 24.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.479 -0.763 . . . . 0.0 109.454 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t 49.41 7.93 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 94' ' ' LEU . 31.7 tt0 -103.62 124.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 109.312 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.17 141.18 25.87 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.054 1.836 . . . . 0.0 112.1 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.43 135.68 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.468 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.492 1.429 0 CA-C-O 121.412 0.505 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -78.56 117.17 19.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.7 mt -92.52 130.47 38.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.309 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.6 m -124.56 144.69 50.0 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -96.77 151.23 19.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.0 mt -58.17 -44.01 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.405 -0.809 . . . . 0.0 109.1 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.1 -14.55 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.781 . . . . 0.0 109.46 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.0 4.7 53.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.194 -0.941 . . . . 0.0 109.364 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.3 mt -87.67 121.45 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.816 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.95 7.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -135.89 135.32 39.6 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 0.0 109.078 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.402 HD22 ' HB2' ' A' ' 76' ' ' GLU . 57.5 p30 -94.0 157.4 16.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 110.278 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.5 19.24 79.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -99.77 150.37 22.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.363 -1.081 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -101.56 131.35 47.78 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.0 179.6 8.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.695 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -120.24 137.21 54.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -127.82 148.45 50.45 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -135.63 134.01 38.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.26 -176.85 1.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -105.71 156.31 18.41 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.47 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -92.53 107.58 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.407 -0.808 . . . . 0.0 110.226 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.2 -27.18 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 109.906 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -171.0 161.64 6.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.564 0.697 . . . . 0.0 110.086 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -143.76 121.02 11.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' ' 37' ' ' GLN . 80.9 mm-40 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.675 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' OG1' ' A' ' 51' ' ' THR . 96.4 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.464 0.65 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 t -100.24 -51.13 3.74 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.716 0.769 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' ' 29' ' ' GLU . 33.2 mt-30 -152.07 154.43 35.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 110.224 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.96 156.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.28 -172.09 34.07 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.233 -1.461 . . . . 0.0 109.853 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.541 HD21 ' NZ ' ' A' ' 49' ' ' LYS . 4.6 mp -119.89 144.55 47.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.756 -0.849 . . . . 0.0 109.396 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 47' ' ' ILE . 68.8 mt -114.55 124.78 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.89 101.63 2.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -106.44 164.66 11.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.983 . . . . 0.0 109.312 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OE2' ' A' ' 44' ' ' GLU . 1.4 mp0 -70.53 -20.24 62.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 110.106 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 p -91.05 -9.62 45.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.952 . . . . 0.0 109.244 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.02 -145.84 14.15 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 41' ' ' LEU . 8.0 mt -139.02 155.14 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -1.024 . . . . 0.0 109.331 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 148.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.88 . . . . 0.0 109.652 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.541 ' NZ ' HD21 ' A' ' 40' ' ' LEU . 68.4 mttm -98.77 138.0 36.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 109.454 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.47 159.54 34.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.145 -0.972 . . . . 0.0 108.58 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.427 ' OG1' HG23 ' A' ' 35' ' ' ILE . 3.8 t -133.66 137.91 45.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.657 . . . . 0.0 109.708 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -104.15 126.96 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.371 0.605 . . . . 0.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -88.03 145.62 25.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 110.361 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -50.43 -29.9 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.601 -0.687 . . . . 0.0 109.35 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -13.39 10.92 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 109.881 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -113.89 44.53 1.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.309 -0.869 . . . . 0.0 109.209 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' ALA . 8.2 pt-20 -35.12 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.716 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.8 mt -109.35 153.5 42.7 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.73 162.26 32.42 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.444 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.86 135.62 54.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.512 -0.743 . . . . 0.0 110.198 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.4 mp -79.49 153.66 29.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 109.839 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -96.79 120.14 36.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.404 -0.81 . . . . 0.0 109.896 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.31 147.92 52.35 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.761 0.791 . . . . 0.0 110.194 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.53 -10.88 48.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -97.64 161.03 13.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 0.0 110.5 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -88.31 146.92 25.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.288 0.566 . . . . 0.0 109.631 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -142.11 145.94 34.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.97 0.89 . . . . 0.0 109.691 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.557 HD21 ' HE ' ' A' ' 70' ' ' ARG . 29.5 tp -111.17 129.76 55.85 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.36 119.81 39.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.588 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.557 ' HE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -119.17 148.03 43.54 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m 56.49 55.75 6.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 120.945 0.402 . . . . 0.0 110.451 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.19 165.8 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.293 -0.879 . . . . 0.0 108.9 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.74 150.38 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.649 0.738 . . . . 0.0 109.444 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.85 137.01 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.788 -0.57 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.77 153.45 17.62 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB2' HD22 ' A' ' 14' ' ' ASN . 82.1 tt0 -91.32 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 109.417 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' ARG . 69.5 t80 -100.57 106.55 18.06 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.761 0.791 . . . . 0.0 109.55 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 44.97 -115.4 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.524 -0.735 . . . . 0.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 63.2 t0 -97.28 -14.27 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' TYR . 75.3 ttt180 -109.01 151.5 26.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.261 -0.9 . . . . 0.0 110.23 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.11 160.22 15.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -146.87 162.82 37.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.295 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.02 126.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 108.943 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -104.93 127.59 52.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.492 -0.755 . . . . 0.0 109.396 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.04 132.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.454 -0.779 . . . . 0.0 108.997 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -125.0 -173.56 2.83 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.662 0.744 . . . . 0.0 109.89 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -40.39 96.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.566 -0.709 . . . . 0.0 109.962 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -68.45 -12.87 61.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -82.93 163.77 20.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 109.822 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -140.69 162.36 35.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.269 -0.894 . . . . 0.0 109.049 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.8 mt -138.38 130.6 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -130.02 134.65 47.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.359 -0.838 . . . . 0.0 109.019 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -74.68 135.46 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -94.78 129.71 41.62 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.889 0.852 . . . . 0.0 110.16 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.4 t -77.44 -6.48 53.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.767 -0.583 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -114.28 95.71 40.13 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.438 -0.789 . . . . 0.0 109.268 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.34 152.05 16.34 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.444 2.096 . . . . 0.0 112.116 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -101.43 134.14 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.783 -179.495 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.498 0.541 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -80.6 113.44 18.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.0 133.79 37.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.591 -0.693 . . . . 0.0 109.868 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.548 ' O ' HD13 ' A' ' 20' ' ' LEU . 93.9 m -127.98 152.03 48.41 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.453 0.644 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.38 147.08 24.55 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.707 0.765 . . . . 0.0 110.162 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.12 -44.28 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.53 -11.25 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.601 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 52.8 t0 -96.73 8.33 44.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -87.11 120.74 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.85 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.2 4.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.843 . . . . 0.0 109.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -134.8 131.54 37.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.353 -0.842 . . . . 0.0 109.122 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.26 160.19 14.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.29 18.98 79.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -103.06 156.38 17.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.504 -0.998 . . . . 0.0 109.899 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -102.81 131.97 49.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -158.57 176.59 12.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 109.866 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' SER . 61.7 m-20 -138.91 142.99 38.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.657 . . . . 0.0 109.648 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 6' ' ' THR . 60.5 tp -159.14 147.14 17.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.034 -1.041 . . . . 0.0 110.423 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -94.06 137.66 33.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.72 158.34 44.08 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.083 0.944 . . . . 0.0 110.661 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.74 152.72 18.84 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.304 0.573 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 59.6 t -93.23 101.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.04 -26.31 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 0.0 109.77 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -168.68 160.34 10.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -135.07 160.08 39.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.186 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -143.14 113.82 7.52 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.483 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 -179.662 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 11.4 p -88.42 -56.5 3.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.568 -0.707 . . . . 0.0 109.769 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.504 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.5 tt0 -154.55 155.24 34.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.433 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.35 149.67 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.2 -158.77 14.63 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.135 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 mt -121.45 149.08 43.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.091 -0.652 . . . . 0.0 109.555 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.3 127.84 55.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.536 0.684 . . . . 0.0 109.407 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.83 96.73 2.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -93.92 157.1 16.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.6 -18.18 64.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.675 -0.641 . . . . 0.0 109.768 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -98.88 -11.52 21.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.378 -0.826 . . . . 0.0 109.153 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -154.06 24.96 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.084 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.06 160.41 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.616 -0.932 . . . . 0.0 109.84 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -160.4 147.14 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.521 -0.737 . . . . 0.0 109.914 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.72 164.65 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.875 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.88 150.0 23.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.167 -0.958 . . . . 0.0 108.98 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -137.24 135.08 36.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.036 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.8 mt -105.62 129.09 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.617 -0.677 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -84.04 139.7 32.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 110.504 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -60.72 -37.2 80.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.655 -0.653 . . . . 0.0 109.391 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.83 -11.07 4.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.822 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -84.61 -25.83 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.131 -0.98 . . . . 0.0 108.974 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 53.94 52.13 13.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.63 -0.669 . . . . 0.0 110.146 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.559 HD13 ' HB1' ' A' ' 56' ' ' ALA . 7.5 mp -104.86 156.12 36.49 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.337 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.31 154.41 74.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.711 2.274 . . . . 0.0 112.7 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.62 142.17 46.53 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.787 0.804 . . . . 0.0 110.626 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.2 mp -81.13 151.0 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.764 -0.585 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.02 136.11 43.45 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.747 0.784 . . . . 0.0 109.945 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 24' ' ' VAL . 10.3 tm0? -72.38 134.9 45.68 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 110.682 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 -13.18 67.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.4 mp0 -97.77 157.58 15.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -1.121 . . . . 0.0 110.681 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 96' ' ' GLU . 12.1 p -100.92 141.07 34.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -134.41 157.03 47.48 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.161 0.982 . . . . 0.0 110.13 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.4 tp -105.31 134.02 49.12 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 mt -110.13 108.84 19.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 92' ' ' GLU . 65.4 mtm180 -112.81 148.2 35.34 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.595 0.712 . . . . 0.0 110.376 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.9 p 51.16 58.17 5.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 122.054 -0.404 . . . . 0.0 110.827 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 18' ' ' ALA . 15.6 m -112.65 165.09 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.517 -0.739 . . . . 0.0 109.319 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 p -123.36 149.25 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 121.724 0.773 . . . . 0.0 109.82 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.34 135.13 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.629 -0.669 . . . . 0.0 109.867 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.62 158.24 17.27 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -100.16 93.76 5.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.949 . . . . 0.0 109.329 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.497 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.1 t80 -106.09 119.27 38.78 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.744 0.783 . . . . 0.0 109.707 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.3 m120 53.51 50.17 17.91 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.336 0.588 . . . . 0.0 110.624 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t0 64.41 -12.69 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.744 -0.598 . . . . 0.0 110.408 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 78' ' ' ASN . 91.6 mtm-85 -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.187 -0.946 . . . . 0.0 110.351 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -76.4 146.11 38.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.602 -0.686 . . . . 0.0 109.355 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -147.14 151.29 36.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.177 -0.952 . . . . 0.0 109.382 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.32 122.45 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -102.18 128.65 48.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 t -100.1 134.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.538 -0.726 . . . . 0.0 109.08 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -131.32 -168.93 2.08 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.71 0.767 . . . . 0.0 109.952 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -62.12 -42.33 99.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.279 0.561 . . . . 0.0 109.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -65.36 -22.2 66.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -81.5 164.26 22.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -140.52 162.55 35.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.4 mt -138.84 132.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.63 -0.669 . . . . 0.0 109.653 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 89.1 mt-10 -131.35 135.96 47.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.548 -0.72 . . . . 0.0 109.218 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.481 ' C ' HD22 ' A' ' 94' ' ' LEU . 88.3 tttt -81.84 135.77 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.481 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.0 mm? -109.86 0.35 18.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.64 -0.663 . . . . 0.0 109.988 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.5 p 49.78 14.91 0.14 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 109.733 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' SER . 24.0 mm-40 -114.07 110.17 48.81 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.281 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.36 151.26 59.72 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.712 2.274 . . . . 0.0 112.724 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -105.56 143.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.7 . . . . 0.0 109.679 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.798 0.809 . . . . 0.0 109.864 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.437 ' CG ' HD22 ' A' ' 19' ' ' ASN . 56.3 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 CA-C-O 121.408 0.503 . . . . 0.0 112.301 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -81.11 113.24 19.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 131.42 34.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.592 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.0 m -119.3 132.52 55.9 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 64.8 mttp -98.5 155.73 17.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 110.085 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.55 -49.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.655 0.741 . . . . 0.0 109.349 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.37 -13.89 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 49.4 t0 -93.03 -3.18 54.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLU . 97.7 mt -58.6 -73.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 110.416 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 11' ' ' ILE . 15.6 m 31.93 29.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.396 0.617 . . . . 0.0 110.923 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.2 tt0 -167.23 114.17 0.78 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.472 -0.768 . . . . 0.0 109.066 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -87.15 153.64 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.78 72.69 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.52 137.21 33.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.094 . . . . 0.0 109.929 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.57 125.44 38.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.04 -167.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.828 . . . . 0.0 109.792 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.437 HD22 ' CG ' ' A' ' 3' ' ' PRO . 60.2 m-20 -117.64 146.29 43.77 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.47 131.17 35.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 0.0 110.475 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -116.55 127.84 54.88 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.525 ' HB3' HD22 ' A' ' 41' ' ' LEU . . . -162.56 169.77 19.7 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -103.59 154.94 18.95 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.873 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.96 113.78 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.375 -0.828 . . . . 0.0 109.656 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -93.41 -22.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.674 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.568 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 48.5 tt0 -152.79 136.07 15.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.783 -1.198 . . . . 0.0 109.609 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 26' ' ' GLN . 4.2 mm? -108.18 143.28 37.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.642 0.734 . . . . 0.0 109.682 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.568 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 61.6 m95 -145.0 119.78 9.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.696 0.76 . . . . 0.0 109.129 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.666 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.62 -0.675 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.467 0.651 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -93.16 -57.93 2.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 109.664 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -149.67 150.72 32.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -141.5 155.8 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.48 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -170.66 -171.15 35.72 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.071 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.48 HD22 ' C ' ' A' ' 39' ' ' GLY . 3.9 mm? -114.09 146.14 40.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.91 -0.759 . . . . 0.0 109.601 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 22' ' ' ALA . 18.9 mt -117.23 124.16 48.38 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.59 0.709 . . . . 0.0 109.096 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' CD1' ' A' ' 25' ' ' ILE . . . -95.28 97.4 2.12 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.6 t0 -99.04 161.23 13.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.273 -1.134 . . . . 0.0 109.304 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.8 mt-10 -66.32 -18.55 65.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.2 p -93.73 -5.1 49.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.01 -144.53 12.71 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -135.64 163.45 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.647 -0.913 . . . . 0.0 109.958 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 151.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.5 159.22 18.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -147.79 153.98 39.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.488 -1.383 . . . . 0.0 108.026 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -133.96 129.82 36.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.477 -0.764 . . . . 0.0 109.906 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -104.33 129.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.593 -0.692 . . . . 0.0 109.67 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -87.91 145.7 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -58.11 -38.22 76.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.496 -0.753 . . . . 0.0 109.309 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -59.51 -4.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 109.695 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.78 -27.91 24.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 108.879 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 55.17 52.96 10.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.627 -0.671 . . . . 0.0 110.244 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.41 147.22 35.9 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.657 -0.652 . . . . 0.0 109.853 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.1 164.39 32.27 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.705 2.27 . . . . 0.0 112.648 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.4 mt -72.99 141.19 47.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.516 -0.74 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.9 mp -84.13 145.11 28.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.75 -0.594 . . . . 0.0 109.846 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.3 137.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.317 -0.864 . . . . 0.0 109.885 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.09 137.52 40.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.702 . . . . 0.0 110.808 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.3 -7.21 72.14 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -106.11 162.21 13.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.366 -1.079 . . . . 0.0 110.689 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -100.96 142.58 32.23 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.79 152.2 51.57 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.97 0.89 . . . . 0.0 110.151 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HB2' HD23 ' A' ' 94' ' ' LEU . 49.1 tp -109.33 131.51 54.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.28 111.14 22.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.368 -0.833 . . . . 0.0 109.158 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 74.8 mtm180 -109.92 149.18 30.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.611 -0.681 . . . . 0.0 110.388 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 2.8 p 52.72 57.77 6.04 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.89 167.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.423 -0.798 . . . . 0.0 109.147 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.56 152.04 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.74 0.781 . . . . 0.0 109.718 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 132.84 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.769 -0.582 . . . . 0.0 109.553 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 147.78 16.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -90.51 101.19 13.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -1.134 . . . . 0.0 109.181 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.63 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 16.0 t80 -97.79 101.12 12.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 109.132 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.63 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 13.0 p30 40.25 -117.58 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 50.1 t0 -90.81 -18.07 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 77' ' ' TYR . 64.3 ttm-85 -100.0 154.46 18.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.169 -0.957 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.79 151.17 19.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 108.78 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -145.41 151.5 38.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.987 -1.071 . . . . 0.0 109.02 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.45 121.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.934 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.62 127.79 53.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.0 133.84 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -133.76 -170.27 2.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 89' ' ' SER . 73.4 tttt -53.83 166.15 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.2 t-20 72.09 -19.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.677 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 87' ' ' LYS . 16.4 p -76.69 162.81 27.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.07 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.0 p -145.22 166.31 25.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.264 -0.897 . . . . 0.0 108.973 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.99 131.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -128.0 131.12 49.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.312 -0.867 . . . . 0.0 108.903 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.77 137.15 51.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 109.639 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -97.26 135.31 39.37 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.958 0.885 . . . . 0.0 110.192 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 m -82.35 -5.88 58.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -121.9 119.89 28.73 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.89 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 161.47 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.509 2.14 . . . . 0.0 112.128 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -98.19 152.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.715 . . . . 0.0 109.997 -179.687 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HB2' HD21 ' A' ' 19' ' ' ASN . 61.7 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 CA-C-O 121.169 0.404 . . . . 0.0 111.993 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.58 120.2 21.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.177 -0.952 . . . . 0.0 110.127 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.6 mm? -89.89 126.42 35.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.6 m -121.99 142.12 50.64 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -95.92 148.35 22.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.045 -1.034 . . . . 0.0 110.121 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.41 -43.61 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.197 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.91 -15.16 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 9.93 29.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 109.933 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.54 122.48 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.077 -1.015 . . . . 0.0 110.0 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.19 -0.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.304 -0.872 . . . . 0.0 109.749 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -131.73 134.29 45.72 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.32 -0.863 . . . . 0.0 109.081 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 57.0 p30 -90.07 159.01 17.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 109.881 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.69 79.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -98.47 147.02 25.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.343 -1.093 . . . . 0.0 109.706 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -97.82 135.13 40.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.418 -0.801 . . . . 0.0 109.592 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -157.39 169.02 25.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.111 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.596 HD21 ' HB2' ' A' ' 3' ' ' PRO . 68.5 m-20 -132.41 136.96 47.12 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.674 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -159.67 178.84 9.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.021 -1.05 . . . . 0.0 110.461 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.6 pttp -128.39 148.45 50.7 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.46 38.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.742 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -93.2 152.5 19.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.592 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.99 99.67 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 110.333 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 mm -73.35 -25.49 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.552 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 53.2 tt0 -166.63 157.85 12.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.0 -1.063 . . . . 0.0 109.702 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.912 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.3 pt? -127.66 153.32 46.61 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.542 -0.724 . . . . 0.0 110.071 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.552 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 44.0 m95 -144.28 123.06 12.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.284 -0.885 . . . . 0.0 109.231 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.513 -0.742 . . . . 0.0 109.455 -179.53 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 17.2 p -87.31 -58.52 2.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.7 tt0 -149.55 155.36 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.957 -1.09 . . . . 0.0 109.771 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 39' ' ' GLY . 53.9 t -137.95 160.92 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 38' ' ' VAL . . . 177.42 -162.75 30.9 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.881 -1.628 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.51 150.6 40.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.894 -0.768 . . . . 0.0 109.142 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.1 129.23 54.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.611 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.0 103.75 2.79 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -103.01 163.86 11.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.99 . . . . 0.0 109.154 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' A' ' 99' ' ' GLU . 47.2 tp10 -69.41 -19.44 63.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -92.31 -10.87 36.77 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.941 -1.1 . . . . 0.0 110.14 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -150.29 21.87 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 pt -132.94 159.12 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.581 -0.952 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.8 tt -161.36 150.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.6 164.07 22.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 108.961 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.12 154.51 31.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.563 -1.336 . . . . 0.0 108.422 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 t -139.56 133.52 30.9 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.239 -0.913 . . . . 0.0 110.251 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.8 mt -105.27 128.7 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -96.64 147.75 23.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 0.0 110.335 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -67.06 -19.31 65.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.725 . . . . 0.0 109.379 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -61.23 -33.26 73.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.842 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.34 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.047 . . . . 0.0 109.276 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.74 61.21 2.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.434 -0.791 . . . . 0.0 110.09 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.74 148.74 38.81 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.606 -0.684 . . . . 0.0 109.398 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.52 161.33 45.51 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.519 2.146 . . . . 0.0 112.189 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.19 143.63 50.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 110.364 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -85.15 148.43 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.573 -0.705 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -95.19 134.55 37.8 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.41 137.16 52.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.51 -12.84 68.81 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.26 158.39 15.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.877 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 p -94.92 143.74 26.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.32 152.55 51.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.816 0.817 . . . . 0.0 110.186 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.41 HD13 ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -100.33 130.84 46.48 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.41 ' H ' HD13 ' A' ' 68' ' ' LEU . 17.5 mt -109.01 105.26 14.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.513 ' NE ' ' OG ' ' A' ' 90' ' ' SER . 87.3 mtm-85 -107.68 133.04 52.67 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m 70.81 59.37 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.116 -0.365 . . . . 0.0 110.76 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 m -112.86 160.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.346 -0.846 . . . . 0.0 109.456 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.45 151.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.499 0.666 . . . . 0.0 109.351 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.59 132.12 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.124 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.28 151.69 18.01 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.445 ' OE2' ' N ' ' A' ' 79' ' ' ASP . 10.8 tm-20 -98.76 93.15 5.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.129 -1.218 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -111.27 117.39 33.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.444 -0.785 . . . . 0.0 110.119 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 80' ' ' ARG . 20.0 t-20 55.57 54.36 8.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.818 . . . . 0.0 110.293 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' N ' ' OE2' ' A' ' 76' ' ' GLU . 91.2 m-20 56.35 -2.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.676 -0.64 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 78' ' ' ASN . 14.6 mmp_? -102.24 158.58 16.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.041 -1.037 . . . . 0.0 109.737 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.23 146.69 25.92 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.88 154.61 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.02 117.2 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.377 -0.827 . . . . 0.0 109.094 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -107.08 127.38 53.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.323 -0.861 . . . . 0.0 109.538 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.4 ' C ' HD22 ' A' ' 86' ' ' ASN . 22.0 t -93.6 124.59 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.697 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -152.55 -173.71 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 109.689 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 57.0 -152.64 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.54 0.686 . . . . 0.0 110.365 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 89' ' ' SER . 92.3 m-20 -83.58 27.18 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 88' ' ' ASN . 12.1 p -47.86 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.513 ' OG ' ' NE ' ' A' ' 70' ' ' ARG . 13.6 p -139.44 161.67 36.9 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.073 -1.017 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.3 mt -140.85 132.87 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.946 . . . . 0.0 109.272 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' CB ' HH12 ' A' ' 70' ' ' ARG . 83.8 tt0 -124.73 124.99 43.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.06 140.52 43.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 109.82 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.08 142.31 29.94 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.8 p -83.85 -3.82 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.589 -0.695 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.88 133.01 21.09 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.429 -0.794 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.77 155.9 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.848 1.699 . . . . 0.0 112.04 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -108.62 133.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 84.7 tt0 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HB2' HD22 ' A' ' 19' ' ' ASN . 57.1 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 CA-C-O 121.47 0.529 . . . . 0.0 112.262 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.4 mp0 -81.36 111.54 17.82 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.348 -0.845 . . . . 0.0 109.56 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.4 mt -91.53 134.25 34.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.669 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -127.15 146.46 50.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.462 0.648 . . . . 0.0 109.381 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.35 147.71 22.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 110.072 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.36 -43.53 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.608 -0.682 . . . . 0.0 109.188 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 9' ' ' VAL . 14.3 p -65.61 -6.3 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.475 -0.765 . . . . 0.0 109.454 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -103.98 6.82 36.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -88.08 115.76 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 109.778 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.56 5.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -125.57 122.81 37.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.788 . . . . 0.0 109.246 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 14.6 t30 -82.02 150.67 27.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.975 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 76.93 19.33 77.71 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -96.32 144.11 26.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.481 -1.011 . . . . 0.0 110.095 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -102.28 130.23 48.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.557 -0.714 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.86 -176.26 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.848 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 3' ' ' PRO . 59.7 m-20 -122.96 146.93 47.17 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.31 133.67 24.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.0 110.514 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -109.89 131.12 55.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.84 159.45 35.07 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.017 0.913 . . . . 0.0 110.883 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 17.5 ttmm -92.08 156.26 17.5 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.14 113.09 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.139 -0.976 . . . . 0.0 110.38 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 pt -90.4 -19.51 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.96 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -167.77 157.47 10.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.986 . . . . 0.0 109.707 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 27' ' ' LEU . 96.1 mt -135.39 159.93 40.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.595 -0.691 . . . . 0.0 109.98 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -144.72 118.14 9.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.435 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.53 -0.731 . . . . 0.0 109.664 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.679 0.752 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.8 p -85.3 -57.16 3.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.658 -0.651 . . . . 0.0 109.911 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.502 ' N ' ' OG ' ' A' ' 36' ' ' SER . 17.4 pt20 -160.48 164.8 31.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.093 -1.005 . . . . 0.0 110.316 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.2 160.34 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.91 -165.76 31.07 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.169 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.34 145.73 49.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.925 -0.75 . . . . 0.0 109.531 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.42 130.58 55.93 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.35 101.33 2.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 44.3 t0 -104.86 162.69 13.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.56 -0.965 . . . . 0.0 109.445 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 13.5 tm-20 -70.3 -18.58 63.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.69 -0.631 . . . . 0.0 109.778 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.5 p -93.9 -9.74 36.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.074 -1.016 . . . . 0.0 109.334 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.93 -146.61 15.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.92 160.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.667 -0.902 . . . . 0.0 109.888 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -158.53 145.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 109.883 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -86.37 164.36 17.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.717 . . . . 0.0 109.992 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -154.29 156.82 37.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.696 -1.253 . . . . 0.0 108.48 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -139.97 129.96 24.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 109.646 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -106.76 131.58 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.333 0.587 . . . . 0.0 109.68 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -90.91 144.07 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 110.362 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -59.63 -31.64 69.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.711 . . . . 0.0 109.406 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.87 -13.39 6.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -87.53 -30.3 20.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 108.938 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 55.3 55.84 7.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.557 -0.715 . . . . 0.0 110.242 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' A' ' 56' ' ' ALA . 8.8 mp -108.0 154.82 40.91 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.611 -0.681 . . . . 0.0 109.398 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.7 156.56 65.23 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.766 2.31 . . . . 0.0 112.528 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.96 144.28 48.95 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.751 0.786 . . . . 0.0 110.394 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -81.5 148.53 29.15 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.36 0.6 . . . . 0.0 109.936 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 98.3 mt-10 -101.35 136.03 41.86 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.802 0.81 . . . . 0.0 110.111 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 27.3 mt-30 -71.77 134.55 46.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.523 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 93.89 -14.48 65.21 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.6 mp0 -95.43 158.41 15.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 110.65 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -90.63 141.98 28.22 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.41 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 35.2 m-85 -133.82 142.83 48.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.842 0.829 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.2 132.0 54.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.99 112.75 25.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.803 . . . . 0.0 109.312 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -109.54 140.45 43.31 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.578 0.704 . . . . 0.0 110.413 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.6 t 56.94 60.04 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.932 -0.48 . . . . 0.0 110.929 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.3 168.11 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 0.0 109.228 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 74' ' ' VAL . 11.5 p -128.08 160.33 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.426 0.632 . . . . 0.0 109.836 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' N ' HG22 ' A' ' 73' ' ' VAL . 56.3 t -103.11 132.73 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.681 -0.637 . . . . 0.0 109.409 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.24 158.81 14.07 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -102.28 91.56 4.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.933 . . . . 0.0 109.392 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.46 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 88.0 t80 -101.37 119.74 39.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.818 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 80' ' ' ARG . 3.7 m120 52.68 43.08 31.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.763 -0.586 . . . . 0.0 110.657 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 68.99 -15.29 0.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.675 -0.641 . . . . 0.0 110.302 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 78' ' ' ASN . 79.9 mtp85 -88.04 159.91 18.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.76 135.52 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -143.33 153.7 43.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 109.332 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -97.2 123.32 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.403 -0.811 . . . . 0.0 108.861 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -108.89 124.47 50.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 0.0 109.366 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.9 132.53 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' LYS . 5.3 p30 -145.62 -178.89 6.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 62.0 tttm -40.91 161.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 9.9 t-20 74.76 -27.36 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 109.795 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 87' ' ' LYS . 23.2 t -79.92 166.01 22.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.923 . . . . 0.0 110.012 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.6 t -148.11 169.93 18.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 109.334 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.2 mt -144.48 136.01 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.455 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.06 127.59 46.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.45 -0.781 . . . . 0.0 109.189 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' C ' HD22 ' A' ' 94' ' ' LEU . 98.5 mttt -74.61 140.72 44.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.536 -0.728 . . . . 0.0 109.515 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.1 mm? -111.01 135.08 52.05 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.818 0.818 . . . . 0.0 110.175 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.2 m -85.66 9.67 15.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.23 92.47 39.93 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.455 -0.778 . . . . 0.0 109.19 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.12 153.25 21.77 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.761 2.308 . . . . 0.0 112.064 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.447 ' H ' ' HE2' ' A' ' 23' ' ' LYS . 96.7 mt -100.84 139.66 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 109.577 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.79 -179.517 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.494 1.544 0 CA-C-O 121.342 0.476 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -81.89 121.99 27.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.437 HD23 HD22 ' A' ' 19' ' ' ASN . 56.9 mt -88.13 131.01 34.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.347 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 20' ' ' LEU . 85.4 m -124.99 138.71 54.22 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -95.66 152.77 18.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.276 -0.89 . . . . 0.0 109.814 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.1 mt -58.29 -44.35 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.548 -0.72 . . . . 0.0 109.361 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.94 -18.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 108.937 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 63.1 t0 -87.87 3.78 47.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -85.6 120.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.047 -1.033 . . . . 0.0 109.678 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.2 p -138.47 -2.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.322 -0.861 . . . . 0.0 109.043 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 97.7 mt-10 -134.58 136.04 42.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.104 -0.997 . . . . 0.0 109.488 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -97.14 156.4 16.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.97 18.67 69.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 24.2 pt20 -103.36 159.49 15.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -1.032 . . . . 0.0 109.71 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.24 135.42 46.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.69 -0.631 . . . . 0.0 109.642 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.29 177.36 11.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 109.796 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 16.1 t30 -133.46 138.16 46.05 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 6' ' ' THR . 57.4 tp -154.29 147.1 24.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.793 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -104.68 140.36 38.15 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . . . -152.27 161.05 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 111.236 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -103.82 153.92 20.18 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 t -93.14 102.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.067 -1.02 . . . . 0.0 110.597 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 pt -84.08 -23.8 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.596 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 47.5 tt0 -152.96 134.92 14.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.911 . . . . 0.0 108.918 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.3 tp -118.06 147.74 42.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.256 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.596 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 80.7 m95 -146.78 128.75 15.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 109.185 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.486 0.66 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 52.3 p -88.0 -55.81 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.836 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.447 ' NE2' HD12 ' A' ' 52' ' ' ILE . 22.8 pt20 -158.23 165.87 33.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.014 . . . . 0.0 110.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.61 160.82 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.11 -166.59 34.26 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.194 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.74 146.77 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.857 . . . . 0.0 109.155 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.5 mt -109.16 125.22 51.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.84 99.43 2.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 22' ' ' ALA . 17.9 m-20 -105.52 164.52 11.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.969 . . . . 0.0 109.479 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -70.48 -18.98 62.98 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.865 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -90.08 -10.51 44.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.106 . . . . 0.0 109.827 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.06 -147.87 18.33 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 48' ' ' ILE . 96.0 mt -134.73 155.81 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.597 -0.943 . . . . 0.0 109.48 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.45 ' N ' HG22 ' A' ' 47' ' ' ILE . 14.2 tt -154.53 148.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.795 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -88.22 154.42 20.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CB ' HG23 ' A' ' 83' ' ' VAL . 18.9 p90 -146.7 154.33 41.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.603 -1.31 . . . . 0.0 108.311 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.482 HG22 ' NE2' ' A' ' 84' ' ' GLN . 15.3 t -135.45 132.32 37.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.447 HD12 ' NE2' ' A' ' 37' ' ' GLN . 94.9 mt -102.77 128.7 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.573 -0.704 . . . . 0.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -83.96 142.68 30.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 110.454 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -60.8 -34.74 74.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -59.33 -9.59 2.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 109.764 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.33 -25.66 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -0.971 . . . . 0.0 108.825 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 42.47 47.3 4.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 110.066 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.55 165.45 14.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.03 147.65 89.16 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.321 2.014 . . . . 0.0 112.242 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.85 142.08 49.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.089 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.3 mp -80.24 143.89 33.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.79 131.99 43.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 109.307 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -70.07 134.45 48.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.0 110.477 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 -13.89 66.39 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -97.4 159.51 14.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -1.159 . . . . 0.0 110.796 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.7 m -93.26 146.73 23.49 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.271 0.558 . . . . 0.0 109.798 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.3 151.02 43.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.025 0.917 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.5 tp -106.3 132.53 52.23 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 mt -109.28 106.03 15.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -105.93 140.96 38.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.353 -0.842 . . . . 0.0 110.265 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.1 t 56.86 61.96 2.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.66 . . . . 0.0 110.983 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.93 164.11 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.43 144.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.518 0.675 . . . . 0.0 109.637 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -94.09 134.27 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 151.54 18.04 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -97.4 95.86 7.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -1.155 . . . . 0.0 109.149 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.3 t80 -102.13 116.22 32.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.085 -1.009 . . . . 0.0 109.758 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.467 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 22.0 t-20 51.31 -126.7 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 110.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 56.8 t0 -95.85 -6.69 38.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 ttm180 -114.83 146.67 40.79 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.809 0.814 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.73 158.2 21.87 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -141.71 156.96 45.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 108.886 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -103.0 123.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' HG22 ' A' ' 51' ' ' THR . 92.4 mm-40 -103.26 126.94 50.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.06 130.48 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 108.871 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.96 -166.83 1.67 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.629 0.728 . . . . 0.0 109.968 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -64.28 -41.93 96.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.666 -0.646 . . . . 0.0 110.14 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -65.69 -11.78 48.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.998 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.1 t -86.34 162.44 18.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.461 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.6 m -135.24 157.96 45.57 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -138.98 130.31 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.056 -1.027 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.98 129.18 48.72 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.323 -0.86 . . . . 0.0 109.156 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.442 ' C ' HD22 ' A' ' 94' ' ' LEU . 78.3 tttt -77.36 138.67 39.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.0 mm? -106.95 138.01 43.94 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.855 0.836 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -83.16 2.25 36.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.817 -0.552 . . . . 0.0 109.512 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 96' ' ' GLU . 2.7 mp0 -103.5 129.71 24.91 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.189 -0.945 . . . . 0.0 109.796 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.64 146.87 30.92 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.872 1.715 . . . . 0.0 112.289 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -110.57 135.44 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.494 -0.754 . . . . 0.0 108.987 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 109.96 -179.415 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.491 1.343 0 CA-C-O 121.567 0.569 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 8.2 pt20 -81.65 118.16 22.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.864 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.3 mt -90.54 131.16 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.2 m -123.02 142.64 50.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.88 146.94 23.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.639 0.733 . . . . 0.0 110.402 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.2 mm -53.62 -46.02 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.8 . . . . 0.0 109.597 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.82 -11.81 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.612 -0.68 . . . . 0.0 109.89 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.72 2.74 44.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -86.98 119.02 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.819 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -151.86 9.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.816 . . . . 0.0 109.459 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -127.35 123.11 35.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.555 -0.716 . . . . 0.0 109.283 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.38 152.02 23.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.438 -0.789 . . . . 0.0 110.057 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.73 79.17 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -98.06 145.2 26.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.092 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.17 129.6 45.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.516 -0.74 . . . . 0.0 109.481 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.21 -175.88 5.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.625 HD21 ' HA ' ' A' ' 70' ' ' ARG . 13.1 t-20 -127.11 141.13 51.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.683 -0.636 . . . . 0.0 109.295 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.96 154.56 49.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.479 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -135.8 135.42 39.87 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.55 -173.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.169 0.985 . . . . 0.0 110.511 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.49 155.84 27.9 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.51 106.5 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.34 -24.0 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.284 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.62 ' HB3' HD21 ' A' ' 40' ' ' LEU . 10.3 tp-100 -161.26 151.41 17.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.043 -1.036 . . . . 0.0 109.529 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.889 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.3 pt? -140.96 163.85 31.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.467 -0.771 . . . . 0.0 109.961 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -145.37 111.14 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.802 0.81 . . . . 0.0 109.5 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.514 0.673 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -93.25 -47.72 6.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -155.05 156.51 36.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.37 141.1 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.665 ' C ' HD23 ' A' ' 40' ' ' LEU . . . -168.81 -154.09 8.73 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.291 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -136.88 153.09 50.85 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.794 -0.827 . . . . 0.0 109.322 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.02 132.12 54.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.64 0.733 . . . . 0.0 109.741 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.97 104.24 3.12 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 1.4 m-20 -103.73 162.68 12.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.654 -0.91 . . . . 0.0 109.375 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.598 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.9 mp0 -69.37 -15.35 63.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -97.0 -6.14 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.86 -147.11 17.28 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.227 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.93 162.89 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.644 -0.916 . . . . 0.0 110.069 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -159.33 150.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.971 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.86 165.64 21.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.648 -0.658 . . . . 0.0 110.023 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 18.6 p90 -158.67 148.7 19.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.156 -0.965 . . . . 0.0 108.89 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -134.6 128.72 33.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.6 mt -105.45 128.44 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 109.414 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.62 143.01 27.22 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.755 0.788 . . . . 0.0 110.373 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 56' ' ' ALA . 39.5 tptt -60.45 -30.59 69.76 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.619 -0.675 . . . . 0.0 109.403 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -58.98 -3.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.838 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -97.14 -28.19 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.172 -0.955 . . . . 0.0 109.051 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 55.2 mp0 48.97 54.7 10.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.21 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.1 mt -110.89 152.85 43.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.73 147.51 71.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.567 2.178 . . . . 0.0 112.709 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 mt -72.34 149.29 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.754 0.788 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -86.86 144.33 27.05 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.446 0.641 . . . . 0.0 110.115 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.88 139.56 31.14 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.884 0.849 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.19 137.87 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.45 -0.781 . . . . 0.0 110.727 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.97 56.34 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -94.39 159.03 15.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 p -90.28 149.3 22.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.295 0.569 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -144.32 145.88 32.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.7 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 19' ' ' ASN . 36.5 tp -113.32 130.57 56.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.605 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 1.9 mp -119.45 113.64 21.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.63 -0.669 . . . . 0.0 109.502 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.625 ' HA ' HD21 ' A' ' 19' ' ' ASN . 85.8 mtp180 -105.92 151.53 24.46 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.76 58.64 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.553 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.3 165.07 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.535 -0.728 . . . . 0.0 109.459 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.87 147.58 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.676 0.75 . . . . 0.0 109.71 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.6 t -87.93 130.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.67 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.9 147.44 16.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -96.81 103.26 15.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.451 -1.029 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' ARG . 71.2 t80 -101.58 107.62 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.737 0.78 . . . . 0.0 109.372 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.427 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 47.5 t30 39.69 -115.65 0.2 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.793 -0.567 . . . . 0.0 110.629 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 97.7 m-20 -93.61 -19.08 21.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.817 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' TYR . 84.8 mtt85 -97.41 159.54 14.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.25 -0.906 . . . . 0.0 110.353 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.88 153.19 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.619 -0.675 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -151.96 164.07 37.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 83' ' ' VAL . 17.0 m -102.91 126.91 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.95 128.77 53.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.325 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.59 134.29 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' LYS . 4.2 p30 -146.34 -174.4 4.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.87 0.843 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 89' ' ' SER . 1.6 pptp? -44.34 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.899 -0.5 . . . . 0.0 109.896 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 t30 67.29 -27.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.676 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 87' ' ' LYS . 12.7 p -79.98 166.9 21.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.156 -0.965 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.8 p -141.14 160.42 40.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -139.38 132.3 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.593 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -128.76 130.16 46.68 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.609 0.719 . . . . 0.0 109.365 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.47 144.3 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.63 -0.668 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.33 145.24 46.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.704 0.764 . . . . 0.0 110.028 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -86.27 16.8 4.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -119.39 118.43 32.42 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.655 -0.653 . . . . 0.0 109.533 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.09 157.8 42.2 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.647 2.231 . . . . 0.0 112.376 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.3 mm -108.27 137.23 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.748 -0.595 . . . . 0.0 109.674 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.763 . . . . 0.0 109.663 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo . . . . . 0 N--CA 1.49 1.307 0 CA-C-O 121.453 0.522 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -79.73 118.62 21.7 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.591 0.71 . . . . 0.0 109.687 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.2 mt -93.73 128.06 39.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.522 ' O ' HD13 ' A' ' 20' ' ' LEU . 14.8 t -129.6 152.69 48.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.557 0.694 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.18 135.1 34.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.341 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -50.97 -34.37 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.758 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.82 1.46 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.854 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -122.48 6.57 9.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.21 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 13' ' ' GLU . 27.7 mt -64.19 -52.42 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 11' ' ' ILE . 12.2 m 4.29 64.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 121.395 0.617 . . . . 0.0 111.383 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 11' ' ' ILE . 38.3 tp10 -174.09 109.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.732 0.777 . . . . 0.0 109.368 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p-10 -82.57 140.52 33.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.5 77.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.05 137.27 32.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -1.16 . . . . 0.0 110.049 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -100.01 129.72 46.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.524 -0.735 . . . . 0.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.99 -175.06 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.398 -0.814 . . . . 0.0 109.932 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 88.0 m-20 -138.35 143.41 39.86 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.434 0.635 . . . . 0.0 109.629 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 6' ' ' THR . 62.2 tp -159.06 145.82 17.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.216 -0.928 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -100.0 141.81 32.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.594 -0.692 . . . . 0.0 109.152 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.538 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . . . -154.73 159.07 40.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.853 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -97.8 150.42 21.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -89.31 101.9 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.551 -0.718 . . . . 0.0 110.754 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.45 -25.61 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -170.61 162.43 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -0.989 . . . . 0.0 109.673 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.43 158.31 43.38 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.7 0.762 . . . . 0.0 110.144 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -148.61 127.94 13.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.437 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.628 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.522 -0.736 . . . . 0.0 109.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 122.024 0.916 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 6.1 p -93.2 -56.62 2.89 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.096 -1.002 . . . . 0.0 109.832 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.515 ' N ' ' OG ' ' A' ' 36' ' ' SER . 80.1 mt-30 -150.01 158.61 44.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.952 -1.093 . . . . 0.0 110.542 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.67 141.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.85 -164.57 13.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.311 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.79 143.85 47.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.854 -0.792 . . . . 0.0 109.749 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.539 HD21 ' CE1' ' A' ' 50' ' ' PHE . 67.4 mt -112.85 128.89 56.57 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.69 0.757 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.01 99.02 2.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' A' ' 22' ' ' ALA . 47.8 m-20 -99.3 156.35 17.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.126 -1.22 . . . . 0.0 109.469 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 44' ' ' GLU . 13.8 pt-20 -68.96 -17.41 63.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.646 -0.659 . . . . 0.0 109.722 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 p -96.76 -11.74 24.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.285 -0.885 . . . . 0.0 109.076 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.84 -146.73 13.53 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.711 ' O ' HD12 ' A' ' 47' ' ' ILE . 2.5 pp -133.78 161.49 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.1 tt -161.97 143.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.756 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.37 148.74 22.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 110.172 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.539 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.9 p90 -138.6 160.03 40.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.945 -1.097 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -134.21 133.19 40.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.339 -0.851 . . . . 0.0 109.982 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.7 129.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.639 0.733 . . . . 0.0 109.656 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -87.1 140.74 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 110.46 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -54.89 -23.63 19.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.57 -0.707 . . . . 0.0 109.539 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.33 -6.97 47.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.705 . . . . 0.0 109.673 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.584 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -86.96 -34.32 19.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.15 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 54.53 53.03 11.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 110.123 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.584 HD13 ' HB1' ' A' ' 56' ' ' ALA . 8.5 mp -105.19 155.46 37.73 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.06 156.03 65.01 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.774 2.316 . . . . 0.0 112.737 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.27 139.78 54.42 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.894 0.854 . . . . 0.0 110.684 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.4 mp -82.93 152.59 25.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.356 0.598 . . . . 0.0 110.113 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -104.31 133.3 49.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.727 0.775 . . . . 0.0 110.228 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -67.88 138.94 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.81 0.814 . . . . 0.0 110.622 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 -9.64 64.8 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -94.08 149.92 20.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.241 . . . . 0.0 110.471 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -89.2 147.56 24.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.45 0.643 . . . . 0.0 109.78 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -141.79 152.6 43.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.164 -0.96 . . . . 0.0 110.154 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HB2' HD21 ' A' ' 94' ' ' LEU . 38.9 tp -106.1 133.8 50.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.38 109.65 20.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.393 -0.817 . . . . 0.0 109.648 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -113.66 142.69 45.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.708 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t 57.06 58.04 4.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.115 0.483 . . . . 0.0 110.774 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.36 163.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.2 154.84 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.774 0.797 . . . . 0.0 109.953 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.5 t -95.34 130.1 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 109.851 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.54 151.05 18.96 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -91.29 96.15 10.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -1.028 . . . . 0.0 109.697 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.529 ' CD2' ' OD1' ' A' ' 78' ' ' ASN . 16.3 t80 -95.17 100.18 12.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 77' ' ' TYR . 1.5 p-10 37.48 -110.52 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -95.14 -20.93 18.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.868 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' TYR . 72.5 ttt180 -98.56 162.7 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.121 -0.987 . . . . 0.0 110.505 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -101.02 150.37 22.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.235 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -143.63 148.08 35.31 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.048 -1.032 . . . . 0.0 109.592 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.45 125.22 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.235 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.58 124.4 49.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.377 -0.827 . . . . 0.0 109.564 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.76 134.63 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -132.13 -167.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.889 0.852 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.68 -41.69 98.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.661 -0.649 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.08 -22.72 67.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -0.941 . . . . 0.0 109.605 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.7 m -80.23 163.99 23.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 p -142.62 162.08 36.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 HD23 ' A' ' 58' ' ' LEU . 79.9 mt -141.56 134.1 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -130.7 135.27 47.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -71.26 136.45 47.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.702 . . . . 0.0 109.597 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 68' ' ' LEU . 98.2 mt -92.57 136.45 33.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.9 t -74.99 -9.02 58.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.713 . . . . 0.0 109.78 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -118.92 137.27 24.84 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.769 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.9 159.15 38.32 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.668 2.245 . . . . 0.0 112.189 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.11 131.53 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.687 . . . . 0.0 109.383 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.873 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.496 1.621 0 CA-C-O 121.399 0.5 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.02 120.25 17.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.864 . . . . 0.0 109.74 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.5 mt -97.02 129.85 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -123.31 151.31 42.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -99.84 147.6 25.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.089 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 46' ' ' GLY . 5.0 pt -58.78 -43.0 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.517 -0.739 . . . . 0.0 109.369 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.8 -7.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.78 15.29 28.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.408 -0.808 . . . . 0.0 109.298 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.43 115.51 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.975 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.28 2.05 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -135.29 131.59 36.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.371 -0.831 . . . . 0.0 109.058 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -95.95 155.64 16.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 19.89 74.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -101.29 156.88 17.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -1.042 . . . . 0.0 109.892 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -106.15 134.2 49.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -176.85 5.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.437 -0.79 . . . . 0.0 109.811 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -120.37 135.0 55.17 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -136.62 138.03 40.74 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.962 -1.086 . . . . 0.0 110.174 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 34.0 ttpt -117.68 134.33 55.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.6 23.56 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.21 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 51.6 tttp -96.53 163.35 13.07 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.05 97.17 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.321 -0.862 . . . . 0.0 110.942 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.7 pt -80.46 -27.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.877 . . . . 0.0 110.225 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -147.33 130.47 16.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -116.42 140.86 48.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.232 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -149.41 137.24 20.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.168 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.26 -0.9 . . . . 0.0 109.71 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.536 0.684 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 m -91.11 -54.1 4.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.502 -0.749 . . . . 0.0 109.607 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.41 ' CD ' HD12 ' A' ' 52' ' ' ILE . 13.9 pt20 -160.98 168.74 23.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 39' ' ' GLY . 94.7 t -146.91 156.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -179.67 -163.8 31.0 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.597 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.79 147.51 51.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.782 -0.834 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.489 HD11 ' CD1' ' A' ' 50' ' ' PHE . 4.9 mp -136.56 144.76 44.36 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.602 0.715 . . . . 0.0 109.806 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.58 135.07 12.07 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' A' ' 44' ' ' GLU . 53.1 t0 -115.21 4.34 14.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.523 -0.986 . . . . 0.0 110.674 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.595 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 65.1 tt0 100.75 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.515 1.052 . . . . 0.0 108.487 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -93.48 -3.56 52.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.153 . . . . 0.0 109.562 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' N ' HD11 ' A' ' 8' ' ' ILE . . . 155.47 -150.46 21.9 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.4 160.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.625 -0.927 . . . . 0.0 109.764 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tp -157.18 141.07 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.013 . . . . 0.0 109.526 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB3' HE22 ' A' ' 82' ' ' GLN . 14.6 ttmm -89.93 132.23 35.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -125.1 154.31 41.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.313 -0.867 . . . . 0.0 109.192 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -132.27 133.32 43.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 HD12 ' CD ' ' A' ' 37' ' ' GLN . 65.7 mt -100.69 122.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.304 -0.873 . . . . 0.0 109.79 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -80.41 149.57 30.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.43 -34.71 78.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -59.67 -20.76 58.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.99 60.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.106 -0.996 . . . . 0.0 108.746 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 44.16 45.5 6.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.585 -0.697 . . . . 0.0 109.969 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.81 150.95 37.29 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.02 160.72 47.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.595 2.197 . . . . 0.0 112.296 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.87 134.87 48.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 110.109 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.2 mp -78.05 146.09 35.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.625 -0.672 . . . . 0.0 109.541 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -86.39 131.11 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -73.12 135.83 44.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.518 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 88.73 5.02 75.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 78.0 mm-40 -113.69 157.54 22.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.413 -1.051 . . . . 0.0 110.896 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 m -85.9 141.79 29.31 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.33 0.585 . . . . 0.0 109.629 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -138.98 145.01 39.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.298 -0.876 . . . . 0.0 109.803 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.45 128.42 55.99 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mp -115.55 116.34 27.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.625 -0.672 . . . . 0.0 109.448 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -108.66 143.09 38.2 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.551 0.691 . . . . 0.0 110.432 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.9 p 60.57 57.51 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 0.0 110.656 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.4 157.82 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.175 -0.953 . . . . 0.0 108.773 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.54 134.38 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.752 . . . . 0.0 109.211 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.09 135.82 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.532 -0.73 . . . . 0.0 109.649 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.76 ' H ' HE22 ' A' ' 84' ' ' GLN . . . -108.81 146.58 16.6 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.23 103.34 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.243 . . . . 0.0 109.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 80' ' ' ARG . 64.9 t80 -97.95 96.97 8.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.223 -0.923 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.65 -119.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.645 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.21 -11.2 39.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 77' ' ' TYR . 89.1 mtm180 -111.15 161.12 16.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 110.115 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.38 153.87 18.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.414 HE22 ' HB3' ' A' ' 49' ' ' LYS . 88.0 mm-40 -140.32 153.94 46.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.146 -0.971 . . . . 0.0 109.133 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.76 113.81 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.241 -0.912 . . . . 0.0 108.582 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.76 HE22 ' H ' ' A' ' 75' ' ' GLY . 2.6 mp0 -103.05 134.98 45.58 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 0.0 109.325 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -102.92 129.42 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -121.36 -174.38 2.84 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.697 0.761 . . . . 0.0 110.047 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.68 -41.68 97.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.68 -0.638 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -65.59 -2.52 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.957 . . . . 0.0 109.767 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -89.82 161.28 16.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.2 t -132.99 151.86 52.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.97 128.32 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.901 -1.125 . . . . 0.0 109.086 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -129.44 135.92 49.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.081 -1.012 . . . . 0.0 109.135 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.2 tttp -79.6 129.78 34.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.33 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 93' ' ' LYS . 3.9 mm? -104.3 134.74 47.01 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.927 0.87 . . . . 0.0 109.982 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -81.81 -3.14 53.22 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -91.78 123.01 64.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.876 -1.14 . . . . 0.0 109.548 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.25 141.82 23.56 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.733 1.622 . . . . 0.0 112.422 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.01 141.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.46 -0.775 . . . . 0.0 109.177 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 0.0 109.223 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 121.379 0.491 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -79.58 112.28 16.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.4 mt -89.89 129.61 36.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.0 109.691 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.6 m -123.88 139.87 53.54 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.421 0.629 . . . . 0.0 109.326 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.24 144.35 25.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.964 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 9' ' ' VAL . 9.5 pt -52.72 -41.7 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.626 -0.671 . . . . 0.0 109.686 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.403 ' N ' HG13 ' A' ' 8' ' ' ILE . 14.8 p -70.03 -11.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -96.59 6.44 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.65 119.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 109.968 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.92 6.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 96.6 mt-10 -131.71 128.01 38.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.542 -0.724 . . . . 0.0 109.369 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 14.6 t30 -88.95 150.03 23.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.848 . . . . 0.0 109.924 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 80.34 21.82 63.98 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 13' ' ' GLU . 4.9 pt20 -103.35 153.2 20.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.575 -0.956 . . . . 0.0 109.837 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -103.9 132.25 50.34 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.507 0.67 . . . . 0.0 109.446 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -160.32 178.87 9.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 109.863 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -120.66 144.98 47.89 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.1 tp -136.59 133.7 36.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.512 -0.742 . . . . 0.0 110.131 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -118.31 132.03 56.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.39 -173.21 0.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.176 0.989 . . . . 0.0 110.806 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.9 ptpt -118.19 155.82 29.82 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.438 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.8 t -90.06 105.75 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.471 -0.768 . . . . 0.0 110.158 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.5 pt -73.19 -25.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.804 -0.56 . . . . 0.0 110.045 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -159.59 148.59 17.94 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.983 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.6 pt? -125.34 152.01 45.3 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.13 117.7 9.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 109.606 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.623 -0.673 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.475 0.655 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 3.0 m -102.05 -46.32 4.9 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.513 0.673 . . . . 0.0 109.894 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -148.82 148.2 29.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.988 -1.07 . . . . 0.0 109.975 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.86 130.74 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.38 -166.93 15.12 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.15 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD21 ' NZ ' ' A' ' 49' ' ' LYS . 4.8 mp -135.31 150.48 50.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.866 -0.784 . . . . 0.0 109.734 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.21 125.22 53.57 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.64 8.13 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.4 p-10 -125.73 -134.69 0.26 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.714 -0.874 . . . . 0.0 109.098 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 81.7 tt0 -119.8 -18.57 8.24 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 15.7 p -93.06 -11.06 33.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.97 -1.081 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 151.65 -143.85 10.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -141.54 158.11 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -1.09 . . . . 0.0 109.432 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -148.86 145.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 109.885 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.462 ' CB ' HE21 ' A' ' 82' ' ' GLN . 67.9 mttm -92.01 127.36 37.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.023 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -122.87 152.76 40.44 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.3 m -131.24 133.44 45.45 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.426 0.631 . . . . 0.0 109.634 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.64 127.1 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -82.5 142.56 31.77 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.597 -0.689 . . . . 0.0 110.118 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' N ' ' OG ' ' A' ' 36' ' ' SER . 78.8 tttt -58.08 -37.32 74.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.541 -0.725 . . . . 0.0 109.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -60.01 -6.11 1.23 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.828 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.884 . . . . 0.0 109.158 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 46.33 51.95 11.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.643 -0.661 . . . . 0.0 109.889 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.4 mt -100.65 153.02 37.97 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.741 -0.599 . . . . 0.0 109.848 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.46 148.89 60.1 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.477 2.118 . . . . 0.0 112.779 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.6 140.12 51.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.512 -0.742 . . . . 0.0 110.379 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.3 mp -83.37 150.33 26.16 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.367 0.603 . . . . 0.0 109.964 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.2 128.2 45.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -66.71 137.99 57.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.662 -0.649 . . . . 0.0 110.712 -179.146 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 86.74 -10.77 66.37 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -98.18 158.19 15.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -1.033 . . . . 0.0 110.674 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 m -91.58 145.67 24.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -141.73 148.82 39.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 109.815 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 tp -110.32 128.76 55.71 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.83 118.05 31.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.531 -0.731 . . . . 0.0 109.728 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -114.86 145.01 42.63 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.692 0.758 . . . . 0.0 110.694 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 63.22 56.57 1.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 18' ' ' ALA . 19.0 m -110.73 161.97 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.512 -0.743 . . . . 0.0 109.381 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 148.43 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.581 0.705 . . . . 0.0 109.59 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.3 t -95.75 132.47 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.676 -0.64 . . . . 0.0 109.686 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.0 16.96 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -94.86 109.39 21.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.534 -0.98 . . . . 0.0 109.403 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 80' ' ' ARG . 40.4 t80 -106.8 106.45 16.97 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.922 0.868 . . . . 0.0 109.483 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 42.64 -118.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -93.07 -17.3 23.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.102 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.7 mtt-85 -100.82 159.78 14.91 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.411 -0.805 . . . . 0.0 110.329 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -104.72 153.32 21.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.462 HE21 ' CB ' ' A' ' 49' ' ' LYS . 40.7 mt-30 -147.81 159.94 43.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.38 123.55 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -99.72 129.35 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -104.41 131.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -127.08 -170.46 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.673 0.749 . . . . 0.0 110.066 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.53 -45.14 91.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.907 -0.496 . . . . 0.0 110.181 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.18 -11.07 7.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 109.758 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.5 p -83.23 163.91 20.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.9 p -138.44 155.67 48.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -139.66 131.77 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 0.0 109.313 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -127.47 130.57 49.47 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -70.34 135.89 49.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.705 -0.622 . . . . 0.0 109.502 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.1 mt -96.92 134.36 40.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.505 -0.747 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.5 p -85.29 -6.34 59.26 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -107.12 130.52 22.74 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.567 -0.708 . . . . 0.0 109.57 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.25 147.39 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.478 2.119 . . . . 0.0 112.242 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.464 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.5 mt -110.27 131.67 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.6 mp0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 110.011 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 N--CA 1.494 1.522 0 CA-C-O 121.416 0.507 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -79.03 115.43 18.7 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.12 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.9 mt -86.95 126.64 34.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.55 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.7 m -120.77 136.78 54.8 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.07 148.39 22.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.23 -43.3 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.528 0.68 . . . . 0.0 109.193 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.22 -13.39 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.429 -0.795 . . . . 0.0 109.535 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 53.2 t0 -95.58 5.52 51.29 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.159 -0.963 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 13' ' ' GLU . 3.7 mm -56.14 -72.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.142 -0.974 . . . . 0.0 109.185 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t 62.59 -32.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 11' ' ' ILE . 52.3 tp10 -145.54 147.6 32.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.883 -1.135 . . . . 0.0 108.987 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -101.48 173.11 6.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.56 0.695 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.43 21.85 79.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 34.3 mt-30 -99.43 145.76 27.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.349 -1.089 . . . . 0.0 109.984 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.27 126.05 39.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.28 -169.98 2.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -126.09 144.07 50.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.69 130.81 38.7 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.715 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -116.05 130.67 56.91 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.16 -173.67 1.14 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.23 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HZ1' ' HB ' ' A' ' 98' ' ' ILE . 3.3 ttmp? -114.26 148.89 36.72 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.831 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.08 123.71 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 pt -88.46 -20.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.432 -0.793 . . . . 0.0 110.45 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -164.91 154.82 13.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.723 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.7 mt -124.36 152.09 43.59 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.443 0.64 . . . . 0.0 110.021 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -137.33 104.92 5.53 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.743 -0.598 . . . . 0.0 109.695 -179.667 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.1 p -90.93 -60.17 1.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.912 0.863 . . . . 0.0 110.437 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.537 ' N ' ' OG ' ' A' ' 36' ' ' SER . 34.8 mt-30 -146.67 155.34 42.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.864 -1.148 . . . . 0.0 109.964 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 39' ' ' GLY . 20.2 t -135.94 161.77 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' ' CE2' ' A' ' 50' ' ' PHE . . . 178.4 -168.17 39.16 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.058 -1.544 . . . . 0.0 109.939 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.08 149.88 52.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.764 -0.845 . . . . 0.0 109.583 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.6 125.72 53.7 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.733 0.778 . . . . 0.0 108.992 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.93 101.2 2.75 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -105.05 164.02 12.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.678 -0.895 . . . . 0.0 109.293 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -71.49 -17.01 62.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.491 -0.756 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.3 p -93.81 -10.85 32.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 109.571 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.61 -149.57 21.23 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 pt -132.98 156.16 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.944 . . . . 0.0 109.701 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -152.47 145.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.865 . . . . 0.0 109.397 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.612 ' H ' HH12 ' A' ' 80' ' ' ARG . 68.3 mttm -80.44 165.35 22.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.807 . . . . 0.0 109.451 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CE2' ' C ' ' A' ' 39' ' ' GLY . 24.6 p90 -154.23 148.6 26.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.513 -1.367 . . . . 0.0 108.08 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.5 m -132.93 132.38 41.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.436 -0.79 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -105.7 127.56 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.491 -0.755 . . . . 0.0 109.38 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -83.76 140.3 32.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.66 -33.01 69.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.466 -0.771 . . . . 0.0 109.226 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -64.14 -6.43 6.54 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.79 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.58 -31.84 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 108.941 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 49.51 52.9 13.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.909 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 mt -101.96 153.93 37.67 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.36 -0.837 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.71 149.65 31.67 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.145 1.896 . . . . 0.0 112.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.0 138.29 57.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 0.0 110.27 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.8 mp -82.86 145.24 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 109.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -105.21 135.36 46.71 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.835 0.826 . . . . 0.0 109.998 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -74.78 146.64 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.022 0.915 . . . . 0.0 110.006 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.72 -11.1 42.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -97.81 150.14 21.58 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.102 -1.234 . . . . 0.0 110.507 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -84.16 143.8 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.364 0.602 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -142.14 150.26 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.08 129.92 55.47 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.31 115.65 28.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.423 -0.798 . . . . 0.0 109.576 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -113.66 146.25 40.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.579 -0.701 . . . . 0.0 110.317 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.1 t 56.96 58.97 3.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.882 -0.511 . . . . 0.0 110.908 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.98 165.73 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.302 -0.873 . . . . 0.0 108.849 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.01 152.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.654 0.74 . . . . 0.0 109.591 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.15 132.08 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.649 -0.657 . . . . 0.0 109.536 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.12 156.24 15.71 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.44 118.17 36.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 109.032 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.5 t80 -135.46 117.89 15.77 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 80' ' ' ARG . 9.4 m120 52.73 55.75 8.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.452 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 56.16 -4.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.68 -0.638 . . . . 0.0 110.808 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' H ' ' A' ' 49' ' ' LYS . 68.3 ttt-85 -102.02 131.91 48.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.093 -1.004 . . . . 0.0 109.598 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 11' ' ' ILE . 13.9 m-85 -78.15 146.3 35.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.488 -0.757 . . . . 0.0 109.233 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -147.32 162.6 38.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 0.0 109.613 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.94 119.77 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.442 -0.787 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -100.56 129.91 46.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 0.0 109.043 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.56 132.39 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.045 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -125.49 -170.12 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.402 -0.811 . . . . 0.0 109.81 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -67.3 -25.42 66.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.654 -0.654 . . . . 0.0 110.102 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -80.72 -9.24 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.776 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 m -88.87 164.07 15.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 0.0 109.675 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.6 m -134.93 158.0 45.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.264 -0.897 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.94 128.87 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.114 -0.991 . . . . 0.0 108.843 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.97 128.56 47.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.311 -0.868 . . . . 0.0 108.919 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.82 137.97 55.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 109.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.2 134.37 46.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.848 . . . . 0.0 109.941 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.9 p -85.5 -2.01 57.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -109.66 127.53 27.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.368 -0.833 . . . . 0.0 109.692 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.55 151.0 41.35 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.121 1.881 . . . . 0.0 112.265 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.554 ' HB ' ' HZ1' ' A' ' 23' ' ' LYS . 96.6 mt -111.01 134.5 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.716 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.497 1.726 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.469 ' N ' HD22 ' A' ' 19' ' ' ASN . 85.1 mt-30 -77.84 115.78 17.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.516 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.72 127.48 35.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.9 m -121.12 137.7 54.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -95.85 151.74 19.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.944 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mm -55.96 -44.56 78.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.77 -18.24 23.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.222 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.28 -0.52 56.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.23 118.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -142.88 -2.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.926 . . . . 0.0 109.192 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.8 140.52 45.93 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.094 -1.004 . . . . 0.0 109.505 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' A' ' 76' ' ' GLU . 39.4 p-10 -92.5 162.93 14.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.53 78.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -94.46 140.45 29.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -1.17 . . . . 0.0 109.682 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -96.48 128.26 43.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.626 -0.671 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.747 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.557 ' C ' HD22 ' A' ' 20' ' ' LEU . 58.9 m-20 -120.69 139.56 52.87 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD22 ' C ' ' A' ' 19' ' ' ASN . 4.4 mm? -116.84 146.68 42.74 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.087 -1.008 . . . . 0.0 109.71 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -138.42 125.33 21.16 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 -175.16 1.06 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.177 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -110.54 151.76 27.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.854 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.47 111.06 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.322 -0.861 . . . . 0.0 110.84 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.7 pt -89.22 -24.38 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -156.56 147.26 21.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 109.449 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 160.61 39.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.249 -0.907 . . . . 0.0 109.37 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -141.21 109.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 109.389 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.618 -179.445 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 121.408 0.623 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.416 ' OG ' ' C ' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -85.04 -58.32 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -151.98 152.01 31.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.258 -0.901 . . . . 0.0 109.871 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.87 133.01 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.27 -156.8 8.45 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.525 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.67 153.49 50.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.87 -0.782 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.46 128.7 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.8 97.84 2.35 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 53.8 t0 -101.37 159.86 14.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -1.045 . . . . 0.0 109.421 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.3 mt-10 -68.99 -14.8 63.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.44 -0.788 . . . . 0.0 109.984 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -98.0 -7.03 30.73 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.155 -0.966 . . . . 0.0 109.577 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.61 -147.81 18.11 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.162 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.663 ' O ' HD12 ' A' ' 47' ' ' ILE . 2.1 pp -135.81 165.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.662 -0.905 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.5 tt -157.5 144.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.147 -0.97 . . . . 0.0 109.91 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.88 130.22 38.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -128.45 154.99 45.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.831 -1.168 . . . . 0.0 108.599 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.6 m -131.33 130.47 42.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.59 -0.694 . . . . 0.0 109.257 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.06 129.62 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.332 -0.855 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.416 ' C ' ' OG ' ' A' ' 36' ' ' SER . 97.9 m95 -82.0 139.91 34.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 110.312 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 56' ' ' ALA . 64.5 tttm -59.63 -37.78 79.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -61.04 -2.04 0.54 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -85.07 -23.71 28.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 108.779 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 53.85 48.28 21.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 109.9 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.77 147.06 35.38 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.533 -0.729 . . . . 0.0 109.581 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 157.27 62.54 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.384 2.056 . . . . 0.0 112.648 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.74 147.39 43.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.054 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.7 mp -85.2 155.19 21.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.528 -0.733 . . . . 0.0 109.556 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 47.2 tp10 -100.47 136.73 39.9 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -71.34 138.6 49.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.405 -0.809 . . . . 0.0 110.488 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.16 -14.81 62.6 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.35 158.45 15.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.327 -1.102 . . . . 0.0 110.667 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -88.15 151.77 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.485 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 31.7 m-85 -142.9 143.72 32.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 109.561 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.45 129.83 56.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.04 122.74 45.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.615 -0.678 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -116.86 151.99 35.41 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.477 0.656 . . . . 0.0 110.536 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m 56.93 54.97 6.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.89 -0.506 . . . . 0.0 110.788 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.21 164.6 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.243 -0.911 . . . . 0.0 108.853 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.51 147.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.564 0.697 . . . . 0.0 109.374 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.89 131.83 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 109.383 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.93 149.94 16.95 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 78' ' ' ASN . 5.5 tm-20 -92.08 100.2 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.034 -1.274 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.8 t80 -95.18 103.61 15.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.93 . . . . 0.0 109.191 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' O ' ' OE2' ' A' ' 76' ' ' GLU . 99.3 m-20 40.25 -110.67 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 0.0 110.684 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -95.89 -19.65 19.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.099 -1.001 . . . . 0.0 110.383 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 77' ' ' TYR . 37.4 mmt180 -101.31 162.61 12.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 110.006 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.37 152.25 21.81 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.426 ' NE2' ' CD1' ' A' ' 77' ' ' TYR . 27.5 mt-30 -142.06 157.81 44.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.16 123.7 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.434 -0.791 . . . . 0.0 109.111 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -104.8 126.64 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.453 -0.779 . . . . 0.0 109.545 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.74 134.93 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.39 -0.819 . . . . 0.0 109.162 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -129.29 -168.57 1.95 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.323 -0.86 . . . . 0.0 109.896 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.63 -41.63 98.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.521 -0.737 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.91 -20.07 66.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.735 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.0 m -81.21 163.88 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.777 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.5 m -137.44 162.27 34.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.85 130.19 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.015 -1.053 . . . . 0.0 108.834 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -130.08 134.71 47.55 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.211 -0.931 . . . . 0.0 109.013 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -75.57 139.54 42.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.532 -0.73 . . . . 0.0 109.902 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.07 141.74 28.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 109.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -85.05 -8.98 58.46 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.24 134.05 20.88 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.336 -0.852 . . . . 0.0 110.033 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 154.02 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.053 1.836 . . . . 0.0 112.155 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -111.64 133.41 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 109.663 -179.496 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.496 1.618 0 CA-C-O 121.359 0.483 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.74 115.66 20.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.95 131.43 35.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -123.57 142.08 51.38 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -93.28 149.86 20.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.073 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.25 -43.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.369 -0.832 . . . . 0.0 109.078 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 p -62.99 -5.7 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -102.02 6.25 41.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.372 -0.83 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.74 112.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 109.551 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.6 m -149.74 4.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -132.91 130.47 39.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.362 -0.836 . . . . 0.0 109.078 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -88.15 160.06 17.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.193 -0.942 . . . . 0.0 110.359 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.52 20.68 72.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -94.29 138.57 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 109.996 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -94.85 126.69 40.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 109.386 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -179.41 7.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -126.3 140.36 52.58 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.36 143.73 40.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.5 135.74 54.2 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.87 -173.69 1.01 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.183 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.09 150.99 28.6 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.863 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.14 97.34 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.086 -1.009 . . . . 0.0 109.932 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 tp -66.47 -32.59 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 121.092 -1.005 . . . . 0.0 110.529 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -147.35 129.7 15.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 109.535 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.78 147.59 41.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.598 -0.689 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -143.51 115.39 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 109.396 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.459 -0.776 . . . . 0.0 109.649 -179.691 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.524 3.232 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -81.72 -57.87 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.394 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.74 165.19 33.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 0.0 110.661 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.76 154.9 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.66 -155.38 17.36 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.393 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.01 155.2 50.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.911 -0.758 . . . . 0.0 109.541 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.35 127.8 55.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.8 105.89 3.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -112.95 167.99 10.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.923 . . . . 0.0 109.484 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -73.01 -17.33 61.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.947 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.8 p -93.17 -12.1 31.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.917 -1.114 . . . . 0.0 109.644 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.69 -148.56 19.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.676 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.3 pp -135.55 160.66 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.992 . . . . 0.0 109.55 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -153.77 147.56 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.189 -0.944 . . . . 0.0 109.76 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -81.07 163.64 23.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 109.189 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -160.6 150.94 18.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.483 -1.386 . . . . 0.0 108.265 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 t -138.42 133.1 32.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.837 . . . . 0.0 109.47 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -105.2 129.77 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.677 -0.639 . . . . 0.0 109.467 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -81.98 139.3 34.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 110.686 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.35 -32.03 72.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.416 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.09 -10.4 10.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.85 -21.88 34.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 47.74 48.89 17.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.985 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt -103.71 152.27 38.9 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.404 -0.81 . . . . 0.0 109.8 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.42 146.5 41.27 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.077 1.851 . . . . 0.0 112.589 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.47 142.78 53.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.0 mp -82.63 143.32 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.514 -0.741 . . . . 0.0 109.667 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -93.41 132.04 38.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.28 -0.888 . . . . 0.0 109.755 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -69.26 139.11 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 110.746 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -11.97 59.56 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -96.06 158.51 15.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -1.109 . . . . 0.0 110.585 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.489 0.661 . . . . 0.0 109.836 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.11 148.78 38.9 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.936 0.874 . . . . 0.0 109.879 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.499 HD21 ' NE ' ' A' ' 70' ' ' ARG . 27.2 tp -107.16 131.41 54.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.9 mt -116.27 111.29 19.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.499 ' NE ' HD21 ' A' ' 68' ' ' LEU . 99.1 mtt180 -115.65 153.04 32.0 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.737 0.779 . . . . 0.0 110.556 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 5.2 p 50.46 56.58 7.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.867 -0.52 . . . . 0.0 110.67 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 167.26 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.98 152.72 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.6 0.714 . . . . 0.0 109.402 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.11 131.44 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.65 -0.656 . . . . 0.0 109.734 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.25 148.56 17.21 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -97.5 107.59 20.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.279 -1.13 . . . . 0.0 108.927 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ARG . 87.1 t80 -107.13 109.22 21.0 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.371 -0.83 . . . . 0.0 109.273 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.483 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 26.6 t-20 38.92 -116.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.483 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 99.4 m-20 -92.81 -20.13 21.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 77' ' ' TYR . 3.6 mpt_? -96.12 162.22 13.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.84 153.89 25.94 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -149.77 161.87 41.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.167 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.17 128.14 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -106.87 124.35 49.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.484 -0.76 . . . . 0.0 109.356 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.7 t -98.4 133.51 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -123.27 -169.09 1.87 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 0.0 109.655 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.45 -38.81 88.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.761 -0.587 . . . . 0.0 109.924 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.55 -12.17 56.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.983 . . . . 0.0 109.902 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 t -87.75 166.66 14.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.4 m -134.82 156.03 49.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.29 -0.881 . . . . 0.0 108.829 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -139.12 130.88 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.094 -1.004 . . . . 0.0 108.981 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -127.22 127.91 45.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.28 -0.888 . . . . 0.0 108.917 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.58 141.92 44.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.27 142.2 37.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.402 ' OG ' ' OE2' ' A' ' 96' ' ' GLU . 94.5 p -88.2 3.18 50.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.616 -0.677 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 96' ' ' GLU . 27.6 mp0 -105.99 133.72 20.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.291 -0.881 . . . . 0.0 109.687 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.51 148.29 37.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.089 1.86 . . . . 0.0 112.157 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.53 134.11 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.9 mp0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.095 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 N--CA 1.494 1.538 0 CA-C-O 121.335 0.473 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.61 115.51 17.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.14 131.32 36.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.849 . . . . 0.0 109.438 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.3 m -124.68 141.06 52.37 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.88 151.75 19.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.3 mt -56.38 -45.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.229 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.7 -17.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.625 -0.672 . . . . 0.0 109.436 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -92.8 2.41 56.77 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -86.21 121.23 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.045 -1.034 . . . . 0.0 109.861 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -147.9 6.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -137.56 135.42 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 76' ' ' GLU . 56.1 p30 -93.32 158.75 15.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.9 20.71 79.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.46 147.62 25.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -1.123 . . . . 0.0 110.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -97.49 126.91 43.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.94 -178.23 6.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.682 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -117.91 145.62 44.52 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.4 tp -134.24 127.86 32.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -114.88 130.21 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.11 170.78 11.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.122 0.963 . . . . 0.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -100.1 155.34 17.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.751 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.45 113.19 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.51 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -147.56 130.5 16.23 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.036 -1.04 . . . . 0.0 109.781 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.929 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.4 pt? -129.68 156.81 43.65 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.293 0.568 . . . . 0.0 109.812 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -144.5 110.5 5.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.575 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.423 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.5 0.667 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -82.52 -62.77 1.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.621 -0.674 . . . . 0.0 109.995 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -152.32 149.19 28.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.968 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.61 154.13 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.14 -159.63 22.68 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 tp -125.27 145.2 50.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.907 -0.76 . . . . 0.0 109.448 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.547 HD21 ' CE1' ' A' ' 50' ' ' PHE . 67.0 mt -108.48 128.68 55.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.514 -0.741 . . . . 0.0 109.201 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 97.83 2.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -103.32 164.31 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.97 . . . . 0.0 109.621 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.09 -20.22 62.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.602 -0.686 . . . . 0.0 110.104 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 p -90.12 -12.65 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.359 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.58 -148.97 20.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.425 ' N ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -132.02 159.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.672 -0.899 . . . . 0.0 109.666 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.42 141.69 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -88.36 144.68 26.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.547 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.5 p90 -141.27 158.63 43.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.73 -1.231 . . . . 0.0 108.49 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -135.03 137.57 43.09 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.514 0.674 . . . . 0.0 109.726 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.6 mt -106.33 129.68 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -86.39 142.94 28.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.376 -0.827 . . . . 0.0 110.378 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -61.93 -32.08 72.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.643 -0.66 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.5 -12.77 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.517 -0.739 . . . . 0.0 109.619 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.23 24.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.948 . . . . 0.0 108.939 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 49.13 52.91 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.815 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 mt -102.37 153.66 37.95 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.1 149.0 45.94 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 122.082 1.855 . . . . 0.0 112.72 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.54 140.89 51.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.264 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.5 mp -82.97 145.04 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.709 -0.619 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 96.1 mt-10 -101.17 139.2 37.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.425 ' OE1' HD22 ' A' ' 27' ' ' LEU . 59.2 tt0 -76.58 138.27 40.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.644 -0.66 . . . . 0.0 110.726 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.02 -18.65 56.94 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 97.8 mt-10 -97.0 159.95 14.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.681 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -89.55 148.59 23.3 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.416 0.627 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.43 143.94 34.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.713 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 tp -109.45 130.44 55.5 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -113.33 122.17 46.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.502 -0.749 . . . . 0.0 109.831 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -120.19 147.1 45.35 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.675 0.75 . . . . 0.0 110.426 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t 57.11 56.86 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.097 0.475 . . . . 0.0 110.751 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.56 166.03 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.81 143.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.602 0.715 . . . . 0.0 109.666 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.83 132.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.65 -0.656 . . . . 0.0 109.655 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.29 153.1 17.77 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.412 ' HB2' HD22 ' A' ' 14' ' ' ASN . 78.4 tt0 -95.71 110.44 22.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -1.147 . . . . 0.0 109.139 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 80' ' ' ARG . 75.4 t80 -103.84 109.73 21.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.145 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 43.75 -119.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.773 . . . . 0.0 110.438 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -94.01 -17.08 23.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.11 -0.994 . . . . 0.0 110.254 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 77' ' ' TYR . 78.4 ttt180 -102.56 144.13 31.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.38 153.27 37.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 0.0 108.955 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -143.82 152.05 40.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.991 -1.068 . . . . 0.0 109.011 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.89 122.27 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.86 128.67 53.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.448 -0.783 . . . . 0.0 109.414 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.11 133.11 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -136.94 -166.32 1.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 89' ' ' SER . 10.0 mtpm? -55.43 167.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.873 -0.517 . . . . 0.0 109.763 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 73.07 -23.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.413 -0.804 . . . . 0.0 109.614 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 87' ' ' LYS . 48.9 m -72.35 159.18 34.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.752 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.9 m -135.04 155.12 51.3 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.336 -0.852 . . . . 0.0 108.871 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -139.26 131.19 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.1 -1.0 . . . . 0.0 109.06 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -131.58 136.91 48.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 0.0 108.917 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -72.45 140.53 48.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.32 132.14 44.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.404 -0.81 . . . . 0.0 109.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -83.1 -4.77 58.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.661 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -115.53 93.66 37.42 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.78 . . . . 0.0 109.441 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.94 156.78 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.525 2.15 . . . . 0.0 112.208 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.7 147.85 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.07 -179.699 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.494 1.524 0 CA-C-O 121.412 0.505 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.42 113.79 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.517 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.32 132.18 36.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.1 m -124.46 143.49 50.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.63 -0.668 . . . . 0.0 109.27 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -94.1 148.08 22.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.7 mt -57.24 -44.74 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 109.399 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.36 -12.31 13.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.565 -0.71 . . . . 0.0 109.385 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 53.7 t0 -97.31 4.89 50.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.2 mt -88.0 121.57 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.99 6.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.208 -0.933 . . . . 0.0 109.417 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -133.49 128.99 36.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -87.81 153.61 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.148 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.88 17.01 78.04 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -96.44 150.12 20.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.425 -1.044 . . . . 0.0 110.045 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -102.33 131.26 49.05 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.4 0.619 . . . . 0.0 109.481 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.63 179.24 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.578 ' C ' HD22 ' A' ' 20' ' ' LEU . 5.0 m-80 -117.15 131.12 56.95 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.578 HD22 ' C ' ' A' ' 19' ' ' ASN . 4.4 mm? -117.18 146.26 43.33 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.898 0.856 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -136.08 131.47 34.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.54 -173.82 0.78 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.039 0.923 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' CE ' ' H ' ' A' ' 98' ' ' ILE . 34.2 ttmt -111.85 150.98 29.62 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.943 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.4 t -86.39 95.02 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.21 -26.7 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.77 . . . . 0.0 109.811 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -143.17 119.25 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.954 -1.091 . . . . 0.0 109.379 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.411 HD11 ' NE2' ' A' ' 37' ' ' GLN . 61.4 tp -109.3 143.63 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 0.0 109.18 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -140.26 107.28 5.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.61 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.677 0.751 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -97.63 -50.06 4.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' NE2' HD11 ' A' ' 27' ' ' LEU . 48.2 tt0 -149.87 146.84 27.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 110.129 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.39 153.01 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.38 -161.58 23.87 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.275 -1.441 . . . . 0.0 109.925 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.76 146.53 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.021 -0.693 . . . . 0.0 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD21 ' CE1' ' A' ' 50' ' ' PHE . 70.3 mt -112.3 127.08 55.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.53 -0.731 . . . . 0.0 109.431 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.35 100.93 2.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -101.25 162.39 12.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.359 -1.083 . . . . 0.0 109.358 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -72.26 -21.93 61.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.601 -0.687 . . . . 0.0 109.893 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.9 p -93.92 -16.12 24.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.208 -0.933 . . . . 0.0 109.136 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.21 -156.98 29.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.014 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 47' ' ' ILE . 15.2 pt -137.98 163.18 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.531 -0.981 . . . . 0.0 109.93 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.2 tt -162.5 152.12 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.196 -0.94 . . . . 0.0 109.716 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -97.12 138.84 34.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.4 p90 -131.49 156.16 46.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.058 -1.026 . . . . 0.0 108.933 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.8 m -131.59 132.28 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.472 0.653 . . . . 0.0 109.64 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.3 mt -98.47 128.23 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 109.699 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -85.0 143.73 28.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -0.792 . . . . 0.0 110.432 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.56 -35.36 74.09 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -58.97 -9.54 1.94 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.575 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.22 -28.13 24.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 108.889 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 45.9 49.99 11.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.639 . . . . 0.0 109.865 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.0 mt -102.78 153.22 38.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.614 -0.679 . . . . 0.0 109.739 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.78 149.91 47.89 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.357 2.038 . . . . 0.0 112.642 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.91 140.4 53.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.469 -0.77 . . . . 0.0 110.335 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -81.57 145.42 30.66 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.423 0.63 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 97.0 mt-10 -94.24 128.78 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 58.3 tt0 -68.5 135.45 51.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.592 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.1 71.59 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.0 mp0 -99.4 162.38 13.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -1.123 . . . . 0.0 110.687 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -98.04 137.13 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -133.75 153.38 51.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.133 0.968 . . . . 0.0 110.08 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 tp -111.74 131.32 55.39 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.9 mt -111.9 120.86 43.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.471 -0.768 . . . . 0.0 109.533 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' O ' ' OG ' ' A' ' 71' ' ' SER . 83.0 mtp180 -117.75 151.37 37.43 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.578 0.704 . . . . 0.0 110.647 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.2 p 51.71 56.2 8.21 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.52 166.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.55 150.03 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.686 0.755 . . . . 0.0 109.888 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.45 132.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.674 . . . . 0.0 109.442 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.75 150.2 16.85 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -88.02 99.7 12.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ARG . 76.2 t80 -98.1 100.71 12.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.251 -0.906 . . . . 0.0 109.225 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 44.7 -119.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 110.7 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 34.6 p-10 -93.65 -7.58 43.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -110.57 155.27 22.56 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.89 0.852 . . . . 0.0 110.184 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -95.95 153.45 17.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 108.848 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -144.11 159.43 42.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.41 126.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -103.13 126.75 50.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.432 -0.792 . . . . 0.0 109.148 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.03 132.24 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -127.01 -168.45 1.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.692 0.758 . . . . 0.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -65.2 -41.76 94.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.762 -0.587 . . . . 0.0 110.18 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -12.2 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.413 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 37.8 t -83.86 164.03 19.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.8 m -136.5 157.59 46.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.327 -0.858 . . . . 0.0 109.044 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 61' ' ' LEU . 96.3 mt -134.96 128.24 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.267 -0.896 . . . . 0.0 109.226 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -129.76 133.12 46.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.467 ' C ' HD22 ' A' ' 94' ' ' LEU . 66.0 tttm -80.1 134.86 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' GLU . 4.0 mm? -107.64 -1.7 20.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.464 -0.772 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 14.3 t 47.28 15.77 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.269 -0.894 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 94' ' ' LEU . 6.9 tp10 -114.83 93.28 33.31 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 108.936 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.8 147.39 41.3 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.683 2.255 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.414 ' H ' ' CE ' ' A' ' 23' ' ' LYS . 29.8 mm -105.74 139.96 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.573 -0.704 . . . . 0.0 109.17 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.495 -179.555 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 CA-C-O 121.272 0.447 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.56 117.96 22.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -87.77 128.67 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.442 ' O ' HD23 ' A' ' 20' ' ' LEU . 84.9 m -124.94 145.64 49.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -97.49 142.71 28.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 pt -52.94 -39.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 0.0 109.733 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.56 -12.19 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.504 -0.748 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -97.17 5.18 50.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.95 123.77 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.159 -0.963 . . . . 0.0 109.951 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.41 8.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -137.45 134.42 35.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 109.243 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.568 ' ND2' ' OE1' ' A' ' 76' ' ' GLU . 45.8 m-80 -92.61 153.74 18.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.369 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.19 71.75 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -95.83 146.86 24.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.66 132.47 52.61 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.352 0.596 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -175.16 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 0.0 109.848 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 27.3 t30 -119.48 140.53 50.31 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 6' ' ' THR . 14.8 mt -133.62 149.03 51.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.383 -0.823 . . . . 0.0 110.165 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -133.07 127.34 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.93 177.5 10.31 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.098 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -109.16 153.15 24.15 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.919 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.0 99.61 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.286 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.51 -26.09 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -158.36 147.43 19.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.361 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.3 pt? -133.54 158.78 42.27 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.51 -0.744 . . . . 0.0 109.628 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -142.41 109.32 5.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.231 -179.599 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.513 0.673 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 t -86.25 -57.43 3.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.991 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -151.41 154.95 37.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.187 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.35 139.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.69 -156.02 10.12 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.327 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.06 152.2 51.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.832 -0.805 . . . . 0.0 109.688 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.75 131.64 54.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.33 99.15 2.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -100.34 160.78 14.06 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.452 -1.028 . . . . 0.0 109.46 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.98 -16.63 63.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 109.85 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -96.63 -11.72 24.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.213 -0.929 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.17 17.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.676 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.6 pp -132.82 162.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.964 . . . . 0.0 109.635 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.444 HD11 ' O ' ' A' ' 81' ' ' PHE . 7.2 tp -156.67 148.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.497 ' HZ1' ' NH1' ' A' ' 80' ' ' ARG . 63.1 mttp -81.53 164.13 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.603 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -157.01 148.07 21.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.64 -1.288 . . . . 0.0 108.543 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -136.42 131.88 34.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.216 -0.927 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.07 130.11 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.664 -0.648 . . . . 0.0 109.578 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -86.85 141.44 28.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 56' ' ' ALA . 12.6 mmtm -56.59 -35.3 68.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.54 -0.725 . . . . 0.0 109.068 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -59.4 -4.6 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.484 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -87.35 -31.08 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 108.909 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 51.22 50.62 18.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 110.089 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.82 152.38 42.29 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.765 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.2 148.34 41.02 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.173 1.915 . . . . 0.0 112.784 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -68.32 144.65 54.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.479 -0.763 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -80.16 145.21 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -102.35 133.91 46.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.368 -0.833 . . . . 0.0 109.48 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -73.71 138.42 44.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.477 -0.764 . . . . 0.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.29 -8.15 79.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -106.04 157.32 17.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.417 -1.049 . . . . 0.0 110.493 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -89.1 147.4 24.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.861 -0.525 . . . . 0.0 109.619 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -140.52 145.75 37.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.819 0.819 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -111.69 131.25 55.42 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 2.8 mp -117.75 115.85 25.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.516 -0.74 . . . . 0.0 109.51 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -109.59 149.12 30.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.52 -0.737 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.68 59.43 3.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.789 -0.569 . . . . 0.0 110.61 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.79 162.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.27 147.96 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.512 0.673 . . . . 0.0 109.473 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.36 127.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.22 156.79 15.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.568 ' OE1' ' ND2' ' A' ' 14' ' ' ASN . 49.6 tp10 -105.6 134.35 48.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -1.006 . . . . 0.0 108.816 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 79' ' ' ASP . 87.9 t80 -129.37 117.93 21.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.744 . . . . 0.0 109.077 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' TYR . 95.0 m-20 39.65 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.707 -0.62 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 77' ' ' TYR . 37.3 p-10 -125.08 -17.61 5.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.309 -0.869 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.497 ' NH1' ' HZ1' ' A' ' 49' ' ' LYS . 96.8 mtt180 -93.25 155.43 17.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.969 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.508 ' CE2' ' OE1' ' A' ' 76' ' ' GLU . 96.0 m-85 -101.81 149.09 24.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 0.0 108.945 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -152.35 161.16 43.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -104.46 127.75 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.29 127.01 46.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.798 . . . . 0.0 109.596 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.59 133.15 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 109.07 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.433 ' N ' ' OG ' ' A' ' 89' ' ' SER . 78.8 m-20 -132.5 -166.16 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -62.36 -40.91 97.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -62.27 -32.31 73.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 86' ' ' ASN . 24.2 p -79.54 164.72 23.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.4 t -139.54 166.92 23.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.468 -0.77 . . . . 0.0 109.111 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -139.59 131.58 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.189 -0.944 . . . . 0.0 109.175 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -128.81 132.43 47.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.299 -0.876 . . . . 0.0 109.147 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.64 139.98 40.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.296 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -101.26 141.57 33.95 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.971 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -84.43 -1.75 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.556 -0.715 . . . . 0.0 109.681 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.04 131.4 23.19 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.433 -0.792 . . . . 0.0 109.692 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.43 152.91 49.81 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.998 1.799 . . . . 0.0 112.439 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.49 134.44 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.54 -0.725 . . . . 0.0 109.14 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.303 -0.873 . . . . 0.0 109.837 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.41 0.504 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -76.72 118.5 19.41 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.303 -0.873 . . . . 0.0 109.35 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.8 mt -93.23 128.29 39.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -127.86 150.5 49.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -97.61 146.99 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.153 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.42 -42.3 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.795 . . . . 0.0 108.956 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.41 -8.97 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.558 -0.714 . . . . 0.0 109.407 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 57.9 t0 -100.18 4.46 44.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.904 . . . . 0.0 109.176 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.56 118.95 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.55 6.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 14' ' ' ASN . 8.0 tm-20 -131.09 129.34 41.76 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.407 -0.808 . . . . 0.0 109.137 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p30 -88.04 150.63 23.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.284 -0.885 . . . . 0.0 110.289 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.85 16.33 79.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -93.07 144.46 25.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.364 -1.08 . . . . 0.0 109.938 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.82 129.69 45.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.695 . . . . 0.0 109.565 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.71 -179.42 7.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.384 -0.822 . . . . 0.0 109.876 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 71' ' ' SER . 77.2 m-20 -140.09 145.48 37.69 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.453 -0.779 . . . . 0.0 109.157 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.96 158.57 30.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -100.57 139.69 35.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.044 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 41' ' ' LEU . . . -153.26 157.51 40.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -103.06 153.89 19.81 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.1 110.45 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.132 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 pt -91.5 -21.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 110.143 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -162.76 153.03 16.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.08 -1.013 . . . . 0.0 109.422 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.5 mt -132.06 157.11 45.0 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.572 0.701 . . . . 0.0 109.909 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' VAL . 46.1 m95 -144.55 118.94 9.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.218 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 0.0 109.571 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.799 0.809 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -81.69 -65.1 1.05 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.547 0.689 . . . . 0.0 109.914 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -149.55 153.24 36.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.011 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 28' ' ' TRP . 3.0 t -137.91 163.75 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.55 33.55 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.1 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -126.96 146.81 50.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.973 -0.722 . . . . 0.0 109.123 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 58.1 mt -109.92 129.41 55.66 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.79 101.74 2.8 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -107.01 165.0 11.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.597 -0.943 . . . . 0.0 109.458 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.96 -18.78 62.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.52 -0.738 . . . . 0.0 109.847 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 p -91.66 -11.56 36.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 109.391 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.25 -146.61 15.89 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.56 151.1 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.691 -0.888 . . . . 0.0 109.636 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tp -146.48 138.06 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.765 . . . . 0.0 109.655 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -83.28 152.52 25.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.382 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.11 154.67 41.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.574 -1.329 . . . . 0.0 107.864 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -132.19 131.06 41.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.637 -0.664 . . . . 0.0 109.743 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.71 128.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -89.41 144.02 26.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -58.22 -34.36 70.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.84 -5.7 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -89.07 -33.41 17.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 108.719 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 49.81 50.25 18.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.597 -0.689 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD13 ' HB1' ' A' ' 56' ' ' ALA . 5.8 mp -102.85 163.11 18.2 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.551 -0.718 . . . . 0.0 109.671 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.79 150.09 84.73 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.577 2.185 . . . . 0.0 112.325 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.5 mt -72.35 142.82 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 110.308 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -84.35 149.52 25.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.668 . . . . 0.0 109.723 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 62' ' ' GLU . 57.0 mp0 -110.14 142.39 41.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.964 0.888 . . . . 0.0 109.593 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -74.56 137.58 42.49 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.541 0.686 . . . . 0.0 110.794 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.49 -14.91 64.4 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.06 155.01 16.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 0.0 110.832 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.468 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 5.7 p -93.39 158.79 15.55 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.489 ' HE2' ' HZ3' ' A' ' 93' ' ' LYS . 90.1 m-85 -149.8 149.28 30.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -103.66 131.73 50.56 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 68' ' ' LEU . 77.0 mt -105.43 107.5 18.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -110.15 139.39 45.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.463 0.649 . . . . 0.0 110.252 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 25.2 t 55.25 59.11 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.88 -0.512 . . . . 0.0 110.908 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.42 165.57 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.34 -0.85 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.78 153.99 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.623 0.725 . . . . 0.0 109.759 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.03 131.28 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 0.0 109.709 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.47 148.13 17.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.29 100.19 12.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -1.166 . . . . 0.0 109.229 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' ARG . 73.5 t80 -101.49 105.2 16.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 t30 40.57 -117.13 0.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.527 -0.733 . . . . 0.0 110.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.63 -18.35 23.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -99.29 162.78 12.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 110.056 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.48 153.0 24.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -146.23 163.13 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 0.0 109.124 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.62 125.89 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -106.08 126.19 51.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.381 -0.824 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -97.17 135.2 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -130.95 -169.41 2.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.479 -0.763 . . . . 0.0 109.747 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.53 -39.45 94.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.649 -0.657 . . . . 0.0 110.224 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -68.0 -19.63 64.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.794 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.57 166.24 17.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -0.843 . . . . 0.0 110.019 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -145.08 164.29 31.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -0.92 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mt -149.4 139.72 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -133.61 143.24 48.5 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.468 -0.77 . . . . 0.0 109.583 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 68.1 mttm -72.81 140.68 47.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.766 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt -111.64 147.72 34.89 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.634 0.73 . . . . 0.0 109.996 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -95.75 6.07 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.0 109.783 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.56 92.08 43.09 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.427 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.09 160.46 8.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.821 2.348 . . . . 0.0 112.117 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.81 139.2 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.552 -0.717 . . . . 0.0 109.55 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 . . . . . 0 C--N 1.303 -1.456 0 O-C-N 121.405 -0.809 . . . . 0.0 109.641 -179.488 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.64 152.6 78.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.585 -0.697 . . . . 0.0 109.935 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.59 163.04 38.44 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.577 2.185 . . . . 0.0 112.143 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -80.32 119.99 23.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -90.91 131.64 36.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 141.95 51.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.84 150.64 20.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 110.106 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mm -55.0 -45.45 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.64 0.733 . . . . 0.0 109.371 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.98 -11.72 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -97.4 3.91 50.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 109.653 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLU . 77.8 mt -59.87 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.306 -0.871 . . . . 0.0 110.483 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' ILE . 11.8 m 31.26 31.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.397 0.617 . . . . 0.0 110.735 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.3 tt0 -166.13 112.78 0.88 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.321 -0.862 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 54.1 p30 -86.91 154.45 20.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 23.98 76.3 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -97.48 140.2 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -1.031 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.91 128.62 44.05 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.44 -170.71 2.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -130.68 135.16 47.56 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.76 148.12 43.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -116.57 132.5 56.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.85 165.68 29.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.045 0.926 . . . . 0.0 110.925 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -105.6 155.69 18.97 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.909 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -88.36 99.78 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.234 -0.916 . . . . 0.0 110.467 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.518 HD11 ' CA ' ' A' ' 42' ' ' GLY . 54.5 mt -69.73 -28.71 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.077 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.27 140.52 18.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 109.24 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.954 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.6 pt? -120.93 150.09 41.62 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.34 0.591 . . . . 0.0 109.926 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -141.03 112.25 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.374 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -71.25 120.73 17.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 109.433 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 23.3 t-20 -91.04 139.16 31.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 109.116 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -101.47 -8.57 21.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 109.066 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' ND1' ' N ' ' A' ' 32' ' ' HIS . 1.6 m80 -79.39 145.63 33.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -69.92 -34.5 73.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.679 . . . . 0.0 110.187 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.8 m -61.03 -46.23 91.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.129 -0.982 . . . . 0.0 109.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.3 mt -108.49 135.5 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.571 0.701 . . . . 0.0 109.566 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 t -96.85 -49.44 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.592 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.42 149.42 28.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.02 142.41 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.693 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -163.17 -161.52 12.61 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.92 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.693 HD12 ' C ' ' A' ' 39' ' ' GLY . 9.5 mp -120.2 146.16 46.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.943 -0.739 . . . . 0.0 109.42 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.3 mt -108.77 124.41 50.55 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.518 ' CA ' HD11 ' A' ' 25' ' ' ILE . . . -95.26 96.75 2.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.8 t0 -100.48 160.85 14.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -1.159 . . . . 0.0 109.387 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 84.3 tt0 -70.36 -20.5 62.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.693 -0.63 . . . . 0.0 109.858 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.4 p -92.15 -12.12 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.16 -153.28 24.46 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.99 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 pt -136.48 159.86 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.547 -0.973 . . . . 0.0 109.918 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -159.2 146.34 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.842 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -90.31 134.9 34.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -129.5 157.27 42.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 108.649 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.2 m -132.89 132.52 42.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.47 127.91 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -85.3 145.54 27.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 110.547 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.54 -36.64 78.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -59.63 -8.89 2.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.474 -0.766 . . . . 0.0 109.899 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 -26.47 24.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 109.044 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.59 51.32 15.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.697 -0.627 . . . . 0.0 109.878 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.0 mt -105.28 148.76 36.8 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.37 161.96 42.61 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.618 2.212 . . . . 0.0 112.637 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.01 141.0 47.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.665 0.745 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.2 mp -84.31 156.67 21.81 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.442 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 42.7 tt0 -99.87 129.59 45.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.388 -0.82 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.448 ' OE1' HD22 ' A' ' 27' ' ' LEU . 58.9 tt0 -65.79 137.63 57.37 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.456 0.646 . . . . 0.0 110.487 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.93 -10.68 64.63 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -94.79 151.68 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -1.135 . . . . 0.0 110.31 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -84.99 140.44 31.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.442 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 33.1 m-85 -133.7 142.87 48.19 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.754 0.787 . . . . 0.0 109.773 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.09 127.79 54.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.64 118.46 35.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -114.18 145.55 41.54 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.408 0.623 . . . . 0.0 110.403 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t 58.17 58.15 3.65 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.726 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.05 165.98 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.343 -0.848 . . . . 0.0 109.273 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.27 149.81 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.729 0.776 . . . . 0.0 110.012 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.02 133.89 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.754 -0.591 . . . . 0.0 109.629 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.28 148.73 16.78 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -94.63 104.64 16.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -1.146 . . . . 0.0 109.148 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 80' ' ' ARG . 84.3 t80 -99.85 106.4 18.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.789 . . . . 0.0 109.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.2 t30 42.19 -116.64 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.549 -0.72 . . . . 0.0 110.757 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.41 -17.12 23.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.085 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 mmm-85 -100.94 156.43 17.39 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.874 0.845 . . . . 0.0 110.373 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -97.79 150.83 20.83 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -145.68 155.5 43.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 109.17 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.85 125.19 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.372 -0.83 . . . . 0.0 108.956 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -106.38 129.25 54.41 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.741 . . . . 0.0 109.279 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.89 131.22 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -136.55 -163.08 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.804 0.812 . . . . 0.0 109.821 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 89' ' ' SER . 33.9 mmtt -57.35 166.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.792 -0.567 . . . . 0.0 109.472 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 12.8 t-20 72.81 -21.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.708 -0.62 . . . . 0.0 109.547 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 87' ' ' LYS . 87.1 p -74.61 159.29 32.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.3 m -136.86 156.22 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.399 -0.813 . . . . 0.0 109.131 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.62 130.66 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -132.16 138.05 47.88 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 0.0 109.355 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' C ' HD22 ' A' ' 94' ' ' LEU . 50.7 mtmt -81.81 138.98 35.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.592 -0.692 . . . . 0.0 109.762 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.1 mm? -110.71 137.73 48.01 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.922 0.868 . . . . 0.0 110.147 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -86.58 8.34 22.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -117.04 91.77 37.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.329 -0.857 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -55.34 152.32 32.62 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.887 2.391 . . . . 0.0 112.136 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.6 mt -101.14 147.79 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.26 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 57.0 mp0 -46.85 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.855 . . . . 0.0 110.201 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 t 53.68 9.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 108.775 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' N ' ' C ' ' A' ' 99' ' ' GLU . . . -154.98 86.34 0.13 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -153.36 111.7 3.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -1.118 . . . . 0.0 109.104 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -164.78 -22.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.171 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -145.8 151.19 37.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -162.19 84.68 0.58 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 108.846 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -90.71 124.25 34.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 53.7 t-80 45.41 -109.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.906 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 80.0 m80 -142.74 143.6 32.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -0.834 . . . . 0.0 109.586 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.668 -179.896 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.501 0.667 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.73 152.39 91.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.569 -0.707 . . . . 0.0 109.875 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.408 ' HB2' HD22 ' A' ' 19' ' ' ASN . 43.6 Cg_endo -67.64 148.76 78.65 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.584 2.189 . . . . 0.0 112.196 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.12 119.87 23.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.914 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -90.39 128.88 36.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.782 . . . . 0.0 109.753 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -128.44 145.01 51.22 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.19 143.0 28.42 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.71 0.767 . . . . 0.0 110.494 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.4 HD13 ' CG2' ' A' ' 48' ' ' ILE . 83.1 mt -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.41 -0.806 . . . . 0.0 109.322 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.41 -10.79 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.448 -0.783 . . . . 0.0 109.918 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -97.51 6.28 48.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 13' ' ' GLU . 44.8 mt -59.85 -70.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.3 m 40.5 17.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.741 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.639 ' H ' HG22 ' A' ' 11' ' ' ILE . 6.5 pt-20 -171.92 130.77 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.808 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.83 167.38 12.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.021 -1.049 . . . . 0.0 110.58 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.17 23.54 77.39 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.1 136.67 35.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -1.03 . . . . 0.0 110.17 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -97.33 127.44 43.3 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -162.71 -169.73 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 43.4 m-20 -140.59 137.86 33.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.568 -0.707 . . . . 0.0 109.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.67 147.45 25.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 110.391 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -101.14 140.92 34.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.53 0.681 . . . . 0.0 109.397 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 161.62 42.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.292 -0.88 . . . . 0.0 110.77 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.02 148.93 25.65 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.355 0.598 . . . . 0.0 109.645 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -87.48 94.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.278 -0.889 . . . . 0.0 110.52 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.511 HD11 ' CA ' ' A' ' 42' ' ' GLY . 52.8 mt -70.61 -31.26 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.499 -0.751 . . . . 0.0 109.324 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -148.07 129.3 14.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.064 -1.022 . . . . 0.0 109.604 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.7 tp -110.89 146.5 36.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -142.57 111.35 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.54 0.686 . . . . 0.0 109.795 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.31 124.11 23.34 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.666 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -103.99 149.63 24.97 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.6 m -139.84 54.8 1.66 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 32' ' ' HIS . 65.5 t-80 -104.44 10.91 35.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.167 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 66.34 -35.82 0.24 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.092 0.472 . . . . 0.0 110.074 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 32' ' ' HIS . 63.7 m -86.36 -40.57 15.3 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.154 -0.967 . . . . 0.0 108.833 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt -105.37 138.49 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.674 0.749 . . . . 0.0 109.593 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -83.53 -56.79 3.54 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.666 0.746 . . . . 0.0 109.963 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -159.11 162.22 36.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.107 -0.996 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.09 159.61 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.18 -157.95 20.58 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -125.76 149.82 48.24 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.973 -0.722 . . . . 0.0 109.976 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.636 HD21 ' CD1' ' A' ' 50' ' ' PHE . 31.5 mt -109.91 124.81 52.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' HD11 ' A' ' 25' ' ' ILE . . . -92.17 94.35 1.9 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.58 159.99 14.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -1.011 . . . . 0.0 109.597 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.13 -17.54 63.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.819 -0.551 . . . . 0.0 109.839 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 p -92.43 -9.66 40.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.25 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.64 -148.29 19.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -138.16 160.56 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.696 -0.885 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.4 ' CG2' HD13 ' A' ' 8' ' ' ILE . 20.0 tt -162.57 158.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.927 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -84.8 164.58 18.39 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.558 -0.714 . . . . 0.0 110.275 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.636 ' CD1' HD21 ' A' ' 41' ' ' LEU . 24.8 p90 -156.06 153.65 29.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.069 -1.019 . . . . 0.0 108.549 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.5 m -136.36 129.57 31.51 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.3 mt -106.52 130.12 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -90.26 142.92 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 110.431 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.42 -35.04 76.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.687 -0.633 . . . . 0.0 109.456 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -58.89 -7.8 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.473 -0.767 . . . . 0.0 109.825 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.52 -23.59 34.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.869 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 51.16 44.26 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 109.887 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.57 151.6 39.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.796 -0.565 . . . . 0.0 109.716 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.54 146.89 50.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.479 2.119 . . . . 0.0 112.804 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.07 141.61 56.09 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.658 0.742 . . . . 0.0 110.491 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -81.1 139.85 35.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.0 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.32 134.08 37.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.466 -0.771 . . . . 0.0 110.17 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.78 136.57 48.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.402 0.62 . . . . 0.0 110.532 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -6.36 83.5 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.59 159.87 15.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -1.001 . . . . 0.0 110.543 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -95.7 148.93 22.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -141.23 150.07 42.18 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.005 0.907 . . . . 0.0 109.964 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.525 HD21 ' HE ' ' A' ' 70' ' ' ARG . 37.0 tp -101.01 132.1 46.57 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 mt -112.72 112.4 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.928 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.525 ' HE ' HD21 ' A' ' 68' ' ' LEU . 94.0 mtt180 -118.64 145.46 45.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 54.91 6.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.04 165.94 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 0.0 109.304 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.859 0.838 . . . . 0.0 109.925 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -92.61 131.71 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.579 -0.7 . . . . 0.0 109.855 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.64 150.5 16.81 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.77 104.85 16.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.6 -0.941 . . . . 0.0 109.364 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 80' ' ' ARG . 42.0 t80 -97.06 104.22 16.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 109.239 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' TYR . 98.7 m-20 39.67 -111.87 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -95.13 -20.19 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.419 -0.801 . . . . 0.0 109.898 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.1 mtt180 -98.85 159.29 15.06 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.905 0.86 . . . . 0.0 110.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.3 149.97 20.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.752 . . . . 0.0 109.14 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.418 ' NE2' ' CD2' ' A' ' 77' ' ' TYR . 6.9 tt0 -144.03 150.96 39.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.89 124.47 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -107.43 126.36 52.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.446 -0.783 . . . . 0.0 109.567 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.22 132.82 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 87' ' ' LYS . 13.5 p30 -146.06 -176.57 5.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.768 0.794 . . . . 0.0 110.014 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' SER . 80.5 tttt -42.84 166.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 1.8 t-20 73.5 -30.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.65 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 87' ' ' LYS . 81.6 p -76.95 164.3 25.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 109.964 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 p -139.63 158.31 44.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.427 -0.796 . . . . 0.0 109.417 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.7 mt -141.89 133.73 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.499 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.37 138.71 46.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.612 0.72 . . . . 0.0 109.232 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 95' ' ' SER . 88.2 tttt -73.05 139.47 46.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.592 -0.692 . . . . 0.0 109.594 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 96' ' ' GLU . 89.3 mt -101.01 -13.37 18.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.443 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 35.9 t 51.91 4.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.758 -0.589 . . . . 0.0 109.732 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 94' ' ' LEU . 37.8 tp10 -107.59 127.29 28.07 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.617 -0.677 . . . . 0.0 109.5 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.82 141.08 29.9 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.411 2.074 . . . . 0.0 112.182 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.3 mt -112.09 135.97 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.77 -0.582 . . . . 0.0 109.456 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 101' ' ' GLY . 51.3 tp10 -91.76 118.5 30.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.39 -5.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.438 ' H ' ' HG3' ' A' ' 99' ' ' GLU . . . -79.71 112.5 3.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 102' ' ' LEU . 3.5 tt -95.21 110.69 22.63 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.444 -1.033 . . . . 0.0 109.513 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.512 ' N ' HD23 ' A' ' 102' ' ' LEU . 42.8 tp10 56.39 114.39 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.543 0.687 . . . . 0.0 110.281 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -150.52 153.2 35.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -134.74 32.49 3.27 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.622 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 53.8 t-80 47.88 -106.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.358 -0.839 . . . . 0.0 109.614 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.622 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 86.1 t60 -152.11 -8.97 0.2 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.795 . . . . 0.0 109.383 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -152.53 -44.01 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.317 -0.864 . . . . 0.0 109.273 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.544 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -86.05 152.71 56.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.41 157.63 61.03 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.679 2.253 . . . . 0.0 112.186 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -79.26 116.31 19.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.313 -0.867 . . . . 0.0 109.471 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt -92.33 129.47 38.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.347 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' ' CD2' ' A' ' 20' ' ' LEU . 83.3 m -125.83 144.14 50.77 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.88 146.29 23.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.052 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.07 -42.36 89.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.176 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.55 -8.54 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.632 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -103.37 9.28 37.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -86.32 124.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.168 -0.957 . . . . 0.0 109.944 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -144.13 8.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 109.286 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -143.37 138.75 29.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.277 -0.89 . . . . 0.0 109.141 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 54.0 p30 -97.52 159.37 14.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.448 -0.783 . . . . 0.0 110.353 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.91 9.91 84.74 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.85 155.55 17.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -1.083 . . . . 0.0 109.691 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.2 134.71 50.66 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.462 0.649 . . . . 0.0 109.572 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -160.17 -176.78 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.905 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 7.7 t30 -122.48 142.97 50.01 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -139.12 128.2 23.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.32 -0.862 . . . . 0.0 109.686 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.667 ' N ' HD13 ' A' ' 20' ' ' LEU . 37.1 ttmt -112.45 132.75 54.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.39 -173.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -112.53 154.91 25.2 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.09 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -92.48 113.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -71.67 -26.77 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 0.0 110.035 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.512 ' NE2' ' OE1' ' A' ' 63' ' ' GLN . 1.3 mm-40 -172.45 167.41 5.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.98 -1.075 . . . . 0.0 109.182 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.7 mt -138.29 160.87 38.36 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.428 0.632 . . . . 0.0 110.005 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.406 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 14.6 t90 -134.86 105.63 6.51 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.55 0.69 . . . . 0.0 109.414 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 37' ' ' GLN . 51.4 tp10 -73.66 119.78 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.291 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -95.67 177.89 5.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 109.079 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.2 p -129.6 0.89 4.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -94.98 170.51 9.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.365 -0.835 . . . . 0.0 109.85 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -88.14 -41.64 12.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.38 -0.825 . . . . 0.0 110.007 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 35' ' ' ILE . 15.7 m -75.36 65.58 1.68 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.55 ' CB ' ' O ' ' A' ' 34' ' ' SER . 2.6 mt 145.15 120.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 121.324 0.583 . . . . 0.0 109.655 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 6.0 t -94.5 -58.36 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.034 . . . . 0.0 109.666 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.543 ' NE2' ' OE1' ' A' ' 29' ' ' GLU . 6.7 mm-40 -145.0 149.29 34.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.046 -1.034 . . . . 0.0 109.979 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.47 127.99 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.4 -159.86 9.48 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.46 149.45 52.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.733 -0.863 . . . . 0.0 109.666 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.85 126.79 53.43 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.59 100.55 2.64 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 46' ' ' GLY . 5.5 p-10 -104.96 161.79 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.297 -1.12 . . . . 0.0 109.285 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.87 -17.38 63.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.743 . . . . 0.0 109.928 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.7 p -94.42 -3.88 49.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' OD2' ' A' ' 43' ' ' ASP . . . 146.47 -144.42 12.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.35 166.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.678 -0.895 . . . . 0.0 110.05 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.78 162.66 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.103 -0.998 . . . . 0.0 109.846 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -97.09 149.77 21.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.0 109.729 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.36 157.46 44.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.431 -1.418 . . . . 0.0 107.801 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -130.93 134.27 46.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.582 -0.699 . . . . 0.0 109.685 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 mm -102.64 127.91 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 109.149 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -83.69 137.26 33.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 110.497 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.92 -33.74 75.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -58.77 -11.03 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.596 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.9 -22.43 27.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -0.939 . . . . 0.0 108.988 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.07 55.76 7.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.64 -0.663 . . . . 0.0 109.914 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -106.03 147.94 35.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.594 -0.691 . . . . 0.0 109.832 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.86 159.77 51.35 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.521 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.66 137.98 55.99 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.627 0.727 . . . . 0.0 109.987 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.1 mp -79.61 155.1 28.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.843 -0.536 . . . . 0.0 109.667 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 3.1 tm-20 -100.54 121.85 42.27 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.955 0.883 . . . . 0.0 109.707 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.512 ' OE1' ' NE2' ' A' ' 26' ' ' GLN . 25.6 mt-30 -63.37 138.31 58.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 -10.93 67.76 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.92 158.82 15.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -1.182 . . . . 0.0 110.458 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 p -95.45 124.87 39.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 44.4 m-85 -118.54 150.07 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.971 0.891 . . . . 0.0 109.78 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.535 HD21 ' HE ' ' A' ' 70' ' ' ARG . 28.8 tp -110.84 127.17 55.32 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 45.7 mt -114.36 114.96 26.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.535 ' HE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -109.93 147.27 33.74 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.458 0.647 . . . . 0.0 110.43 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 t 58.26 58.5 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.015 0.436 . . . . 0.0 110.772 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' ALA . 16.4 m -109.2 160.41 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.301 -0.874 . . . . 0.0 108.886 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.77 144.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.618 0.723 . . . . 0.0 109.533 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.8 t -92.19 131.75 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.58 22.12 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.491 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 97.3 mt-10 -96.96 135.04 39.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -1.116 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -135.99 119.72 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.84 . . . . 0.0 109.621 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 51.8 48.12 23.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.7 t0 60.57 20.0 9.86 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.679 -0.638 . . . . 0.0 110.449 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -128.54 155.07 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -74.63 137.57 42.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -148.62 152.07 36.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.052 -1.03 . . . . 0.0 108.977 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.96 124.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.95 126.34 51.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.46 132.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.88 -170.29 1.84 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.68 0.753 . . . . 0.0 109.874 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -66.15 -42.91 88.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.766 -0.584 . . . . 0.0 110.43 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -61.15 -7.7 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -83.32 164.41 20.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -136.07 154.93 50.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.312 -0.867 . . . . 0.0 108.875 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.57 127.6 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -128.39 131.6 48.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 108.957 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 136.06 36.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLU . 9.5 mp -103.86 -3.96 24.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.479 -0.763 . . . . 0.0 109.454 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t 49.41 7.93 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 94' ' ' LEU . 31.7 tt0 -103.62 124.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 109.312 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.17 141.18 25.87 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.054 1.836 . . . . 0.0 112.1 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.43 135.68 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 102' ' ' LEU . 36.5 tt0 -98.57 121.6 40.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.54 48.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.35 -143.62 11.77 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.404 ' O ' ' OE2' ' A' ' 99' ' ' GLU . 69.2 mt -102.48 -65.31 1.0 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -1.139 . . . . 0.0 109.343 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.16 142.11 49.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 110.581 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' A' ' 104' ' ' HIS . 60.3 t-80 -145.83 24.17 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 51.5 91.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 109.505 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.27 137.51 46.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -142.82 144.99 32.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -144.95 139.24 27.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.165 -179.723 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.6 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.492 0.663 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.43 58.55 0.26 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.411 -0.805 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 154.64 63.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.787 2.325 . . . . 0.0 112.047 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -78.56 117.17 19.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.7 mt -92.52 130.47 38.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.309 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.6 m -124.56 144.69 50.0 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -96.77 151.23 19.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.0 mt -58.17 -44.01 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.405 -0.809 . . . . 0.0 109.1 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.1 -14.55 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.781 . . . . 0.0 109.46 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.0 4.7 53.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.194 -0.941 . . . . 0.0 109.364 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.3 mt -87.67 121.45 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.816 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.95 7.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -135.89 135.32 39.6 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 0.0 109.078 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.402 HD22 ' HB2' ' A' ' 76' ' ' GLU . 57.5 p30 -94.0 157.4 16.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 110.278 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.5 19.24 79.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -99.77 150.37 22.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.363 -1.081 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -101.56 131.35 47.78 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.0 179.6 8.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.695 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -120.24 137.21 54.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -127.82 148.45 50.45 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -135.63 134.01 38.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.26 -176.85 1.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -105.71 156.31 18.41 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.47 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -92.53 107.58 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.407 -0.808 . . . . 0.0 110.226 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.2 -27.18 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 109.906 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -171.0 161.64 6.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.564 0.697 . . . . 0.0 110.086 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -143.76 121.02 11.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' ' 37' ' ' GLN . 80.9 mm-40 -82.18 135.94 35.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.675 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -94.49 148.95 21.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 108.784 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.3 p -104.86 -10.73 17.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.248 -0.907 . . . . 0.0 109.139 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -72.3 141.32 48.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.245 -0.909 . . . . 0.0 109.7 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -33.47 75.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.292 -0.88 . . . . 0.0 109.971 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -64.33 -77.44 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.586 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.4 mt -67.29 147.1 12.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.609 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 13.8 t -100.24 -51.13 3.74 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.716 0.769 . . . . 0.0 109.691 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' ' 29' ' ' GLU . 33.2 mt-30 -152.07 154.43 35.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 110.224 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.96 156.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.28 -172.09 34.07 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.233 -1.461 . . . . 0.0 109.853 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.541 HD21 ' NZ ' ' A' ' 49' ' ' LYS . 4.6 mp -119.89 144.55 47.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.756 -0.849 . . . . 0.0 109.396 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 47' ' ' ILE . 68.8 mt -114.55 124.78 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.89 101.63 2.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -106.44 164.66 11.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.983 . . . . 0.0 109.312 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OE2' ' A' ' 44' ' ' GLU . 1.4 mp0 -70.53 -20.24 62.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 110.106 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 p -91.05 -9.62 45.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.952 . . . . 0.0 109.244 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.02 -145.84 14.15 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 41' ' ' LEU . 8.0 mt -139.02 155.14 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -1.024 . . . . 0.0 109.331 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 148.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.88 . . . . 0.0 109.652 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.541 ' NZ ' HD21 ' A' ' 40' ' ' LEU . 68.4 mttm -98.77 138.0 36.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 109.454 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.47 159.54 34.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.145 -0.972 . . . . 0.0 108.58 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.427 ' OG1' HG23 ' A' ' 35' ' ' ILE . 3.8 t -133.66 137.91 45.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.657 . . . . 0.0 109.708 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -104.15 126.96 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.371 0.605 . . . . 0.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -88.03 145.62 25.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 110.361 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -50.43 -29.9 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.601 -0.687 . . . . 0.0 109.35 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -13.39 10.92 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 109.881 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -113.89 44.53 1.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.309 -0.869 . . . . 0.0 109.209 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' ALA . 8.2 pt-20 -35.12 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.716 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.8 mt -109.35 153.5 42.7 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.73 162.26 32.42 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.444 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.86 135.62 54.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.512 -0.743 . . . . 0.0 110.198 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.4 mp -79.49 153.66 29.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 109.839 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -96.79 120.14 36.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.404 -0.81 . . . . 0.0 109.896 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.31 147.92 52.35 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.761 0.791 . . . . 0.0 110.194 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.53 -10.88 48.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -97.64 161.03 13.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 0.0 110.5 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -88.31 146.92 25.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.288 0.566 . . . . 0.0 109.631 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -142.11 145.94 34.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.97 0.89 . . . . 0.0 109.691 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.557 HD21 ' HE ' ' A' ' 70' ' ' ARG . 29.5 tp -111.17 129.76 55.85 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.36 119.81 39.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.588 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.557 ' HE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -119.17 148.03 43.54 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m 56.49 55.75 6.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 120.945 0.402 . . . . 0.0 110.451 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.19 165.8 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.293 -0.879 . . . . 0.0 108.9 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.74 150.38 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.649 0.738 . . . . 0.0 109.444 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.85 137.01 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.788 -0.57 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.77 153.45 17.62 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB2' HD22 ' A' ' 14' ' ' ASN . 82.1 tt0 -91.32 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 109.417 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' ARG . 69.5 t80 -100.57 106.55 18.06 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.761 0.791 . . . . 0.0 109.55 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 44.97 -115.4 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.524 -0.735 . . . . 0.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 63.2 t0 -97.28 -14.27 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' TYR . 75.3 ttt180 -109.01 151.5 26.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.261 -0.9 . . . . 0.0 110.23 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.11 160.22 15.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -146.87 162.82 37.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.295 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.02 126.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 108.943 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -104.93 127.59 52.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.492 -0.755 . . . . 0.0 109.396 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.04 132.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.454 -0.779 . . . . 0.0 108.997 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -125.0 -173.56 2.83 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.662 0.744 . . . . 0.0 109.89 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -40.39 96.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.566 -0.709 . . . . 0.0 109.962 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -68.45 -12.87 61.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -82.93 163.77 20.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 109.822 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -140.69 162.36 35.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.269 -0.894 . . . . 0.0 109.049 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.8 mt -138.38 130.6 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -130.02 134.65 47.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.359 -0.838 . . . . 0.0 109.019 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -74.68 135.46 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -94.78 129.71 41.62 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.889 0.852 . . . . 0.0 110.16 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.4 t -77.44 -6.48 53.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.767 -0.583 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -114.28 95.71 40.13 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.438 -0.789 . . . . 0.0 109.268 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.34 152.05 16.34 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.444 2.096 . . . . 0.0 112.116 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -101.43 134.14 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -85.34 132.49 34.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.783 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.66 75.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.76 -106.65 0.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 102' ' ' LEU . 10.0 mp -94.37 109.2 21.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.24 . . . . 0.0 109.413 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -68.9 -37.16 78.79 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.348 0.594 . . . . 0.0 109.693 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.465 ' ND1' ' N ' ' A' ' 104' ' ' HIS . 6.3 p-80 -153.0 152.44 31.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 108.842 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.744 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.457 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 48.4 t-80 45.62 -101.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.886 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.527 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 56.3 t-80 47.05 -115.87 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.527 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 60.6 t-80 -66.01 -42.65 89.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.29 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -164.72 59.16 0.66 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.615 -0.678 . . . . 0.0 109.466 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.42 156.94 57.68 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.62 2.214 . . . . 0.0 112.062 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -80.6 113.44 18.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.0 133.79 37.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.591 -0.693 . . . . 0.0 109.868 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.548 ' O ' HD13 ' A' ' 20' ' ' LEU . 93.9 m -127.98 152.03 48.41 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.453 0.644 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.38 147.08 24.55 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.707 0.765 . . . . 0.0 110.162 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.12 -44.28 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.53 -11.25 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.601 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 52.8 t0 -96.73 8.33 44.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -87.11 120.74 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.85 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.2 4.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.843 . . . . 0.0 109.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -134.8 131.54 37.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.353 -0.842 . . . . 0.0 109.122 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.26 160.19 14.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.29 18.98 79.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -103.06 156.38 17.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.504 -0.998 . . . . 0.0 109.899 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -102.81 131.97 49.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -158.57 176.59 12.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 109.866 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' SER . 61.7 m-20 -138.91 142.99 38.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.657 . . . . 0.0 109.648 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 6' ' ' THR . 60.5 tp -159.14 147.14 17.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.034 -1.041 . . . . 0.0 110.423 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -94.06 137.66 33.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.72 158.34 44.08 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.083 0.944 . . . . 0.0 110.661 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.74 152.72 18.84 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.304 0.573 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 59.6 t -93.23 101.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.04 -26.31 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 0.0 109.77 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -168.68 160.34 10.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -135.07 160.08 39.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.186 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -143.14 113.82 7.52 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.483 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.77 130.26 41.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -115.83 126.68 54.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 33' ' ' GLU . 1.9 m -109.48 13.86 23.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.581 -0.699 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 32' ' ' HIS . 61.9 t-80 -67.29 7.26 0.45 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.385 -0.822 . . . . 0.0 109.297 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 31' ' ' THR . 76.4 tt0 65.33 -55.81 0.32 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.184 0.516 . . . . 0.0 110.091 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 32' ' ' HIS . 78.1 p -59.66 -41.94 91.72 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.126 -0.984 . . . . 0.0 108.919 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.1 mt -103.79 136.46 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 109.449 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 11.4 p -88.42 -56.5 3.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.568 -0.707 . . . . 0.0 109.769 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.504 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.5 tt0 -154.55 155.24 34.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.433 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.35 149.67 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.2 -158.77 14.63 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.135 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 mt -121.45 149.08 43.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.091 -0.652 . . . . 0.0 109.555 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.3 127.84 55.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.536 0.684 . . . . 0.0 109.407 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.83 96.73 2.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -93.92 157.1 16.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.6 -18.18 64.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.675 -0.641 . . . . 0.0 109.768 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -98.88 -11.52 21.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.378 -0.826 . . . . 0.0 109.153 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -154.06 24.96 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.084 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.06 160.41 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.616 -0.932 . . . . 0.0 109.84 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -160.4 147.14 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.521 -0.737 . . . . 0.0 109.914 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.72 164.65 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.875 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.88 150.0 23.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.167 -0.958 . . . . 0.0 108.98 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -137.24 135.08 36.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.036 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.8 mt -105.62 129.09 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.617 -0.677 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -84.04 139.7 32.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 110.504 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -60.72 -37.2 80.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.655 -0.653 . . . . 0.0 109.391 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.83 -11.07 4.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.822 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -84.61 -25.83 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.131 -0.98 . . . . 0.0 108.974 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 53.94 52.13 13.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.63 -0.669 . . . . 0.0 110.146 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.559 HD13 ' HB1' ' A' ' 56' ' ' ALA . 7.5 mp -104.86 156.12 36.49 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.337 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.31 154.41 74.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.711 2.274 . . . . 0.0 112.7 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.62 142.17 46.53 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.787 0.804 . . . . 0.0 110.626 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.2 mp -81.13 151.0 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.764 -0.585 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.02 136.11 43.45 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.747 0.784 . . . . 0.0 109.945 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 24' ' ' VAL . 10.3 tm0? -72.38 134.9 45.68 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 110.682 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 -13.18 67.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.4 mp0 -97.77 157.58 15.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -1.121 . . . . 0.0 110.681 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 96' ' ' GLU . 12.1 p -100.92 141.07 34.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -134.41 157.03 47.48 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.161 0.982 . . . . 0.0 110.13 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.4 tp -105.31 134.02 49.12 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 mt -110.13 108.84 19.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 92' ' ' GLU . 65.4 mtm180 -112.81 148.2 35.34 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.595 0.712 . . . . 0.0 110.376 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.9 p 51.16 58.17 5.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 122.054 -0.404 . . . . 0.0 110.827 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 18' ' ' ALA . 15.6 m -112.65 165.09 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.517 -0.739 . . . . 0.0 109.319 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 p -123.36 149.25 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 121.724 0.773 . . . . 0.0 109.82 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.34 135.13 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.629 -0.669 . . . . 0.0 109.867 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.62 158.24 17.27 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -100.16 93.76 5.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.949 . . . . 0.0 109.329 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.497 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.1 t80 -106.09 119.27 38.78 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.744 0.783 . . . . 0.0 109.707 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.3 m120 53.51 50.17 17.91 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.336 0.588 . . . . 0.0 110.624 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t0 64.41 -12.69 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.744 -0.598 . . . . 0.0 110.408 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 78' ' ' ASN . 91.6 mtm-85 -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.187 -0.946 . . . . 0.0 110.351 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -76.4 146.11 38.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.602 -0.686 . . . . 0.0 109.355 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -147.14 151.29 36.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.177 -0.952 . . . . 0.0 109.382 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.32 122.45 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -102.18 128.65 48.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 t -100.1 134.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.538 -0.726 . . . . 0.0 109.08 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -131.32 -168.93 2.08 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.71 0.767 . . . . 0.0 109.952 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -62.12 -42.33 99.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.279 0.561 . . . . 0.0 109.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -65.36 -22.2 66.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -81.5 164.26 22.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -140.52 162.55 35.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.4 mt -138.84 132.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.63 -0.669 . . . . 0.0 109.653 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 89.1 mt-10 -131.35 135.96 47.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.548 -0.72 . . . . 0.0 109.218 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.481 ' C ' HD22 ' A' ' 94' ' ' LEU . 88.3 tttt -81.84 135.77 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.481 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.0 mm? -109.86 0.35 18.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.64 -0.663 . . . . 0.0 109.988 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.5 p 49.78 14.91 0.14 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 109.733 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' SER . 24.0 mm-40 -114.07 110.17 48.81 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.281 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.36 151.26 59.72 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.712 2.274 . . . . 0.0 112.724 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -105.56 143.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.7 . . . . 0.0 109.679 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -89.49 123.53 33.68 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.798 0.809 . . . . 0.0 109.864 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 100' ' ' VAL . 2.2 m -91.11 39.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.34 21.34 64.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.7 tp -82.85 102.25 11.51 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.338 -1.096 . . . . 0.0 109.774 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -170.71 -29.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.426 0.632 . . . . 0.0 109.35 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.43 17.68 3.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -59.55 -45.22 92.44 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -69.39 139.67 54.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -128.58 65.78 1.41 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.778 -0.576 . . . . 0.0 109.666 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 74.1 m80 46.37 -165.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.791 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.296 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -73.86 152.37 88.94 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.437 ' CG ' HD22 ' A' ' 19' ' ' ASN . 56.3 Cg_endo -69.67 169.68 18.24 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.69 2.26 . . . . 0.0 112.301 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -81.11 113.24 19.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 131.42 34.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.592 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.0 m -119.3 132.52 55.9 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 64.8 mttp -98.5 155.73 17.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 110.085 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.55 -49.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.655 0.741 . . . . 0.0 109.349 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.37 -13.89 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 49.4 t0 -93.03 -3.18 54.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLU . 97.7 mt -58.6 -73.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 110.416 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 11' ' ' ILE . 15.6 m 31.93 29.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.396 0.617 . . . . 0.0 110.923 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.2 tt0 -167.23 114.17 0.78 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.472 -0.768 . . . . 0.0 109.066 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -87.15 153.64 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.78 72.69 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.52 137.21 33.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.094 . . . . 0.0 109.929 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.57 125.44 38.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.04 -167.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.828 . . . . 0.0 109.792 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.437 HD22 ' CG ' ' A' ' 3' ' ' PRO . 60.2 m-20 -117.64 146.29 43.77 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.47 131.17 35.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 0.0 110.475 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -116.55 127.84 54.88 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.525 ' HB3' HD22 ' A' ' 41' ' ' LEU . . . -162.56 169.77 19.7 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -103.59 154.94 18.95 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.873 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.96 113.78 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.375 -0.828 . . . . 0.0 109.656 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -93.41 -22.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.674 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.568 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 48.5 tt0 -152.79 136.07 15.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.783 -1.198 . . . . 0.0 109.609 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 26' ' ' GLN . 4.2 mm? -108.18 143.28 37.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.642 0.734 . . . . 0.0 109.682 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.568 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 61.6 m95 -145.0 119.78 9.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.696 0.76 . . . . 0.0 109.129 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.666 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.4 pm0 -89.3 144.08 26.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.62 -0.675 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.638 HD22 HD12 ' A' ' 35' ' ' ILE . 58.5 t-20 -144.84 127.46 16.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.195 -0.941 . . . . 0.0 108.995 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.1 OUTLIER -145.23 18.85 1.57 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.127 -0.983 . . . . 0.0 108.694 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -68.39 -43.54 77.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.573 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -120.21 -134.05 0.31 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.745 -0.597 . . . . 0.0 109.43 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.9 p -84.71 -2.57 57.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 108.826 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.638 HD12 HD22 ' A' ' 30' ' ' ASN . 45.4 mt -72.8 128.49 35.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 109.605 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -93.16 -57.93 2.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 109.664 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -149.67 150.72 32.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -141.5 155.8 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -170.66 -171.15 35.72 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.071 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.48 HD22 ' C ' ' A' ' 39' ' ' GLY . 3.9 mm? -114.09 146.14 40.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.91 -0.759 . . . . 0.0 109.601 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 22' ' ' ALA . 18.9 mt -117.23 124.16 48.38 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.59 0.709 . . . . 0.0 109.096 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' CD1' ' A' ' 25' ' ' ILE . . . -95.28 97.4 2.12 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.6 t0 -99.04 161.23 13.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.273 -1.134 . . . . 0.0 109.304 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.8 mt-10 -66.32 -18.55 65.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.2 p -93.73 -5.1 49.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.01 -144.53 12.71 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -135.64 163.45 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.647 -0.913 . . . . 0.0 109.958 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 151.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.5 159.22 18.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -147.79 153.98 39.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.488 -1.383 . . . . 0.0 108.026 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -133.96 129.82 36.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.477 -0.764 . . . . 0.0 109.906 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -104.33 129.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.593 -0.692 . . . . 0.0 109.67 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -87.91 145.7 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -58.11 -38.22 76.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.496 -0.753 . . . . 0.0 109.309 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -59.51 -4.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 109.695 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.78 -27.91 24.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 108.879 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 55.17 52.96 10.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.627 -0.671 . . . . 0.0 110.244 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.41 147.22 35.9 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.657 -0.652 . . . . 0.0 109.853 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.1 164.39 32.27 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.705 2.27 . . . . 0.0 112.648 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.4 mt -72.99 141.19 47.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.516 -0.74 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.9 mp -84.13 145.11 28.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.75 -0.594 . . . . 0.0 109.846 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.3 137.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.317 -0.864 . . . . 0.0 109.885 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.09 137.52 40.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.702 . . . . 0.0 110.808 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.3 -7.21 72.14 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -106.11 162.21 13.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.366 -1.079 . . . . 0.0 110.689 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -100.96 142.58 32.23 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.79 152.2 51.57 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.97 0.89 . . . . 0.0 110.151 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HB2' HD23 ' A' ' 94' ' ' LEU . 49.1 tp -109.33 131.51 54.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.28 111.14 22.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.368 -0.833 . . . . 0.0 109.158 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 74.8 mtm180 -109.92 149.18 30.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.611 -0.681 . . . . 0.0 110.388 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 2.8 p 52.72 57.77 6.04 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.89 167.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.423 -0.798 . . . . 0.0 109.147 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.56 152.04 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.74 0.781 . . . . 0.0 109.718 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 132.84 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.769 -0.582 . . . . 0.0 109.553 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 147.78 16.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -90.51 101.19 13.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -1.134 . . . . 0.0 109.181 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.63 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 16.0 t80 -97.79 101.12 12.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 109.132 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.63 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 13.0 p30 40.25 -117.58 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 50.1 t0 -90.81 -18.07 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 77' ' ' TYR . 64.3 ttm-85 -100.0 154.46 18.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.169 -0.957 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.79 151.17 19.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 108.78 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -145.41 151.5 38.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.987 -1.071 . . . . 0.0 109.02 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.45 121.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.934 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.62 127.79 53.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.0 133.84 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -133.76 -170.27 2.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 89' ' ' SER . 73.4 tttt -53.83 166.15 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.2 t-20 72.09 -19.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.677 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 87' ' ' LYS . 16.4 p -76.69 162.81 27.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.07 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.0 p -145.22 166.31 25.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.264 -0.897 . . . . 0.0 108.973 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.99 131.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -128.0 131.12 49.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.312 -0.867 . . . . 0.0 108.903 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.77 137.15 51.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 109.639 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -97.26 135.31 39.37 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.958 0.885 . . . . 0.0 110.192 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 m -82.35 -5.88 58.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -121.9 119.89 28.73 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.89 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 161.47 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.509 2.14 . . . . 0.0 112.128 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -98.19 152.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 101' ' ' GLY . 96.7 mt-10 -47.23 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.715 . . . . 0.0 109.997 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 t 60.56 -72.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 99' ' ' GLU . . . -77.31 -80.35 0.66 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.422 ' CG ' ' H ' ' A' ' 103' ' ' GLU . 3.8 tp -151.9 -145.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -1.231 . . . . 0.0 109.983 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 102' ' ' LEU . 48.5 tp10 -97.57 107.91 20.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.742 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.0 m80 44.93 -163.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.905 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -65.4 -38.07 88.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 109.326 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 49.31 90.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.422 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.23 144.76 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.45 -43.71 89.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 56.1 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -53.27 152.78 7.7 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.545 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HB2' HD21 ' A' ' 19' ' ' ASN . 61.7 Cg_endo -71.18 177.01 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.58 2.187 . . . . 0.0 111.993 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.58 120.2 21.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.177 -0.952 . . . . 0.0 110.127 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.6 mm? -89.89 126.42 35.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.6 m -121.99 142.12 50.64 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -95.92 148.35 22.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.045 -1.034 . . . . 0.0 110.121 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.41 -43.61 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.197 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.91 -15.16 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 9.93 29.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 109.933 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.54 122.48 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.077 -1.015 . . . . 0.0 110.0 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.19 -0.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.304 -0.872 . . . . 0.0 109.749 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -131.73 134.29 45.72 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.32 -0.863 . . . . 0.0 109.081 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 57.0 p30 -90.07 159.01 17.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 109.881 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.69 79.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -98.47 147.02 25.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.343 -1.093 . . . . 0.0 109.706 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -97.82 135.13 40.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.418 -0.801 . . . . 0.0 109.592 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -157.39 169.02 25.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.111 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.596 HD21 ' HB2' ' A' ' 3' ' ' PRO . 68.5 m-20 -132.41 136.96 47.12 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.674 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -159.67 178.84 9.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.021 -1.05 . . . . 0.0 110.461 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.6 pttp -128.39 148.45 50.7 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.46 38.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.742 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -93.2 152.5 19.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.592 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.99 99.67 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 110.333 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 mm -73.35 -25.49 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.552 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 53.2 tt0 -166.63 157.85 12.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.0 -1.063 . . . . 0.0 109.702 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.912 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.3 pt? -127.66 153.32 46.61 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.542 -0.724 . . . . 0.0 110.071 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.552 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 44.0 m95 -144.28 123.06 12.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.284 -0.885 . . . . 0.0 109.231 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -68.38 140.26 55.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.513 -0.742 . . . . 0.0 109.455 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 10.8 p-10 -59.11 140.06 56.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.056 -1.028 . . . . 0.0 109.477 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.0 p -97.96 -0.88 43.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.0 108.856 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.536 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 55.5 m80 -143.02 152.84 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' A' ' 34' ' ' SER . 17.2 pt-20 -57.64 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.486 -0.759 . . . . 0.0 110.172 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 33' ' ' GLU . 1.9 p 71.2 -55.15 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.469 -0.769 . . . . 0.0 110.034 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.5 mt -87.27 135.75 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.972 -1.08 . . . . 0.0 109.302 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 17.2 p -87.31 -58.52 2.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.7 tt0 -149.55 155.36 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.957 -1.09 . . . . 0.0 109.771 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 39' ' ' GLY . 53.9 t -137.95 160.92 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 38' ' ' VAL . . . 177.42 -162.75 30.9 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.881 -1.628 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.51 150.6 40.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.894 -0.768 . . . . 0.0 109.142 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.1 129.23 54.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.611 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.0 103.75 2.79 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -103.01 163.86 11.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.99 . . . . 0.0 109.154 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' A' ' 99' ' ' GLU . 47.2 tp10 -69.41 -19.44 63.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -92.31 -10.87 36.77 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.941 -1.1 . . . . 0.0 110.14 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -150.29 21.87 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 pt -132.94 159.12 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.581 -0.952 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.8 tt -161.36 150.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.6 164.07 22.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 108.961 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.12 154.51 31.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.563 -1.336 . . . . 0.0 108.422 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 t -139.56 133.52 30.9 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.239 -0.913 . . . . 0.0 110.251 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.8 mt -105.27 128.7 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -96.64 147.75 23.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 0.0 110.335 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -67.06 -19.31 65.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.725 . . . . 0.0 109.379 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -61.23 -33.26 73.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.842 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.34 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.047 . . . . 0.0 109.276 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.74 61.21 2.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.434 -0.791 . . . . 0.0 110.09 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.74 148.74 38.81 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.606 -0.684 . . . . 0.0 109.398 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.52 161.33 45.51 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.519 2.146 . . . . 0.0 112.189 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.19 143.63 50.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 110.364 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -85.15 148.43 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.573 -0.705 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -95.19 134.55 37.8 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.41 137.16 52.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.51 -12.84 68.81 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.26 158.39 15.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.877 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 p -94.92 143.74 26.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.32 152.55 51.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.816 0.817 . . . . 0.0 110.186 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.41 HD13 ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -100.33 130.84 46.48 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.41 ' H ' HD13 ' A' ' 68' ' ' LEU . 17.5 mt -109.01 105.26 14.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.513 ' NE ' ' OG ' ' A' ' 90' ' ' SER . 87.3 mtm-85 -107.68 133.04 52.67 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m 70.81 59.37 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.116 -0.365 . . . . 0.0 110.76 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 m -112.86 160.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.346 -0.846 . . . . 0.0 109.456 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.45 151.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.499 0.666 . . . . 0.0 109.351 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.59 132.12 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.124 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.28 151.69 18.01 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' OE2' ' N ' ' A' ' 79' ' ' ASP . 10.8 tm-20 -98.76 93.15 5.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.129 -1.218 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -111.27 117.39 33.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.444 -0.785 . . . . 0.0 110.119 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 80' ' ' ARG . 20.0 t-20 55.57 54.36 8.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.818 . . . . 0.0 110.293 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' N ' ' OE2' ' A' ' 76' ' ' GLU . 91.2 m-20 56.35 -2.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.676 -0.64 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 78' ' ' ASN . 14.6 mmp_? -102.24 158.58 16.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.041 -1.037 . . . . 0.0 109.737 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.23 146.69 25.92 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.88 154.61 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.02 117.2 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.377 -0.827 . . . . 0.0 109.094 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -107.08 127.38 53.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.323 -0.861 . . . . 0.0 109.538 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.4 ' C ' HD22 ' A' ' 86' ' ' ASN . 22.0 t -93.6 124.59 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.697 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -152.55 -173.71 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 109.689 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 57.0 -152.64 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.54 0.686 . . . . 0.0 110.365 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 89' ' ' SER . 92.3 m-20 -83.58 27.18 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 88' ' ' ASN . 12.1 p -47.86 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.513 ' OG ' ' NE ' ' A' ' 70' ' ' ARG . 13.6 p -139.44 161.67 36.9 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.073 -1.017 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.3 mt -140.85 132.87 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.946 . . . . 0.0 109.272 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' CB ' HH12 ' A' ' 70' ' ' ARG . 83.8 tt0 -124.73 124.99 43.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.06 140.52 43.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 109.82 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.08 142.31 29.94 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.8 p -83.85 -3.82 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.589 -0.695 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.88 133.01 21.09 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.429 -0.794 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.77 155.9 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.848 1.699 . . . . 0.0 112.04 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -108.62 133.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 84.7 tt0 -88.79 124.0 33.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.87 -7.73 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.51 119.61 5.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -98.92 110.78 23.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -1.018 . . . . 0.0 108.75 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.08 140.92 57.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.679 -0.638 . . . . 0.0 110.265 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -59.38 -85.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.302 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -158.06 157.09 32.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.278 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -96.69 20.63 10.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -0.874 . . . . 0.0 108.983 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -59.94 -41.48 91.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.578 -0.701 . . . . 0.0 109.811 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -67.6 127.69 33.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.573 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 78.3 m80 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.357 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 46.08 57.21 16.39 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.764 -0.585 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HB2' HD22 ' A' ' 19' ' ' ASN . 57.1 Cg_endo -71.19 159.15 52.94 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 112.262 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.4 mp0 -81.36 111.54 17.82 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.348 -0.845 . . . . 0.0 109.56 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.4 mt -91.53 134.25 34.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.669 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -127.15 146.46 50.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.462 0.648 . . . . 0.0 109.381 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.35 147.71 22.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 110.072 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.36 -43.53 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.608 -0.682 . . . . 0.0 109.188 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 9' ' ' VAL . 14.3 p -65.61 -6.3 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.475 -0.765 . . . . 0.0 109.454 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -103.98 6.82 36.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -88.08 115.76 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 109.778 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.56 5.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -125.57 122.81 37.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.788 . . . . 0.0 109.246 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 14.6 t30 -82.02 150.67 27.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.975 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 76.93 19.33 77.71 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -96.32 144.11 26.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.481 -1.011 . . . . 0.0 110.095 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -102.28 130.23 48.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.557 -0.714 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.86 -176.26 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.848 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 3' ' ' PRO . 59.7 m-20 -122.96 146.93 47.17 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.31 133.67 24.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.0 110.514 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -109.89 131.12 55.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.84 159.45 35.07 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.017 0.913 . . . . 0.0 110.883 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 17.5 ttmm -92.08 156.26 17.5 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.14 113.09 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.139 -0.976 . . . . 0.0 110.38 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 pt -90.4 -19.51 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.96 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -167.77 157.47 10.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.986 . . . . 0.0 109.707 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 27' ' ' LEU . 96.1 mt -135.39 159.93 40.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.595 -0.691 . . . . 0.0 109.98 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -144.72 118.14 9.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.435 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -72.86 132.76 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.53 -0.731 . . . . 0.0 109.664 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -120.03 125.73 49.05 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 108.943 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 33' ' ' GLU . 20.1 p -106.12 21.95 16.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.456 -0.777 . . . . 0.0 109.242 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 t-80 -68.98 13.68 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.491 -0.756 . . . . 0.0 109.384 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 31' ' ' THR . 95.6 mt-10 58.58 -68.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.076 0.465 . . . . 0.0 110.337 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' HIS . 48.9 m -51.56 -39.44 57.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 0.0 108.945 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.37 140.94 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.679 0.752 . . . . 0.0 109.414 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.8 p -85.3 -57.16 3.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.658 -0.651 . . . . 0.0 109.911 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.502 ' N ' ' OG ' ' A' ' 36' ' ' SER . 17.4 pt20 -160.48 164.8 31.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.093 -1.005 . . . . 0.0 110.316 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.2 160.34 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.91 -165.76 31.07 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.169 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.34 145.73 49.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.925 -0.75 . . . . 0.0 109.531 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.42 130.58 55.93 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.35 101.33 2.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 44.3 t0 -104.86 162.69 13.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.56 -0.965 . . . . 0.0 109.445 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 13.5 tm-20 -70.3 -18.58 63.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.69 -0.631 . . . . 0.0 109.778 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.5 p -93.9 -9.74 36.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.074 -1.016 . . . . 0.0 109.334 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.93 -146.61 15.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.92 160.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.667 -0.902 . . . . 0.0 109.888 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -158.53 145.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 109.883 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -86.37 164.36 17.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.717 . . . . 0.0 109.992 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -154.29 156.82 37.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.696 -1.253 . . . . 0.0 108.48 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -139.97 129.96 24.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 109.646 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -106.76 131.58 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.333 0.587 . . . . 0.0 109.68 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -90.91 144.07 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 110.362 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -59.63 -31.64 69.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.711 . . . . 0.0 109.406 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.87 -13.39 6.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -87.53 -30.3 20.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 108.938 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 55.3 55.84 7.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.557 -0.715 . . . . 0.0 110.242 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' A' ' 56' ' ' ALA . 8.8 mp -108.0 154.82 40.91 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.611 -0.681 . . . . 0.0 109.398 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.7 156.56 65.23 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.766 2.31 . . . . 0.0 112.528 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.96 144.28 48.95 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.751 0.786 . . . . 0.0 110.394 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -81.5 148.53 29.15 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.36 0.6 . . . . 0.0 109.936 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 98.3 mt-10 -101.35 136.03 41.86 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.802 0.81 . . . . 0.0 110.111 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 27.3 mt-30 -71.77 134.55 46.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.523 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 93.89 -14.48 65.21 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.6 mp0 -95.43 158.41 15.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 110.65 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -90.63 141.98 28.22 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.41 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 35.2 m-85 -133.82 142.83 48.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.842 0.829 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.2 132.0 54.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.99 112.75 25.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.803 . . . . 0.0 109.312 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -109.54 140.45 43.31 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.578 0.704 . . . . 0.0 110.413 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.6 t 56.94 60.04 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.932 -0.48 . . . . 0.0 110.929 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.3 168.11 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 0.0 109.228 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 74' ' ' VAL . 11.5 p -128.08 160.33 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.426 0.632 . . . . 0.0 109.836 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' N ' HG22 ' A' ' 73' ' ' VAL . 56.3 t -103.11 132.73 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.681 -0.637 . . . . 0.0 109.409 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.24 158.81 14.07 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -102.28 91.56 4.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.933 . . . . 0.0 109.392 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.46 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 88.0 t80 -101.37 119.74 39.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.818 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 80' ' ' ARG . 3.7 m120 52.68 43.08 31.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.763 -0.586 . . . . 0.0 110.657 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 68.99 -15.29 0.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.675 -0.641 . . . . 0.0 110.302 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 78' ' ' ASN . 79.9 mtp85 -88.04 159.91 18.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.76 135.52 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -143.33 153.7 43.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 109.332 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -97.2 123.32 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.403 -0.811 . . . . 0.0 108.861 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -108.89 124.47 50.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 0.0 109.366 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.9 132.53 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' LYS . 5.3 p30 -145.62 -178.89 6.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 62.0 tttm -40.91 161.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 9.9 t-20 74.76 -27.36 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 109.795 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 87' ' ' LYS . 23.2 t -79.92 166.01 22.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.923 . . . . 0.0 110.012 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.6 t -148.11 169.93 18.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 109.334 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.2 mt -144.48 136.01 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.455 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.06 127.59 46.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.45 -0.781 . . . . 0.0 109.189 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' C ' HD22 ' A' ' 94' ' ' LEU . 98.5 mttt -74.61 140.72 44.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.536 -0.728 . . . . 0.0 109.515 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.1 mm? -111.01 135.08 52.05 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.818 0.818 . . . . 0.0 110.175 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.2 m -85.66 9.67 15.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.23 92.47 39.93 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.455 -0.778 . . . . 0.0 109.19 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.12 153.25 21.77 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.761 2.308 . . . . 0.0 112.064 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.447 ' H ' ' HE2' ' A' ' 23' ' ' LYS . 96.7 mt -100.84 139.66 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 109.577 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.67 129.55 35.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.79 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.94 -12.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.04 -158.03 24.64 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 102' ' ' LEU . 39.5 tp 43.22 74.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.54 -0.976 . . . . 0.0 109.621 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.83 -11.04 43.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.72 -0.613 . . . . 0.0 109.937 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 106' ' ' HIS . 98.1 m-70 -63.79 -44.82 92.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.274 -0.892 . . . . 0.0 109.003 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 51.6 t-80 47.18 14.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 104' ' ' HIS . 12.6 t-80 -75.91 68.21 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -87.2 -9.13 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.66 -0.65 . . . . 0.0 109.856 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -79.99 -13.2 59.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.443 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.827 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.321 0.581 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 52.49 59.56 14.06 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.302 -0.874 . . . . 0.0 109.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.56 156.23 61.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.609 2.206 . . . . 0.0 112.121 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -81.89 121.99 27.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.437 HD23 HD22 ' A' ' 19' ' ' ASN . 56.9 mt -88.13 131.01 34.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.347 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 20' ' ' LEU . 85.4 m -124.99 138.71 54.22 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -95.66 152.77 18.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.276 -0.89 . . . . 0.0 109.814 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.1 mt -58.29 -44.35 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.548 -0.72 . . . . 0.0 109.361 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.94 -18.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 108.937 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 63.1 t0 -87.87 3.78 47.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -85.6 120.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.047 -1.033 . . . . 0.0 109.678 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.2 p -138.47 -2.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.322 -0.861 . . . . 0.0 109.043 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 97.7 mt-10 -134.58 136.04 42.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.104 -0.997 . . . . 0.0 109.488 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -97.14 156.4 16.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.97 18.67 69.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 24.2 pt20 -103.36 159.49 15.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -1.032 . . . . 0.0 109.71 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.24 135.42 46.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.69 -0.631 . . . . 0.0 109.642 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.29 177.36 11.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 109.796 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 16.1 t30 -133.46 138.16 46.05 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 6' ' ' THR . 57.4 tp -154.29 147.1 24.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.793 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -104.68 140.36 38.15 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . . . -152.27 161.05 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 111.236 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -103.82 153.92 20.18 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 t -93.14 102.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.067 -1.02 . . . . 0.0 110.597 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 pt -84.08 -23.8 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.596 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 47.5 tt0 -152.96 134.92 14.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.911 . . . . 0.0 108.918 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.3 tp -118.06 147.74 42.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.256 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.596 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 80.7 m95 -146.78 128.75 15.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 109.185 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -85.62 140.45 30.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.39 128.76 47.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 108.871 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -99.95 -5.09 28.8 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.225 -0.922 . . . . 0.0 109.081 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -80.47 127.98 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.759 . . . . 0.0 109.252 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' O ' ' CB ' ' A' ' 34' ' ' SER . 75.6 tt0 -51.76 167.6 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER 76.28 -47.16 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.546 -0.722 . . . . 0.0 109.414 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -97.12 134.4 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 52.3 p -88.0 -55.81 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.836 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.447 ' NE2' HD12 ' A' ' 52' ' ' ILE . 22.8 pt20 -158.23 165.87 33.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.014 . . . . 0.0 110.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.61 160.82 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.11 -166.59 34.26 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.194 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.74 146.77 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.857 . . . . 0.0 109.155 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.5 mt -109.16 125.22 51.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.84 99.43 2.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 22' ' ' ALA . 17.9 m-20 -105.52 164.52 11.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.969 . . . . 0.0 109.479 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -70.48 -18.98 62.98 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.865 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -90.08 -10.51 44.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.106 . . . . 0.0 109.827 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.06 -147.87 18.33 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 48' ' ' ILE . 96.0 mt -134.73 155.81 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.597 -0.943 . . . . 0.0 109.48 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.45 ' N ' HG22 ' A' ' 47' ' ' ILE . 14.2 tt -154.53 148.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.795 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -88.22 154.42 20.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CB ' HG23 ' A' ' 83' ' ' VAL . 18.9 p90 -146.7 154.33 41.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.603 -1.31 . . . . 0.0 108.311 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.482 HG22 ' NE2' ' A' ' 84' ' ' GLN . 15.3 t -135.45 132.32 37.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.447 HD12 ' NE2' ' A' ' 37' ' ' GLN . 94.9 mt -102.77 128.7 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.573 -0.704 . . . . 0.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -83.96 142.68 30.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 110.454 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -60.8 -34.74 74.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -59.33 -9.59 2.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 109.764 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.33 -25.66 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -0.971 . . . . 0.0 108.825 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 42.47 47.3 4.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 110.066 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.55 165.45 14.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.03 147.65 89.16 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.321 2.014 . . . . 0.0 112.242 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.85 142.08 49.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.089 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.3 mp -80.24 143.89 33.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.79 131.99 43.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 109.307 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -70.07 134.45 48.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.0 110.477 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 -13.89 66.39 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -97.4 159.51 14.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -1.159 . . . . 0.0 110.796 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.7 m -93.26 146.73 23.49 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.271 0.558 . . . . 0.0 109.798 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.3 151.02 43.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.025 0.917 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.5 tp -106.3 132.53 52.23 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 mt -109.28 106.03 15.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -105.93 140.96 38.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.353 -0.842 . . . . 0.0 110.265 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.1 t 56.86 61.96 2.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.66 . . . . 0.0 110.983 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.93 164.11 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.43 144.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.518 0.675 . . . . 0.0 109.637 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -94.09 134.27 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 151.54 18.04 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -97.4 95.86 7.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -1.155 . . . . 0.0 109.149 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.3 t80 -102.13 116.22 32.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.085 -1.009 . . . . 0.0 109.758 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.467 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 22.0 t-20 51.31 -126.7 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 110.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 56.8 t0 -95.85 -6.69 38.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 ttm180 -114.83 146.67 40.79 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.809 0.814 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.73 158.2 21.87 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -141.71 156.96 45.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 108.886 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -103.0 123.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' HG22 ' A' ' 51' ' ' THR . 92.4 mm-40 -103.26 126.94 50.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.06 130.48 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 108.871 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.96 -166.83 1.67 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.629 0.728 . . . . 0.0 109.968 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -64.28 -41.93 96.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.666 -0.646 . . . . 0.0 110.14 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -65.69 -11.78 48.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.998 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.1 t -86.34 162.44 18.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.461 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.6 m -135.24 157.96 45.57 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -138.98 130.31 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.056 -1.027 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.98 129.18 48.72 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.323 -0.86 . . . . 0.0 109.156 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' C ' HD22 ' A' ' 94' ' ' LEU . 78.3 tttt -77.36 138.67 39.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.0 mm? -106.95 138.01 43.94 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.855 0.836 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -83.16 2.25 36.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.817 -0.552 . . . . 0.0 109.512 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 96' ' ' GLU . 2.7 mp0 -103.5 129.71 24.91 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.189 -0.945 . . . . 0.0 109.796 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.64 146.87 30.92 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.872 1.715 . . . . 0.0 112.289 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -110.57 135.44 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.494 -0.754 . . . . 0.0 108.987 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -88.0 122.39 31.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 109.96 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.72 -4.16 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.43 122.64 4.95 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.5 mt -97.91 111.44 23.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -1.114 . . . . 0.0 109.088 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -76.82 -4.28 42.76 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.404 0.621 . . . . 0.0 109.668 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -148.7 164.86 33.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 108.852 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -123.78 163.95 20.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.521 -0.737 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -74.06 154.87 39.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.299 -0.876 . . . . 0.0 109.599 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -68.68 127.96 34.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.807 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -94.1 126.04 39.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 109.468 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.639 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.535 0.683 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 57.29 60.23 7.0 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.706 -0.621 . . . . 0.0 110.082 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 159.71 50.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.627 2.218 . . . . 0.0 112.206 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 8.2 pt20 -81.65 118.16 22.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.864 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.3 mt -90.54 131.16 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.2 m -123.02 142.64 50.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.88 146.94 23.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.639 0.733 . . . . 0.0 110.402 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.2 mm -53.62 -46.02 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.8 . . . . 0.0 109.597 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.82 -11.81 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.612 -0.68 . . . . 0.0 109.89 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.72 2.74 44.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -86.98 119.02 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.819 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -151.86 9.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.816 . . . . 0.0 109.459 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -127.35 123.11 35.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.555 -0.716 . . . . 0.0 109.283 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.38 152.02 23.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.438 -0.789 . . . . 0.0 110.057 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.73 79.17 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -98.06 145.2 26.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.092 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.17 129.6 45.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.516 -0.74 . . . . 0.0 109.481 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.21 -175.88 5.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.625 HD21 ' HA ' ' A' ' 70' ' ' ARG . 13.1 t-20 -127.11 141.13 51.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.683 -0.636 . . . . 0.0 109.295 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.96 154.56 49.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.479 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -135.8 135.42 39.87 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.55 -173.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.169 0.985 . . . . 0.0 110.511 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.49 155.84 27.9 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.51 106.5 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.34 -24.0 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.284 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.62 ' HB3' HD21 ' A' ' 40' ' ' LEU . 10.3 tp-100 -161.26 151.41 17.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.043 -1.036 . . . . 0.0 109.529 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.889 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.3 pt? -140.96 163.85 31.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.467 -0.771 . . . . 0.0 109.961 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -145.37 111.14 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.802 0.81 . . . . 0.0 109.5 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.01 124.85 26.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -127.58 141.21 51.7 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -0.796 . . . . 0.0 108.886 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -116.13 29.93 7.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' SER . 76.8 m-70 -66.05 6.32 0.4 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 31' ' ' THR . 74.0 tt0 68.23 -54.9 0.52 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.178 0.513 . . . . 0.0 109.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' HIS . 40.6 t -60.5 -44.54 95.89 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.122 -0.987 . . . . 0.0 108.748 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -110.94 142.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.514 0.673 . . . . 0.0 109.425 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -93.25 -47.72 6.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -155.05 156.51 36.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.37 141.1 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.665 ' C ' HD23 ' A' ' 40' ' ' LEU . . . -168.81 -154.09 8.73 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.291 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -136.88 153.09 50.85 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.794 -0.827 . . . . 0.0 109.322 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.02 132.12 54.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.64 0.733 . . . . 0.0 109.741 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.97 104.24 3.12 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 1.4 m-20 -103.73 162.68 12.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.654 -0.91 . . . . 0.0 109.375 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.598 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.9 mp0 -69.37 -15.35 63.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -97.0 -6.14 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.86 -147.11 17.28 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.227 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.93 162.89 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.644 -0.916 . . . . 0.0 110.069 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -159.33 150.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.971 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.86 165.64 21.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.648 -0.658 . . . . 0.0 110.023 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 18.6 p90 -158.67 148.7 19.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.156 -0.965 . . . . 0.0 108.89 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -134.6 128.72 33.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.6 mt -105.45 128.44 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 109.414 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.62 143.01 27.22 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.755 0.788 . . . . 0.0 110.373 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 56' ' ' ALA . 39.5 tptt -60.45 -30.59 69.76 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.619 -0.675 . . . . 0.0 109.403 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -58.98 -3.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.838 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -97.14 -28.19 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.172 -0.955 . . . . 0.0 109.051 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 55.2 mp0 48.97 54.7 10.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.21 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.1 mt -110.89 152.85 43.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.73 147.51 71.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.567 2.178 . . . . 0.0 112.709 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 mt -72.34 149.29 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.754 0.788 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -86.86 144.33 27.05 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.446 0.641 . . . . 0.0 110.115 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.88 139.56 31.14 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.884 0.849 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.19 137.87 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.45 -0.781 . . . . 0.0 110.727 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.97 56.34 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -94.39 159.03 15.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 p -90.28 149.3 22.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.295 0.569 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -144.32 145.88 32.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.7 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 19' ' ' ASN . 36.5 tp -113.32 130.57 56.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.605 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 1.9 mp -119.45 113.64 21.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.63 -0.669 . . . . 0.0 109.502 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.625 ' HA ' HD21 ' A' ' 19' ' ' ASN . 85.8 mtp180 -105.92 151.53 24.46 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.76 58.64 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.553 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.3 165.07 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.535 -0.728 . . . . 0.0 109.459 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.87 147.58 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.676 0.75 . . . . 0.0 109.71 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.6 t -87.93 130.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.67 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.9 147.44 16.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -96.81 103.26 15.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.451 -1.029 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' ARG . 71.2 t80 -101.58 107.62 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.737 0.78 . . . . 0.0 109.372 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.427 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 47.5 t30 39.69 -115.65 0.2 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.793 -0.567 . . . . 0.0 110.629 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 97.7 m-20 -93.61 -19.08 21.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.817 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' TYR . 84.8 mtt85 -97.41 159.54 14.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.25 -0.906 . . . . 0.0 110.353 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.88 153.19 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.619 -0.675 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -151.96 164.07 37.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 83' ' ' VAL . 17.0 m -102.91 126.91 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.95 128.77 53.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.325 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.59 134.29 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' LYS . 4.2 p30 -146.34 -174.4 4.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.87 0.843 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 89' ' ' SER . 1.6 pptp? -44.34 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.899 -0.5 . . . . 0.0 109.896 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 t30 67.29 -27.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.676 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 87' ' ' LYS . 12.7 p -79.98 166.9 21.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.156 -0.965 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.8 p -141.14 160.42 40.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -139.38 132.3 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.593 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -128.76 130.16 46.68 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.609 0.719 . . . . 0.0 109.365 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.47 144.3 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.63 -0.668 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.33 145.24 46.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.704 0.764 . . . . 0.0 110.028 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -86.27 16.8 4.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -119.39 118.43 32.42 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.655 -0.653 . . . . 0.0 109.533 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.09 157.8 42.2 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.647 2.231 . . . . 0.0 112.376 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.3 mm -108.27 137.23 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.748 -0.595 . . . . 0.0 109.674 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.03 122.09 38.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.763 . . . . 0.0 109.663 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.62 80.61 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -119.31 19.32 9.98 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 104' ' ' HIS . 5.5 tp -62.18 -39.37 92.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.408 -1.054 . . . . 0.0 109.706 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.64 -13.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.717 -0.614 . . . . 0.0 110.015 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 102' ' ' LEU . 79.5 m80 -88.86 127.85 35.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 108.868 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 106' ' ' HIS . 46.6 p-80 -148.22 40.09 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 85.7 t60 48.24 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.437 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -147.43 -55.12 0.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.51 -0.744 . . . . 0.0 109.441 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -154.54 139.83 17.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.583 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 63.4 m170 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.617 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' C ' ' A' ' 2' ' ' GLU . 38.3 ttm . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 2.7 mp0 -32.08 96.1 0.09 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 CA-C-O 121.137 0.494 . . . . 0.0 110.369 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 1' ' ' MET . 41.7 Cg_exo -55.26 141.11 81.53 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.43 2.086 . . . . 0.0 112.001 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -79.73 118.62 21.7 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.591 0.71 . . . . 0.0 109.687 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.2 mt -93.73 128.06 39.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.522 ' O ' HD13 ' A' ' 20' ' ' LEU . 14.8 t -129.6 152.69 48.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.557 0.694 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.18 135.1 34.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.341 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -50.97 -34.37 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.758 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.82 1.46 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.854 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -122.48 6.57 9.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.21 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 13' ' ' GLU . 27.7 mt -64.19 -52.42 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 11' ' ' ILE . 12.2 m 4.29 64.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 121.395 0.617 . . . . 0.0 111.383 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 11' ' ' ILE . 38.3 tp10 -174.09 109.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.732 0.777 . . . . 0.0 109.368 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p-10 -82.57 140.52 33.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.5 77.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.05 137.27 32.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -1.16 . . . . 0.0 110.049 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -100.01 129.72 46.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.524 -0.735 . . . . 0.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.99 -175.06 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.398 -0.814 . . . . 0.0 109.932 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 88.0 m-20 -138.35 143.41 39.86 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.434 0.635 . . . . 0.0 109.629 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 6' ' ' THR . 62.2 tp -159.06 145.82 17.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.216 -0.928 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -100.0 141.81 32.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.594 -0.692 . . . . 0.0 109.152 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.538 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . . . -154.73 159.07 40.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.853 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -97.8 150.42 21.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -89.31 101.9 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.551 -0.718 . . . . 0.0 110.754 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.45 -25.61 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -170.61 162.43 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -0.989 . . . . 0.0 109.673 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.43 158.31 43.38 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.7 0.762 . . . . 0.0 110.144 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -148.61 127.94 13.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.437 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.628 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -95.17 131.39 41.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.522 -0.736 . . . . 0.0 109.918 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 3.3 p-10 -95.3 163.69 13.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.404 -0.81 . . . . 0.0 109.056 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.33 5.09 29.3 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 98.4 m-70 -96.25 139.4 32.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.86 -27.39 64.79 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.623 -0.673 . . . . 0.0 110.194 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 47.2 t -60.06 -46.22 90.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.205 -0.935 . . . . 0.0 108.807 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.595 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.8 mt -109.96 141.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.024 0.916 . . . . 0.0 109.75 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 6.1 p -93.2 -56.62 2.89 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.096 -1.002 . . . . 0.0 109.832 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.515 ' N ' ' OG ' ' A' ' 36' ' ' SER . 80.1 mt-30 -150.01 158.61 44.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.952 -1.093 . . . . 0.0 110.542 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.67 141.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.85 -164.57 13.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.311 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.79 143.85 47.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.854 -0.792 . . . . 0.0 109.749 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.539 HD21 ' CE1' ' A' ' 50' ' ' PHE . 67.4 mt -112.85 128.89 56.57 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.69 0.757 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.01 99.02 2.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' A' ' 22' ' ' ALA . 47.8 m-20 -99.3 156.35 17.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.126 -1.22 . . . . 0.0 109.469 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 44' ' ' GLU . 13.8 pt-20 -68.96 -17.41 63.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.646 -0.659 . . . . 0.0 109.722 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 p -96.76 -11.74 24.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.285 -0.885 . . . . 0.0 109.076 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.84 -146.73 13.53 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.711 ' O ' HD12 ' A' ' 47' ' ' ILE . 2.5 pp -133.78 161.49 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.1 tt -161.97 143.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.756 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.37 148.74 22.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 110.172 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.539 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.9 p90 -138.6 160.03 40.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.945 -1.097 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -134.21 133.19 40.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.339 -0.851 . . . . 0.0 109.982 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.7 129.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.639 0.733 . . . . 0.0 109.656 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CE3' ' O ' ' A' ' 34' ' ' SER . 74.5 m95 -87.1 140.74 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 110.46 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -54.89 -23.63 19.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.57 -0.707 . . . . 0.0 109.539 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.33 -6.97 47.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.705 . . . . 0.0 109.673 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.584 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -86.96 -34.32 19.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.15 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 54.53 53.03 11.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 110.123 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.584 HD13 ' HB1' ' A' ' 56' ' ' ALA . 8.5 mp -105.19 155.46 37.73 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.06 156.03 65.01 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.774 2.316 . . . . 0.0 112.737 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.27 139.78 54.42 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.894 0.854 . . . . 0.0 110.684 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.4 mp -82.93 152.59 25.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.356 0.598 . . . . 0.0 110.113 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -104.31 133.3 49.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.727 0.775 . . . . 0.0 110.228 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -67.88 138.94 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.81 0.814 . . . . 0.0 110.622 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 -9.64 64.8 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -94.08 149.92 20.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.241 . . . . 0.0 110.471 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -89.2 147.56 24.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.45 0.643 . . . . 0.0 109.78 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -141.79 152.6 43.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.164 -0.96 . . . . 0.0 110.154 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HB2' HD21 ' A' ' 94' ' ' LEU . 38.9 tp -106.1 133.8 50.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.38 109.65 20.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.393 -0.817 . . . . 0.0 109.648 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -113.66 142.69 45.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.708 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t 57.06 58.04 4.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.115 0.483 . . . . 0.0 110.774 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.36 163.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.2 154.84 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.774 0.797 . . . . 0.0 109.953 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.5 t -95.34 130.1 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 109.851 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.54 151.05 18.96 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -91.29 96.15 10.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -1.028 . . . . 0.0 109.697 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.529 ' CD2' ' OD1' ' A' ' 78' ' ' ASN . 16.3 t80 -95.17 100.18 12.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 77' ' ' TYR . 1.5 p-10 37.48 -110.52 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -95.14 -20.93 18.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.868 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' TYR . 72.5 ttt180 -98.56 162.7 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.121 -0.987 . . . . 0.0 110.505 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -101.02 150.37 22.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.235 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -143.63 148.08 35.31 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.048 -1.032 . . . . 0.0 109.592 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.45 125.22 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.235 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.58 124.4 49.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.377 -0.827 . . . . 0.0 109.564 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.76 134.63 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -132.13 -167.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.889 0.852 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.68 -41.69 98.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.661 -0.649 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.08 -22.72 67.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -0.941 . . . . 0.0 109.605 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.7 m -80.23 163.99 23.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 p -142.62 162.08 36.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 HD23 ' A' ' 58' ' ' LEU . 79.9 mt -141.56 134.1 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -130.7 135.27 47.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -71.26 136.45 47.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.702 . . . . 0.0 109.597 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 68' ' ' LEU . 98.2 mt -92.57 136.45 33.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.9 t -74.99 -9.02 58.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.713 . . . . 0.0 109.78 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -118.92 137.27 24.84 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.769 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.9 159.15 38.32 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.668 2.245 . . . . 0.0 112.189 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.11 131.53 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.687 . . . . 0.0 109.383 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.15 123.58 45.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.873 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.58 -15.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.85 77.59 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.24 -42.95 99.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -1.039 . . . . 0.0 109.82 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 48.88 65.87 1.25 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.642 0.734 . . . . 0.0 110.334 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.16 -59.67 4.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -0.807 . . . . 0.0 109.001 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -173.32 76.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.228 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -157.24 119.17 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -93.21 -10.88 34.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.541 -0.725 . . . . 0.0 109.888 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -65.28 -40.53 94.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 56.1 t-80 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 2' ' ' GLU . 74.5 mtm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 1' ' ' MET . 46.2 mm-40 59.52 146.72 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.625 . . . . 0.0 110.157 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.64 157.97 58.76 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.391 2.061 . . . . 0.0 112.334 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.02 120.25 17.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.864 . . . . 0.0 109.74 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.5 mt -97.02 129.85 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -123.31 151.31 42.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -99.84 147.6 25.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.089 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 46' ' ' GLY . 5.0 pt -58.78 -43.0 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.517 -0.739 . . . . 0.0 109.369 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.8 -7.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.78 15.29 28.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.408 -0.808 . . . . 0.0 109.298 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.43 115.51 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.975 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.28 2.05 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -135.29 131.59 36.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.371 -0.831 . . . . 0.0 109.058 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -95.95 155.64 16.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 19.89 74.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -101.29 156.88 17.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -1.042 . . . . 0.0 109.892 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -106.15 134.2 49.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -176.85 5.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.437 -0.79 . . . . 0.0 109.811 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -120.37 135.0 55.17 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -136.62 138.03 40.74 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.962 -1.086 . . . . 0.0 110.174 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 34.0 ttpt -117.68 134.33 55.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.6 23.56 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.21 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 51.6 tttp -96.53 163.35 13.07 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.05 97.17 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.321 -0.862 . . . . 0.0 110.942 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.7 pt -80.46 -27.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.877 . . . . 0.0 110.225 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -147.33 130.47 16.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -116.42 140.86 48.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.232 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -149.41 137.24 20.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.168 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -88.87 142.38 27.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.26 -0.9 . . . . 0.0 109.71 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.684 HD22 ' H ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -100.57 142.72 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.258 -0.901 . . . . 0.0 109.012 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.684 ' H ' HD22 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -118.01 19.74 13.53 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.445 -0.785 . . . . 0.0 109.037 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.489 ' C ' ' H ' ' A' ' 34' ' ' SER . 6.2 t-160 -75.13 0.9 14.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' O ' ' CE ' ' A' ' 54' ' ' LYS . 74.1 tt0 66.65 -36.32 0.26 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.107 0.48 . . . . 0.0 110.013 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 32' ' ' HIS . 89.1 p -87.84 -6.13 58.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.845 -1.16 . . . . 0.0 108.863 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -124.36 149.7 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.536 0.684 . . . . 0.0 109.991 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 m -91.11 -54.1 4.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.502 -0.749 . . . . 0.0 109.607 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.41 ' CD ' HD12 ' A' ' 52' ' ' ILE . 13.9 pt20 -160.98 168.74 23.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 39' ' ' GLY . 94.7 t -146.91 156.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -179.67 -163.8 31.0 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.597 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.79 147.51 51.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.782 -0.834 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.489 HD11 ' CD1' ' A' ' 50' ' ' PHE . 4.9 mp -136.56 144.76 44.36 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.602 0.715 . . . . 0.0 109.806 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.493 ' O ' HG11 ' A' ' 100' ' ' VAL . . . -102.58 135.07 12.07 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' A' ' 44' ' ' GLU . 53.1 t0 -115.21 4.34 14.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.523 -0.986 . . . . 0.0 110.674 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.595 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 65.1 tt0 100.75 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.515 1.052 . . . . 0.0 108.487 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -93.48 -3.56 52.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.153 . . . . 0.0 109.562 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' N ' HD11 ' A' ' 8' ' ' ILE . . . 155.47 -150.46 21.9 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.4 160.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.625 -0.927 . . . . 0.0 109.764 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tp -157.18 141.07 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.013 . . . . 0.0 109.526 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB3' HE22 ' A' ' 82' ' ' GLN . 14.6 ttmm -89.93 132.23 35.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -125.1 154.31 41.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.313 -0.867 . . . . 0.0 109.192 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -132.27 133.32 43.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 HD12 ' CD ' ' A' ' 37' ' ' GLN . 65.7 mt -100.69 122.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.304 -0.873 . . . . 0.0 109.79 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -80.41 149.57 30.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' CE ' ' O ' ' A' ' 33' ' ' GLU . 67.8 mttm -64.43 -34.71 78.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 109.71 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -59.67 -20.76 58.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.99 60.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.106 -0.996 . . . . 0.0 108.746 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 44.16 45.5 6.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.585 -0.697 . . . . 0.0 109.969 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.81 150.95 37.29 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.02 160.72 47.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.595 2.197 . . . . 0.0 112.296 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.87 134.87 48.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 110.109 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.2 mp -78.05 146.09 35.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.625 -0.672 . . . . 0.0 109.541 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -86.39 131.11 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -73.12 135.83 44.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.518 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 88.73 5.02 75.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 78.0 mm-40 -113.69 157.54 22.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.413 -1.051 . . . . 0.0 110.896 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 m -85.9 141.79 29.31 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.33 0.585 . . . . 0.0 109.629 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -138.98 145.01 39.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.298 -0.876 . . . . 0.0 109.803 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.45 128.42 55.99 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mp -115.55 116.34 27.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.625 -0.672 . . . . 0.0 109.448 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -108.66 143.09 38.2 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.551 0.691 . . . . 0.0 110.432 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.9 p 60.57 57.51 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 0.0 110.656 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.4 157.82 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.175 -0.953 . . . . 0.0 108.773 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.54 134.38 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.752 . . . . 0.0 109.211 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.09 135.82 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.532 -0.73 . . . . 0.0 109.649 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.76 ' H ' HE22 ' A' ' 84' ' ' GLN . . . -108.81 146.58 16.6 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.23 103.34 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.243 . . . . 0.0 109.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 80' ' ' ARG . 64.9 t80 -97.95 96.97 8.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.223 -0.923 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.65 -119.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.645 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.21 -11.2 39.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 77' ' ' TYR . 89.1 mtm180 -111.15 161.12 16.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 110.115 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.38 153.87 18.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.414 HE22 ' HB3' ' A' ' 49' ' ' LYS . 88.0 mm-40 -140.32 153.94 46.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.146 -0.971 . . . . 0.0 109.133 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.76 113.81 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.241 -0.912 . . . . 0.0 108.582 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.76 HE22 ' H ' ' A' ' 75' ' ' GLY . 2.6 mp0 -103.05 134.98 45.58 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 0.0 109.325 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -102.92 129.42 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -121.36 -174.38 2.84 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.697 0.761 . . . . 0.0 110.047 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.68 -41.68 97.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.68 -0.638 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -65.59 -2.52 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.957 . . . . 0.0 109.767 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -89.82 161.28 16.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.2 t -132.99 151.86 52.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.97 128.32 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.901 -1.125 . . . . 0.0 109.086 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -129.44 135.92 49.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.081 -1.012 . . . . 0.0 109.135 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.2 tttp -79.6 129.78 34.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.33 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 93' ' ' LYS . 3.9 mm? -104.3 134.74 47.01 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.927 0.87 . . . . 0.0 109.982 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -81.81 -3.14 53.22 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -91.78 123.01 64.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.876 -1.14 . . . . 0.0 109.548 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.25 141.82 23.56 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.733 1.622 . . . . 0.0 112.422 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.01 141.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.46 -0.775 . . . . 0.0 109.177 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -48.38 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 0.0 109.223 -179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.493 HG11 ' O ' ' A' ' 42' ' ' GLY . 19.7 m 33.14 38.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.694 0.759 . . . . 0.0 110.287 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 99' ' ' GLU . . . 82.22 78.08 1.03 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.553 HD23 ' C ' ' A' ' 102' ' ' LEU . 4.1 tt -107.35 111.03 23.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.316 -1.108 . . . . 0.0 109.188 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.504 ' N ' HD23 ' A' ' 102' ' ' LEU . 44.8 tt0 40.5 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.745 -0.597 . . . . 0.0 110.688 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 102' ' ' LEU . 43.0 t-80 49.85 13.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 108.91 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' GLU . 30.9 m170 -59.91 -40.95 90.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -138.3 142.36 39.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.14 -43.55 91.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.859 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.402 ' H ' ' H ' ' A' ' 109' ' ' HIS . 84.2 t60 -150.93 -17.09 0.22 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.0 109.129 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.402 ' H ' ' H ' ' A' ' 108' ' ' HIS . 86.0 t60 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.309 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.613 0.72 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.62 59.2 1.19 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.728 -0.608 . . . . 0.0 109.995 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.62 158.14 51.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.493 2.128 . . . . 0.0 112.24 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -79.58 112.28 16.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.4 mt -89.89 129.61 36.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.0 109.691 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.6 m -123.88 139.87 53.54 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.421 0.629 . . . . 0.0 109.326 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.24 144.35 25.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.964 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 9' ' ' VAL . 9.5 pt -52.72 -41.7 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.626 -0.671 . . . . 0.0 109.686 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' N ' HG13 ' A' ' 8' ' ' ILE . 14.8 p -70.03 -11.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -96.59 6.44 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.65 119.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 109.968 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.92 6.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 96.6 mt-10 -131.71 128.01 38.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.542 -0.724 . . . . 0.0 109.369 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 15' ' ' GLY . 14.6 t30 -88.95 150.03 23.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.848 . . . . 0.0 109.924 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 14' ' ' ASN . . . 80.34 21.82 63.98 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 13' ' ' GLU . 4.9 pt20 -103.35 153.2 20.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.575 -0.956 . . . . 0.0 109.837 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -103.9 132.25 50.34 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.507 0.67 . . . . 0.0 109.446 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -160.32 178.87 9.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 109.863 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -120.66 144.98 47.89 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.1 tp -136.59 133.7 36.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.512 -0.742 . . . . 0.0 110.131 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -118.31 132.03 56.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.39 -173.21 0.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.176 0.989 . . . . 0.0 110.806 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.9 ptpt -118.19 155.82 29.82 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.438 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.8 t -90.06 105.75 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.471 -0.768 . . . . 0.0 110.158 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.5 pt -73.19 -25.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.804 -0.56 . . . . 0.0 110.045 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -159.59 148.59 17.94 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.983 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.6 pt? -125.34 152.01 45.3 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.13 117.7 9.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 109.606 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 56.4 mp0 -94.75 125.45 39.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.623 -0.673 . . . . 0.0 109.386 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.427 HD21 HG21 ' A' ' 35' ' ' ILE . 31.5 p-10 -149.18 170.51 18.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 t -150.66 46.78 0.87 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 109.112 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -54.27 -37.36 64.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -167.26 -99.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.3 p -87.38 -6.37 58.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.191 -0.943 . . . . 0.0 108.935 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 30' ' ' ASN . 94.4 mt -80.56 131.71 33.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 3.0 m -102.05 -46.32 4.9 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.513 0.673 . . . . 0.0 109.894 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -148.82 148.2 29.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.988 -1.07 . . . . 0.0 109.975 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.86 130.74 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.38 -166.93 15.12 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.15 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD21 ' NZ ' ' A' ' 49' ' ' LYS . 4.8 mp -135.31 150.48 50.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.866 -0.784 . . . . 0.0 109.734 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.21 125.22 53.57 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.64 8.13 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.4 p-10 -125.73 -134.69 0.26 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.714 -0.874 . . . . 0.0 109.098 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 81.7 tt0 -119.8 -18.57 8.24 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 15.7 p -93.06 -11.06 33.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.97 -1.081 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 151.65 -143.85 10.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -141.54 158.11 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -1.09 . . . . 0.0 109.432 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -148.86 145.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 109.885 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.462 ' CB ' HE21 ' A' ' 82' ' ' GLN . 67.9 mttm -92.01 127.36 37.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.023 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -122.87 152.76 40.44 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.3 m -131.24 133.44 45.45 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.426 0.631 . . . . 0.0 109.634 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.64 127.1 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -82.5 142.56 31.77 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.597 -0.689 . . . . 0.0 110.118 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' N ' ' OG ' ' A' ' 36' ' ' SER . 78.8 tttt -58.08 -37.32 74.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.541 -0.725 . . . . 0.0 109.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -60.01 -6.11 1.23 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.828 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.884 . . . . 0.0 109.158 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 46.33 51.95 11.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.643 -0.661 . . . . 0.0 109.889 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.4 mt -100.65 153.02 37.97 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.741 -0.599 . . . . 0.0 109.848 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.46 148.89 60.1 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.477 2.118 . . . . 0.0 112.779 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.6 140.12 51.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.512 -0.742 . . . . 0.0 110.379 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.3 mp -83.37 150.33 26.16 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.367 0.603 . . . . 0.0 109.964 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.2 128.2 45.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -66.71 137.99 57.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.662 -0.649 . . . . 0.0 110.712 -179.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 86.74 -10.77 66.37 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -98.18 158.19 15.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -1.033 . . . . 0.0 110.674 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 m -91.58 145.67 24.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -141.73 148.82 39.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 109.815 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 tp -110.32 128.76 55.71 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.83 118.05 31.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.531 -0.731 . . . . 0.0 109.728 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -114.86 145.01 42.63 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.692 0.758 . . . . 0.0 110.694 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 63.22 56.57 1.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 18' ' ' ALA . 19.0 m -110.73 161.97 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.512 -0.743 . . . . 0.0 109.381 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 148.43 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.581 0.705 . . . . 0.0 109.59 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.3 t -95.75 132.47 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.676 -0.64 . . . . 0.0 109.686 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.0 16.96 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -94.86 109.39 21.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.534 -0.98 . . . . 0.0 109.403 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 80' ' ' ARG . 40.4 t80 -106.8 106.45 16.97 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.922 0.868 . . . . 0.0 109.483 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 42.64 -118.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -93.07 -17.3 23.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.102 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.7 mtt-85 -100.82 159.78 14.91 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.411 -0.805 . . . . 0.0 110.329 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -104.72 153.32 21.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.462 HE21 ' CB ' ' A' ' 49' ' ' LYS . 40.7 mt-30 -147.81 159.94 43.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.38 123.55 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -99.72 129.35 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -104.41 131.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -127.08 -170.46 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.673 0.749 . . . . 0.0 110.066 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.53 -45.14 91.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.907 -0.496 . . . . 0.0 110.181 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.18 -11.07 7.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 109.758 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.5 p -83.23 163.91 20.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.9 p -138.44 155.67 48.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -139.66 131.77 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 0.0 109.313 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -127.47 130.57 49.47 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -70.34 135.89 49.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.705 -0.622 . . . . 0.0 109.502 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.1 mt -96.92 134.36 40.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.505 -0.747 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.5 p -85.29 -6.34 59.26 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -107.12 130.52 22.74 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.567 -0.708 . . . . 0.0 109.57 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.25 147.39 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.478 2.119 . . . . 0.0 112.242 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.464 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.5 mt -110.27 131.67 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.6 mp0 -97.54 123.24 41.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 100' ' ' VAL . 94.8 t -84.57 -3.38 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.65 144.47 3.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.36 -0.83 57.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -1.024 . . . . 0.0 109.177 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 51.13 -167.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -93.82 118.69 31.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -148.73 23.39 0.99 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.39 -0.819 . . . . 0.0 108.941 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.61 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 36.3 t-80 51.11 -117.17 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.718 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.61 ' N ' ' CG ' ' A' ' 106' ' ' HIS . 50.3 t-80 -87.75 155.32 19.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.959 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -155.3 153.78 31.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.605 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.189 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -140.1 74.16 31.14 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.67 148.57 92.73 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.886 2.391 . . . . 0.0 112.017 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -79.03 115.43 18.7 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.12 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.9 mt -86.95 126.64 34.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.55 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.7 m -120.77 136.78 54.8 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.07 148.39 22.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.23 -43.3 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.528 0.68 . . . . 0.0 109.193 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.22 -13.39 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.429 -0.795 . . . . 0.0 109.535 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 53.2 t0 -95.58 5.52 51.29 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.159 -0.963 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 13' ' ' GLU . 3.7 mm -56.14 -72.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.142 -0.974 . . . . 0.0 109.185 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t 62.59 -32.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 11' ' ' ILE . 52.3 tp10 -145.54 147.6 32.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.883 -1.135 . . . . 0.0 108.987 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -101.48 173.11 6.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.56 0.695 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.43 21.85 79.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 34.3 mt-30 -99.43 145.76 27.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.349 -1.089 . . . . 0.0 109.984 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.27 126.05 39.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.28 -169.98 2.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -126.09 144.07 50.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.69 130.81 38.7 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.715 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -116.05 130.67 56.91 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.16 -173.67 1.14 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.23 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HZ1' ' HB ' ' A' ' 98' ' ' ILE . 3.3 ttmp? -114.26 148.89 36.72 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.831 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.08 123.71 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 pt -88.46 -20.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.432 -0.793 . . . . 0.0 110.45 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -164.91 154.82 13.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.723 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.7 mt -124.36 152.09 43.59 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.443 0.64 . . . . 0.0 110.021 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -137.33 104.92 5.53 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.71 131.91 34.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.743 -0.598 . . . . 0.0 109.695 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.596 HD21 ' C ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -111.71 -31.88 6.83 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m 63.27 6.73 2.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.504 -0.748 . . . . 0.0 109.32 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 35' ' ' ILE . 32.6 m-70 -74.19 150.53 40.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.99 -41.31 91.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 t -67.39 -54.06 23.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.096 -1.002 . . . . 0.0 109.624 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.537 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 69.8 mt -107.42 137.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.596 ' C ' HD21 ' A' ' 30' ' ' ASN . 9.1 p -90.93 -60.17 1.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.912 0.863 . . . . 0.0 110.437 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.537 ' N ' ' OG ' ' A' ' 36' ' ' SER . 34.8 mt-30 -146.67 155.34 42.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.864 -1.148 . . . . 0.0 109.964 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 39' ' ' GLY . 20.2 t -135.94 161.77 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' ' CE2' ' A' ' 50' ' ' PHE . . . 178.4 -168.17 39.16 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.058 -1.544 . . . . 0.0 109.939 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.08 149.88 52.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.764 -0.845 . . . . 0.0 109.583 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.6 125.72 53.7 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.733 0.778 . . . . 0.0 108.992 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.93 101.2 2.75 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -105.05 164.02 12.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.678 -0.895 . . . . 0.0 109.293 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -71.49 -17.01 62.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.491 -0.756 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.3 p -93.81 -10.85 32.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 109.571 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.61 -149.57 21.23 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 pt -132.98 156.16 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.944 . . . . 0.0 109.701 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -152.47 145.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.865 . . . . 0.0 109.397 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.612 ' H ' HH12 ' A' ' 80' ' ' ARG . 68.3 mttm -80.44 165.35 22.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.807 . . . . 0.0 109.451 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CE2' ' C ' ' A' ' 39' ' ' GLY . 24.6 p90 -154.23 148.6 26.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.513 -1.367 . . . . 0.0 108.08 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.5 m -132.93 132.38 41.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.436 -0.79 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -105.7 127.56 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.491 -0.755 . . . . 0.0 109.38 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -83.76 140.3 32.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.66 -33.01 69.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.466 -0.771 . . . . 0.0 109.226 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -64.14 -6.43 6.54 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.79 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.58 -31.84 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 108.941 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 49.51 52.9 13.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.909 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 mt -101.96 153.93 37.67 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.36 -0.837 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.71 149.65 31.67 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.145 1.896 . . . . 0.0 112.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.0 138.29 57.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 0.0 110.27 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.8 mp -82.86 145.24 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 109.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -105.21 135.36 46.71 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.835 0.826 . . . . 0.0 109.998 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -74.78 146.64 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.022 0.915 . . . . 0.0 110.006 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.72 -11.1 42.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -97.81 150.14 21.58 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.102 -1.234 . . . . 0.0 110.507 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -84.16 143.8 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.364 0.602 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -142.14 150.26 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.08 129.92 55.47 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.31 115.65 28.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.423 -0.798 . . . . 0.0 109.576 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -113.66 146.25 40.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.579 -0.701 . . . . 0.0 110.317 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.1 t 56.96 58.97 3.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.882 -0.511 . . . . 0.0 110.908 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.98 165.73 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.302 -0.873 . . . . 0.0 108.849 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.01 152.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.654 0.74 . . . . 0.0 109.591 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.15 132.08 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.649 -0.657 . . . . 0.0 109.536 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.12 156.24 15.71 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.44 118.17 36.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 109.032 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.5 t80 -135.46 117.89 15.77 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 80' ' ' ARG . 9.4 m120 52.73 55.75 8.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.452 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 56.16 -4.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.68 -0.638 . . . . 0.0 110.808 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' H ' ' A' ' 49' ' ' LYS . 68.3 ttt-85 -102.02 131.91 48.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.093 -1.004 . . . . 0.0 109.598 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 11' ' ' ILE . 13.9 m-85 -78.15 146.3 35.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.488 -0.757 . . . . 0.0 109.233 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -147.32 162.6 38.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 0.0 109.613 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.94 119.77 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.442 -0.787 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -100.56 129.91 46.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 0.0 109.043 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.56 132.39 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.045 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -125.49 -170.12 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.402 -0.811 . . . . 0.0 109.81 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -67.3 -25.42 66.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.654 -0.654 . . . . 0.0 110.102 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -80.72 -9.24 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.776 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 m -88.87 164.07 15.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 0.0 109.675 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.6 m -134.93 158.0 45.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.264 -0.897 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.94 128.87 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.114 -0.991 . . . . 0.0 108.843 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.97 128.56 47.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.311 -0.868 . . . . 0.0 108.919 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.82 137.97 55.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 109.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.2 134.37 46.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.848 . . . . 0.0 109.941 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.9 p -85.5 -2.01 57.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -109.66 127.53 27.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.368 -0.833 . . . . 0.0 109.692 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.55 151.0 41.35 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.121 1.881 . . . . 0.0 112.265 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.554 ' HB ' ' HZ1' ' A' ' 23' ' ' LYS . 96.6 mt -111.01 134.5 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -105.8 122.77 46.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.6 m -106.61 -6.56 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' LEU . . . -94.82 -164.94 35.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 102' ' ' LEU . 10.0 mp 41.61 67.47 0.55 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.478 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' HIS . 73.7 mm-40 -74.57 131.95 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.416 0.627 . . . . 0.0 110.323 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 49.19 -90.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 0.0 109.526 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' GLU . 80.3 m80 -137.92 -172.46 3.26 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.033 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -66.48 136.1 55.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -80.06 145.11 32.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.4 -0.813 . . . . 0.0 110.051 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -81.03 145.09 31.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.697 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 tpp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.316 0.579 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.28 157.12 75.84 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.149 -0.969 . . . . 0.0 109.685 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 143.88 21.7 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.055 1.837 . . . . 0.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.469 ' N ' HD22 ' A' ' 19' ' ' ASN . 85.1 mt-30 -77.84 115.78 17.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.516 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.72 127.48 35.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.9 m -121.12 137.7 54.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -95.85 151.74 19.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.944 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mm -55.96 -44.56 78.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.77 -18.24 23.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.222 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.28 -0.52 56.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.23 118.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -142.88 -2.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.926 . . . . 0.0 109.192 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.8 140.52 45.93 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.094 -1.004 . . . . 0.0 109.505 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' A' ' 76' ' ' GLU . 39.4 p-10 -92.5 162.93 14.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.53 78.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -94.46 140.45 29.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -1.17 . . . . 0.0 109.682 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -96.48 128.26 43.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.626 -0.671 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.747 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.557 ' C ' HD22 ' A' ' 20' ' ' LEU . 58.9 m-20 -120.69 139.56 52.87 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD22 ' C ' ' A' ' 19' ' ' ASN . 4.4 mm? -116.84 146.68 42.74 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.087 -1.008 . . . . 0.0 109.71 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -138.42 125.33 21.16 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 -175.16 1.06 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.177 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -110.54 151.76 27.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.854 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.47 111.06 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.322 -0.861 . . . . 0.0 110.84 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.7 pt -89.22 -24.38 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -156.56 147.26 21.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 109.449 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 160.61 39.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.249 -0.907 . . . . 0.0 109.37 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -141.21 109.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 109.389 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.87 129.14 39.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.618 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -105.17 153.97 20.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.296 -0.877 . . . . 0.0 109.151 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.2 p -144.84 58.67 1.3 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.471 ' C ' ' H ' ' A' ' 34' ' ' SER . 76.3 t60 -124.49 17.73 8.89 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 55.52 2.93 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.776 -0.578 . . . . 0.0 110.66 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 32' ' ' HIS . 39.2 t -110.44 -49.02 3.09 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -108.16 140.73 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.684 -0.635 . . . . 0.0 109.524 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.416 ' OG ' ' C ' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -85.04 -58.32 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -151.98 152.01 31.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.258 -0.901 . . . . 0.0 109.871 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.87 133.01 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.27 -156.8 8.45 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.525 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.67 153.49 50.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.87 -0.782 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.46 128.7 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.8 97.84 2.35 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 53.8 t0 -101.37 159.86 14.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -1.045 . . . . 0.0 109.421 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.3 mt-10 -68.99 -14.8 63.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.44 -0.788 . . . . 0.0 109.984 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -98.0 -7.03 30.73 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.155 -0.966 . . . . 0.0 109.577 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.61 -147.81 18.11 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.162 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.663 ' O ' HD12 ' A' ' 47' ' ' ILE . 2.1 pp -135.81 165.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.662 -0.905 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.5 tt -157.5 144.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.147 -0.97 . . . . 0.0 109.91 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.88 130.22 38.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -128.45 154.99 45.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.831 -1.168 . . . . 0.0 108.599 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.6 m -131.33 130.47 42.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.59 -0.694 . . . . 0.0 109.257 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.06 129.62 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.332 -0.855 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.416 ' C ' ' OG ' ' A' ' 36' ' ' SER . 97.9 m95 -82.0 139.91 34.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 110.312 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 56' ' ' ALA . 64.5 tttm -59.63 -37.78 79.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -61.04 -2.04 0.54 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -85.07 -23.71 28.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 108.779 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 53.85 48.28 21.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 109.9 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.77 147.06 35.38 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.533 -0.729 . . . . 0.0 109.581 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 157.27 62.54 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.384 2.056 . . . . 0.0 112.648 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.74 147.39 43.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.054 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.7 mp -85.2 155.19 21.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.528 -0.733 . . . . 0.0 109.556 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 47.2 tp10 -100.47 136.73 39.9 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -71.34 138.6 49.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.405 -0.809 . . . . 0.0 110.488 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.16 -14.81 62.6 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.35 158.45 15.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.327 -1.102 . . . . 0.0 110.667 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -88.15 151.77 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.485 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 31.7 m-85 -142.9 143.72 32.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 109.561 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.45 129.83 56.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.04 122.74 45.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.615 -0.678 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -116.86 151.99 35.41 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.477 0.656 . . . . 0.0 110.536 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m 56.93 54.97 6.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.89 -0.506 . . . . 0.0 110.788 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.21 164.6 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.243 -0.911 . . . . 0.0 108.853 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.51 147.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.564 0.697 . . . . 0.0 109.374 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.89 131.83 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 109.383 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.93 149.94 16.95 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 78' ' ' ASN . 5.5 tm-20 -92.08 100.2 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.034 -1.274 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.8 t80 -95.18 103.61 15.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.93 . . . . 0.0 109.191 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' O ' ' OE2' ' A' ' 76' ' ' GLU . 99.3 m-20 40.25 -110.67 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 0.0 110.684 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -95.89 -19.65 19.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.099 -1.001 . . . . 0.0 110.383 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 77' ' ' TYR . 37.4 mmt180 -101.31 162.61 12.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 110.006 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.37 152.25 21.81 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.426 ' NE2' ' CD1' ' A' ' 77' ' ' TYR . 27.5 mt-30 -142.06 157.81 44.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.16 123.7 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.434 -0.791 . . . . 0.0 109.111 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -104.8 126.64 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.453 -0.779 . . . . 0.0 109.545 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.74 134.93 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.39 -0.819 . . . . 0.0 109.162 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -129.29 -168.57 1.95 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.323 -0.86 . . . . 0.0 109.896 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.63 -41.63 98.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.521 -0.737 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.91 -20.07 66.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.735 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.0 m -81.21 163.88 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.777 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.5 m -137.44 162.27 34.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.85 130.19 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.015 -1.053 . . . . 0.0 108.834 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -130.08 134.71 47.55 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.211 -0.931 . . . . 0.0 109.013 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -75.57 139.54 42.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.532 -0.73 . . . . 0.0 109.902 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.07 141.74 28.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 109.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -85.05 -8.98 58.46 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.24 134.05 20.88 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.336 -0.852 . . . . 0.0 110.033 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 154.02 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.053 1.836 . . . . 0.0 112.155 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -111.64 133.41 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -87.65 123.0 32.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 109.663 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.65 -15.77 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.78 122.11 6.14 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.0 107.47 19.05 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.318 -1.107 . . . . 0.0 109.209 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.25 -3.66 40.91 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.72 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.3 m80 48.54 43.16 19.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.174 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -59.94 -44.57 94.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.503 -0.748 . . . . 0.0 109.409 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -150.81 163.44 38.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 109.341 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -138.15 45.92 2.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.385 -0.822 . . . . 0.0 109.34 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.87 -42.47 97.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.136 -0.977 . . . . 0.0 109.206 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.593 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -59.71 153.34 52.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.18 155.74 66.92 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.653 2.235 . . . . 0.0 112.093 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.74 115.66 20.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.95 131.43 35.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -123.57 142.08 51.38 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -93.28 149.86 20.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.073 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.25 -43.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.369 -0.832 . . . . 0.0 109.078 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 p -62.99 -5.7 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -102.02 6.25 41.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.372 -0.83 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.74 112.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 109.551 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.6 m -149.74 4.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -132.91 130.47 39.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.362 -0.836 . . . . 0.0 109.078 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -88.15 160.06 17.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.193 -0.942 . . . . 0.0 110.359 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.52 20.68 72.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -94.29 138.57 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 109.996 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -94.85 126.69 40.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 109.386 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -179.41 7.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -126.3 140.36 52.58 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.36 143.73 40.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.5 135.74 54.2 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.87 -173.69 1.01 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.183 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.09 150.99 28.6 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.863 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.14 97.34 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.086 -1.009 . . . . 0.0 109.932 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 tp -66.47 -32.59 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 121.092 -1.005 . . . . 0.0 110.529 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -147.35 129.7 15.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 109.535 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.78 147.59 41.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.598 -0.689 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -143.51 115.39 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 109.396 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.54 131.62 44.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.459 -0.776 . . . . 0.0 109.649 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -115.19 120.27 39.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.417 -0.802 . . . . 0.0 109.168 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 33' ' ' GLU . 69.3 p -110.99 8.25 21.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.486 -0.759 . . . . 0.0 109.1 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 32.2 m170 -58.87 -0.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tm-20 79.21 -51.49 0.43 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 35' ' ' ILE . 83.7 p -83.6 87.72 7.03 Favored 'General case' 0 C--O 1.201 -1.474 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 ' CB ' ' O ' ' A' ' 34' ' ' SER . 26.2 mt 124.87 137.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 C-N-CA 123.731 0.813 . . . . 0.0 109.218 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -81.72 -57.87 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.394 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.74 165.19 33.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 0.0 110.661 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.76 154.9 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.66 -155.38 17.36 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.393 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.01 155.2 50.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.911 -0.758 . . . . 0.0 109.541 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.35 127.8 55.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.8 105.89 3.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -112.95 167.99 10.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.923 . . . . 0.0 109.484 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -73.01 -17.33 61.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.947 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.8 p -93.17 -12.1 31.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.917 -1.114 . . . . 0.0 109.644 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.69 -148.56 19.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.676 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.3 pp -135.55 160.66 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.992 . . . . 0.0 109.55 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -153.77 147.56 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.189 -0.944 . . . . 0.0 109.76 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -81.07 163.64 23.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 109.189 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -160.6 150.94 18.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.483 -1.386 . . . . 0.0 108.265 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 t -138.42 133.1 32.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.837 . . . . 0.0 109.47 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -105.2 129.77 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.677 -0.639 . . . . 0.0 109.467 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -81.98 139.3 34.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 110.686 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.35 -32.03 72.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.416 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.09 -10.4 10.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.85 -21.88 34.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 47.74 48.89 17.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.985 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt -103.71 152.27 38.9 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.404 -0.81 . . . . 0.0 109.8 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.42 146.5 41.27 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.077 1.851 . . . . 0.0 112.589 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.47 142.78 53.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.0 mp -82.63 143.32 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.514 -0.741 . . . . 0.0 109.667 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -93.41 132.04 38.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.28 -0.888 . . . . 0.0 109.755 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -69.26 139.11 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 110.746 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -11.97 59.56 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -96.06 158.51 15.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -1.109 . . . . 0.0 110.585 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.489 0.661 . . . . 0.0 109.836 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.11 148.78 38.9 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.936 0.874 . . . . 0.0 109.879 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.499 HD21 ' NE ' ' A' ' 70' ' ' ARG . 27.2 tp -107.16 131.41 54.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.9 mt -116.27 111.29 19.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.499 ' NE ' HD21 ' A' ' 68' ' ' LEU . 99.1 mtt180 -115.65 153.04 32.0 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.737 0.779 . . . . 0.0 110.556 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 5.2 p 50.46 56.58 7.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.867 -0.52 . . . . 0.0 110.67 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 167.26 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.98 152.72 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.6 0.714 . . . . 0.0 109.402 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.11 131.44 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.65 -0.656 . . . . 0.0 109.734 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.25 148.56 17.21 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -97.5 107.59 20.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.279 -1.13 . . . . 0.0 108.927 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ARG . 87.1 t80 -107.13 109.22 21.0 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.371 -0.83 . . . . 0.0 109.273 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.483 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 26.6 t-20 38.92 -116.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.483 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 99.4 m-20 -92.81 -20.13 21.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 77' ' ' TYR . 3.6 mpt_? -96.12 162.22 13.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.84 153.89 25.94 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -149.77 161.87 41.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.167 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.17 128.14 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -106.87 124.35 49.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.484 -0.76 . . . . 0.0 109.356 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.7 t -98.4 133.51 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -123.27 -169.09 1.87 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 0.0 109.655 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.45 -38.81 88.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.761 -0.587 . . . . 0.0 109.924 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.55 -12.17 56.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.983 . . . . 0.0 109.902 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 t -87.75 166.66 14.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.4 m -134.82 156.03 49.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.29 -0.881 . . . . 0.0 108.829 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -139.12 130.88 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.094 -1.004 . . . . 0.0 108.981 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -127.22 127.91 45.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.28 -0.888 . . . . 0.0 108.917 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.58 141.92 44.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.27 142.2 37.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.402 ' OG ' ' OE2' ' A' ' 96' ' ' GLU . 94.5 p -88.2 3.18 50.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.616 -0.677 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 27.6 mp0 -105.99 133.72 20.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.291 -0.881 . . . . 0.0 109.687 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.51 148.29 37.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.089 1.86 . . . . 0.0 112.157 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.53 134.11 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 56.9 mp0 -88.79 120.93 30.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.095 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 t -91.52 80.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.58 87.92 0.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 102' ' ' LEU . 3.7 mm? 44.36 -98.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.525 -0.985 . . . . 0.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' HIS . 97.4 mt-10 -142.9 -67.27 0.37 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.465 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.8 t60 60.04 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' GLU . 97.8 m-70 -87.37 123.12 31.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -100.65 130.61 46.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.483 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 52.3 p-80 -59.85 -43.98 94.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.926 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.483 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 58.7 t-80 -149.24 156.61 42.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.736 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.492 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 36.7 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.068 -0.967 . . . . 0.0 109.709 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.401 0.62 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -166.15 57.78 0.47 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.214 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 161.09 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.749 2.3 . . . . 0.0 112.154 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.61 115.51 17.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.14 131.32 36.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.849 . . . . 0.0 109.438 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.3 m -124.68 141.06 52.37 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.88 151.75 19.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.3 mt -56.38 -45.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.229 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.7 -17.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.625 -0.672 . . . . 0.0 109.436 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -92.8 2.41 56.77 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -86.21 121.23 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.045 -1.034 . . . . 0.0 109.861 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -147.9 6.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -137.56 135.42 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 76' ' ' GLU . 56.1 p30 -93.32 158.75 15.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.9 20.71 79.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.46 147.62 25.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -1.123 . . . . 0.0 110.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -97.49 126.91 43.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.94 -178.23 6.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.682 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -117.91 145.62 44.52 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.4 tp -134.24 127.86 32.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -114.88 130.21 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.11 170.78 11.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.122 0.963 . . . . 0.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -100.1 155.34 17.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.751 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.45 113.19 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.51 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -147.56 130.5 16.23 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.036 -1.04 . . . . 0.0 109.781 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.929 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.4 pt? -129.68 156.81 43.65 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.293 0.568 . . . . 0.0 109.812 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -144.5 110.5 5.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.98 117.8 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.52 137.76 40.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.269 -0.895 . . . . 0.0 109.176 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 33' ' ' GLU . 61.6 p -122.43 7.66 9.58 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.537 -0.727 . . . . 0.0 109.113 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -66.15 2.2 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 31' ' ' THR . 23.3 tp10 70.22 -47.57 0.63 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.706 -0.621 . . . . 0.0 110.023 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 t -60.05 -46.33 89.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.979 -1.076 . . . . 0.0 109.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt -107.8 135.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.435 -0.79 . . . . 0.0 109.485 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -82.52 -62.77 1.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.621 -0.674 . . . . 0.0 109.995 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -152.32 149.19 28.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.968 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.61 154.13 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.14 -159.63 22.68 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 tp -125.27 145.2 50.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.907 -0.76 . . . . 0.0 109.448 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.547 HD21 ' CE1' ' A' ' 50' ' ' PHE . 67.0 mt -108.48 128.68 55.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.514 -0.741 . . . . 0.0 109.201 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 97.83 2.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -103.32 164.31 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.97 . . . . 0.0 109.621 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.09 -20.22 62.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.602 -0.686 . . . . 0.0 110.104 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 p -90.12 -12.65 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.359 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.58 -148.97 20.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.425 ' N ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -132.02 159.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.672 -0.899 . . . . 0.0 109.666 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.42 141.69 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -88.36 144.68 26.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.547 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.5 p90 -141.27 158.63 43.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.73 -1.231 . . . . 0.0 108.49 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -135.03 137.57 43.09 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.514 0.674 . . . . 0.0 109.726 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.6 mt -106.33 129.68 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -86.39 142.94 28.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.376 -0.827 . . . . 0.0 110.378 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -61.93 -32.08 72.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.643 -0.66 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.5 -12.77 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.517 -0.739 . . . . 0.0 109.619 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.23 24.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.948 . . . . 0.0 108.939 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 49.13 52.91 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.815 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 mt -102.37 153.66 37.95 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.1 149.0 45.94 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 122.082 1.855 . . . . 0.0 112.72 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.54 140.89 51.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.264 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.5 mp -82.97 145.04 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.709 -0.619 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 96.1 mt-10 -101.17 139.2 37.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.425 ' OE1' HD22 ' A' ' 27' ' ' LEU . 59.2 tt0 -76.58 138.27 40.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.644 -0.66 . . . . 0.0 110.726 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.02 -18.65 56.94 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 97.8 mt-10 -97.0 159.95 14.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.681 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -89.55 148.59 23.3 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.416 0.627 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.43 143.94 34.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.713 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 tp -109.45 130.44 55.5 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -113.33 122.17 46.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.502 -0.749 . . . . 0.0 109.831 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -120.19 147.1 45.35 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.675 0.75 . . . . 0.0 110.426 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t 57.11 56.86 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.097 0.475 . . . . 0.0 110.751 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.56 166.03 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.81 143.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.602 0.715 . . . . 0.0 109.666 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.83 132.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.65 -0.656 . . . . 0.0 109.655 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.29 153.1 17.77 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.412 ' HB2' HD22 ' A' ' 14' ' ' ASN . 78.4 tt0 -95.71 110.44 22.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -1.147 . . . . 0.0 109.139 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 80' ' ' ARG . 75.4 t80 -103.84 109.73 21.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.145 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 43.75 -119.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.773 . . . . 0.0 110.438 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -94.01 -17.08 23.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.11 -0.994 . . . . 0.0 110.254 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 77' ' ' TYR . 78.4 ttt180 -102.56 144.13 31.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.38 153.27 37.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 0.0 108.955 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -143.82 152.05 40.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.991 -1.068 . . . . 0.0 109.011 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.89 122.27 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.86 128.67 53.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.448 -0.783 . . . . 0.0 109.414 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.11 133.11 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -136.94 -166.32 1.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 89' ' ' SER . 10.0 mtpm? -55.43 167.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.873 -0.517 . . . . 0.0 109.763 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 73.07 -23.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.413 -0.804 . . . . 0.0 109.614 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 87' ' ' LYS . 48.9 m -72.35 159.18 34.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.752 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.9 m -135.04 155.12 51.3 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.336 -0.852 . . . . 0.0 108.871 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -139.26 131.19 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.1 -1.0 . . . . 0.0 109.06 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -131.58 136.91 48.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 0.0 108.917 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -72.45 140.53 48.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.32 132.14 44.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.404 -0.81 . . . . 0.0 109.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -83.1 -4.77 58.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.661 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -115.53 93.66 37.42 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.78 . . . . 0.0 109.441 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.94 156.78 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.525 2.15 . . . . 0.0 112.208 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.7 147.85 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.05 -82.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.07 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t 61.09 60.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.33 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.54 32.38 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.8 tp -99.26 107.97 20.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 104' ' ' HIS . 74.2 tt0 -153.92 1.62 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 103' ' ' GLU . 96.5 m-70 53.09 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 109.357 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -136.06 135.88 39.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 109.206 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -77.77 146.35 35.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.677 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' HIS . 95.9 m-70 -75.73 144.75 41.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 107' ' ' HIS . 79.3 m80 49.42 -177.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.461 -0.775 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.697 -179.832 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mmm . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -165.0 58.19 0.57 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.4 156.06 62.48 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.673 2.249 . . . . 0.0 112.119 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.42 113.79 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.517 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.32 132.18 36.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.1 m -124.46 143.49 50.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.63 -0.668 . . . . 0.0 109.27 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -94.1 148.08 22.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.7 mt -57.24 -44.74 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 109.399 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.36 -12.31 13.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.565 -0.71 . . . . 0.0 109.385 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 53.7 t0 -97.31 4.89 50.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.2 mt -88.0 121.57 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.99 6.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.208 -0.933 . . . . 0.0 109.417 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -133.49 128.99 36.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -87.81 153.61 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.148 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.88 17.01 78.04 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -96.44 150.12 20.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.425 -1.044 . . . . 0.0 110.045 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -102.33 131.26 49.05 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.4 0.619 . . . . 0.0 109.481 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.63 179.24 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.578 ' C ' HD22 ' A' ' 20' ' ' LEU . 5.0 m-80 -117.15 131.12 56.95 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.578 HD22 ' C ' ' A' ' 19' ' ' ASN . 4.4 mm? -117.18 146.26 43.33 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.898 0.856 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -136.08 131.47 34.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.54 -173.82 0.78 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.039 0.923 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' CE ' ' H ' ' A' ' 98' ' ' ILE . 34.2 ttmt -111.85 150.98 29.62 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.943 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.4 t -86.39 95.02 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.21 -26.7 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.77 . . . . 0.0 109.811 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -143.17 119.25 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.954 -1.091 . . . . 0.0 109.379 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD11 ' NE2' ' A' ' 37' ' ' GLN . 61.4 tp -109.3 143.63 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 0.0 109.18 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -140.26 107.28 5.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.61 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -73.01 116.93 14.12 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' ND1' ' A' ' 32' ' ' HIS . 48.9 t-20 -102.8 134.23 46.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.259 -0.901 . . . . 0.0 109.175 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.17 11.26 37.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 108.905 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.465 ' ND1' ' OD1' ' A' ' 30' ' ' ASN . 24.3 m80 -79.4 147.4 32.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.34 -41.2 73.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.32 -0.862 . . . . 0.0 110.068 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 t -63.65 -51.47 65.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.313 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 32' ' ' HIS . 93.8 mt -106.58 133.7 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.677 0.751 . . . . 0.0 109.446 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -97.63 -50.06 4.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' NE2' HD11 ' A' ' 27' ' ' LEU . 48.2 tt0 -149.87 146.84 27.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 110.129 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.39 153.01 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.38 -161.58 23.87 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.275 -1.441 . . . . 0.0 109.925 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.76 146.53 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.021 -0.693 . . . . 0.0 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD21 ' CE1' ' A' ' 50' ' ' PHE . 70.3 mt -112.3 127.08 55.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.53 -0.731 . . . . 0.0 109.431 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.35 100.93 2.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -101.25 162.39 12.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.359 -1.083 . . . . 0.0 109.358 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -72.26 -21.93 61.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.601 -0.687 . . . . 0.0 109.893 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.9 p -93.92 -16.12 24.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.208 -0.933 . . . . 0.0 109.136 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.21 -156.98 29.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.014 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 47' ' ' ILE . 15.2 pt -137.98 163.18 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.531 -0.981 . . . . 0.0 109.93 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.2 tt -162.5 152.12 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.196 -0.94 . . . . 0.0 109.716 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -97.12 138.84 34.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.4 p90 -131.49 156.16 46.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.058 -1.026 . . . . 0.0 108.933 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.8 m -131.59 132.28 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.472 0.653 . . . . 0.0 109.64 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.3 mt -98.47 128.23 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 109.699 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -85.0 143.73 28.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -0.792 . . . . 0.0 110.432 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.56 -35.36 74.09 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -58.97 -9.54 1.94 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.575 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.22 -28.13 24.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 108.889 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 45.9 49.99 11.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.639 . . . . 0.0 109.865 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.0 mt -102.78 153.22 38.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.614 -0.679 . . . . 0.0 109.739 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.78 149.91 47.89 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.357 2.038 . . . . 0.0 112.642 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.91 140.4 53.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.469 -0.77 . . . . 0.0 110.335 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -81.57 145.42 30.66 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.423 0.63 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 97.0 mt-10 -94.24 128.78 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 58.3 tt0 -68.5 135.45 51.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.592 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.1 71.59 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.0 mp0 -99.4 162.38 13.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -1.123 . . . . 0.0 110.687 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -98.04 137.13 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -133.75 153.38 51.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.133 0.968 . . . . 0.0 110.08 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 tp -111.74 131.32 55.39 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.9 mt -111.9 120.86 43.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.471 -0.768 . . . . 0.0 109.533 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' O ' ' OG ' ' A' ' 71' ' ' SER . 83.0 mtp180 -117.75 151.37 37.43 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.578 0.704 . . . . 0.0 110.647 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.2 p 51.71 56.2 8.21 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.52 166.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.55 150.03 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.686 0.755 . . . . 0.0 109.888 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.45 132.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.674 . . . . 0.0 109.442 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.75 150.2 16.85 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -88.02 99.7 12.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ARG . 76.2 t80 -98.1 100.71 12.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.251 -0.906 . . . . 0.0 109.225 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 44.7 -119.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 110.7 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 34.6 p-10 -93.65 -7.58 43.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -110.57 155.27 22.56 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.89 0.852 . . . . 0.0 110.184 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -95.95 153.45 17.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 108.848 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -144.11 159.43 42.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.41 126.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -103.13 126.75 50.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.432 -0.792 . . . . 0.0 109.148 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.03 132.24 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -127.01 -168.45 1.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.692 0.758 . . . . 0.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -65.2 -41.76 94.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.762 -0.587 . . . . 0.0 110.18 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -12.2 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.413 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 37.8 t -83.86 164.03 19.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.8 m -136.5 157.59 46.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.327 -0.858 . . . . 0.0 109.044 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 61' ' ' LEU . 96.3 mt -134.96 128.24 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.267 -0.896 . . . . 0.0 109.226 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -129.76 133.12 46.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.467 ' C ' HD22 ' A' ' 94' ' ' LEU . 66.0 tttm -80.1 134.86 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' GLU . 4.0 mm? -107.64 -1.7 20.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.464 -0.772 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 14.3 t 47.28 15.77 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.269 -0.894 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 94' ' ' LEU . 6.9 tp10 -114.83 93.28 33.31 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 108.936 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.8 147.39 41.3 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.683 2.255 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.414 ' H ' ' CE ' ' A' ' 23' ' ' LYS . 29.8 mm -105.74 139.96 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.573 -0.704 . . . . 0.0 109.17 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -93.79 122.43 36.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.495 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.2 m -101.83 -5.48 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 103' ' ' GLU . . . 156.03 -94.26 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 103' ' ' GLU . 73.4 mt 56.04 5.48 0.17 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.481 -1.011 . . . . 0.0 109.312 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 101' ' ' GLY . 97.8 mt-10 44.21 -170.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.735 0.778 . . . . 0.0 110.751 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -152.97 127.5 9.35 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -154.6 24.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 108.875 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 47.2 77.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.475 -0.766 . . . . 0.0 109.293 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.49 139.64 38.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.61 -0.681 . . . . 0.0 110.037 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -73.2 139.02 45.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.677 -179.86 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -91.08 156.44 44.04 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.368 -0.833 . . . . 0.0 109.575 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.97 157.29 62.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.571 2.181 . . . . 0.0 111.971 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.56 117.96 22.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -87.77 128.67 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.442 ' O ' HD23 ' A' ' 20' ' ' LEU . 84.9 m -124.94 145.64 49.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -97.49 142.71 28.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 pt -52.94 -39.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 0.0 109.733 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.56 -12.19 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.504 -0.748 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -97.17 5.18 50.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.95 123.77 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.159 -0.963 . . . . 0.0 109.951 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.41 8.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -137.45 134.42 35.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 109.243 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.568 ' ND2' ' OE1' ' A' ' 76' ' ' GLU . 45.8 m-80 -92.61 153.74 18.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.369 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.19 71.75 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -95.83 146.86 24.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.66 132.47 52.61 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.352 0.596 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -175.16 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 0.0 109.848 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 27.3 t30 -119.48 140.53 50.31 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 6' ' ' THR . 14.8 mt -133.62 149.03 51.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.383 -0.823 . . . . 0.0 110.165 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -133.07 127.34 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.93 177.5 10.31 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.098 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -109.16 153.15 24.15 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.919 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.0 99.61 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.286 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.51 -26.09 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -158.36 147.43 19.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.361 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.3 pt? -133.54 158.78 42.27 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.51 -0.744 . . . . 0.0 109.628 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -142.41 109.32 5.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -68.29 123.63 21.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.231 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 35' ' ' ILE . 7.9 t-20 -134.8 123.37 23.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.406 -0.809 . . . . 0.0 109.261 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -136.71 24.18 3.12 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.368 -0.833 . . . . 0.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.46 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.441 -0.787 . . . . 0.0 109.837 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -73.66 -110.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 109.443 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -116.02 10.85 15.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 30' ' ' ASN . 89.8 mt -81.13 133.15 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 t -86.25 -57.43 3.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.991 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -151.41 154.95 37.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.187 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.35 139.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.69 -156.02 10.12 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.327 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.06 152.2 51.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.832 -0.805 . . . . 0.0 109.688 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.75 131.64 54.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.33 99.15 2.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -100.34 160.78 14.06 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.452 -1.028 . . . . 0.0 109.46 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.98 -16.63 63.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 109.85 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -96.63 -11.72 24.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.213 -0.929 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.17 17.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.676 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.6 pp -132.82 162.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.964 . . . . 0.0 109.635 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.444 HD11 ' O ' ' A' ' 81' ' ' PHE . 7.2 tp -156.67 148.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.497 ' HZ1' ' NH1' ' A' ' 80' ' ' ARG . 63.1 mttp -81.53 164.13 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.603 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -157.01 148.07 21.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.64 -1.288 . . . . 0.0 108.543 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -136.42 131.88 34.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.216 -0.927 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.07 130.11 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.664 -0.648 . . . . 0.0 109.578 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -86.85 141.44 28.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 56' ' ' ALA . 12.6 mmtm -56.59 -35.3 68.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.54 -0.725 . . . . 0.0 109.068 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -59.4 -4.6 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.484 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -87.35 -31.08 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 108.909 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 51.22 50.62 18.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 110.089 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.82 152.38 42.29 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.765 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.2 148.34 41.02 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.173 1.915 . . . . 0.0 112.784 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -68.32 144.65 54.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.479 -0.763 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -80.16 145.21 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -102.35 133.91 46.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.368 -0.833 . . . . 0.0 109.48 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -73.71 138.42 44.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.477 -0.764 . . . . 0.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.29 -8.15 79.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -106.04 157.32 17.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.417 -1.049 . . . . 0.0 110.493 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -89.1 147.4 24.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.861 -0.525 . . . . 0.0 109.619 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -140.52 145.75 37.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.819 0.819 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -111.69 131.25 55.42 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 2.8 mp -117.75 115.85 25.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.516 -0.74 . . . . 0.0 109.51 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -109.59 149.12 30.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.52 -0.737 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.68 59.43 3.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.789 -0.569 . . . . 0.0 110.61 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.79 162.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.27 147.96 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.512 0.673 . . . . 0.0 109.473 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.36 127.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.22 156.79 15.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.568 ' OE1' ' ND2' ' A' ' 14' ' ' ASN . 49.6 tp10 -105.6 134.35 48.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -1.006 . . . . 0.0 108.816 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 79' ' ' ASP . 87.9 t80 -129.37 117.93 21.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.744 . . . . 0.0 109.077 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' TYR . 95.0 m-20 39.65 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.707 -0.62 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 77' ' ' TYR . 37.3 p-10 -125.08 -17.61 5.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.309 -0.869 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.497 ' NH1' ' HZ1' ' A' ' 49' ' ' LYS . 96.8 mtt180 -93.25 155.43 17.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.969 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.508 ' CE2' ' OE1' ' A' ' 76' ' ' GLU . 96.0 m-85 -101.81 149.09 24.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 0.0 108.945 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -152.35 161.16 43.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -104.46 127.75 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.29 127.01 46.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.798 . . . . 0.0 109.596 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.59 133.15 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 109.07 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.433 ' N ' ' OG ' ' A' ' 89' ' ' SER . 78.8 m-20 -132.5 -166.16 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -62.36 -40.91 97.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -62.27 -32.31 73.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 86' ' ' ASN . 24.2 p -79.54 164.72 23.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.4 t -139.54 166.92 23.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.468 -0.77 . . . . 0.0 109.111 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -139.59 131.58 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.189 -0.944 . . . . 0.0 109.175 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -128.81 132.43 47.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.299 -0.876 . . . . 0.0 109.147 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.64 139.98 40.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.296 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -101.26 141.57 33.95 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.971 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -84.43 -1.75 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.556 -0.715 . . . . 0.0 109.681 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.04 131.4 23.19 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.433 -0.792 . . . . 0.0 109.692 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.43 152.91 49.81 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.998 1.799 . . . . 0.0 112.439 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.49 134.44 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.54 -0.725 . . . . 0.0 109.14 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -93.8 118.52 31.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.303 -0.873 . . . . 0.0 109.837 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.85 -31.2 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.3 104.23 0.66 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt 43.39 72.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.596 -0.943 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.03 128.37 35.81 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.452 0.644 . . . . 0.0 110.39 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 105' ' ' HIS . 45.5 t-80 -155.52 173.95 15.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 104' ' ' HIS . 97.9 m-70 -57.54 -157.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 109.515 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -76.28 -9.51 58.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.27 125.1 21.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -149.0 139.06 22.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.176 -0.952 . . . . 0.0 109.511 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 109' ' ' HIS . 13.6 p-80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mmm . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.57 0.7 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 2.4 mt-10 -82.61 -49.4 0.81 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.279 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 74.4 Cg_endo -77.58 162.43 30.33 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.123 1.882 . . . . 0.0 112.28 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -76.72 118.5 19.41 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.303 -0.873 . . . . 0.0 109.35 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.8 mt -93.23 128.29 39.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -127.86 150.5 49.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -97.61 146.99 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.153 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.42 -42.3 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.795 . . . . 0.0 108.956 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.41 -8.97 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.558 -0.714 . . . . 0.0 109.407 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 57.9 t0 -100.18 4.46 44.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.904 . . . . 0.0 109.176 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.56 118.95 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.55 6.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 14' ' ' ASN . 8.0 tm-20 -131.09 129.34 41.76 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.407 -0.808 . . . . 0.0 109.137 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p30 -88.04 150.63 23.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.284 -0.885 . . . . 0.0 110.289 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.85 16.33 79.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -93.07 144.46 25.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.364 -1.08 . . . . 0.0 109.938 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.82 129.69 45.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.695 . . . . 0.0 109.565 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.71 -179.42 7.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.384 -0.822 . . . . 0.0 109.876 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 71' ' ' SER . 77.2 m-20 -140.09 145.48 37.69 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.453 -0.779 . . . . 0.0 109.157 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.96 158.57 30.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -100.57 139.69 35.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.044 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 41' ' ' LEU . . . -153.26 157.51 40.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -103.06 153.89 19.81 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.1 110.45 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.132 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 pt -91.5 -21.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 110.143 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -162.76 153.03 16.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.08 -1.013 . . . . 0.0 109.422 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.5 mt -132.06 157.11 45.0 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.572 0.701 . . . . 0.0 109.909 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' VAL . 46.1 m95 -144.55 118.94 9.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.218 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 128.17 34.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.6 141.68 35.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.317 -0.864 . . . . 0.0 109.122 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 33' ' ' GLU . 70.8 p -120.83 11.59 11.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.461 -0.775 . . . . 0.0 109.142 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -62.62 10.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.509 -0.744 . . . . 0.0 109.377 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.616 ' H ' ' C ' ' A' ' 31' ' ' THR . 96.8 mt-10 56.44 16.1 2.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 110.703 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 t -131.74 -32.71 1.45 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.384 -0.823 . . . . 0.0 108.935 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.41 138.62 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.799 0.809 . . . . 0.0 109.432 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -81.69 -65.1 1.05 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.547 0.689 . . . . 0.0 109.914 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -149.55 153.24 36.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.011 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 28' ' ' TRP . 3.0 t -137.91 163.75 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.55 33.55 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.1 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -126.96 146.81 50.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.973 -0.722 . . . . 0.0 109.123 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 58.1 mt -109.92 129.41 55.66 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.79 101.74 2.8 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -107.01 165.0 11.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.597 -0.943 . . . . 0.0 109.458 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.96 -18.78 62.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.52 -0.738 . . . . 0.0 109.847 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 p -91.66 -11.56 36.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 109.391 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.25 -146.61 15.89 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.56 151.1 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.691 -0.888 . . . . 0.0 109.636 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tp -146.48 138.06 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.765 . . . . 0.0 109.655 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -83.28 152.52 25.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.382 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.11 154.67 41.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.574 -1.329 . . . . 0.0 107.864 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -132.19 131.06 41.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.637 -0.664 . . . . 0.0 109.743 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.71 128.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -89.41 144.02 26.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HZ3' ' HA ' ' A' ' 33' ' ' GLU . 53.8 mtmt -58.22 -34.36 70.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.84 -5.7 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -89.07 -33.41 17.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 108.719 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 49.81 50.25 18.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.597 -0.689 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD13 ' HB1' ' A' ' 56' ' ' ALA . 5.8 mp -102.85 163.11 18.2 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.551 -0.718 . . . . 0.0 109.671 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.79 150.09 84.73 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.577 2.185 . . . . 0.0 112.325 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.5 mt -72.35 142.82 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 110.308 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -84.35 149.52 25.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.668 . . . . 0.0 109.723 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 57.0 mp0 -110.14 142.39 41.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.964 0.888 . . . . 0.0 109.593 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -74.56 137.58 42.49 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.541 0.686 . . . . 0.0 110.794 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.49 -14.91 64.4 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.06 155.01 16.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 0.0 110.832 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.468 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 5.7 p -93.39 158.79 15.55 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.489 ' HE2' ' HZ3' ' A' ' 93' ' ' LYS . 90.1 m-85 -149.8 149.28 30.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -103.66 131.73 50.56 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 68' ' ' LEU . 77.0 mt -105.43 107.5 18.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -110.15 139.39 45.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.463 0.649 . . . . 0.0 110.252 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 25.2 t 55.25 59.11 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.88 -0.512 . . . . 0.0 110.908 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.42 165.57 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.34 -0.85 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.78 153.99 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.623 0.725 . . . . 0.0 109.759 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.03 131.28 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 0.0 109.709 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.47 148.13 17.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.29 100.19 12.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -1.166 . . . . 0.0 109.229 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' ARG . 73.5 t80 -101.49 105.2 16.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 t30 40.57 -117.13 0.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.527 -0.733 . . . . 0.0 110.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.63 -18.35 23.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -99.29 162.78 12.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 110.056 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.48 153.0 24.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -146.23 163.13 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 0.0 109.124 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.62 125.89 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -106.08 126.19 51.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.381 -0.824 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -97.17 135.2 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -130.95 -169.41 2.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.479 -0.763 . . . . 0.0 109.747 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.53 -39.45 94.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.649 -0.657 . . . . 0.0 110.224 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -68.0 -19.63 64.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.794 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.57 166.24 17.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -0.843 . . . . 0.0 110.019 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -145.08 164.29 31.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -0.92 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mt -149.4 139.72 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -133.61 143.24 48.5 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.468 -0.77 . . . . 0.0 109.583 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 68.1 mttm -72.81 140.68 47.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.766 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt -111.64 147.72 34.89 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.634 0.73 . . . . 0.0 109.996 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -95.75 6.07 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.0 109.783 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.56 92.08 43.09 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.427 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.09 160.46 8.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.821 2.348 . . . . 0.0 112.117 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.81 139.2 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.552 -0.717 . . . . 0.0 109.55 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 101' ' ' GLY . 48.7 tp10 -71.19 126.58 29.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -0.809 . . . . 0.0 109.641 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.2 2.45 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.424 ' O ' ' OE2' ' A' ' 99' ' ' GLU . . . -151.14 106.22 0.3 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.442 ' CD2' ' H ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -89.43 102.23 14.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.333 -1.098 . . . . 0.0 109.239 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 103' ' ' GLU . 57.2 mp0 -46.54 98.68 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.493 0.663 . . . . 0.0 110.583 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -65.89 -41.88 90.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.817 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 107' ' ' HIS . 81.7 t60 -150.11 -56.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.422 -0.799 . . . . 0.0 109.113 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 46.02 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.43 -0.794 . . . . 0.0 109.845 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' HIS . 85.1 t60 -153.08 69.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.196 -0.94 . . . . 0.0 109.36 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -66.3 -43.43 86.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.489 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.18 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 CA-C-O 121.577 0.574 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -80.32 119.99 23.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.9 mm? -90.91 131.64 36.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 141.95 51.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.84 150.64 20.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 110.106 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mm -55.0 -45.45 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.64 0.733 . . . . 0.0 109.371 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.98 -11.72 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -97.4 3.91 50.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 109.653 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLU . 77.8 mt -59.87 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.306 -0.871 . . . . 0.0 110.483 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' ILE . 11.8 m 31.26 31.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.397 0.617 . . . . 0.0 110.735 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.3 tt0 -166.13 112.78 0.88 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.321 -0.862 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 54.1 p30 -86.91 154.45 20.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 23.98 76.3 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -97.48 140.2 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -1.031 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.91 128.62 44.05 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.44 -170.71 2.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -130.68 135.16 47.56 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.76 148.12 43.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -116.57 132.5 56.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.85 165.68 29.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.045 0.926 . . . . 0.0 110.925 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -105.6 155.69 18.97 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.909 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -88.36 99.78 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.234 -0.916 . . . . 0.0 110.467 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.518 HD11 ' CA ' ' A' ' 42' ' ' GLY . 54.5 mt -69.73 -28.71 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.077 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.27 140.52 18.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 109.24 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.6 pt? -120.93 150.09 41.62 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.34 0.591 . . . . 0.0 109.926 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -141.03 112.25 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.374 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 109.433 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.571 0.701 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 t -96.85 -49.44 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.592 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.42 149.42 28.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.02 142.41 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.693 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -163.17 -161.52 12.61 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.92 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.693 HD12 ' C ' ' A' ' 39' ' ' GLY . 9.5 mp -120.2 146.16 46.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.943 -0.739 . . . . 0.0 109.42 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.3 mt -108.77 124.41 50.55 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.518 ' CA ' HD11 ' A' ' 25' ' ' ILE . . . -95.26 96.75 2.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.8 t0 -100.48 160.85 14.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -1.159 . . . . 0.0 109.387 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 84.3 tt0 -70.36 -20.5 62.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.693 -0.63 . . . . 0.0 109.858 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.4 p -92.15 -12.12 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.16 -153.28 24.46 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.99 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 pt -136.48 159.86 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.547 -0.973 . . . . 0.0 109.918 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -159.2 146.34 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.842 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -90.31 134.9 34.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -129.5 157.27 42.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 108.649 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.2 m -132.89 132.52 42.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.47 127.91 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -85.3 145.54 27.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 110.547 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.54 -36.64 78.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -59.63 -8.89 2.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.474 -0.766 . . . . 0.0 109.899 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 -26.47 24.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 109.044 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.59 51.32 15.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.697 -0.627 . . . . 0.0 109.878 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.0 mt -105.28 148.76 36.8 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.37 161.96 42.61 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.618 2.212 . . . . 0.0 112.637 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.01 141.0 47.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.665 0.745 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.2 mp -84.31 156.67 21.81 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.442 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 42.7 tt0 -99.87 129.59 45.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.388 -0.82 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.448 ' OE1' HD22 ' A' ' 27' ' ' LEU . 58.9 tt0 -65.79 137.63 57.37 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.456 0.646 . . . . 0.0 110.487 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.93 -10.68 64.63 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -94.79 151.68 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -1.135 . . . . 0.0 110.31 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -84.99 140.44 31.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.442 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 33.1 m-85 -133.7 142.87 48.19 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.754 0.787 . . . . 0.0 109.773 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.09 127.79 54.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.64 118.46 35.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -114.18 145.55 41.54 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.408 0.623 . . . . 0.0 110.403 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t 58.17 58.15 3.65 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.726 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.05 165.98 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.343 -0.848 . . . . 0.0 109.273 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.27 149.81 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.729 0.776 . . . . 0.0 110.012 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.02 133.89 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.754 -0.591 . . . . 0.0 109.629 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.28 148.73 16.78 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -94.63 104.64 16.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -1.146 . . . . 0.0 109.148 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 80' ' ' ARG . 84.3 t80 -99.85 106.4 18.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.789 . . . . 0.0 109.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.2 t30 42.19 -116.64 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.549 -0.72 . . . . 0.0 110.757 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.41 -17.12 23.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.085 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 mmm-85 -100.94 156.43 17.39 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.874 0.845 . . . . 0.0 110.373 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -97.79 150.83 20.83 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.68 155.5 43.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 109.17 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.85 125.19 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.372 -0.83 . . . . 0.0 108.956 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -106.38 129.25 54.41 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.741 . . . . 0.0 109.279 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.89 131.22 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -136.55 -163.08 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.804 0.812 . . . . 0.0 109.821 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 89' ' ' SER . 33.9 mmtt -57.35 166.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.792 -0.567 . . . . 0.0 109.472 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 12.8 t-20 72.81 -21.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.708 -0.62 . . . . 0.0 109.547 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 87' ' ' LYS . 87.1 p -74.61 159.29 32.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.3 m -136.86 156.22 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.399 -0.813 . . . . 0.0 109.131 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.62 130.66 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -132.16 138.05 47.88 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 0.0 109.355 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' C ' HD22 ' A' ' 94' ' ' LEU . 50.7 mtmt -81.81 138.98 35.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.592 -0.692 . . . . 0.0 109.762 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.1 mm? -110.71 137.73 48.01 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.922 0.868 . . . . 0.0 110.147 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -86.58 8.34 22.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -117.04 91.77 37.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.329 -0.857 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -55.34 152.32 32.62 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.887 2.391 . . . . 0.0 112.136 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.6 mt -101.14 147.79 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.26 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 57.0 mp0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.855 . . . . 0.0 110.201 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.408 ' HB2' HD22 ' A' ' 19' ' ' ASN . 43.6 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.376 0.49 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.12 119.87 23.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.914 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.9 mm? -90.39 128.88 36.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.782 . . . . 0.0 109.753 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -128.44 145.01 51.22 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.19 143.0 28.42 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.71 0.767 . . . . 0.0 110.494 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.4 HD13 ' CG2' ' A' ' 48' ' ' ILE . 83.1 mt -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.41 -0.806 . . . . 0.0 109.322 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.41 -10.79 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.448 -0.783 . . . . 0.0 109.918 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -97.51 6.28 48.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 13' ' ' GLU . 44.8 mt -59.85 -70.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.3 m 40.5 17.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.741 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.639 ' H ' HG22 ' A' ' 11' ' ' ILE . 6.5 pt-20 -171.92 130.77 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.808 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.83 167.38 12.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.021 -1.049 . . . . 0.0 110.58 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.17 23.54 77.39 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.1 136.67 35.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -1.03 . . . . 0.0 110.17 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -97.33 127.44 43.3 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -162.71 -169.73 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 43.4 m-20 -140.59 137.86 33.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.568 -0.707 . . . . 0.0 109.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.67 147.45 25.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 110.391 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -101.14 140.92 34.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.53 0.681 . . . . 0.0 109.397 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 161.62 42.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.292 -0.88 . . . . 0.0 110.77 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.02 148.93 25.65 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.355 0.598 . . . . 0.0 109.645 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -87.48 94.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.278 -0.889 . . . . 0.0 110.52 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.511 HD11 ' CA ' ' A' ' 42' ' ' GLY . 52.8 mt -70.61 -31.26 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.499 -0.751 . . . . 0.0 109.324 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -148.07 129.3 14.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.064 -1.022 . . . . 0.0 109.604 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.444 HD11 HE21 ' A' ' 37' ' ' GLN . 60.7 tp -110.89 146.5 36.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -142.57 111.35 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.54 0.686 . . . . 0.0 109.795 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.666 . . . . 0.0 109.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.674 0.749 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -83.53 -56.79 3.54 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.666 0.746 . . . . 0.0 109.963 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.444 HE21 HD11 ' A' ' 27' ' ' LEU . 5.6 pt20 -159.11 162.22 36.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.107 -0.996 . . . . 0.0 110.44 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.09 159.61 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.18 -157.95 20.58 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -125.76 149.82 48.24 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.973 -0.722 . . . . 0.0 109.976 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.636 HD21 ' CD1' ' A' ' 50' ' ' PHE . 31.5 mt -109.91 124.81 52.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' HD11 ' A' ' 25' ' ' ILE . . . -92.17 94.35 1.9 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.58 159.99 14.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -1.011 . . . . 0.0 109.597 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.13 -17.54 63.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.819 -0.551 . . . . 0.0 109.839 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 p -92.43 -9.66 40.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.25 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.64 -148.29 19.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -138.16 160.56 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.696 -0.885 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.4 ' CG2' HD13 ' A' ' 8' ' ' ILE . 20.0 tt -162.57 158.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.927 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -84.8 164.58 18.39 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.558 -0.714 . . . . 0.0 110.275 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.636 ' CD1' HD21 ' A' ' 41' ' ' LEU . 24.8 p90 -156.06 153.65 29.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.069 -1.019 . . . . 0.0 108.549 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.516 ' OG1' ' NE2' ' A' ' 82' ' ' GLN . 69.5 m -136.36 129.57 31.51 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.3 mt -106.52 130.12 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -90.26 142.92 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 110.431 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.42 -35.04 76.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.687 -0.633 . . . . 0.0 109.456 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -58.89 -7.8 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.473 -0.767 . . . . 0.0 109.825 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.52 -23.59 34.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.869 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 51.16 44.26 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 109.887 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.57 151.6 39.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.796 -0.565 . . . . 0.0 109.716 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.54 146.89 50.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.479 2.119 . . . . 0.0 112.804 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.07 141.61 56.09 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.658 0.742 . . . . 0.0 110.491 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -81.1 139.85 35.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.0 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.32 134.08 37.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.466 -0.771 . . . . 0.0 110.17 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.78 136.57 48.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.402 0.62 . . . . 0.0 110.532 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -6.36 83.5 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.59 159.87 15.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -1.001 . . . . 0.0 110.543 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -95.7 148.93 22.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -141.23 150.07 42.18 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.005 0.907 . . . . 0.0 109.964 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.525 HD21 ' HE ' ' A' ' 70' ' ' ARG . 37.0 tp -101.01 132.1 46.57 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 mt -112.72 112.4 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.928 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.525 ' HE ' HD21 ' A' ' 68' ' ' LEU . 94.0 mtt180 -118.64 145.46 45.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 54.91 6.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.04 165.94 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 0.0 109.304 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.859 0.838 . . . . 0.0 109.925 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -92.61 131.71 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.579 -0.7 . . . . 0.0 109.855 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.64 150.5 16.81 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.77 104.85 16.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.6 -0.941 . . . . 0.0 109.364 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 80' ' ' ARG . 42.0 t80 -97.06 104.22 16.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 109.239 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' TYR . 98.7 m-20 39.67 -111.87 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -95.13 -20.19 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.419 -0.801 . . . . 0.0 109.898 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.1 mtt180 -98.85 159.29 15.06 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.905 0.86 . . . . 0.0 110.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.3 149.97 20.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.752 . . . . 0.0 109.14 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 51' ' ' THR . 57.1 tt0 -144.03 150.96 39.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.89 124.47 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -107.43 126.36 52.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.446 -0.783 . . . . 0.0 109.567 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.22 132.82 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 87' ' ' LYS . 13.5 p30 -146.06 -176.57 5.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.768 0.794 . . . . 0.0 110.014 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' SER . 80.5 tttt -42.84 166.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 1.8 t-20 73.5 -30.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.65 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 87' ' ' LYS . 81.6 p -76.95 164.3 25.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 109.964 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 p -139.63 158.31 44.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.427 -0.796 . . . . 0.0 109.417 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.7 mt -141.89 133.73 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.499 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.37 138.71 46.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.612 0.72 . . . . 0.0 109.232 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 95' ' ' SER . 88.2 tttt -73.05 139.47 46.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.592 -0.692 . . . . 0.0 109.594 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 96' ' ' GLU . 89.3 mt -101.01 -13.37 18.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.443 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 35.9 t 51.91 4.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.758 -0.589 . . . . 0.0 109.732 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 94' ' ' LEU . 37.8 tp10 -107.59 127.29 28.07 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.617 -0.677 . . . . 0.0 109.5 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.82 141.08 29.9 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.411 2.074 . . . . 0.0 112.182 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.3 mt -112.09 135.97 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.77 -0.582 . . . . 0.0 109.456 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 -179.704 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.497 1.735 0 CA-C-O 121.495 0.54 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -79.26 116.31 19.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.313 -0.867 . . . . 0.0 109.471 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt -92.33 129.47 38.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.347 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' ' CD2' ' A' ' 20' ' ' LEU . 83.3 m -125.83 144.14 50.77 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.88 146.29 23.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.052 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.07 -42.36 89.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.176 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.55 -8.54 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.632 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -103.37 9.28 37.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -86.32 124.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.168 -0.957 . . . . 0.0 109.944 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -144.13 8.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 109.286 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -143.37 138.75 29.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.277 -0.89 . . . . 0.0 109.141 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 54.0 p30 -97.52 159.37 14.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.448 -0.783 . . . . 0.0 110.353 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.91 9.91 84.74 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.85 155.55 17.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -1.083 . . . . 0.0 109.691 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.2 134.71 50.66 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.462 0.649 . . . . 0.0 109.572 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -160.17 -176.78 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.905 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 7.7 t30 -122.48 142.97 50.01 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -139.12 128.2 23.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.32 -0.862 . . . . 0.0 109.686 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.667 ' N ' HD13 ' A' ' 20' ' ' LEU . 37.1 ttmt -112.45 132.75 54.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.39 -173.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -112.53 154.91 25.2 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.09 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -92.48 113.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -71.67 -26.77 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 0.0 110.035 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.502 ' OE1' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -172.45 167.41 5.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.98 -1.075 . . . . 0.0 109.182 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.716 ' N ' HE21 ' A' ' 63' ' ' GLN . 82.7 mt -138.29 160.87 38.36 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.428 0.632 . . . . 0.0 110.005 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.406 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 14.6 t90 -134.86 105.63 6.51 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.55 0.69 . . . . 0.0 109.414 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 37' ' ' GLN . 51.4 tp10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.291 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.515 2.798 0 CA-C-O 121.324 0.583 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -94.5 -58.36 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.034 . . . . 0.0 109.666 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.543 ' NE2' ' OE1' ' A' ' 29' ' ' GLU . 6.7 mm-40 -145.0 149.29 34.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.046 -1.034 . . . . 0.0 109.979 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.47 127.99 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.4 -159.86 9.48 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.46 149.45 52.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.733 -0.863 . . . . 0.0 109.666 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.85 126.79 53.43 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.59 100.55 2.64 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 46' ' ' GLY . 5.5 p-10 -104.96 161.79 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.297 -1.12 . . . . 0.0 109.285 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.87 -17.38 63.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.743 . . . . 0.0 109.928 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.7 p -94.42 -3.88 49.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' OD2' ' A' ' 43' ' ' ASP . . . 146.47 -144.42 12.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.35 166.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.678 -0.895 . . . . 0.0 110.05 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.78 162.66 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.103 -0.998 . . . . 0.0 109.846 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -97.09 149.77 21.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.0 109.729 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.36 157.46 44.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.431 -1.418 . . . . 0.0 107.801 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -130.93 134.27 46.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.582 -0.699 . . . . 0.0 109.685 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 mm -102.64 127.91 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 109.149 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -83.69 137.26 33.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 110.497 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.92 -33.74 75.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -58.77 -11.03 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.596 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.9 -22.43 27.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -0.939 . . . . 0.0 108.988 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.07 55.76 7.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.64 -0.663 . . . . 0.0 109.914 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -106.03 147.94 35.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.594 -0.691 . . . . 0.0 109.832 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.86 159.77 51.35 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.521 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.66 137.98 55.99 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.627 0.727 . . . . 0.0 109.987 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.1 mp -79.61 155.1 28.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.843 -0.536 . . . . 0.0 109.667 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 3.1 tm-20 -100.54 121.85 42.27 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.955 0.883 . . . . 0.0 109.707 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 27' ' ' LEU . 98.8 mt-30 -63.37 138.31 58.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 -10.93 67.76 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.92 158.82 15.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -1.182 . . . . 0.0 110.458 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 p -95.45 124.87 39.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.433 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 44.4 m-85 -118.54 150.07 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.971 0.891 . . . . 0.0 109.78 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.535 HD21 ' HE ' ' A' ' 70' ' ' ARG . 28.8 tp -110.84 127.17 55.32 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 45.7 mt -114.36 114.96 26.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.535 ' HE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -109.93 147.27 33.74 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.458 0.647 . . . . 0.0 110.43 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 t 58.26 58.5 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.015 0.436 . . . . 0.0 110.772 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' ALA . 16.4 m -109.2 160.41 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.301 -0.874 . . . . 0.0 108.886 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.77 144.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.618 0.723 . . . . 0.0 109.533 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.8 t -92.19 131.75 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.58 22.12 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.491 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 97.3 mt-10 -96.96 135.04 39.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -1.116 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -135.99 119.72 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.84 . . . . 0.0 109.621 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 51.8 48.12 23.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.7 t0 60.57 20.0 9.86 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.679 -0.638 . . . . 0.0 110.449 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -128.54 155.07 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -74.63 137.57 42.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -148.62 152.07 36.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.052 -1.03 . . . . 0.0 108.977 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.96 124.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -104.95 126.34 51.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.46 132.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.88 -170.29 1.84 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.68 0.753 . . . . 0.0 109.874 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -66.15 -42.91 88.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.766 -0.584 . . . . 0.0 110.43 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.503 ' ND2' ' H ' ' A' ' 88' ' ' ASN . 2.0 p30 -61.15 -7.7 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -83.32 164.41 20.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -136.07 154.93 50.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.312 -0.867 . . . . 0.0 108.875 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.57 127.6 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -128.39 131.6 48.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 108.957 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 136.06 36.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLU . 9.5 mp -103.86 -3.96 24.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.479 -0.763 . . . . 0.0 109.454 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t 49.41 7.93 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 94' ' ' LEU . 31.7 tt0 -103.62 124.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 109.312 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.17 141.18 25.87 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.054 1.836 . . . . 0.0 112.1 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.43 135.68 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.468 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.492 1.429 0 CA-C-O 121.412 0.505 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -78.56 117.17 19.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.7 mt -92.52 130.47 38.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.309 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.6 m -124.56 144.69 50.0 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -96.77 151.23 19.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.0 mt -58.17 -44.01 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.405 -0.809 . . . . 0.0 109.1 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.1 -14.55 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.781 . . . . 0.0 109.46 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.0 4.7 53.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.194 -0.941 . . . . 0.0 109.364 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.3 mt -87.67 121.45 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.816 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.95 7.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -135.89 135.32 39.6 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 0.0 109.078 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.402 HD22 ' HB2' ' A' ' 76' ' ' GLU . 57.5 p30 -94.0 157.4 16.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 110.278 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.5 19.24 79.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -99.77 150.37 22.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.363 -1.081 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -101.56 131.35 47.78 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.0 179.6 8.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.695 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -120.24 137.21 54.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -127.82 148.45 50.45 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -135.63 134.01 38.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.26 -176.85 1.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -105.71 156.31 18.41 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.47 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -92.53 107.58 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.407 -0.808 . . . . 0.0 110.226 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.2 -27.18 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 109.906 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -171.0 161.64 6.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.564 0.697 . . . . 0.0 110.086 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -143.76 121.02 11.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' ' 37' ' ' GLN . 80.9 mm-40 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.675 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 ' OG1' ' A' ' 51' ' ' THR . 96.4 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.464 0.65 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 t -100.24 -51.13 3.74 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.716 0.769 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' ' 29' ' ' GLU . 33.2 mt-30 -152.07 154.43 35.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 110.224 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.96 156.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.28 -172.09 34.07 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.233 -1.461 . . . . 0.0 109.853 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.541 HD21 ' NZ ' ' A' ' 49' ' ' LYS . 4.6 mp -119.89 144.55 47.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.756 -0.849 . . . . 0.0 109.396 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 47' ' ' ILE . 68.8 mt -114.55 124.78 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.89 101.63 2.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -106.44 164.66 11.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.983 . . . . 0.0 109.312 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' OE2' ' N ' ' A' ' 44' ' ' GLU . 1.4 mp0 -70.53 -20.24 62.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 110.106 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 p -91.05 -9.62 45.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.952 . . . . 0.0 109.244 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.02 -145.84 14.15 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 41' ' ' LEU . 8.0 mt -139.02 155.14 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -1.024 . . . . 0.0 109.331 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 148.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.88 . . . . 0.0 109.652 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.541 ' NZ ' HD21 ' A' ' 40' ' ' LEU . 68.4 mttm -98.77 138.0 36.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 109.454 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.47 159.54 34.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.145 -0.972 . . . . 0.0 108.58 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.427 ' OG1' HG23 ' A' ' 35' ' ' ILE . 3.8 t -133.66 137.91 45.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.657 . . . . 0.0 109.708 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -104.15 126.96 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.371 0.605 . . . . 0.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -88.03 145.62 25.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 110.361 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -50.43 -29.9 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.601 -0.687 . . . . 0.0 109.35 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -13.39 10.92 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 109.881 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -113.89 44.53 1.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.309 -0.869 . . . . 0.0 109.209 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' ALA . 8.2 pt-20 -35.12 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.716 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.8 mt -109.35 153.5 42.7 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.73 162.26 32.42 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.444 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.86 135.62 54.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.512 -0.743 . . . . 0.0 110.198 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.4 mp -79.49 153.66 29.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 109.839 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -96.79 120.14 36.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.404 -0.81 . . . . 0.0 109.896 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.31 147.92 52.35 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.761 0.791 . . . . 0.0 110.194 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.53 -10.88 48.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -97.64 161.03 13.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 0.0 110.5 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -88.31 146.92 25.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.288 0.566 . . . . 0.0 109.631 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -142.11 145.94 34.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.97 0.89 . . . . 0.0 109.691 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.557 HD21 ' HE ' ' A' ' 70' ' ' ARG . 29.5 tp -111.17 129.76 55.85 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.36 119.81 39.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.588 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.557 ' HE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -119.17 148.03 43.54 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m 56.49 55.75 6.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 120.945 0.402 . . . . 0.0 110.451 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.19 165.8 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.293 -0.879 . . . . 0.0 108.9 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.74 150.38 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.649 0.738 . . . . 0.0 109.444 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.85 137.01 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.788 -0.57 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.77 153.45 17.62 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB2' HD22 ' A' ' 14' ' ' ASN . 82.1 tt0 -91.32 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 109.417 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' ARG . 69.5 t80 -100.57 106.55 18.06 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.761 0.791 . . . . 0.0 109.55 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 44.97 -115.4 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.524 -0.735 . . . . 0.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 63.2 t0 -97.28 -14.27 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' TYR . 75.3 ttt180 -109.01 151.5 26.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.261 -0.9 . . . . 0.0 110.23 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.11 160.22 15.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.528 HE21 HE21 ' A' ' 84' ' ' GLN . 13.2 pt20 -146.87 162.82 37.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.295 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.02 126.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 108.943 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.528 HE21 HE21 ' A' ' 82' ' ' GLN . 87.4 mt-30 -104.93 127.59 52.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.492 -0.755 . . . . 0.0 109.396 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.04 132.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.454 -0.779 . . . . 0.0 108.997 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -125.0 -173.56 2.83 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.662 0.744 . . . . 0.0 109.89 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -40.39 96.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.566 -0.709 . . . . 0.0 109.962 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -68.45 -12.87 61.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -82.93 163.77 20.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 109.822 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -140.69 162.36 35.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.269 -0.894 . . . . 0.0 109.049 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.8 mt -138.38 130.6 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -130.02 134.65 47.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.359 -0.838 . . . . 0.0 109.019 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -74.68 135.46 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -94.78 129.71 41.62 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.889 0.852 . . . . 0.0 110.16 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.4 t -77.44 -6.48 53.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.767 -0.583 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -114.28 95.71 40.13 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.438 -0.789 . . . . 0.0 109.268 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.34 152.05 16.34 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.444 2.096 . . . . 0.0 112.116 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -101.43 134.14 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.783 -179.495 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.498 0.541 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -80.6 113.44 18.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.0 133.79 37.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.591 -0.693 . . . . 0.0 109.868 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.548 ' O ' HD13 ' A' ' 20' ' ' LEU . 93.9 m -127.98 152.03 48.41 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.453 0.644 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.38 147.08 24.55 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.707 0.765 . . . . 0.0 110.162 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.12 -44.28 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.53 -11.25 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.601 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 52.8 t0 -96.73 8.33 44.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -87.11 120.74 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.85 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.2 4.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.843 . . . . 0.0 109.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -134.8 131.54 37.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.353 -0.842 . . . . 0.0 109.122 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.26 160.19 14.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.29 18.98 79.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -103.06 156.38 17.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.504 -0.998 . . . . 0.0 109.899 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -102.81 131.97 49.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -158.57 176.59 12.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 109.866 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' SER . 61.7 m-20 -138.91 142.99 38.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.657 . . . . 0.0 109.648 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 6' ' ' THR . 60.5 tp -159.14 147.14 17.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.034 -1.041 . . . . 0.0 110.423 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -94.06 137.66 33.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.72 158.34 44.08 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.083 0.944 . . . . 0.0 110.661 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.74 152.72 18.84 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.304 0.573 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 59.6 t -93.23 101.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.04 -26.31 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 0.0 109.77 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -168.68 160.34 10.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -135.07 160.08 39.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.186 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -143.14 113.82 7.52 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.483 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 -179.662 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 11.4 p -88.42 -56.5 3.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.568 -0.707 . . . . 0.0 109.769 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.504 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.5 tt0 -154.55 155.24 34.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.433 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.35 149.67 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.2 -158.77 14.63 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.135 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 mt -121.45 149.08 43.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.091 -0.652 . . . . 0.0 109.555 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.3 127.84 55.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.536 0.684 . . . . 0.0 109.407 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.83 96.73 2.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -93.92 157.1 16.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.6 -18.18 64.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.675 -0.641 . . . . 0.0 109.768 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -98.88 -11.52 21.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.378 -0.826 . . . . 0.0 109.153 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -154.06 24.96 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.084 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.06 160.41 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.616 -0.932 . . . . 0.0 109.84 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -160.4 147.14 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.521 -0.737 . . . . 0.0 109.914 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.72 164.65 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.875 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.88 150.0 23.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.167 -0.958 . . . . 0.0 108.98 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -137.24 135.08 36.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.036 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.8 mt -105.62 129.09 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.617 -0.677 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -84.04 139.7 32.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 110.504 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -60.72 -37.2 80.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.655 -0.653 . . . . 0.0 109.391 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.83 -11.07 4.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.822 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -84.61 -25.83 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.131 -0.98 . . . . 0.0 108.974 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 53.94 52.13 13.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.63 -0.669 . . . . 0.0 110.146 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.559 HD13 ' HB1' ' A' ' 56' ' ' ALA . 7.5 mp -104.86 156.12 36.49 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.337 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.31 154.41 74.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.711 2.274 . . . . 0.0 112.7 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.62 142.17 46.53 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.787 0.804 . . . . 0.0 110.626 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.2 mp -81.13 151.0 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.764 -0.585 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.02 136.11 43.45 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.747 0.784 . . . . 0.0 109.945 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 24' ' ' VAL . 10.3 tm0? -72.38 134.9 45.68 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 110.682 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 -13.18 67.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.4 mp0 -97.77 157.58 15.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -1.121 . . . . 0.0 110.681 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 96' ' ' GLU . 12.1 p -100.92 141.07 34.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -134.41 157.03 47.48 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.161 0.982 . . . . 0.0 110.13 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.4 tp -105.31 134.02 49.12 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 mt -110.13 108.84 19.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 92' ' ' GLU . 65.4 mtm180 -112.81 148.2 35.34 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.595 0.712 . . . . 0.0 110.376 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.9 p 51.16 58.17 5.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 122.054 -0.404 . . . . 0.0 110.827 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 18' ' ' ALA . 15.6 m -112.65 165.09 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.517 -0.739 . . . . 0.0 109.319 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 p -123.36 149.25 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 121.724 0.773 . . . . 0.0 109.82 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.34 135.13 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.629 -0.669 . . . . 0.0 109.867 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.62 158.24 17.27 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -100.16 93.76 5.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.949 . . . . 0.0 109.329 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.497 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.1 t80 -106.09 119.27 38.78 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.744 0.783 . . . . 0.0 109.707 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.3 m120 53.51 50.17 17.91 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.336 0.588 . . . . 0.0 110.624 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t0 64.41 -12.69 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.744 -0.598 . . . . 0.0 110.408 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 78' ' ' ASN . 91.6 mtm-85 -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.187 -0.946 . . . . 0.0 110.351 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -76.4 146.11 38.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.602 -0.686 . . . . 0.0 109.355 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -147.14 151.29 36.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.177 -0.952 . . . . 0.0 109.382 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.32 122.45 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -102.18 128.65 48.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 t -100.1 134.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.538 -0.726 . . . . 0.0 109.08 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -131.32 -168.93 2.08 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.71 0.767 . . . . 0.0 109.952 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -62.12 -42.33 99.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.279 0.561 . . . . 0.0 109.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -65.36 -22.2 66.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -81.5 164.26 22.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -140.52 162.55 35.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.4 mt -138.84 132.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.63 -0.669 . . . . 0.0 109.653 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 89.1 mt-10 -131.35 135.96 47.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.548 -0.72 . . . . 0.0 109.218 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.481 ' C ' HD22 ' A' ' 94' ' ' LEU . 88.3 tttt -81.84 135.77 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.481 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.0 mm? -109.86 0.35 18.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.64 -0.663 . . . . 0.0 109.988 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.5 p 49.78 14.91 0.14 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 109.733 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' SER . 24.0 mm-40 -114.07 110.17 48.81 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.281 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.36 151.26 59.72 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.712 2.274 . . . . 0.0 112.724 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -105.56 143.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.7 . . . . 0.0 109.679 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.798 0.809 . . . . 0.0 109.864 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.437 ' CG ' HD22 ' A' ' 19' ' ' ASN . 56.3 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 CA-C-O 121.408 0.503 . . . . 0.0 112.301 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -81.11 113.24 19.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 131.42 34.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.592 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.0 m -119.3 132.52 55.9 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 64.8 mttp -98.5 155.73 17.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 110.085 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.55 -49.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.655 0.741 . . . . 0.0 109.349 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.37 -13.89 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 49.4 t0 -93.03 -3.18 54.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLU . 97.7 mt -58.6 -73.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 110.416 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 11' ' ' ILE . 15.6 m 31.93 29.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.396 0.617 . . . . 0.0 110.923 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.2 tt0 -167.23 114.17 0.78 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.472 -0.768 . . . . 0.0 109.066 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -87.15 153.64 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.78 72.69 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -94.52 137.21 33.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.094 . . . . 0.0 109.929 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.57 125.44 38.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.04 -167.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.828 . . . . 0.0 109.792 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.437 HD22 ' CG ' ' A' ' 3' ' ' PRO . 60.2 m-20 -117.64 146.29 43.77 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.47 131.17 35.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 0.0 110.475 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -116.55 127.84 54.88 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.525 ' HB3' HD22 ' A' ' 41' ' ' LEU . . . -162.56 169.77 19.7 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -103.59 154.94 18.95 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.873 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.96 113.78 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.375 -0.828 . . . . 0.0 109.656 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -93.41 -22.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.674 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.698 ' NE2' ' HE1' ' A' ' 28' ' ' TRP . 18.2 tt0 -152.79 136.07 15.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.783 -1.198 . . . . 0.0 109.609 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 26' ' ' GLN . 4.2 mm? -108.18 143.28 37.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.642 0.734 . . . . 0.0 109.682 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.698 ' HE1' ' NE2' ' A' ' 26' ' ' GLN . 61.6 m95 -145.0 119.78 9.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.696 0.76 . . . . 0.0 109.129 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.666 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.4 pm0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.62 -0.675 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.467 0.651 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -93.16 -57.93 2.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 109.664 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -149.67 150.72 32.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -141.5 155.8 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.48 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -170.66 -171.15 35.72 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.071 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.48 HD22 ' C ' ' A' ' 39' ' ' GLY . 3.9 mm? -114.09 146.14 40.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.91 -0.759 . . . . 0.0 109.601 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 22' ' ' ALA . 18.9 mt -117.23 124.16 48.38 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.59 0.709 . . . . 0.0 109.096 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' CD1' ' A' ' 25' ' ' ILE . . . -95.28 97.4 2.12 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.6 t0 -99.04 161.23 13.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.273 -1.134 . . . . 0.0 109.304 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.8 mt-10 -66.32 -18.55 65.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.2 p -93.73 -5.1 49.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.01 -144.53 12.71 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -135.64 163.45 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.647 -0.913 . . . . 0.0 109.958 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 151.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.5 159.22 18.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -147.79 153.98 39.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.488 -1.383 . . . . 0.0 108.026 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -133.96 129.82 36.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.477 -0.764 . . . . 0.0 109.906 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -104.33 129.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.593 -0.692 . . . . 0.0 109.67 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -87.91 145.7 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -58.11 -38.22 76.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.496 -0.753 . . . . 0.0 109.309 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -59.51 -4.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 109.695 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.78 -27.91 24.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 108.879 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 55.17 52.96 10.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.627 -0.671 . . . . 0.0 110.244 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.41 147.22 35.9 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.657 -0.652 . . . . 0.0 109.853 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.1 164.39 32.27 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.705 2.27 . . . . 0.0 112.648 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.4 mt -72.99 141.19 47.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.516 -0.74 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.9 mp -84.13 145.11 28.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.75 -0.594 . . . . 0.0 109.846 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.3 137.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.317 -0.864 . . . . 0.0 109.885 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.09 137.52 40.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.702 . . . . 0.0 110.808 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.3 -7.21 72.14 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -106.11 162.21 13.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.366 -1.079 . . . . 0.0 110.689 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -100.96 142.58 32.23 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.79 152.2 51.57 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.97 0.89 . . . . 0.0 110.151 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HB2' HD23 ' A' ' 94' ' ' LEU . 49.1 tp -109.33 131.51 54.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.28 111.14 22.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.368 -0.833 . . . . 0.0 109.158 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 74.8 mtm180 -109.92 149.18 30.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.611 -0.681 . . . . 0.0 110.388 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 2.8 p 52.72 57.77 6.04 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.89 167.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.423 -0.798 . . . . 0.0 109.147 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.56 152.04 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.74 0.781 . . . . 0.0 109.718 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 132.84 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.769 -0.582 . . . . 0.0 109.553 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 147.78 16.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -90.51 101.19 13.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -1.134 . . . . 0.0 109.181 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.63 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 16.0 t80 -97.79 101.12 12.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 109.132 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.63 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 13.0 p30 40.25 -117.58 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 50.1 t0 -90.81 -18.07 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 77' ' ' TYR . 64.3 ttm-85 -100.0 154.46 18.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.169 -0.957 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.79 151.17 19.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 108.78 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -145.41 151.5 38.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.987 -1.071 . . . . 0.0 109.02 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.45 121.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.934 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.62 127.79 53.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.0 133.84 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -133.76 -170.27 2.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 89' ' ' SER . 73.4 tttt -53.83 166.15 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.2 t-20 72.09 -19.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.677 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 87' ' ' LYS . 16.4 p -76.69 162.81 27.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.07 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.0 p -145.22 166.31 25.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.264 -0.897 . . . . 0.0 108.973 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.99 131.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -128.0 131.12 49.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.312 -0.867 . . . . 0.0 108.903 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.77 137.15 51.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 109.639 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -97.26 135.31 39.37 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.958 0.885 . . . . 0.0 110.192 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 m -82.35 -5.88 58.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -121.9 119.89 28.73 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.89 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 161.47 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.509 2.14 . . . . 0.0 112.128 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -98.19 152.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.715 . . . . 0.0 109.997 -179.687 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 CA-C-O 121.169 0.404 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.58 120.2 21.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.177 -0.952 . . . . 0.0 110.127 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.543 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.6 mm? -89.89 126.42 35.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.6 m -121.99 142.12 50.64 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -95.92 148.35 22.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.045 -1.034 . . . . 0.0 110.121 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.41 -43.61 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.197 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.91 -15.16 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 9.93 29.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 109.933 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.54 122.48 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.077 -1.015 . . . . 0.0 110.0 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.19 -0.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.304 -0.872 . . . . 0.0 109.749 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -131.73 134.29 45.72 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.32 -0.863 . . . . 0.0 109.081 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 57.0 p30 -90.07 159.01 17.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 109.881 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.69 79.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -98.47 147.02 25.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.343 -1.093 . . . . 0.0 109.706 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -97.82 135.13 40.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.418 -0.801 . . . . 0.0 109.592 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.432 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -157.39 169.02 25.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.111 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 71' ' ' SER . 11.3 m120 -132.41 136.96 47.12 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.674 ' C ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -159.67 178.84 9.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.021 -1.05 . . . . 0.0 110.461 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.6 pttp -128.39 148.45 50.7 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.46 38.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.742 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -93.2 152.5 19.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.592 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.99 99.67 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 110.333 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 mm -73.35 -25.49 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.552 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 53.2 tt0 -166.63 157.85 12.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.0 -1.063 . . . . 0.0 109.702 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.912 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -127.66 153.32 46.61 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.542 -0.724 . . . . 0.0 110.071 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.552 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 44.0 m95 -144.28 123.06 12.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.284 -0.885 . . . . 0.0 109.231 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.513 -0.742 . . . . 0.0 109.455 -179.53 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 17.2 p -87.31 -58.52 2.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.7 tt0 -149.55 155.36 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.957 -1.09 . . . . 0.0 109.771 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 39' ' ' GLY . 53.9 t -137.95 160.92 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 38' ' ' VAL . . . 177.42 -162.75 30.9 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.881 -1.628 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.51 150.6 40.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.894 -0.768 . . . . 0.0 109.142 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.1 129.23 54.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.611 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.0 103.75 2.79 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -103.01 163.86 11.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.99 . . . . 0.0 109.154 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' A' ' 99' ' ' GLU . 47.2 tp10 -69.41 -19.44 63.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -92.31 -10.87 36.77 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.941 -1.1 . . . . 0.0 110.14 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -150.29 21.87 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 pt -132.94 159.12 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.581 -0.952 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.8 tt -161.36 150.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.6 164.07 22.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 108.961 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.12 154.51 31.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.563 -1.336 . . . . 0.0 108.422 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 t -139.56 133.52 30.9 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.239 -0.913 . . . . 0.0 110.251 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.8 mt -105.27 128.7 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -96.64 147.75 23.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 0.0 110.335 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -67.06 -19.31 65.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.725 . . . . 0.0 109.379 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -61.23 -33.26 73.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.842 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.34 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.047 . . . . 0.0 109.276 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.74 61.21 2.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.434 -0.791 . . . . 0.0 110.09 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.74 148.74 38.81 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.606 -0.684 . . . . 0.0 109.398 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.52 161.33 45.51 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.519 2.146 . . . . 0.0 112.189 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.19 143.63 50.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 110.364 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -85.15 148.43 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.573 -0.705 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -95.19 134.55 37.8 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.41 137.16 52.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.51 -12.84 68.81 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.26 158.39 15.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.877 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 p -94.92 143.74 26.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.32 152.55 51.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.816 0.817 . . . . 0.0 110.186 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.41 HD13 ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -100.33 130.84 46.48 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.41 ' H ' HD13 ' A' ' 68' ' ' LEU . 17.5 mt -109.01 105.26 14.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.513 ' NE ' ' OG ' ' A' ' 90' ' ' SER . 87.3 mtm-85 -107.68 133.04 52.67 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.665 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 1.1 m 70.81 59.37 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.116 -0.365 . . . . 0.0 110.76 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 m -112.86 160.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.346 -0.846 . . . . 0.0 109.456 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.45 151.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.499 0.666 . . . . 0.0 109.351 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.59 132.12 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.124 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.432 ' HA3' HE21 ' A' ' 84' ' ' GLN . . . -112.28 151.69 18.01 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.445 ' OE2' ' N ' ' A' ' 79' ' ' ASP . 10.8 tm-20 -98.76 93.15 5.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.129 -1.218 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -111.27 117.39 33.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.444 -0.785 . . . . 0.0 110.119 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 80' ' ' ARG . 20.0 t-20 55.57 54.36 8.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.818 . . . . 0.0 110.293 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.445 ' N ' ' OE2' ' A' ' 76' ' ' GLU . 91.2 m-20 56.35 -2.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.676 -0.64 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 78' ' ' ASN . 14.6 mmp_? -102.24 158.58 16.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.041 -1.037 . . . . 0.0 109.737 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.23 146.69 25.92 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.88 154.61 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.02 117.2 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.377 -0.827 . . . . 0.0 109.094 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.432 HE21 ' HA3' ' A' ' 75' ' ' GLY . 39.2 mt-30 -107.08 127.38 53.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.323 -0.861 . . . . 0.0 109.538 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.4 ' C ' HD22 ' A' ' 86' ' ' ASN . 22.0 t -93.6 124.59 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.697 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -152.55 -173.71 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 109.689 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 57.0 -152.64 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.54 0.686 . . . . 0.0 110.365 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 89' ' ' SER . 92.3 m-20 -83.58 27.18 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 88' ' ' ASN . 12.1 p -47.86 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.513 ' OG ' ' NE ' ' A' ' 70' ' ' ARG . 13.6 p -139.44 161.67 36.9 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.073 -1.017 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.3 mt -140.85 132.87 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.946 . . . . 0.0 109.272 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' CB ' HH12 ' A' ' 70' ' ' ARG . 83.8 tt0 -124.73 124.99 43.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.06 140.52 43.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 109.82 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.08 142.31 29.94 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.8 p -83.85 -3.82 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.589 -0.695 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.88 133.01 21.09 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.429 -0.794 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.77 155.9 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.848 1.699 . . . . 0.0 112.04 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -108.62 133.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 84.7 tt0 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HB2' HD22 ' A' ' 19' ' ' ASN . 57.1 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 CA-C-O 121.47 0.529 . . . . 0.0 112.262 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.4 mp0 -81.36 111.54 17.82 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.348 -0.845 . . . . 0.0 109.56 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.4 mt -91.53 134.25 34.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.669 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -127.15 146.46 50.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.462 0.648 . . . . 0.0 109.381 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.35 147.71 22.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 110.072 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.36 -43.53 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.608 -0.682 . . . . 0.0 109.188 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 9' ' ' VAL . 14.3 p -65.61 -6.3 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.475 -0.765 . . . . 0.0 109.454 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -103.98 6.82 36.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -88.08 115.76 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 109.778 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.56 5.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -125.57 122.81 37.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.788 . . . . 0.0 109.246 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 15' ' ' GLY . 2.3 t-20 -82.02 150.67 27.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.975 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.587 ' N ' ' ND2' ' A' ' 14' ' ' ASN . . . 76.93 19.33 77.71 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -96.32 144.11 26.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.481 -1.011 . . . . 0.0 110.095 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -102.28 130.23 48.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.557 -0.714 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.86 -176.26 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.848 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 3' ' ' PRO . 59.7 m-20 -122.96 146.93 47.17 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.31 133.67 24.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.0 110.514 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -109.89 131.12 55.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.84 159.45 35.07 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.017 0.913 . . . . 0.0 110.883 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 17.5 ttmm -92.08 156.26 17.5 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.14 113.09 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.139 -0.976 . . . . 0.0 110.38 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 pt -90.4 -19.51 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.96 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -167.77 157.47 10.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.986 . . . . 0.0 109.707 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.498 ' N ' HE21 ' A' ' 63' ' ' GLN . 96.1 mt -135.39 159.93 40.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.595 -0.691 . . . . 0.0 109.98 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -144.72 118.14 9.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.435 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.53 -0.731 . . . . 0.0 109.664 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.679 0.752 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.8 p -85.3 -57.16 3.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.658 -0.651 . . . . 0.0 109.911 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.502 ' N ' ' OG ' ' A' ' 36' ' ' SER . 17.4 pt20 -160.48 164.8 31.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.093 -1.005 . . . . 0.0 110.316 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.2 160.34 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.91 -165.76 31.07 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.169 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.34 145.73 49.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.925 -0.75 . . . . 0.0 109.531 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.42 130.58 55.93 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.35 101.33 2.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 44.3 t0 -104.86 162.69 13.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.56 -0.965 . . . . 0.0 109.445 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 13.5 tm-20 -70.3 -18.58 63.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.69 -0.631 . . . . 0.0 109.778 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.5 p -93.9 -9.74 36.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.074 -1.016 . . . . 0.0 109.334 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.93 -146.61 15.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.92 160.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.667 -0.902 . . . . 0.0 109.888 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -158.53 145.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 109.883 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -86.37 164.36 17.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.717 . . . . 0.0 109.992 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -154.29 156.82 37.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.696 -1.253 . . . . 0.0 108.48 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -139.97 129.96 24.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 109.646 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -106.76 131.58 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.333 0.587 . . . . 0.0 109.68 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -90.91 144.07 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 110.362 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -59.63 -31.64 69.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.711 . . . . 0.0 109.406 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.87 -13.39 6.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -87.53 -30.3 20.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 108.938 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 55.3 55.84 7.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.557 -0.715 . . . . 0.0 110.242 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' A' ' 56' ' ' ALA . 8.8 mp -108.0 154.82 40.91 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.611 -0.681 . . . . 0.0 109.398 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.7 156.56 65.23 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.766 2.31 . . . . 0.0 112.528 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.96 144.28 48.95 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.751 0.786 . . . . 0.0 110.394 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -81.5 148.53 29.15 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.36 0.6 . . . . 0.0 109.936 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 98.3 mt-10 -101.35 136.03 41.86 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.802 0.81 . . . . 0.0 110.111 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.498 HE21 ' N ' ' A' ' 27' ' ' LEU . 97.5 mt-30 -71.77 134.55 46.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.523 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 93.89 -14.48 65.21 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.6 mp0 -95.43 158.41 15.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 110.65 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -90.63 141.98 28.22 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.41 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 35.2 m-85 -133.82 142.83 48.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.842 0.829 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.2 132.0 54.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.99 112.75 25.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.803 . . . . 0.0 109.312 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -109.54 140.45 43.31 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.578 0.704 . . . . 0.0 110.413 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.6 t 56.94 60.04 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.932 -0.48 . . . . 0.0 110.929 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.3 168.11 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 0.0 109.228 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 74' ' ' VAL . 11.5 p -128.08 160.33 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.426 0.632 . . . . 0.0 109.836 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 56.3 t -103.11 132.73 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.681 -0.637 . . . . 0.0 109.409 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.24 158.81 14.07 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -102.28 91.56 4.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.933 . . . . 0.0 109.392 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.46 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 88.0 t80 -101.37 119.74 39.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.818 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 80' ' ' ARG . 3.7 m120 52.68 43.08 31.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.763 -0.586 . . . . 0.0 110.657 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 68.99 -15.29 0.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.675 -0.641 . . . . 0.0 110.302 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 78' ' ' ASN . 79.9 mtp85 -88.04 159.91 18.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.76 135.52 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -143.33 153.7 43.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 109.332 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -97.2 123.32 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.403 -0.811 . . . . 0.0 108.861 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -108.89 124.47 50.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 0.0 109.366 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.9 132.53 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' LYS . 5.3 p30 -145.62 -178.89 6.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 62.0 tttm -40.91 161.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 74.76 -27.36 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 109.795 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 87' ' ' LYS . 23.2 t -79.92 166.01 22.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.923 . . . . 0.0 110.012 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.6 t -148.11 169.93 18.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 109.334 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.2 mt -144.48 136.01 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.455 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.06 127.59 46.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.45 -0.781 . . . . 0.0 109.189 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' C ' HD22 ' A' ' 94' ' ' LEU . 98.5 mttt -74.61 140.72 44.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.536 -0.728 . . . . 0.0 109.515 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.1 mm? -111.01 135.08 52.05 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.818 0.818 . . . . 0.0 110.175 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.2 m -85.66 9.67 15.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.23 92.47 39.93 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.455 -0.778 . . . . 0.0 109.19 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.12 153.25 21.77 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.761 2.308 . . . . 0.0 112.064 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.447 ' H ' ' HE2' ' A' ' 23' ' ' LYS . 96.7 mt -100.84 139.66 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 109.577 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.79 -179.517 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.494 1.544 0 CA-C-O 121.342 0.476 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -81.89 121.99 27.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.437 HD23 HD22 ' A' ' 19' ' ' ASN . 56.9 mt -88.13 131.01 34.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.347 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 20' ' ' LEU . 85.4 m -124.99 138.71 54.22 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -95.66 152.77 18.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.276 -0.89 . . . . 0.0 109.814 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.1 mt -58.29 -44.35 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.548 -0.72 . . . . 0.0 109.361 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.94 -18.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 108.937 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 t0 -87.87 3.78 47.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -85.6 120.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.047 -1.033 . . . . 0.0 109.678 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.2 p -138.47 -2.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.322 -0.861 . . . . 0.0 109.043 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 97.7 mt-10 -134.58 136.04 42.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.104 -0.997 . . . . 0.0 109.488 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -97.14 156.4 16.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.97 18.67 69.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 24.2 pt20 -103.36 159.49 15.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -1.032 . . . . 0.0 109.71 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.24 135.42 46.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.69 -0.631 . . . . 0.0 109.642 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.29 177.36 11.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 109.796 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 16.1 t30 -133.46 138.16 46.05 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 6' ' ' THR . 57.4 tp -154.29 147.1 24.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.793 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -104.68 140.36 38.15 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . . . -152.27 161.05 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 111.236 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -103.82 153.92 20.18 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 t -93.14 102.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.067 -1.02 . . . . 0.0 110.597 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 pt -84.08 -23.8 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.596 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 47.5 tt0 -152.96 134.92 14.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.911 . . . . 0.0 108.918 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.3 tp -118.06 147.74 42.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.256 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.596 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 80.7 m95 -146.78 128.75 15.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 109.185 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.486 0.66 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 52.3 p -88.0 -55.81 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.836 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.447 ' NE2' HD12 ' A' ' 52' ' ' ILE . 22.8 pt20 -158.23 165.87 33.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.014 . . . . 0.0 110.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.61 160.82 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.11 -166.59 34.26 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.194 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.74 146.77 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.857 . . . . 0.0 109.155 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.5 mt -109.16 125.22 51.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.84 99.43 2.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 22' ' ' ALA . 17.9 m-20 -105.52 164.52 11.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.969 . . . . 0.0 109.479 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -70.48 -18.98 62.98 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.865 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -90.08 -10.51 44.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.106 . . . . 0.0 109.827 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.06 -147.87 18.33 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 48' ' ' ILE . 96.0 mt -134.73 155.81 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.597 -0.943 . . . . 0.0 109.48 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.45 ' N ' HG22 ' A' ' 47' ' ' ILE . 14.2 tt -154.53 148.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.795 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -88.22 154.42 20.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CB ' HG23 ' A' ' 83' ' ' VAL . 18.9 p90 -146.7 154.33 41.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.603 -1.31 . . . . 0.0 108.311 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.482 HG22 ' NE2' ' A' ' 84' ' ' GLN . 15.3 t -135.45 132.32 37.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.447 HD12 ' NE2' ' A' ' 37' ' ' GLN . 94.9 mt -102.77 128.7 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.573 -0.704 . . . . 0.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -83.96 142.68 30.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 110.454 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -60.8 -34.74 74.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -59.33 -9.59 2.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 109.764 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.33 -25.66 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -0.971 . . . . 0.0 108.825 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 42.47 47.3 4.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 110.066 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.55 165.45 14.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.03 147.65 89.16 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.321 2.014 . . . . 0.0 112.242 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.85 142.08 49.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.089 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.3 mp -80.24 143.89 33.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.79 131.99 43.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 109.307 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -70.07 134.45 48.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.0 110.477 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 -13.89 66.39 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -97.4 159.51 14.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -1.159 . . . . 0.0 110.796 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.7 m -93.26 146.73 23.49 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.271 0.558 . . . . 0.0 109.798 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.3 151.02 43.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.025 0.917 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.5 tp -106.3 132.53 52.23 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 mt -109.28 106.03 15.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -105.93 140.96 38.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.353 -0.842 . . . . 0.0 110.265 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.1 t 56.86 61.96 2.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.66 . . . . 0.0 110.983 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.93 164.11 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.43 144.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.518 0.675 . . . . 0.0 109.637 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -94.09 134.27 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 151.54 18.04 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -97.4 95.86 7.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -1.155 . . . . 0.0 109.149 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.3 t80 -102.13 116.22 32.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.085 -1.009 . . . . 0.0 109.758 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.467 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 22.0 t-20 51.31 -126.7 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 110.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 56.8 t0 -95.85 -6.69 38.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 ttm180 -114.83 146.67 40.79 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.809 0.814 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.73 158.2 21.87 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -141.71 156.96 45.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 108.886 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -103.0 123.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' HG22 ' A' ' 51' ' ' THR . 92.4 mm-40 -103.26 126.94 50.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.06 130.48 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 108.871 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.96 -166.83 1.67 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.629 0.728 . . . . 0.0 109.968 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -64.28 -41.93 96.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.666 -0.646 . . . . 0.0 110.14 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 88' ' ' ASN . 2.3 p30 -65.69 -11.78 48.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.998 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.1 t -86.34 162.44 18.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.461 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.6 m -135.24 157.96 45.57 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -138.98 130.31 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.056 -1.027 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.98 129.18 48.72 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.323 -0.86 . . . . 0.0 109.156 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.442 ' C ' HD22 ' A' ' 94' ' ' LEU . 78.3 tttt -77.36 138.67 39.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.0 mm? -106.95 138.01 43.94 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.855 0.836 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -83.16 2.25 36.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.817 -0.552 . . . . 0.0 109.512 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 96' ' ' GLU . 2.7 mp0 -103.5 129.71 24.91 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.189 -0.945 . . . . 0.0 109.796 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.64 146.87 30.92 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.872 1.715 . . . . 0.0 112.289 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -110.57 135.44 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.494 -0.754 . . . . 0.0 108.987 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 109.96 -179.415 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.491 1.343 0 CA-C-O 121.567 0.569 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -81.65 118.16 22.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.864 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.568 ' CD2' HD22 ' A' ' 19' ' ' ASN . 47.3 mt -90.54 131.16 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.2 m -123.02 142.64 50.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.88 146.94 23.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.639 0.733 . . . . 0.0 110.402 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.2 mm -53.62 -46.02 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.8 . . . . 0.0 109.597 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.82 -11.81 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.612 -0.68 . . . . 0.0 109.89 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.72 2.74 44.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -86.98 119.02 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.819 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -151.86 9.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.816 . . . . 0.0 109.459 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -127.35 123.11 35.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.555 -0.716 . . . . 0.0 109.283 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.38 152.02 23.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.438 -0.789 . . . . 0.0 110.057 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.73 79.17 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -98.06 145.2 26.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.092 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.17 129.6 45.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.516 -0.74 . . . . 0.0 109.481 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.21 -175.88 5.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.568 HD22 ' CD2' ' A' ' 5' ' ' LEU . 27.7 t30 -127.11 141.13 51.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.683 -0.636 . . . . 0.0 109.295 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.96 154.56 49.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.479 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -135.8 135.42 39.87 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.55 -173.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.169 0.985 . . . . 0.0 110.511 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.49 155.84 27.9 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.51 106.5 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.34 -24.0 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.284 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.62 ' HB3' HD21 ' A' ' 40' ' ' LEU . 10.3 tp-100 -161.26 151.41 17.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.043 -1.036 . . . . 0.0 109.529 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.889 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -140.96 163.85 31.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.467 -0.771 . . . . 0.0 109.961 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -145.37 111.14 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.802 0.81 . . . . 0.0 109.5 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.514 0.673 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -93.25 -47.72 6.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -155.05 156.51 36.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.37 141.1 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.665 ' C ' HD23 ' A' ' 40' ' ' LEU . . . -168.81 -154.09 8.73 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.291 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -136.88 153.09 50.85 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.794 -0.827 . . . . 0.0 109.322 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.02 132.12 54.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.64 0.733 . . . . 0.0 109.741 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.97 104.24 3.12 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 1.4 m-20 -103.73 162.68 12.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.654 -0.91 . . . . 0.0 109.375 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.598 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.9 mp0 -69.37 -15.35 63.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -97.0 -6.14 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.86 -147.11 17.28 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.227 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.93 162.89 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.644 -0.916 . . . . 0.0 110.069 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -159.33 150.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.971 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.86 165.64 21.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.648 -0.658 . . . . 0.0 110.023 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 18.6 p90 -158.67 148.7 19.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.156 -0.965 . . . . 0.0 108.89 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -134.6 128.72 33.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.6 mt -105.45 128.44 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 109.414 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.62 143.01 27.22 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.755 0.788 . . . . 0.0 110.373 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 56' ' ' ALA . 39.5 tptt -60.45 -30.59 69.76 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.619 -0.675 . . . . 0.0 109.403 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -58.98 -3.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.838 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -97.14 -28.19 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.172 -0.955 . . . . 0.0 109.051 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 57' ' ' GLU . 55.2 mp0 48.97 54.7 10.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.21 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.1 mt -110.89 152.85 43.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.73 147.51 71.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.567 2.178 . . . . 0.0 112.709 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 mt -72.34 149.29 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.754 0.788 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -86.86 144.33 27.05 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.446 0.641 . . . . 0.0 110.115 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.88 139.56 31.14 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.884 0.849 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.19 137.87 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.45 -0.781 . . . . 0.0 110.727 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.97 56.34 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -94.39 159.03 15.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 p -90.28 149.3 22.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.295 0.569 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -144.32 145.88 32.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.7 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 19' ' ' ASN . 36.5 tp -113.32 130.57 56.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 1.9 mp -119.45 113.64 21.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.63 -0.669 . . . . 0.0 109.502 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -105.92 151.53 24.46 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.76 58.64 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.553 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.3 165.07 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.535 -0.728 . . . . 0.0 109.459 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.87 147.58 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.676 0.75 . . . . 0.0 109.71 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.6 t -87.93 130.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.67 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.9 147.44 16.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -96.81 103.26 15.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.451 -1.029 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' ARG . 71.2 t80 -101.58 107.62 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.737 0.78 . . . . 0.0 109.372 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.427 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 47.5 t30 39.69 -115.65 0.2 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.793 -0.567 . . . . 0.0 110.629 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 97.7 m-20 -93.61 -19.08 21.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.817 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' TYR . 84.8 mtt85 -97.41 159.54 14.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.25 -0.906 . . . . 0.0 110.353 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.88 153.19 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.619 -0.675 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -151.96 164.07 37.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 83' ' ' VAL . 17.0 m -102.91 126.91 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.95 128.77 53.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.325 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.59 134.29 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' LYS . 4.2 p30 -146.34 -174.4 4.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.87 0.843 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 89' ' ' SER . 1.6 pptp? -44.34 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.899 -0.5 . . . . 0.0 109.896 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 t30 67.29 -27.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.676 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 87' ' ' LYS . 12.7 p -79.98 166.9 21.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.156 -0.965 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.8 p -141.14 160.42 40.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -139.38 132.3 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.593 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -128.76 130.16 46.68 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.609 0.719 . . . . 0.0 109.365 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.47 144.3 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.63 -0.668 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.33 145.24 46.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.704 0.764 . . . . 0.0 110.028 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -86.27 16.8 4.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -119.39 118.43 32.42 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.655 -0.653 . . . . 0.0 109.533 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.09 157.8 42.2 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.647 2.231 . . . . 0.0 112.376 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.3 mm -108.27 137.23 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.748 -0.595 . . . . 0.0 109.674 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.763 . . . . 0.0 109.663 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo . . . . . 0 N--CA 1.49 1.307 0 CA-C-O 121.453 0.522 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -79.73 118.62 21.7 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.591 0.71 . . . . 0.0 109.687 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.2 mt -93.73 128.06 39.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.522 ' O ' HD13 ' A' ' 20' ' ' LEU . 14.8 t -129.6 152.69 48.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.557 0.694 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.18 135.1 34.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.341 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -50.97 -34.37 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.758 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.82 1.46 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.854 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -122.48 6.57 9.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.21 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 13' ' ' GLU . 27.7 mt -64.19 -52.42 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 11' ' ' ILE . 12.2 m 4.29 64.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 121.395 0.617 . . . . 0.0 111.383 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 11' ' ' ILE . 38.3 tp10 -174.09 109.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.732 0.777 . . . . 0.0 109.368 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p-10 -82.57 140.52 33.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.5 77.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.05 137.27 32.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -1.16 . . . . 0.0 110.049 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -100.01 129.72 46.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.524 -0.735 . . . . 0.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.99 -175.06 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.398 -0.814 . . . . 0.0 109.932 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 88.0 m-20 -138.35 143.41 39.86 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.434 0.635 . . . . 0.0 109.629 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 6' ' ' THR . 62.2 tp -159.06 145.82 17.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.216 -0.928 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -100.0 141.81 32.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.594 -0.692 . . . . 0.0 109.152 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.538 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . . . -154.73 159.07 40.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.853 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -97.8 150.42 21.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -89.31 101.9 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.551 -0.718 . . . . 0.0 110.754 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.45 -25.61 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -170.61 162.43 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -0.989 . . . . 0.0 109.673 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.43 158.31 43.38 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.7 0.762 . . . . 0.0 110.144 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -148.61 127.94 13.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.437 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.628 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.522 -0.736 . . . . 0.0 109.918 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 122.024 0.916 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 6.1 p -93.2 -56.62 2.89 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.096 -1.002 . . . . 0.0 109.832 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.515 ' N ' ' OG ' ' A' ' 36' ' ' SER . 80.1 mt-30 -150.01 158.61 44.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.952 -1.093 . . . . 0.0 110.542 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.67 141.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.85 -164.57 13.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.311 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.79 143.85 47.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.854 -0.792 . . . . 0.0 109.749 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.539 HD21 ' CE1' ' A' ' 50' ' ' PHE . 67.4 mt -112.85 128.89 56.57 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.69 0.757 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.01 99.02 2.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' A' ' 22' ' ' ALA . 47.8 m-20 -99.3 156.35 17.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.126 -1.22 . . . . 0.0 109.469 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 44' ' ' GLU . 13.8 pt-20 -68.96 -17.41 63.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.646 -0.659 . . . . 0.0 109.722 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 p -96.76 -11.74 24.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.285 -0.885 . . . . 0.0 109.076 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.84 -146.73 13.53 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.711 ' O ' HD12 ' A' ' 47' ' ' ILE . 2.5 pp -133.78 161.49 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.1 tt -161.97 143.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.756 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.37 148.74 22.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 110.172 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.539 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.9 p90 -138.6 160.03 40.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.945 -1.097 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -134.21 133.19 40.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.339 -0.851 . . . . 0.0 109.982 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.7 129.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.639 0.733 . . . . 0.0 109.656 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -87.1 140.74 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 110.46 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -54.89 -23.63 19.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.57 -0.707 . . . . 0.0 109.539 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.33 -6.97 47.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.705 . . . . 0.0 109.673 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.584 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -86.96 -34.32 19.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.15 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 54.53 53.03 11.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 110.123 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.584 HD13 ' HB1' ' A' ' 56' ' ' ALA . 8.5 mp -105.19 155.46 37.73 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.06 156.03 65.01 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.774 2.316 . . . . 0.0 112.737 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.27 139.78 54.42 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.894 0.854 . . . . 0.0 110.684 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.4 mp -82.93 152.59 25.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.356 0.598 . . . . 0.0 110.113 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -104.31 133.3 49.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.727 0.775 . . . . 0.0 110.228 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -67.88 138.94 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.81 0.814 . . . . 0.0 110.622 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 -9.64 64.8 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -94.08 149.92 20.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.241 . . . . 0.0 110.471 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -89.2 147.56 24.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.45 0.643 . . . . 0.0 109.78 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -141.79 152.6 43.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.164 -0.96 . . . . 0.0 110.154 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HB2' HD21 ' A' ' 94' ' ' LEU . 38.9 tp -106.1 133.8 50.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.38 109.65 20.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.393 -0.817 . . . . 0.0 109.648 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -113.66 142.69 45.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.708 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t 57.06 58.04 4.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.115 0.483 . . . . 0.0 110.774 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.36 163.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.2 154.84 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.774 0.797 . . . . 0.0 109.953 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.5 t -95.34 130.1 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 109.851 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.54 151.05 18.96 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -91.29 96.15 10.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -1.028 . . . . 0.0 109.697 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.529 ' CD2' ' OD1' ' A' ' 78' ' ' ASN . 16.3 t80 -95.17 100.18 12.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 77' ' ' TYR . 1.5 p-10 37.48 -110.52 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -95.14 -20.93 18.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.868 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' TYR . 72.5 ttt180 -98.56 162.7 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.121 -0.987 . . . . 0.0 110.505 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -101.02 150.37 22.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.235 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -143.63 148.08 35.31 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.048 -1.032 . . . . 0.0 109.592 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.45 125.22 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.235 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.58 124.4 49.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.377 -0.827 . . . . 0.0 109.564 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.76 134.63 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -132.13 -167.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.889 0.852 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.68 -41.69 98.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.661 -0.649 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.08 -22.72 67.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -0.941 . . . . 0.0 109.605 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.7 m -80.23 163.99 23.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 p -142.62 162.08 36.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 HD23 ' A' ' 58' ' ' LEU . 79.9 mt -141.56 134.1 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -130.7 135.27 47.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -71.26 136.45 47.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.702 . . . . 0.0 109.597 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 68' ' ' LEU . 98.2 mt -92.57 136.45 33.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.9 t -74.99 -9.02 58.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.713 . . . . 0.0 109.78 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -118.92 137.27 24.84 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.769 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.9 159.15 38.32 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.668 2.245 . . . . 0.0 112.189 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.11 131.53 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.687 . . . . 0.0 109.383 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.873 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.496 1.621 0 CA-C-O 121.399 0.5 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.02 120.25 17.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.864 . . . . 0.0 109.74 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.5 mt -97.02 129.85 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -123.31 151.31 42.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -99.84 147.6 25.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.089 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 46' ' ' GLY . 5.0 pt -58.78 -43.0 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.517 -0.739 . . . . 0.0 109.369 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.8 -7.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.78 15.29 28.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.408 -0.808 . . . . 0.0 109.298 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.43 115.51 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.975 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.28 2.05 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -135.29 131.59 36.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.371 -0.831 . . . . 0.0 109.058 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -95.95 155.64 16.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 19.89 74.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -101.29 156.88 17.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -1.042 . . . . 0.0 109.892 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -106.15 134.2 49.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -176.85 5.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.437 -0.79 . . . . 0.0 109.811 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 70' ' ' ARG . 9.9 m120 -120.37 135.0 55.17 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -136.62 138.03 40.74 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.962 -1.086 . . . . 0.0 110.174 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 34.0 ttpt -117.68 134.33 55.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.6 23.56 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.21 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 51.6 tttp -96.53 163.35 13.07 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.05 97.17 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.321 -0.862 . . . . 0.0 110.942 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.7 pt -80.46 -27.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.877 . . . . 0.0 110.225 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -147.33 130.47 16.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -116.42 140.86 48.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.232 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -149.41 137.24 20.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.168 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.26 -0.9 . . . . 0.0 109.71 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.536 0.684 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 m -91.11 -54.1 4.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.502 -0.749 . . . . 0.0 109.607 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.41 ' CD ' HD12 ' A' ' 52' ' ' ILE . 13.9 pt20 -160.98 168.74 23.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 39' ' ' GLY . 94.7 t -146.91 156.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -179.67 -163.8 31.0 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.597 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.79 147.51 51.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.782 -0.834 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.489 HD11 ' CD1' ' A' ' 50' ' ' PHE . 4.9 mp -136.56 144.76 44.36 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.602 0.715 . . . . 0.0 109.806 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.58 135.07 12.07 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' A' ' 44' ' ' GLU . 53.1 t0 -115.21 4.34 14.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.523 -0.986 . . . . 0.0 110.674 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.595 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 65.1 tt0 100.75 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.515 1.052 . . . . 0.0 108.487 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -93.48 -3.56 52.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.153 . . . . 0.0 109.562 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' N ' HD11 ' A' ' 8' ' ' ILE . . . 155.47 -150.46 21.9 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.4 160.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.625 -0.927 . . . . 0.0 109.764 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tp -157.18 141.07 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.013 . . . . 0.0 109.526 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB3' HE22 ' A' ' 82' ' ' GLN . 14.6 ttmm -89.93 132.23 35.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -125.1 154.31 41.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.313 -0.867 . . . . 0.0 109.192 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -132.27 133.32 43.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 HD12 ' CD ' ' A' ' 37' ' ' GLN . 65.7 mt -100.69 122.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.304 -0.873 . . . . 0.0 109.79 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -80.41 149.57 30.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.43 -34.71 78.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -59.67 -20.76 58.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.99 60.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.106 -0.996 . . . . 0.0 108.746 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 44.16 45.5 6.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.585 -0.697 . . . . 0.0 109.969 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.81 150.95 37.29 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.02 160.72 47.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.595 2.197 . . . . 0.0 112.296 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.87 134.87 48.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 110.109 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.2 mp -78.05 146.09 35.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.625 -0.672 . . . . 0.0 109.541 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -86.39 131.11 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -73.12 135.83 44.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.518 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 88.73 5.02 75.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 78.0 mm-40 -113.69 157.54 22.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.413 -1.051 . . . . 0.0 110.896 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 m -85.9 141.79 29.31 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.33 0.585 . . . . 0.0 109.629 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -138.98 145.01 39.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.298 -0.876 . . . . 0.0 109.803 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.45 128.42 55.99 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mp -115.55 116.34 27.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.625 -0.672 . . . . 0.0 109.448 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' HA ' HD22 ' A' ' 19' ' ' ASN . 84.5 mtp180 -108.66 143.09 38.2 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.551 0.691 . . . . 0.0 110.432 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.9 p 60.57 57.51 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 0.0 110.656 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.4 157.82 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.175 -0.953 . . . . 0.0 108.773 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.54 134.38 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.752 . . . . 0.0 109.211 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.09 135.82 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.532 -0.73 . . . . 0.0 109.649 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.76 ' H ' HE22 ' A' ' 84' ' ' GLN . . . -108.81 146.58 16.6 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.23 103.34 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.243 . . . . 0.0 109.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 80' ' ' ARG . 64.9 t80 -97.95 96.97 8.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.223 -0.923 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.65 -119.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.645 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.21 -11.2 39.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 77' ' ' TYR . 89.1 mtm180 -111.15 161.12 16.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 110.115 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.38 153.87 18.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.414 HE22 ' HB3' ' A' ' 49' ' ' LYS . 88.0 mm-40 -140.32 153.94 46.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.146 -0.971 . . . . 0.0 109.133 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.76 113.81 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.241 -0.912 . . . . 0.0 108.582 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.76 HE22 ' H ' ' A' ' 75' ' ' GLY . 2.6 mp0 -103.05 134.98 45.58 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 0.0 109.325 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -102.92 129.42 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -121.36 -174.38 2.84 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.697 0.761 . . . . 0.0 110.047 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.68 -41.68 97.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.68 -0.638 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -65.59 -2.52 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.957 . . . . 0.0 109.767 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -89.82 161.28 16.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.2 t -132.99 151.86 52.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.97 128.32 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.901 -1.125 . . . . 0.0 109.086 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -129.44 135.92 49.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.081 -1.012 . . . . 0.0 109.135 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.2 tttp -79.6 129.78 34.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.33 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 93' ' ' LYS . 3.9 mm? -104.3 134.74 47.01 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.927 0.87 . . . . 0.0 109.982 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -81.81 -3.14 53.22 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -91.78 123.01 64.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.876 -1.14 . . . . 0.0 109.548 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.25 141.82 23.56 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.733 1.622 . . . . 0.0 112.422 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.01 141.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.46 -0.775 . . . . 0.0 109.177 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 0.0 109.223 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 121.379 0.491 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -79.58 112.28 16.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.4 mt -89.89 129.61 36.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.0 109.691 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.6 m -123.88 139.87 53.54 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.421 0.629 . . . . 0.0 109.326 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.24 144.35 25.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.964 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 9' ' ' VAL . 9.5 pt -52.72 -41.7 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.626 -0.671 . . . . 0.0 109.686 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.403 ' N ' HG13 ' A' ' 8' ' ' ILE . 14.8 p -70.03 -11.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -96.59 6.44 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.65 119.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 109.968 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.92 6.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 96.6 mt-10 -131.71 128.01 38.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.542 -0.724 . . . . 0.0 109.369 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.597 ' ND2' ' N ' ' A' ' 15' ' ' GLY . 2.3 t-20 -88.95 150.03 23.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.848 . . . . 0.0 109.924 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.597 ' N ' ' ND2' ' A' ' 14' ' ' ASN . . . 80.34 21.82 63.98 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 13' ' ' GLU . 4.9 pt20 -103.35 153.2 20.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.575 -0.956 . . . . 0.0 109.837 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -103.9 132.25 50.34 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.507 0.67 . . . . 0.0 109.446 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -160.32 178.87 9.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 109.863 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -120.66 144.98 47.89 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.1 tp -136.59 133.7 36.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.512 -0.742 . . . . 0.0 110.131 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -118.31 132.03 56.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.39 -173.21 0.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.176 0.989 . . . . 0.0 110.806 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.9 ptpt -118.19 155.82 29.82 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.438 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 95.8 t -90.06 105.75 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.471 -0.768 . . . . 0.0 110.158 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.449 ' C ' HE21 ' A' ' 63' ' ' GLN . 34.5 pt -73.19 -25.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.804 -0.56 . . . . 0.0 110.045 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -159.59 148.59 17.94 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.983 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.6 pt? -125.34 152.01 45.3 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.13 117.7 9.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 109.606 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.623 -0.673 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.475 0.655 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 3.0 m -102.05 -46.32 4.9 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.513 0.673 . . . . 0.0 109.894 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -148.82 148.2 29.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.988 -1.07 . . . . 0.0 109.975 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.86 130.74 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.38 -166.93 15.12 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.15 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD21 ' NZ ' ' A' ' 49' ' ' LYS . 4.8 mp -135.31 150.48 50.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.866 -0.784 . . . . 0.0 109.734 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.21 125.22 53.57 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.64 8.13 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.4 p-10 -125.73 -134.69 0.26 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.714 -0.874 . . . . 0.0 109.098 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 81.7 tt0 -119.8 -18.57 8.24 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 15.7 p -93.06 -11.06 33.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.97 -1.081 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 151.65 -143.85 10.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -141.54 158.11 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -1.09 . . . . 0.0 109.432 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -148.86 145.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 109.885 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.455 ' NZ ' HD21 ' A' ' 40' ' ' LEU . 67.9 mttm -92.01 127.36 37.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.023 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -122.87 152.76 40.44 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.3 m -131.24 133.44 45.45 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.426 0.631 . . . . 0.0 109.634 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.64 127.1 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -82.5 142.56 31.77 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.597 -0.689 . . . . 0.0 110.118 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' N ' ' OG ' ' A' ' 36' ' ' SER . 78.8 tttt -58.08 -37.32 74.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.541 -0.725 . . . . 0.0 109.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -6.11 1.23 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.828 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.884 . . . . 0.0 109.158 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 46.33 51.95 11.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.643 -0.661 . . . . 0.0 109.889 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.4 mt -100.65 153.02 37.97 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.741 -0.599 . . . . 0.0 109.848 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.46 148.89 60.1 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.477 2.118 . . . . 0.0 112.779 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.6 140.12 51.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.512 -0.742 . . . . 0.0 110.379 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.3 mp -83.37 150.33 26.16 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.367 0.603 . . . . 0.0 109.964 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.2 128.2 45.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.449 HE21 ' C ' ' A' ' 25' ' ' ILE . 11.1 tm0? -66.71 137.99 57.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.662 -0.649 . . . . 0.0 110.712 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 86.74 -10.77 66.37 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -98.18 158.19 15.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -1.033 . . . . 0.0 110.674 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 m -91.58 145.67 24.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -141.73 148.82 39.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 109.815 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 tp -110.32 128.76 55.71 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.83 118.05 31.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.531 -0.731 . . . . 0.0 109.728 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -114.86 145.01 42.63 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.692 0.758 . . . . 0.0 110.694 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 63.22 56.57 1.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 18' ' ' ALA . 19.0 m -110.73 161.97 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.512 -0.743 . . . . 0.0 109.381 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 148.43 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.581 0.705 . . . . 0.0 109.59 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 65.3 t -95.75 132.47 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.676 -0.64 . . . . 0.0 109.686 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.0 16.96 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -94.86 109.39 21.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.534 -0.98 . . . . 0.0 109.403 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.674 ' CB ' HE21 ' A' ' 82' ' ' GLN . 40.4 t80 -106.8 106.45 16.97 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.922 0.868 . . . . 0.0 109.483 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.4 m120 42.64 -118.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -93.07 -17.3 23.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.102 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.7 mtt-85 -100.82 159.78 14.91 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.411 -0.805 . . . . 0.0 110.329 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -104.72 153.32 21.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.674 HE21 ' CB ' ' A' ' 77' ' ' TYR . 43.5 mt-30 -147.81 159.94 43.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.38 123.55 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.72 129.35 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -104.41 131.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -127.08 -170.46 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.673 0.749 . . . . 0.0 110.066 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.53 -45.14 91.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.907 -0.496 . . . . 0.0 110.181 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.18 -11.07 7.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 109.758 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.5 p -83.23 163.91 20.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.9 p -138.44 155.67 48.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -139.66 131.77 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 0.0 109.313 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -127.47 130.57 49.47 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -70.34 135.89 49.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.705 -0.622 . . . . 0.0 109.502 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.1 mt -96.92 134.36 40.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.505 -0.747 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.5 p -85.29 -6.34 59.26 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -107.12 130.52 22.74 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.567 -0.708 . . . . 0.0 109.57 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.25 147.39 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.478 2.119 . . . . 0.0 112.242 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.464 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.5 mt -110.27 131.67 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.6 mp0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 110.011 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 N--CA 1.494 1.522 0 CA-C-O 121.416 0.507 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.03 115.43 18.7 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.12 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.9 mt -86.95 126.64 34.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.55 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.7 m -120.77 136.78 54.8 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.07 148.39 22.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.23 -43.3 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.528 0.68 . . . . 0.0 109.193 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.22 -13.39 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.429 -0.795 . . . . 0.0 109.535 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 53.2 t0 -95.58 5.52 51.29 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.159 -0.963 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 13' ' ' GLU . 3.7 mm -56.14 -72.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.142 -0.974 . . . . 0.0 109.185 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t 62.59 -32.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 11' ' ' ILE . 52.3 tp10 -145.54 147.6 32.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.883 -1.135 . . . . 0.0 108.987 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -101.48 173.11 6.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.56 0.695 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.43 21.85 79.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 34.3 mt-30 -99.43 145.76 27.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.349 -1.089 . . . . 0.0 109.984 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.27 126.05 39.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.464 ' C ' HD22 ' A' ' 19' ' ' ASN . . . -162.28 -169.98 2.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -126.09 144.07 50.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.69 130.81 38.7 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.715 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -116.05 130.67 56.91 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.16 -173.67 1.14 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.23 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HZ1' ' HB ' ' A' ' 98' ' ' ILE . 3.3 ttmp? -114.26 148.89 36.72 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.831 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.08 123.71 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 pt -88.46 -20.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.432 -0.793 . . . . 0.0 110.45 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -164.91 154.82 13.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.723 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.7 mt -124.36 152.09 43.59 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.443 0.64 . . . . 0.0 110.021 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -137.33 104.92 5.53 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' HG2' HE21 ' A' ' 37' ' ' GLN . 96.9 mt-10 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.743 -0.598 . . . . 0.0 109.695 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.1 p -90.93 -60.17 1.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.912 0.863 . . . . 0.0 110.437 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.537 ' N ' ' OG ' ' A' ' 36' ' ' SER . 81.3 mt-30 -146.67 155.34 42.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.864 -1.148 . . . . 0.0 109.964 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 39' ' ' GLY . 20.2 t -135.94 161.77 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' ' CE2' ' A' ' 50' ' ' PHE . . . 178.4 -168.17 39.16 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.058 -1.544 . . . . 0.0 109.939 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.08 149.88 52.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.764 -0.845 . . . . 0.0 109.583 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.6 125.72 53.7 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.733 0.778 . . . . 0.0 108.992 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.93 101.2 2.75 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -105.05 164.02 12.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.678 -0.895 . . . . 0.0 109.293 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -71.49 -17.01 62.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.491 -0.756 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.3 p -93.81 -10.85 32.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 109.571 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.61 -149.57 21.23 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 pt -132.98 156.16 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.944 . . . . 0.0 109.701 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -152.47 145.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.865 . . . . 0.0 109.397 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.612 ' H ' HH12 ' A' ' 80' ' ' ARG . 68.3 mttm -80.44 165.35 22.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.807 . . . . 0.0 109.451 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CE2' ' C ' ' A' ' 39' ' ' GLY . 24.6 p90 -154.23 148.6 26.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.513 -1.367 . . . . 0.0 108.08 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.5 m -132.93 132.38 41.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.436 -0.79 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -105.7 127.56 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.491 -0.755 . . . . 0.0 109.38 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -83.76 140.3 32.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.66 -33.01 69.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.466 -0.771 . . . . 0.0 109.226 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -64.14 -6.43 6.54 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.79 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.58 -31.84 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 108.941 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 49.51 52.9 13.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.909 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 mt -101.96 153.93 37.67 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.36 -0.837 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.71 149.65 31.67 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.145 1.896 . . . . 0.0 112.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.0 138.29 57.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 0.0 110.27 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.8 mp -82.86 145.24 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 109.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -105.21 135.36 46.71 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.835 0.826 . . . . 0.0 109.998 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -74.78 146.64 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.022 0.915 . . . . 0.0 110.006 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.72 -11.1 42.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -97.81 150.14 21.58 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.102 -1.234 . . . . 0.0 110.507 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -84.16 143.8 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.364 0.602 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -142.14 150.26 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.08 129.92 55.47 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.31 115.65 28.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.423 -0.798 . . . . 0.0 109.576 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -113.66 146.25 40.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.579 -0.701 . . . . 0.0 110.317 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.1 t 56.96 58.97 3.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.882 -0.511 . . . . 0.0 110.908 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.98 165.73 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.302 -0.873 . . . . 0.0 108.849 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.01 152.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.654 0.74 . . . . 0.0 109.591 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.15 132.08 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.649 -0.657 . . . . 0.0 109.536 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.12 156.24 15.71 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.44 118.17 36.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 109.032 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.5 t80 -135.46 117.89 15.77 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 80' ' ' ARG . 9.4 m120 52.73 55.75 8.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.452 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 56.16 -4.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.68 -0.638 . . . . 0.0 110.808 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' H ' ' A' ' 49' ' ' LYS . 68.3 ttt-85 -102.02 131.91 48.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.093 -1.004 . . . . 0.0 109.598 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 11' ' ' ILE . 13.9 m-85 -78.15 146.3 35.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.488 -0.757 . . . . 0.0 109.233 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -147.32 162.6 38.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 0.0 109.613 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.94 119.77 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.442 -0.787 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -100.56 129.91 46.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 0.0 109.043 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.56 132.39 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.045 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -125.49 -170.12 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.402 -0.811 . . . . 0.0 109.81 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -67.3 -25.42 66.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.654 -0.654 . . . . 0.0 110.102 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -80.72 -9.24 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.776 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 m -88.87 164.07 15.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 0.0 109.675 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.6 m -134.93 158.0 45.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.264 -0.897 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.94 128.87 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.114 -0.991 . . . . 0.0 108.843 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.97 128.56 47.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.311 -0.868 . . . . 0.0 108.919 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.82 137.97 55.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 109.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.2 134.37 46.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.848 . . . . 0.0 109.941 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.9 p -85.5 -2.01 57.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -109.66 127.53 27.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.368 -0.833 . . . . 0.0 109.692 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.55 151.0 41.35 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.121 1.881 . . . . 0.0 112.265 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.554 ' HB ' ' HZ1' ' A' ' 23' ' ' LYS . 96.6 mt -111.01 134.5 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.716 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.497 1.726 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.469 ' N ' HD22 ' A' ' 19' ' ' ASN . 85.1 mt-30 -77.84 115.78 17.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.516 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.72 127.48 35.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.9 m -121.12 137.7 54.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -95.85 151.74 19.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.944 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mm -55.96 -44.56 78.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.77 -18.24 23.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.222 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.28 -0.52 56.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.23 118.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -142.88 -2.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.926 . . . . 0.0 109.192 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.8 140.52 45.93 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.094 -1.004 . . . . 0.0 109.505 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' A' ' 76' ' ' GLU . 39.4 p-10 -92.5 162.93 14.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.53 78.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -94.46 140.45 29.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -1.17 . . . . 0.0 109.682 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -96.48 128.26 43.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.626 -0.671 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.747 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.557 ' C ' HD22 ' A' ' 20' ' ' LEU . 58.9 m-20 -120.69 139.56 52.87 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD22 ' C ' ' A' ' 19' ' ' ASN . 4.4 mm? -116.84 146.68 42.74 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.087 -1.008 . . . . 0.0 109.71 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -138.42 125.33 21.16 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 -175.16 1.06 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.177 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -110.54 151.76 27.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.854 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.47 111.06 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.322 -0.861 . . . . 0.0 110.84 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.7 pt -89.22 -24.38 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -156.56 147.26 21.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 109.449 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 160.61 39.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.249 -0.907 . . . . 0.0 109.37 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -141.21 109.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 109.389 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.618 -179.445 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 121.408 0.623 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.416 ' OG ' ' C ' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -85.04 -58.32 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -151.98 152.01 31.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.258 -0.901 . . . . 0.0 109.871 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.87 133.01 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.27 -156.8 8.45 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.525 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.67 153.49 50.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.87 -0.782 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.46 128.7 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.8 97.84 2.35 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 53.8 t0 -101.37 159.86 14.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -1.045 . . . . 0.0 109.421 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.3 mt-10 -68.99 -14.8 63.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.44 -0.788 . . . . 0.0 109.984 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -98.0 -7.03 30.73 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.155 -0.966 . . . . 0.0 109.577 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.61 -147.81 18.11 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.162 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 47' ' ' ILE . 2.1 pp -135.81 165.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.662 -0.905 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.5 tt -157.5 144.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.147 -0.97 . . . . 0.0 109.91 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.88 130.22 38.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -128.45 154.99 45.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.831 -1.168 . . . . 0.0 108.599 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.6 m -131.33 130.47 42.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.59 -0.694 . . . . 0.0 109.257 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.06 129.62 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.332 -0.855 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.416 ' C ' ' OG ' ' A' ' 36' ' ' SER . 97.9 m95 -82.0 139.91 34.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 110.312 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 56' ' ' ALA . 64.5 tttm -59.63 -37.78 79.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -61.04 -2.04 0.54 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -85.07 -23.71 28.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 108.779 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 53.85 48.28 21.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 109.9 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.77 147.06 35.38 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.533 -0.729 . . . . 0.0 109.581 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 157.27 62.54 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.384 2.056 . . . . 0.0 112.648 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.74 147.39 43.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.054 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.7 mp -85.2 155.19 21.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.528 -0.733 . . . . 0.0 109.556 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 47.2 tp10 -100.47 136.73 39.9 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -71.34 138.6 49.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.405 -0.809 . . . . 0.0 110.488 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.16 -14.81 62.6 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.35 158.45 15.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.327 -1.102 . . . . 0.0 110.667 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -88.15 151.77 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.485 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 31.7 m-85 -142.9 143.72 32.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 109.561 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.45 129.83 56.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.04 122.74 45.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.615 -0.678 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -116.86 151.99 35.41 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.477 0.656 . . . . 0.0 110.536 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m 56.93 54.97 6.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.89 -0.506 . . . . 0.0 110.788 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.21 164.6 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.243 -0.911 . . . . 0.0 108.853 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.51 147.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.564 0.697 . . . . 0.0 109.374 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.89 131.83 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 109.383 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.93 149.94 16.95 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 78' ' ' ASN . 5.5 tm-20 -92.08 100.2 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.034 -1.274 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.8 t80 -95.18 103.61 15.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.93 . . . . 0.0 109.191 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' O ' ' OE2' ' A' ' 76' ' ' GLU . 99.3 m-20 40.25 -110.67 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 0.0 110.684 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -95.89 -19.65 19.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.099 -1.001 . . . . 0.0 110.383 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 77' ' ' TYR . 37.4 mmt180 -101.31 162.61 12.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 110.006 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.37 152.25 21.81 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.426 ' NE2' ' CD1' ' A' ' 77' ' ' TYR . 27.5 mt-30 -142.06 157.81 44.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.16 123.7 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.434 -0.791 . . . . 0.0 109.111 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -104.8 126.64 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.453 -0.779 . . . . 0.0 109.545 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.74 134.93 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.39 -0.819 . . . . 0.0 109.162 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -129.29 -168.57 1.95 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.323 -0.86 . . . . 0.0 109.896 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.63 -41.63 98.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.521 -0.737 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.91 -20.07 66.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.735 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.0 m -81.21 163.88 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.777 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.5 m -137.44 162.27 34.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.85 130.19 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.015 -1.053 . . . . 0.0 108.834 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -130.08 134.71 47.55 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.211 -0.931 . . . . 0.0 109.013 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -75.57 139.54 42.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.532 -0.73 . . . . 0.0 109.902 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.07 141.74 28.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 109.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -85.05 -8.98 58.46 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.24 134.05 20.88 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.336 -0.852 . . . . 0.0 110.033 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 154.02 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.053 1.836 . . . . 0.0 112.155 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -111.64 133.41 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 109.663 -179.496 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.496 1.618 0 CA-C-O 121.359 0.483 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.74 115.66 20.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.95 131.43 35.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -123.57 142.08 51.38 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -93.28 149.86 20.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.073 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.25 -43.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.369 -0.832 . . . . 0.0 109.078 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 p -62.99 -5.7 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -102.02 6.25 41.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.372 -0.83 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.74 112.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 109.551 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.6 m -149.74 4.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -132.91 130.47 39.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.362 -0.836 . . . . 0.0 109.078 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -88.15 160.06 17.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.193 -0.942 . . . . 0.0 110.359 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.52 20.68 72.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -94.29 138.57 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 109.996 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -94.85 126.69 40.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 109.386 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -179.41 7.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -126.3 140.36 52.58 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.36 143.73 40.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.5 135.74 54.2 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.87 -173.69 1.01 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.183 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.09 150.99 28.6 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.863 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.14 97.34 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.086 -1.009 . . . . 0.0 109.932 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 tp -66.47 -32.59 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 121.092 -1.005 . . . . 0.0 110.529 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -147.35 129.7 15.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 109.535 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.78 147.59 41.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.598 -0.689 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -143.51 115.39 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 109.396 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.459 -0.776 . . . . 0.0 109.649 -179.691 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.524 3.232 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -81.72 -57.87 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.394 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.74 165.19 33.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 0.0 110.661 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.76 154.9 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.66 -155.38 17.36 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.393 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.01 155.2 50.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.911 -0.758 . . . . 0.0 109.541 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.35 127.8 55.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.8 105.89 3.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -112.95 167.99 10.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.923 . . . . 0.0 109.484 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -73.01 -17.33 61.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.947 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.8 p -93.17 -12.1 31.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.917 -1.114 . . . . 0.0 109.644 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.69 -148.56 19.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 47' ' ' ILE . 2.3 pp -135.55 160.66 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.992 . . . . 0.0 109.55 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -153.77 147.56 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.189 -0.944 . . . . 0.0 109.76 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -81.07 163.64 23.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 109.189 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -160.6 150.94 18.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.483 -1.386 . . . . 0.0 108.265 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 t -138.42 133.1 32.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.837 . . . . 0.0 109.47 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -105.2 129.77 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.677 -0.639 . . . . 0.0 109.467 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -81.98 139.3 34.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 110.686 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.35 -32.03 72.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.416 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.09 -10.4 10.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.85 -21.88 34.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 47.74 48.89 17.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.985 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt -103.71 152.27 38.9 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.404 -0.81 . . . . 0.0 109.8 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.42 146.5 41.27 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.077 1.851 . . . . 0.0 112.589 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.47 142.78 53.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.0 mp -82.63 143.32 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.514 -0.741 . . . . 0.0 109.667 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -93.41 132.04 38.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.28 -0.888 . . . . 0.0 109.755 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -69.26 139.11 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 110.746 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -11.97 59.56 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -96.06 158.51 15.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -1.109 . . . . 0.0 110.585 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.489 0.661 . . . . 0.0 109.836 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.11 148.78 38.9 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.936 0.874 . . . . 0.0 109.879 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.499 HD21 ' NE ' ' A' ' 70' ' ' ARG . 27.2 tp -107.16 131.41 54.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.9 mt -116.27 111.29 19.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.499 ' NE ' HD21 ' A' ' 68' ' ' LEU . 99.1 mtt180 -115.65 153.04 32.0 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.737 0.779 . . . . 0.0 110.556 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 5.2 p 50.46 56.58 7.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.867 -0.52 . . . . 0.0 110.67 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 167.26 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.98 152.72 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.6 0.714 . . . . 0.0 109.402 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.11 131.44 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.65 -0.656 . . . . 0.0 109.734 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.25 148.56 17.21 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -97.5 107.59 20.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.279 -1.13 . . . . 0.0 108.927 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ARG . 87.1 t80 -107.13 109.22 21.0 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.371 -0.83 . . . . 0.0 109.273 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.483 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 26.6 t-20 38.92 -116.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.483 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 99.4 m-20 -92.81 -20.13 21.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 77' ' ' TYR . 3.6 mpt_? -96.12 162.22 13.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.84 153.89 25.94 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -149.77 161.87 41.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.167 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.17 128.14 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.87 124.35 49.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.484 -0.76 . . . . 0.0 109.356 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.7 t -98.4 133.51 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -123.27 -169.09 1.87 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 0.0 109.655 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.45 -38.81 88.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.761 -0.587 . . . . 0.0 109.924 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.55 -12.17 56.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.983 . . . . 0.0 109.902 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 t -87.75 166.66 14.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.4 m -134.82 156.03 49.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.29 -0.881 . . . . 0.0 108.829 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -139.12 130.88 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.094 -1.004 . . . . 0.0 108.981 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -127.22 127.91 45.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.28 -0.888 . . . . 0.0 108.917 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.58 141.92 44.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.27 142.2 37.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.402 ' OG ' ' OE2' ' A' ' 96' ' ' GLU . 94.5 p -88.2 3.18 50.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.616 -0.677 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 27.6 mp0 -105.99 133.72 20.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.291 -0.881 . . . . 0.0 109.687 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.51 148.29 37.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.089 1.86 . . . . 0.0 112.157 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.53 134.11 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.9 mp0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.095 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 N--CA 1.494 1.538 0 CA-C-O 121.335 0.473 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.61 115.51 17.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.14 131.32 36.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.849 . . . . 0.0 109.438 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.3 m -124.68 141.06 52.37 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.88 151.75 19.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.3 mt -56.38 -45.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.229 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.7 -17.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.625 -0.672 . . . . 0.0 109.436 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -92.8 2.41 56.77 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -86.21 121.23 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.045 -1.034 . . . . 0.0 109.861 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -147.9 6.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -137.56 135.42 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 76' ' ' GLU . 56.1 p30 -93.32 158.75 15.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.9 20.71 79.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.46 147.62 25.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -1.123 . . . . 0.0 110.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -97.49 126.91 43.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.94 -178.23 6.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.682 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.404 HD22 ' HG2' ' A' ' 70' ' ' ARG . 5.0 m120 -117.91 145.62 44.52 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.4 tp -134.24 127.86 32.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -114.88 130.21 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.11 170.78 11.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.122 0.963 . . . . 0.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -100.1 155.34 17.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.751 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.45 113.19 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.51 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -147.56 130.5 16.23 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.036 -1.04 . . . . 0.0 109.781 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.929 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.4 pt? -129.68 156.81 43.65 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.293 0.568 . . . . 0.0 109.812 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -144.5 110.5 5.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.575 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.423 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.5 0.667 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -82.52 -62.77 1.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.621 -0.674 . . . . 0.0 109.995 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -152.32 149.19 28.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.968 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.61 154.13 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.14 -159.63 22.68 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 tp -125.27 145.2 50.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.907 -0.76 . . . . 0.0 109.448 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.547 HD21 ' CE1' ' A' ' 50' ' ' PHE . 67.0 mt -108.48 128.68 55.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.514 -0.741 . . . . 0.0 109.201 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 97.83 2.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -103.32 164.31 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.97 . . . . 0.0 109.621 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.09 -20.22 62.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.602 -0.686 . . . . 0.0 110.104 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 p -90.12 -12.65 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.359 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.58 -148.97 20.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.425 ' N ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -132.02 159.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.672 -0.899 . . . . 0.0 109.666 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.42 141.69 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -88.36 144.68 26.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.547 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.5 p90 -141.27 158.63 43.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.73 -1.231 . . . . 0.0 108.49 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -135.03 137.57 43.09 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.514 0.674 . . . . 0.0 109.726 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.6 mt -106.33 129.68 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -86.39 142.94 28.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.376 -0.827 . . . . 0.0 110.378 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -61.93 -32.08 72.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.643 -0.66 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.5 -12.77 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.517 -0.739 . . . . 0.0 109.619 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.23 24.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.948 . . . . 0.0 108.939 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 49.13 52.91 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.815 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 mt -102.37 153.66 37.95 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.1 149.0 45.94 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 122.082 1.855 . . . . 0.0 112.72 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.54 140.89 51.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.264 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.5 mp -82.97 145.04 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.709 -0.619 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 96.1 mt-10 -101.17 139.2 37.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.425 ' OE1' HD22 ' A' ' 27' ' ' LEU . 59.2 tt0 -76.58 138.27 40.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.644 -0.66 . . . . 0.0 110.726 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.02 -18.65 56.94 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 97.8 mt-10 -97.0 159.95 14.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.681 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -89.55 148.59 23.3 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.416 0.627 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.43 143.94 34.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.713 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 tp -109.45 130.44 55.5 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -113.33 122.17 46.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.502 -0.749 . . . . 0.0 109.831 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HG2' HD22 ' A' ' 19' ' ' ASN . 84.1 mtp180 -120.19 147.1 45.35 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.675 0.75 . . . . 0.0 110.426 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t 57.11 56.86 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.097 0.475 . . . . 0.0 110.751 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.56 166.03 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.81 143.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.602 0.715 . . . . 0.0 109.666 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.83 132.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.65 -0.656 . . . . 0.0 109.655 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.29 153.1 17.77 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.412 ' HB2' HD22 ' A' ' 14' ' ' ASN . 78.4 tt0 -95.71 110.44 22.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -1.147 . . . . 0.0 109.139 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 80' ' ' ARG . 75.4 t80 -103.84 109.73 21.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.145 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 43.75 -119.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.773 . . . . 0.0 110.438 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -94.01 -17.08 23.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.11 -0.994 . . . . 0.0 110.254 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 77' ' ' TYR . 78.4 ttt180 -102.56 144.13 31.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.38 153.27 37.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 0.0 108.955 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -143.82 152.05 40.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.991 -1.068 . . . . 0.0 109.011 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.89 122.27 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.86 128.67 53.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.448 -0.783 . . . . 0.0 109.414 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.11 133.11 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -136.94 -166.32 1.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 89' ' ' SER . 10.0 mtpm? -55.43 167.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.873 -0.517 . . . . 0.0 109.763 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 73.07 -23.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.413 -0.804 . . . . 0.0 109.614 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 87' ' ' LYS . 48.9 m -72.35 159.18 34.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.752 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.9 m -135.04 155.12 51.3 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.336 -0.852 . . . . 0.0 108.871 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -139.26 131.19 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.1 -1.0 . . . . 0.0 109.06 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -131.58 136.91 48.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 0.0 108.917 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -72.45 140.53 48.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.32 132.14 44.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.404 -0.81 . . . . 0.0 109.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -83.1 -4.77 58.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.661 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -115.53 93.66 37.42 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.78 . . . . 0.0 109.441 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.94 156.78 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.525 2.15 . . . . 0.0 112.208 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.7 147.85 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.07 -179.699 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.494 1.524 0 CA-C-O 121.412 0.505 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.42 113.79 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.517 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.32 132.18 36.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.1 m -124.46 143.49 50.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.63 -0.668 . . . . 0.0 109.27 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -94.1 148.08 22.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.7 mt -57.24 -44.74 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 109.399 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.36 -12.31 13.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.565 -0.71 . . . . 0.0 109.385 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 53.7 t0 -97.31 4.89 50.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.2 mt -88.0 121.57 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.99 6.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.208 -0.933 . . . . 0.0 109.417 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -133.49 128.99 36.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -87.81 153.61 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.148 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.88 17.01 78.04 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -96.44 150.12 20.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.425 -1.044 . . . . 0.0 110.045 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -102.33 131.26 49.05 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.4 0.619 . . . . 0.0 109.481 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.63 179.24 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.578 ' C ' HD22 ' A' ' 20' ' ' LEU . 5.0 m-80 -117.15 131.12 56.95 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.578 HD22 ' C ' ' A' ' 19' ' ' ASN . 4.4 mm? -117.18 146.26 43.33 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.898 0.856 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -136.08 131.47 34.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.54 -173.82 0.78 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.039 0.923 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' CE ' ' H ' ' A' ' 98' ' ' ILE . 34.2 ttmt -111.85 150.98 29.62 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.943 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.4 t -86.39 95.02 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.21 -26.7 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.77 . . . . 0.0 109.811 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -143.17 119.25 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.954 -1.091 . . . . 0.0 109.379 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.411 HD11 ' NE2' ' A' ' 37' ' ' GLN . 61.4 tp -109.3 143.63 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 0.0 109.18 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -140.26 107.28 5.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.61 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.677 0.751 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -97.63 -50.06 4.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' NE2' HD11 ' A' ' 27' ' ' LEU . 48.2 tt0 -149.87 146.84 27.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 110.129 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.39 153.01 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.38 -161.58 23.87 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.275 -1.441 . . . . 0.0 109.925 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.76 146.53 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.021 -0.693 . . . . 0.0 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD21 ' CE1' ' A' ' 50' ' ' PHE . 70.3 mt -112.3 127.08 55.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.53 -0.731 . . . . 0.0 109.431 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.35 100.93 2.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -101.25 162.39 12.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.359 -1.083 . . . . 0.0 109.358 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -72.26 -21.93 61.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.601 -0.687 . . . . 0.0 109.893 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.9 p -93.92 -16.12 24.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.208 -0.933 . . . . 0.0 109.136 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.21 -156.98 29.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.014 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 47' ' ' ILE . 15.2 pt -137.98 163.18 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.531 -0.981 . . . . 0.0 109.93 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.2 tt -162.5 152.12 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.196 -0.94 . . . . 0.0 109.716 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -97.12 138.84 34.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.4 p90 -131.49 156.16 46.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.058 -1.026 . . . . 0.0 108.933 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.8 m -131.59 132.28 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.472 0.653 . . . . 0.0 109.64 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.3 mt -98.47 128.23 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 109.699 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -85.0 143.73 28.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -0.792 . . . . 0.0 110.432 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.56 -35.36 74.09 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -58.97 -9.54 1.94 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.575 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.22 -28.13 24.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 108.889 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 45.9 49.99 11.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.639 . . . . 0.0 109.865 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.0 mt -102.78 153.22 38.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.614 -0.679 . . . . 0.0 109.739 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.78 149.91 47.89 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.357 2.038 . . . . 0.0 112.642 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.91 140.4 53.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.469 -0.77 . . . . 0.0 110.335 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -81.57 145.42 30.66 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.423 0.63 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 97.0 mt-10 -94.24 128.78 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 58.3 tt0 -68.5 135.45 51.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.592 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.1 71.59 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.0 mp0 -99.4 162.38 13.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -1.123 . . . . 0.0 110.687 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -98.04 137.13 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -133.75 153.38 51.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.133 0.968 . . . . 0.0 110.08 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 tp -111.74 131.32 55.39 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.9 mt -111.9 120.86 43.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.471 -0.768 . . . . 0.0 109.533 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' O ' ' OG ' ' A' ' 71' ' ' SER . 83.0 mtp180 -117.75 151.37 37.43 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.578 0.704 . . . . 0.0 110.647 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.2 p 51.71 56.2 8.21 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.52 166.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.55 150.03 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.686 0.755 . . . . 0.0 109.888 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.45 132.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.674 . . . . 0.0 109.442 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.75 150.2 16.85 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -88.02 99.7 12.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ARG . 76.2 t80 -98.1 100.71 12.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.251 -0.906 . . . . 0.0 109.225 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 44.7 -119.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 110.7 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 34.6 p-10 -93.65 -7.58 43.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -110.57 155.27 22.56 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.89 0.852 . . . . 0.0 110.184 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -95.95 153.45 17.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 108.848 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -144.11 159.43 42.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.41 126.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -103.13 126.75 50.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.432 -0.792 . . . . 0.0 109.148 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.03 132.24 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -127.01 -168.45 1.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.692 0.758 . . . . 0.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -65.2 -41.76 94.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.762 -0.587 . . . . 0.0 110.18 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -64.48 -12.2 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.413 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 37.8 t -83.86 164.03 19.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.8 m -136.5 157.59 46.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.327 -0.858 . . . . 0.0 109.044 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 61' ' ' LEU . 96.3 mt -134.96 128.24 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.267 -0.896 . . . . 0.0 109.226 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -129.76 133.12 46.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.467 ' C ' HD22 ' A' ' 94' ' ' LEU . 66.0 tttm -80.1 134.86 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' GLU . 4.0 mm? -107.64 -1.7 20.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.464 -0.772 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 14.3 t 47.28 15.77 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.269 -0.894 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 94' ' ' LEU . 6.9 tp10 -114.83 93.28 33.31 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 108.936 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.8 147.39 41.3 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.683 2.255 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.414 ' H ' ' CE ' ' A' ' 23' ' ' LYS . 29.8 mm -105.74 139.96 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.573 -0.704 . . . . 0.0 109.17 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.495 -179.555 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 CA-C-O 121.272 0.447 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.56 117.96 22.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -87.77 128.67 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.442 ' O ' HD23 ' A' ' 20' ' ' LEU . 84.9 m -124.94 145.64 49.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -97.49 142.71 28.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 pt -52.94 -39.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 0.0 109.733 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.56 -12.19 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.504 -0.748 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -97.17 5.18 50.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.95 123.77 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.159 -0.963 . . . . 0.0 109.951 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.41 8.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -137.45 134.42 35.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 109.243 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.418 ' OD1' ' OE1' ' A' ' 76' ' ' GLU . 16.0 m120 -92.61 153.74 18.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.369 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.19 71.75 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -95.83 146.86 24.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.66 132.47 52.61 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.352 0.596 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -175.16 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 0.0 109.848 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 27.3 t30 -119.48 140.53 50.31 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 6' ' ' THR . 14.8 mt -133.62 149.03 51.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.383 -0.823 . . . . 0.0 110.165 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -133.07 127.34 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.93 177.5 10.31 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.098 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -109.16 153.15 24.15 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.919 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.0 99.61 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.286 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.51 -26.09 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -158.36 147.43 19.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.361 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.903 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -133.54 158.78 42.27 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.51 -0.744 . . . . 0.0 109.628 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -142.41 109.32 5.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.231 -179.599 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.513 0.673 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 t -86.25 -57.43 3.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.991 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -151.41 154.95 37.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.187 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.35 139.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.69 -156.02 10.12 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.327 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.06 152.2 51.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.832 -0.805 . . . . 0.0 109.688 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.75 131.64 54.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.33 99.15 2.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -100.34 160.78 14.06 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.452 -1.028 . . . . 0.0 109.46 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.98 -16.63 63.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 109.85 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -96.63 -11.72 24.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.213 -0.929 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.17 17.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.676 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.6 pp -132.82 162.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.964 . . . . 0.0 109.635 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.444 HD11 ' O ' ' A' ' 81' ' ' PHE . 7.2 tp -156.67 148.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.497 ' HZ1' ' NH1' ' A' ' 80' ' ' ARG . 63.1 mttp -81.53 164.13 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.603 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -157.01 148.07 21.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.64 -1.288 . . . . 0.0 108.543 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -136.42 131.88 34.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.216 -0.927 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.07 130.11 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.664 -0.648 . . . . 0.0 109.578 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -86.85 141.44 28.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 56' ' ' ALA . 12.6 mmtm -56.59 -35.3 68.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.54 -0.725 . . . . 0.0 109.068 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -59.4 -4.6 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.484 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -87.35 -31.08 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 108.909 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 51.22 50.62 18.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 110.089 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.82 152.38 42.29 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.765 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.2 148.34 41.02 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.173 1.915 . . . . 0.0 112.784 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -68.32 144.65 54.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.479 -0.763 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -80.16 145.21 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -102.35 133.91 46.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.368 -0.833 . . . . 0.0 109.48 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.71 138.42 44.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.477 -0.764 . . . . 0.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.29 -8.15 79.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -106.04 157.32 17.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.417 -1.049 . . . . 0.0 110.493 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -89.1 147.4 24.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.861 -0.525 . . . . 0.0 109.619 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -140.52 145.75 37.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.819 0.819 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -111.69 131.25 55.42 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 2.8 mp -117.75 115.85 25.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.516 -0.74 . . . . 0.0 109.51 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -109.59 149.12 30.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.52 -0.737 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.68 59.43 3.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.789 -0.569 . . . . 0.0 110.61 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.79 162.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.27 147.96 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.512 0.673 . . . . 0.0 109.473 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.36 127.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.22 156.79 15.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.508 ' OE1' ' CE2' ' A' ' 81' ' ' PHE . 49.6 tp10 -105.6 134.35 48.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -1.006 . . . . 0.0 108.816 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 79' ' ' ASP . 87.9 t80 -129.37 117.93 21.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.744 . . . . 0.0 109.077 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' TYR . 95.0 m-20 39.65 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.707 -0.62 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 77' ' ' TYR . 37.3 p-10 -125.08 -17.61 5.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.309 -0.869 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.497 ' NH1' ' HZ1' ' A' ' 49' ' ' LYS . 96.8 mtt180 -93.25 155.43 17.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.969 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.508 ' CE2' ' OE1' ' A' ' 76' ' ' GLU . 96.0 m-85 -101.81 149.09 24.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 0.0 108.945 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -152.35 161.16 43.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -104.46 127.75 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.29 127.01 46.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.798 . . . . 0.0 109.596 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.59 133.15 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 109.07 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.433 ' N ' ' OG ' ' A' ' 89' ' ' SER . 78.8 m-20 -132.5 -166.16 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -62.36 -40.91 97.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -62.27 -32.31 73.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 86' ' ' ASN . 24.2 p -79.54 164.72 23.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.4 t -139.54 166.92 23.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.468 -0.77 . . . . 0.0 109.111 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -139.59 131.58 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.189 -0.944 . . . . 0.0 109.175 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -128.81 132.43 47.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.299 -0.876 . . . . 0.0 109.147 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.64 139.98 40.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.296 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -101.26 141.57 33.95 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.971 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -84.43 -1.75 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.556 -0.715 . . . . 0.0 109.681 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.04 131.4 23.19 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.433 -0.792 . . . . 0.0 109.692 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.43 152.91 49.81 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.998 1.799 . . . . 0.0 112.439 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.49 134.44 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.54 -0.725 . . . . 0.0 109.14 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.303 -0.873 . . . . 0.0 109.837 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.41 0.504 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -76.72 118.5 19.41 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.303 -0.873 . . . . 0.0 109.35 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.8 mt -93.23 128.29 39.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -127.86 150.5 49.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -97.61 146.99 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.153 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.42 -42.3 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.795 . . . . 0.0 108.956 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.41 -8.97 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.558 -0.714 . . . . 0.0 109.407 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 57.9 t0 -100.18 4.46 44.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.904 . . . . 0.0 109.176 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.56 118.95 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.55 6.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 14' ' ' ASN . 8.0 tm-20 -131.09 129.34 41.76 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.407 -0.808 . . . . 0.0 109.137 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p30 -88.04 150.63 23.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.284 -0.885 . . . . 0.0 110.289 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.85 16.33 79.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -93.07 144.46 25.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.364 -1.08 . . . . 0.0 109.938 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.82 129.69 45.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.695 . . . . 0.0 109.565 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.71 -179.42 7.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.384 -0.822 . . . . 0.0 109.876 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 71' ' ' SER . 77.2 m-20 -140.09 145.48 37.69 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.453 -0.779 . . . . 0.0 109.157 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.96 158.57 30.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -100.57 139.69 35.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.044 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 41' ' ' LEU . . . -153.26 157.51 40.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -103.06 153.89 19.81 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.1 110.45 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.132 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 pt -91.5 -21.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 110.143 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' NE2' HE22 ' A' ' 63' ' ' GLN . 67.8 tp60 -162.76 153.03 16.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.08 -1.013 . . . . 0.0 109.422 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.528 ' N ' HE21 ' A' ' 63' ' ' GLN . 91.5 mt -132.06 157.11 45.0 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.572 0.701 . . . . 0.0 109.909 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' VAL . 46.1 m95 -144.55 118.94 9.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.218 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 0.0 109.571 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.799 0.809 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -81.69 -65.1 1.05 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.547 0.689 . . . . 0.0 109.914 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -149.55 153.24 36.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.011 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 28' ' ' TRP . 3.0 t -137.91 163.75 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.55 33.55 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.1 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -126.96 146.81 50.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.973 -0.722 . . . . 0.0 109.123 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 58.1 mt -109.92 129.41 55.66 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.79 101.74 2.8 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -107.01 165.0 11.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.597 -0.943 . . . . 0.0 109.458 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.96 -18.78 62.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.52 -0.738 . . . . 0.0 109.847 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 p -91.66 -11.56 36.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 109.391 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.25 -146.61 15.89 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.56 151.1 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.691 -0.888 . . . . 0.0 109.636 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tp -146.48 138.06 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.765 . . . . 0.0 109.655 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -83.28 152.52 25.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.382 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.11 154.67 41.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.574 -1.329 . . . . 0.0 107.864 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -132.19 131.06 41.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.637 -0.664 . . . . 0.0 109.743 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.71 128.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -89.41 144.02 26.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -58.22 -34.36 70.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.84 -5.7 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -89.07 -33.41 17.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 108.719 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 49.81 50.25 18.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.597 -0.689 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD13 ' HB1' ' A' ' 56' ' ' ALA . 5.8 mp -102.85 163.11 18.2 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.551 -0.718 . . . . 0.0 109.671 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.79 150.09 84.73 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.577 2.185 . . . . 0.0 112.325 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.5 mt -72.35 142.82 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 110.308 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -84.35 149.52 25.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.668 . . . . 0.0 109.723 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 57.0 mp0 -110.14 142.39 41.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.964 0.888 . . . . 0.0 109.593 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.528 HE21 ' N ' ' A' ' 27' ' ' LEU . 99.5 mt-30 -74.56 137.58 42.49 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.541 0.686 . . . . 0.0 110.794 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.49 -14.91 64.4 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.06 155.01 16.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 0.0 110.832 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.468 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 5.7 p -93.39 158.79 15.55 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.489 ' HE2' ' HZ3' ' A' ' 93' ' ' LYS . 90.1 m-85 -149.8 149.28 30.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -103.66 131.73 50.56 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 68' ' ' LEU . 77.0 mt -105.43 107.5 18.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -110.15 139.39 45.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.463 0.649 . . . . 0.0 110.252 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 25.2 t 55.25 59.11 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.88 -0.512 . . . . 0.0 110.908 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.42 165.57 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.34 -0.85 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.78 153.99 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.623 0.725 . . . . 0.0 109.759 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.03 131.28 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 0.0 109.709 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.47 148.13 17.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.29 100.19 12.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -1.166 . . . . 0.0 109.229 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' ARG . 73.5 t80 -101.49 105.2 16.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 t30 40.57 -117.13 0.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.527 -0.733 . . . . 0.0 110.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.63 -18.35 23.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -99.29 162.78 12.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 110.056 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.48 153.0 24.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.23 163.13 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 0.0 109.124 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.62 125.89 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -106.08 126.19 51.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.381 -0.824 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -97.17 135.2 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -130.95 -169.41 2.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.479 -0.763 . . . . 0.0 109.747 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.53 -39.45 94.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.649 -0.657 . . . . 0.0 110.224 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -68.0 -19.63 64.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.794 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.57 166.24 17.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -0.843 . . . . 0.0 110.019 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -145.08 164.29 31.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -0.92 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mt -149.4 139.72 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -133.61 143.24 48.5 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.468 -0.77 . . . . 0.0 109.583 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 68.1 mttm -72.81 140.68 47.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.766 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt -111.64 147.72 34.89 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.634 0.73 . . . . 0.0 109.996 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -95.75 6.07 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.0 109.783 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.56 92.08 43.09 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.427 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.09 160.46 8.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.821 2.348 . . . . 0.0 112.117 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.81 139.2 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.552 -0.717 . . . . 0.0 109.55 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 . . . . . 0 C--N 1.303 -1.456 0 O-C-N 121.405 -0.809 . . . . 0.0 109.641 -179.488 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.64 152.6 78.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.585 -0.697 . . . . 0.0 109.935 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.59 163.04 38.44 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.577 2.185 . . . . 0.0 112.143 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -80.32 119.99 23.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.9 mm? -90.91 131.64 36.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 141.95 51.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.84 150.64 20.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 110.106 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mm -55.0 -45.45 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.64 0.733 . . . . 0.0 109.371 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.98 -11.72 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -97.4 3.91 50.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 109.653 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' GLU . 77.8 mt -59.87 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.306 -0.871 . . . . 0.0 110.483 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' ILE . 11.8 m 31.26 31.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.397 0.617 . . . . 0.0 110.735 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.3 tt0 -166.13 112.78 0.88 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.321 -0.862 . . . . 0.0 109.157 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 54.1 p30 -86.91 154.45 20.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.21 -0.931 . . . . 0.0 109.947 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 23.98 76.3 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -97.48 140.2 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -1.031 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.91 128.62 44.05 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.44 -170.71 2.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -130.68 135.16 47.56 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.76 148.12 43.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.207 -0.933 . . . . 0.0 110.329 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -116.57 132.5 56.67 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.85 165.68 29.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.045 0.926 . . . . 0.0 110.925 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -105.6 155.69 18.97 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.909 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -88.36 99.78 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.234 -0.916 . . . . 0.0 110.467 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.518 HD11 ' CA ' ' A' ' 42' ' ' GLY . 54.5 mt -69.73 -28.71 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.077 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.27 140.52 18.56 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.162 -0.961 . . . . 0.0 109.24 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.6 pt? -120.93 150.09 41.62 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.34 0.591 . . . . 0.0 109.926 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -141.03 112.25 7.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 109.374 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -71.25 120.73 17.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 109.433 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 23.3 t-20 -91.04 139.16 31.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.933 . . . . 0.0 109.116 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 m -101.47 -8.57 21.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 109.066 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' N ' ' ND1' ' A' ' 32' ' ' HIS . 1.6 m80 -79.39 145.63 33.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.6 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -69.92 -34.5 73.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.614 -0.679 . . . . 0.0 110.187 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.8 m -61.03 -46.23 91.56 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.129 -0.982 . . . . 0.0 109.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.3 mt -108.49 135.5 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.571 0.701 . . . . 0.0 109.566 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 t -96.85 -49.44 5.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.592 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -152.42 149.42 28.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.02 142.41 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.693 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -163.17 -161.52 12.61 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.329 -1.415 . . . . 0.0 109.92 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.693 HD12 ' C ' ' A' ' 39' ' ' GLY . 9.5 mp -120.2 146.16 46.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.943 -0.739 . . . . 0.0 109.42 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.3 mt -108.77 124.41 50.55 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.518 ' CA ' HD11 ' A' ' 25' ' ' ILE . . . -95.26 96.75 2.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.8 t0 -100.48 160.85 14.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -1.159 . . . . 0.0 109.387 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 84.3 tt0 -70.36 -20.5 62.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.693 -0.63 . . . . 0.0 109.858 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.4 p -92.15 -12.12 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.16 -153.28 24.46 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.99 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 pt -136.48 159.86 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.547 -0.973 . . . . 0.0 109.918 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -159.2 146.34 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.352 -0.842 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -90.31 134.9 34.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -129.5 157.27 42.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 0.0 108.649 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.2 m -132.89 132.52 42.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.47 127.91 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -85.3 145.54 27.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 110.547 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -60.54 -36.64 78.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -59.63 -8.89 2.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.474 -0.766 . . . . 0.0 109.899 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.32 -26.47 24.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 109.044 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.59 51.32 15.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.697 -0.627 . . . . 0.0 109.878 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.0 mt -105.28 148.76 36.8 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 109.9 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.37 161.96 42.61 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.618 2.212 . . . . 0.0 112.637 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.01 141.0 47.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.665 0.745 . . . . 0.0 110.412 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.2 mp -84.31 156.67 21.81 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.442 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 42.7 tt0 -99.87 129.59 45.98 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.388 -0.82 . . . . 0.0 109.742 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.448 ' OE1' HD22 ' A' ' 27' ' ' LEU . 58.9 tt0 -65.79 137.63 57.37 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.456 0.646 . . . . 0.0 110.487 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.93 -10.68 64.63 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -94.79 151.68 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -1.135 . . . . 0.0 110.31 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -84.99 140.44 31.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.442 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 33.1 m-85 -133.7 142.87 48.19 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.754 0.787 . . . . 0.0 109.773 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.09 127.79 54.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.64 118.46 35.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -114.18 145.55 41.54 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.408 0.623 . . . . 0.0 110.403 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t 58.17 58.15 3.65 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.726 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.05 165.98 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.343 -0.848 . . . . 0.0 109.273 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.27 149.81 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.729 0.776 . . . . 0.0 110.012 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.02 133.89 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.754 -0.591 . . . . 0.0 109.629 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.28 148.73 16.78 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -94.63 104.64 16.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -1.146 . . . . 0.0 109.148 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 80' ' ' ARG . 84.3 t80 -99.85 106.4 18.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.789 . . . . 0.0 109.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.2 t30 42.19 -116.64 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.549 -0.72 . . . . 0.0 110.757 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.41 -17.12 23.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.085 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 mmm-85 -100.94 156.43 17.39 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.874 0.845 . . . . 0.0 110.373 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -97.79 150.83 20.83 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.68 155.5 43.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.048 -1.032 . . . . 0.0 109.17 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.85 125.19 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.372 -0.83 . . . . 0.0 108.956 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -106.38 129.25 54.41 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.741 . . . . 0.0 109.279 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.89 131.22 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -136.55 -163.08 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.804 0.812 . . . . 0.0 109.821 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 89' ' ' SER . 33.9 mmtt -57.35 166.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.792 -0.567 . . . . 0.0 109.472 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 12.8 t-20 72.81 -21.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.708 -0.62 . . . . 0.0 109.547 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 87' ' ' LYS . 87.1 p -74.61 159.29 32.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.3 m -136.86 156.22 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.399 -0.813 . . . . 0.0 109.131 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.62 130.66 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.239 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -132.16 138.05 47.88 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 0.0 109.355 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' C ' HD22 ' A' ' 94' ' ' LEU . 50.7 mtmt -81.81 138.98 35.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.592 -0.692 . . . . 0.0 109.762 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.1 mm? -110.71 137.73 48.01 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.922 0.868 . . . . 0.0 110.147 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 t -86.58 8.34 22.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -117.04 91.77 37.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.329 -0.857 . . . . 0.0 109.135 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -55.34 152.32 32.62 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.887 2.391 . . . . 0.0 112.136 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.6 mt -101.14 147.79 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.685 . . . . 0.0 109.26 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 57.0 mp0 -46.85 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.855 . . . . 0.0 110.201 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 t 53.68 9.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 108.775 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' N ' ' C ' ' A' ' 99' ' ' GLU . . . -154.98 86.34 0.13 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -153.36 111.7 3.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -1.118 . . . . 0.0 109.104 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -164.78 -22.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.171 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -145.8 151.19 37.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -162.19 84.68 0.58 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 108.846 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -90.71 124.25 34.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 53.7 t-80 45.41 -109.41 0.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.906 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 80.0 m80 -142.74 143.6 32.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -0.834 . . . . 0.0 109.586 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.668 -179.896 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.501 0.667 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.73 152.39 91.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.569 -0.707 . . . . 0.0 109.875 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.408 ' HB2' HD22 ' A' ' 19' ' ' ASN . 43.6 Cg_endo -67.64 148.76 78.65 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.584 2.189 . . . . 0.0 112.196 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.12 119.87 23.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.914 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.9 mm? -90.39 128.88 36.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.782 . . . . 0.0 109.753 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -128.44 145.01 51.22 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.19 143.0 28.42 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.71 0.767 . . . . 0.0 110.494 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.4 HD13 ' CG2' ' A' ' 48' ' ' ILE . 83.1 mt -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.41 -0.806 . . . . 0.0 109.322 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.41 -10.79 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.448 -0.783 . . . . 0.0 109.918 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -97.51 6.28 48.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 13' ' ' GLU . 44.8 mt -59.85 -70.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.3 m 40.5 17.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.457 0.646 . . . . 0.0 110.741 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.639 ' H ' HG22 ' A' ' 11' ' ' ILE . 6.5 pt-20 -171.92 130.77 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.808 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.83 167.38 12.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.021 -1.049 . . . . 0.0 110.58 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.17 23.54 77.39 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.1 136.67 35.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.449 -1.03 . . . . 0.0 110.17 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -97.33 127.44 43.3 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -162.71 -169.73 2.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 110.008 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 43.4 m-20 -140.59 137.86 33.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.568 -0.707 . . . . 0.0 109.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.67 147.45 25.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 110.391 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -101.14 140.92 34.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.53 0.681 . . . . 0.0 109.397 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 161.62 42.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.292 -0.88 . . . . 0.0 110.77 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.02 148.93 25.65 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.355 0.598 . . . . 0.0 109.645 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -87.48 94.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.278 -0.889 . . . . 0.0 110.52 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.511 HD11 ' CA ' ' A' ' 42' ' ' GLY . 52.8 mt -70.61 -31.26 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.499 -0.751 . . . . 0.0 109.324 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -148.07 129.3 14.66 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.064 -1.022 . . . . 0.0 109.604 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.444 HD11 HE21 ' A' ' 37' ' ' GLN . 60.7 tp -110.89 146.5 36.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -142.57 111.35 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.54 0.686 . . . . 0.0 109.795 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.31 124.11 23.34 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.635 -0.666 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' A' ' 32' ' ' HIS . 7.1 t30 -103.99 149.63 24.97 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.6 m -139.84 54.8 1.66 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 32' ' ' HIS . 65.5 t-80 -104.44 10.91 35.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.167 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 66.34 -35.82 0.24 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.092 0.472 . . . . 0.0 110.074 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 32' ' ' HIS . 63.7 m -86.36 -40.57 15.3 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.154 -0.967 . . . . 0.0 108.833 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt -105.37 138.49 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.674 0.749 . . . . 0.0 109.593 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 t -83.53 -56.79 3.54 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.666 0.746 . . . . 0.0 109.963 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.444 HE21 HD11 ' A' ' 27' ' ' LEU . 5.6 pt20 -159.11 162.22 36.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.107 -0.996 . . . . 0.0 110.44 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.09 159.61 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.18 -157.95 20.58 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.2 mt -125.76 149.82 48.24 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.973 -0.722 . . . . 0.0 109.976 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.636 HD21 ' CD1' ' A' ' 50' ' ' PHE . 31.5 mt -109.91 124.81 52.02 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' CA ' HD11 ' A' ' 25' ' ' ILE . . . -92.17 94.35 1.9 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -101.58 159.99 14.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -1.011 . . . . 0.0 109.597 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.13 -17.54 63.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.819 -0.551 . . . . 0.0 109.839 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 p -92.43 -9.66 40.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.25 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.64 -148.29 19.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -138.16 160.56 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.696 -0.885 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.4 ' CG2' HD13 ' A' ' 8' ' ' ILE . 20.0 tt -162.57 158.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.927 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -84.8 164.58 18.39 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.558 -0.714 . . . . 0.0 110.275 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.636 ' CD1' HD21 ' A' ' 41' ' ' LEU . 24.8 p90 -156.06 153.65 29.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.069 -1.019 . . . . 0.0 108.549 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.516 ' OG1' ' NE2' ' A' ' 82' ' ' GLN . 69.5 m -136.36 129.57 31.51 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.3 mt -106.52 130.12 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -90.26 142.92 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 110.431 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.42 -35.04 76.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.687 -0.633 . . . . 0.0 109.456 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -58.89 -7.8 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.473 -0.767 . . . . 0.0 109.825 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.52 -23.59 34.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 108.869 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 51.16 44.26 28.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 109.887 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.57 151.6 39.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.796 -0.565 . . . . 0.0 109.716 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.54 146.89 50.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.479 2.119 . . . . 0.0 112.804 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.3 mt -68.07 141.61 56.09 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.658 0.742 . . . . 0.0 110.491 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -81.1 139.85 35.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.0 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.32 134.08 37.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.466 -0.771 . . . . 0.0 110.17 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -70.78 136.57 48.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.402 0.62 . . . . 0.0 110.532 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.37 -6.36 83.5 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.59 159.87 15.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.498 -1.001 . . . . 0.0 110.543 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -95.7 148.93 22.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -141.23 150.07 42.18 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.005 0.907 . . . . 0.0 109.964 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.525 HD21 ' HE ' ' A' ' 70' ' ' ARG . 37.0 tp -101.01 132.1 46.57 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 mt -112.72 112.4 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.928 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.525 ' HE ' HD21 ' A' ' 68' ' ' LEU . 94.0 mtt180 -118.64 145.46 45.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 54.91 6.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.04 165.94 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 0.0 109.304 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.859 0.838 . . . . 0.0 109.925 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.8 t -92.61 131.71 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.579 -0.7 . . . . 0.0 109.855 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.64 150.5 16.81 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -93.77 104.85 16.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.6 -0.941 . . . . 0.0 109.364 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 80' ' ' ARG . 42.0 t80 -97.06 104.22 16.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 109.239 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' TYR . 98.7 m-20 39.67 -111.87 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -95.13 -20.19 19.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.419 -0.801 . . . . 0.0 109.898 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.1 mtt180 -98.85 159.29 15.06 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.905 0.86 . . . . 0.0 110.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.3 149.97 20.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.752 . . . . 0.0 109.14 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 51' ' ' THR . 57.1 tt0 -144.03 150.96 39.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.89 124.47 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -107.43 126.36 52.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.446 -0.783 . . . . 0.0 109.567 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.22 132.82 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 87' ' ' LYS . 13.5 p30 -146.06 -176.57 5.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.768 0.794 . . . . 0.0 110.014 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' SER . 80.5 tttt -42.84 166.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 1.8 t-20 73.5 -30.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.65 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 87' ' ' LYS . 81.6 p -76.95 164.3 25.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.839 . . . . 0.0 109.964 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 p -139.63 158.31 44.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.427 -0.796 . . . . 0.0 109.417 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.7 mt -141.89 133.73 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.499 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.37 138.71 46.43 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.612 0.72 . . . . 0.0 109.232 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 95' ' ' SER . 88.2 tttt -73.05 139.47 46.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.592 -0.692 . . . . 0.0 109.594 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 96' ' ' GLU . 89.3 mt -101.01 -13.37 18.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.54 -0.725 . . . . 0.0 109.566 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.443 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 35.9 t 51.91 4.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.758 -0.589 . . . . 0.0 109.732 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 94' ' ' LEU . 37.8 tp10 -107.59 127.29 28.07 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.617 -0.677 . . . . 0.0 109.5 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.82 141.08 29.9 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.411 2.074 . . . . 0.0 112.182 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.3 mt -112.09 135.97 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.77 -0.582 . . . . 0.0 109.456 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 101' ' ' GLY . 51.3 tp10 -91.76 118.5 30.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.39 -5.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.438 ' H ' ' HG3' ' A' ' 99' ' ' GLU . . . -79.71 112.5 3.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 102' ' ' LEU . 3.5 tt -95.21 110.69 22.63 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.444 -1.033 . . . . 0.0 109.513 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.512 ' N ' HD23 ' A' ' 102' ' ' LEU . 42.8 tp10 56.39 114.39 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.543 0.687 . . . . 0.0 110.281 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -150.52 153.2 35.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -134.74 32.49 3.27 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.622 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 53.8 t-80 47.88 -106.99 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.358 -0.839 . . . . 0.0 109.614 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.622 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 86.1 t60 -152.11 -8.97 0.2 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.795 . . . . 0.0 109.383 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -152.53 -44.01 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.317 -0.864 . . . . 0.0 109.273 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.544 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -86.05 152.71 56.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.41 157.63 61.03 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.679 2.253 . . . . 0.0 112.186 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -79.26 116.31 19.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.313 -0.867 . . . . 0.0 109.471 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt -92.33 129.47 38.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.347 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' ' CD2' ' A' ' 20' ' ' LEU . 83.3 m -125.83 144.14 50.77 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.88 146.29 23.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.052 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.07 -42.36 89.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.176 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.55 -8.54 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.632 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -103.37 9.28 37.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -86.32 124.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.168 -0.957 . . . . 0.0 109.944 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -144.13 8.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 109.286 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -143.37 138.75 29.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.277 -0.89 . . . . 0.0 109.141 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 54.0 p30 -97.52 159.37 14.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.448 -0.783 . . . . 0.0 110.353 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.91 9.91 84.74 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.85 155.55 17.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.36 -1.083 . . . . 0.0 109.691 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -108.2 134.71 50.66 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.462 0.649 . . . . 0.0 109.572 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -160.17 -176.78 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.905 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 7.7 t30 -122.48 142.97 50.01 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -139.12 128.2 23.82 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.32 -0.862 . . . . 0.0 109.686 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.667 ' N ' HD13 ' A' ' 20' ' ' LEU . 37.1 ttmt -112.45 132.75 54.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.39 -173.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -112.53 154.91 25.2 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.09 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -92.48 113.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -0.907 . . . . 0.0 110.696 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -71.67 -26.77 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.441 -0.787 . . . . 0.0 110.035 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.502 ' OE1' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -172.45 167.41 5.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.98 -1.075 . . . . 0.0 109.182 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.716 ' N ' HE21 ' A' ' 63' ' ' GLN . 82.7 mt -138.29 160.87 38.36 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.428 0.632 . . . . 0.0 110.005 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.406 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 14.6 t90 -134.86 105.63 6.51 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.55 0.69 . . . . 0.0 109.414 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 37' ' ' GLN . 51.4 tp10 -73.66 119.78 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.291 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 32' ' ' HIS . 0.9 OUTLIER -95.67 177.89 5.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 109.079 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.2 p -129.6 0.89 4.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.593 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 93.8 m-70 -94.98 170.51 9.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.365 -0.835 . . . . 0.0 109.85 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -88.14 -41.64 12.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.38 -0.825 . . . . 0.0 110.007 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 35' ' ' ILE . 15.7 m -75.36 65.58 1.68 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.56 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 2.6 mt 145.15 120.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 121.324 0.583 . . . . 0.0 109.655 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -94.5 -58.36 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.034 . . . . 0.0 109.666 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.543 ' NE2' ' OE1' ' A' ' 29' ' ' GLU . 6.7 mm-40 -145.0 149.29 34.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.046 -1.034 . . . . 0.0 109.979 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.47 127.99 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.4 -159.86 9.48 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.46 149.45 52.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.733 -0.863 . . . . 0.0 109.666 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.85 126.79 53.43 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.59 100.55 2.64 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 46' ' ' GLY . 5.5 p-10 -104.96 161.79 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.297 -1.12 . . . . 0.0 109.285 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.87 -17.38 63.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.743 . . . . 0.0 109.928 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.7 p -94.42 -3.88 49.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' OD2' ' A' ' 43' ' ' ASP . . . 146.47 -144.42 12.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.35 166.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.678 -0.895 . . . . 0.0 110.05 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.78 162.66 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.103 -0.998 . . . . 0.0 109.846 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -97.09 149.77 21.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.0 109.729 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.36 157.46 44.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.431 -1.418 . . . . 0.0 107.801 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -130.93 134.27 46.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.582 -0.699 . . . . 0.0 109.685 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.0 mm -102.64 127.91 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.374 -0.829 . . . . 0.0 109.149 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -83.69 137.26 33.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.144 -0.972 . . . . 0.0 110.497 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.92 -33.74 75.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -58.77 -11.03 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.793 . . . . 0.0 109.596 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.9 -22.43 27.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.198 -0.939 . . . . 0.0 108.988 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 55.07 55.76 7.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.64 -0.663 . . . . 0.0 109.914 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -106.03 147.94 35.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.594 -0.691 . . . . 0.0 109.832 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.86 159.77 51.35 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.521 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.66 137.98 55.99 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.627 0.727 . . . . 0.0 109.987 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.1 mp -79.61 155.1 28.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.843 -0.536 . . . . 0.0 109.667 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 3.1 tm-20 -100.54 121.85 42.27 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.955 0.883 . . . . 0.0 109.707 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 27' ' ' LEU . 98.8 mt-30 -63.37 138.31 58.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 -10.93 67.76 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.92 158.82 15.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -1.182 . . . . 0.0 110.458 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 p -95.45 124.87 39.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 44.4 m-85 -118.54 150.07 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.971 0.891 . . . . 0.0 109.78 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.535 HD21 ' HE ' ' A' ' 70' ' ' ARG . 28.8 tp -110.84 127.17 55.32 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 45.7 mt -114.36 114.96 26.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.535 ' HE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -109.93 147.27 33.74 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.458 0.647 . . . . 0.0 110.43 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 t 58.26 58.5 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.015 0.436 . . . . 0.0 110.772 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 18' ' ' ALA . 16.4 m -109.2 160.41 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.301 -0.874 . . . . 0.0 108.886 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.77 144.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.618 0.723 . . . . 0.0 109.533 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.8 t -92.19 131.75 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.58 22.12 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.491 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 97.3 mt-10 -96.96 135.04 39.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.303 -1.116 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -135.99 119.72 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.84 . . . . 0.0 109.621 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 51.8 48.12 23.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.487 -0.758 . . . . 0.0 110.456 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.7 t0 60.57 20.0 9.86 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.679 -0.638 . . . . 0.0 110.449 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -128.54 155.07 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -74.63 137.57 42.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -148.62 152.07 36.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.052 -1.03 . . . . 0.0 108.977 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.96 124.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -104.95 126.34 51.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 109.223 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.46 132.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.88 -170.29 1.84 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.68 0.753 . . . . 0.0 109.874 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -66.15 -42.91 88.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.766 -0.584 . . . . 0.0 110.43 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.503 ' ND2' ' H ' ' A' ' 88' ' ' ASN . 2.0 p30 -61.15 -7.7 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -83.32 164.41 20.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.829 . . . . 0.0 109.899 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -136.07 154.93 50.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.312 -0.867 . . . . 0.0 108.875 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.57 127.6 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -128.39 131.6 48.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 108.957 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 136.06 36.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 96' ' ' GLU . 9.5 mp -103.86 -3.96 24.14 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.479 -0.763 . . . . 0.0 109.454 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 t 49.41 7.93 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 94' ' ' LEU . 31.7 tt0 -103.62 124.73 36.96 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 109.312 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.17 141.18 25.87 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.054 1.836 . . . . 0.0 112.1 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.43 135.68 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 102' ' ' LEU . 36.5 tt0 -98.57 121.6 40.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.53 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 t -98.54 48.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.35 -143.62 11.77 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.404 ' O ' ' OE2' ' A' ' 99' ' ' GLU . 69.2 mt -102.48 -65.31 1.0 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -1.139 . . . . 0.0 109.343 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -72.16 142.11 49.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 110.581 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.489 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 60.3 t-80 -145.83 24.17 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 51.5 91.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 109.505 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.27 137.51 46.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -142.82 144.99 32.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 0.0 109.46 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -144.95 139.24 27.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.165 -179.723 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.6 mtm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.492 0.663 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.43 58.55 0.26 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.411 -0.805 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 154.64 63.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.787 2.325 . . . . 0.0 112.047 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -78.56 117.17 19.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.7 mt -92.52 130.47 38.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.309 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.6 m -124.56 144.69 50.0 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -96.77 151.23 19.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.0 mt -58.17 -44.01 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.405 -0.809 . . . . 0.0 109.1 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.1 -14.55 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.781 . . . . 0.0 109.46 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.0 4.7 53.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.194 -0.941 . . . . 0.0 109.364 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.3 mt -87.67 121.45 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.816 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.95 7.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -135.89 135.32 39.6 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.324 -0.86 . . . . 0.0 109.078 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.402 HD22 ' HB2' ' A' ' 76' ' ' GLU . 57.5 p30 -94.0 157.4 16.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 110.278 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.5 19.24 79.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -99.77 150.37 22.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.363 -1.081 . . . . 0.0 109.72 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -101.56 131.35 47.78 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.443 0.639 . . . . 0.0 109.562 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.0 179.6 8.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 109.695 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -120.24 137.21 54.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -127.82 148.45 50.45 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -135.63 134.01 38.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.26 -176.85 1.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -105.71 156.31 18.41 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.47 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.2 t -92.53 107.58 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.407 -0.808 . . . . 0.0 110.226 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.2 -27.18 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 109.906 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -171.0 161.64 6.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.564 0.697 . . . . 0.0 110.086 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -143.76 121.02 11.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' OE2' ' NE2' ' A' ' 37' ' ' GLN . 80.9 mm-40 -82.18 135.94 35.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.497 -0.752 . . . . 0.0 109.675 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.557 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -94.49 148.95 21.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 108.784 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.3 p -104.86 -10.73 17.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.248 -0.907 . . . . 0.0 109.139 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -72.3 141.32 48.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.245 -0.909 . . . . 0.0 109.7 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -33.47 75.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.292 -0.88 . . . . 0.0 109.971 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.5 t -64.33 -77.44 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.4 mt -67.29 147.1 12.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 13.8 t -100.24 -51.13 3.74 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.716 0.769 . . . . 0.0 109.691 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.404 ' NE2' ' OE2' ' A' ' 29' ' ' GLU . 33.2 mt-30 -152.07 154.43 35.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 110.224 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 m -139.96 156.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.28 -172.09 34.07 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.233 -1.461 . . . . 0.0 109.853 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.541 HD21 ' NZ ' ' A' ' 49' ' ' LYS . 4.6 mp -119.89 144.55 47.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.756 -0.849 . . . . 0.0 109.396 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 47' ' ' ILE . 68.8 mt -114.55 124.78 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.89 101.63 2.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -106.44 164.66 11.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.983 . . . . 0.0 109.312 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' OE2' ' N ' ' A' ' 44' ' ' GLU . 1.4 mp0 -70.53 -20.24 62.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.612 -0.68 . . . . 0.0 110.106 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 p -91.05 -9.62 45.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.952 . . . . 0.0 109.244 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.02 -145.84 14.15 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 41' ' ' LEU . 8.0 mt -139.02 155.14 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -1.024 . . . . 0.0 109.331 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 148.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.88 . . . . 0.0 109.652 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.541 ' NZ ' HD21 ' A' ' 40' ' ' LEU . 68.4 mttm -98.77 138.0 36.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 109.454 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -127.47 159.54 34.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.145 -0.972 . . . . 0.0 108.58 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.427 ' OG1' HG23 ' A' ' 35' ' ' ILE . 3.8 t -133.66 137.91 45.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.648 -0.657 . . . . 0.0 109.708 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.7 mt -104.15 126.96 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.371 0.605 . . . . 0.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -88.03 145.62 25.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 110.361 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -50.43 -29.9 11.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.601 -0.687 . . . . 0.0 109.35 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -13.39 10.92 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 109.881 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -113.89 44.53 1.62 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.309 -0.869 . . . . 0.0 109.209 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' ALA . 8.2 pt-20 -35.12 81.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.716 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' A' ' 56' ' ' ALA . 11.8 mt -109.35 153.5 42.7 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.539 -0.726 . . . . 0.0 109.493 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.73 162.26 32.42 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.444 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.86 135.62 54.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.512 -0.743 . . . . 0.0 110.198 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.4 mp -79.49 153.66 29.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 109.839 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -96.79 120.14 36.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.404 -0.81 . . . . 0.0 109.896 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.31 147.92 52.35 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.761 0.791 . . . . 0.0 110.194 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.53 -10.88 48.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -97.64 161.03 13.96 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 0.0 110.5 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -88.31 146.92 25.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.288 0.566 . . . . 0.0 109.631 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -142.11 145.94 34.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.97 0.89 . . . . 0.0 109.691 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.557 HD21 ' HE ' ' A' ' 70' ' ' ARG . 29.5 tp -111.17 129.76 55.85 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.36 119.81 39.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.588 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.557 ' HE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -119.17 148.03 43.54 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m 56.49 55.75 6.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 120.945 0.402 . . . . 0.0 110.451 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.19 165.8 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.293 -0.879 . . . . 0.0 108.9 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.74 150.38 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.649 0.738 . . . . 0.0 109.444 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.85 137.01 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.788 -0.57 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.77 153.45 17.62 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB2' HD22 ' A' ' 14' ' ' ASN . 82.1 tt0 -91.32 103.72 16.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 109.417 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 80' ' ' ARG . 69.5 t80 -100.57 106.55 18.06 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.761 0.791 . . . . 0.0 109.55 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 44.97 -115.4 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.524 -0.735 . . . . 0.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 79' ' ' ASP . 63.2 t0 -97.28 -14.27 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' TYR . 75.3 ttt180 -109.01 151.5 26.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.261 -0.9 . . . . 0.0 110.23 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.11 160.22 15.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.528 HE21 HE21 ' A' ' 84' ' ' GLN . 13.2 pt20 -146.87 162.82 37.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.295 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.02 126.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 108.943 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.528 HE21 HE21 ' A' ' 82' ' ' GLN . 87.4 mt-30 -104.93 127.59 52.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.492 -0.755 . . . . 0.0 109.396 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.04 132.31 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.454 -0.779 . . . . 0.0 108.997 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -125.0 -173.56 2.83 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.662 0.744 . . . . 0.0 109.89 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -40.39 96.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.566 -0.709 . . . . 0.0 109.962 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -68.45 -12.87 61.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -82.93 163.77 20.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 109.822 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -140.69 162.36 35.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.269 -0.894 . . . . 0.0 109.049 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.8 mt -138.38 130.6 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 109.274 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -130.02 134.65 47.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.359 -0.838 . . . . 0.0 109.019 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -74.68 135.46 41.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -94.78 129.71 41.62 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.889 0.852 . . . . 0.0 110.16 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.4 t -77.44 -6.48 53.59 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.767 -0.583 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -114.28 95.71 40.13 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.438 -0.789 . . . . 0.0 109.268 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.34 152.05 16.34 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.444 2.096 . . . . 0.0 112.116 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -101.43 134.14 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -85.34 132.49 34.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.783 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.4 t -109.66 75.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.76 -106.65 0.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 102' ' ' LEU . 10.0 mp -94.37 109.2 21.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.24 . . . . 0.0 109.413 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -68.9 -37.16 78.79 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.348 0.594 . . . . 0.0 109.693 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.465 ' N ' ' ND1' ' A' ' 104' ' ' HIS . 6.3 p-80 -153.0 152.44 31.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 108.842 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.744 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.457 ' CG ' ' N ' ' A' ' 107' ' ' HIS . 86.4 t60 45.62 -101.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.886 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.527 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 56.3 t-80 47.05 -115.87 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.527 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 60.6 t-80 -66.01 -42.65 89.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.29 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -164.72 59.16 0.66 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.615 -0.678 . . . . 0.0 109.466 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.42 156.94 57.68 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.62 2.214 . . . . 0.0 112.062 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -80.6 113.44 18.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.0 133.79 37.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.591 -0.693 . . . . 0.0 109.868 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.548 ' O ' HD13 ' A' ' 20' ' ' LEU . 93.9 m -127.98 152.03 48.41 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.453 0.644 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.38 147.08 24.55 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.707 0.765 . . . . 0.0 110.162 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.12 -44.28 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 109.416 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.53 -11.25 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.71 . . . . 0.0 109.601 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 52.8 t0 -96.73 8.33 44.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -87.11 120.74 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.85 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.2 4.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.843 . . . . 0.0 109.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -134.8 131.54 37.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.353 -0.842 . . . . 0.0 109.122 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.26 160.19 14.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.29 18.98 79.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -103.06 156.38 17.72 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.504 -0.998 . . . . 0.0 109.899 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -102.81 131.97 49.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.593 -0.692 . . . . 0.0 109.61 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -158.57 176.59 12.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 109.866 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' SER . 61.7 m-20 -138.91 142.99 38.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.657 . . . . 0.0 109.648 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 6' ' ' THR . 60.5 tp -159.14 147.14 17.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.034 -1.041 . . . . 0.0 110.423 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -94.06 137.66 33.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.72 158.34 44.08 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.083 0.944 . . . . 0.0 110.661 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.74 152.72 18.84 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.304 0.573 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 59.6 t -93.23 101.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.04 -26.31 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 0.0 109.77 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -168.68 160.34 10.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -135.07 160.08 39.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.631 -0.668 . . . . 0.0 110.186 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -143.14 113.82 7.52 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.483 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.77 130.26 41.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.364 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -115.83 126.68 54.29 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 33' ' ' GLU . 1.9 m -109.48 13.86 23.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.581 -0.699 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.473 ' O ' ' ND1' ' A' ' 32' ' ' HIS . 61.9 t-80 -67.29 7.26 0.45 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.385 -0.822 . . . . 0.0 109.297 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 31' ' ' THR . 76.4 tt0 65.33 -55.81 0.32 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.184 0.516 . . . . 0.0 110.091 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 32' ' ' HIS . 78.1 p -59.66 -41.94 91.72 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.126 -0.984 . . . . 0.0 108.919 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.1 mt -103.79 136.46 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 109.449 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 11.4 p -88.42 -56.5 3.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.568 -0.707 . . . . 0.0 109.769 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.504 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.5 tt0 -154.55 155.24 34.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.433 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.35 149.67 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.2 -158.77 14.63 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.135 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 mt -121.45 149.08 43.56 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.091 -0.652 . . . . 0.0 109.555 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.3 127.84 55.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.536 0.684 . . . . 0.0 109.407 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.83 96.73 2.05 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -93.92 157.1 16.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.6 -18.18 64.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.675 -0.641 . . . . 0.0 109.768 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -98.88 -11.52 21.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.378 -0.826 . . . . 0.0 109.153 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.43 -154.06 24.96 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.084 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.06 160.41 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.616 -0.932 . . . . 0.0 109.84 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.9 tt -160.4 147.14 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.521 -0.737 . . . . 0.0 109.914 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -81.72 164.65 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.875 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.88 150.0 23.97 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.167 -0.958 . . . . 0.0 108.98 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -137.24 135.08 36.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.036 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.8 mt -105.62 129.09 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.617 -0.677 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -84.04 139.7 32.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 110.504 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -60.72 -37.2 80.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.655 -0.653 . . . . 0.0 109.391 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.83 -11.07 4.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.419 -0.801 . . . . 0.0 109.822 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -84.61 -25.83 28.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.131 -0.98 . . . . 0.0 108.974 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 53.94 52.13 13.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.63 -0.669 . . . . 0.0 110.146 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.559 HD13 ' HB1' ' A' ' 56' ' ' ALA . 7.5 mp -104.86 156.12 36.49 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.567 -0.708 . . . . 0.0 109.337 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.31 154.41 74.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.711 2.274 . . . . 0.0 112.7 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.62 142.17 46.53 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.787 0.804 . . . . 0.0 110.626 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.2 mp -81.13 151.0 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.764 -0.585 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.02 136.11 43.45 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.747 0.784 . . . . 0.0 109.945 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 24' ' ' VAL . 10.3 tm0? -72.38 134.9 45.68 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 110.682 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 -13.18 67.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.4 mp0 -97.77 157.58 15.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.294 -1.121 . . . . 0.0 110.681 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 96' ' ' GLU . 12.1 p -100.92 141.07 34.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -134.41 157.03 47.48 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.161 0.982 . . . . 0.0 110.13 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.4 tp -105.31 134.02 49.12 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 mt -110.13 108.84 19.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 92' ' ' GLU . 65.4 mtm180 -112.81 148.2 35.34 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.595 0.712 . . . . 0.0 110.376 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.9 p 51.16 58.17 5.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 122.054 -0.404 . . . . 0.0 110.827 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 18' ' ' ALA . 15.6 m -112.65 165.09 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.517 -0.739 . . . . 0.0 109.319 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 p -123.36 149.25 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-O 121.724 0.773 . . . . 0.0 109.82 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.34 135.13 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.629 -0.669 . . . . 0.0 109.867 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.62 158.24 17.27 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -100.16 93.76 5.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.586 -0.949 . . . . 0.0 109.329 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.497 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.1 t80 -106.09 119.27 38.78 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.744 0.783 . . . . 0.0 109.707 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.3 m120 53.51 50.17 17.91 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.336 0.588 . . . . 0.0 110.624 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.4 t0 64.41 -12.69 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.744 -0.598 . . . . 0.0 110.408 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 78' ' ' ASN . 91.6 mtm-85 -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.187 -0.946 . . . . 0.0 110.351 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -76.4 146.11 38.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.602 -0.686 . . . . 0.0 109.355 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -147.14 151.29 36.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.177 -0.952 . . . . 0.0 109.382 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.32 122.45 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -102.18 128.65 48.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.6 t -100.1 134.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.538 -0.726 . . . . 0.0 109.08 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -131.32 -168.93 2.08 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.71 0.767 . . . . 0.0 109.952 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -62.12 -42.33 99.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.279 0.561 . . . . 0.0 109.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -65.36 -22.2 66.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -81.5 164.26 22.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -140.52 162.55 35.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.4 mt -138.84 132.35 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.63 -0.669 . . . . 0.0 109.653 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 89.1 mt-10 -131.35 135.96 47.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.548 -0.72 . . . . 0.0 109.218 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.481 ' C ' HD22 ' A' ' 94' ' ' LEU . 88.3 tttt -81.84 135.77 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.481 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.0 mm? -109.86 0.35 18.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.64 -0.663 . . . . 0.0 109.988 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.5 p 49.78 14.91 0.14 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.711 -0.618 . . . . 0.0 109.733 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' SER . 24.0 mm-40 -114.07 110.17 48.81 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.561 -0.712 . . . . 0.0 109.281 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.36 151.26 59.72 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.712 2.274 . . . . 0.0 112.724 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -105.56 143.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.7 . . . . 0.0 109.679 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -89.49 123.53 33.68 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.798 0.809 . . . . 0.0 109.864 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 100' ' ' VAL . 2.2 m -91.11 39.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.34 21.34 64.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.7 tp -82.85 102.25 11.51 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.338 -1.096 . . . . 0.0 109.774 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -170.71 -29.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.426 0.632 . . . . 0.0 109.35 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.43 17.68 3.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -59.55 -45.22 92.44 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -69.39 139.67 54.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.386 -0.821 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -128.58 65.78 1.41 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.778 -0.576 . . . . 0.0 109.666 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 74.1 m80 46.37 -165.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.791 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.0 m80 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.296 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -73.86 152.37 88.94 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.437 ' CG ' HD22 ' A' ' 19' ' ' ASN . 56.3 Cg_endo -69.67 169.68 18.24 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.69 2.26 . . . . 0.0 112.301 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -81.11 113.24 19.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.412 -0.805 . . . . 0.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 131.42 34.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.592 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.0 m -119.3 132.52 55.9 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 64.8 mttp -98.5 155.73 17.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 110.085 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.8 mm -52.55 -49.48 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.655 0.741 . . . . 0.0 109.349 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.37 -13.89 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 49.4 t0 -93.03 -3.18 54.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 13' ' ' GLU . 97.7 mt -58.6 -73.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 110.416 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 11' ' ' ILE . 15.6 m 31.93 29.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.396 0.617 . . . . 0.0 110.923 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 11' ' ' ILE . 81.2 tt0 -167.23 114.17 0.78 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.472 -0.768 . . . . 0.0 109.066 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -87.15 153.64 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.78 72.69 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -94.52 137.21 33.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.094 . . . . 0.0 109.929 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -93.57 125.44 38.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.04 -167.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.828 . . . . 0.0 109.792 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.437 HD22 ' CG ' ' A' ' 3' ' ' PRO . 60.2 m-20 -117.64 146.29 43.77 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.47 131.17 35.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 0.0 110.475 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -116.55 127.84 54.88 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.525 ' HB3' HD22 ' A' ' 41' ' ' LEU . . . -162.56 169.77 19.7 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -103.59 154.94 18.95 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.873 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.96 113.78 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.375 -0.828 . . . . 0.0 109.656 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -93.41 -22.21 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.674 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.698 ' NE2' ' HE1' ' A' ' 28' ' ' TRP . 18.2 tt0 -152.79 136.07 15.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.783 -1.198 . . . . 0.0 109.609 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 26' ' ' GLN . 4.2 mm? -108.18 143.28 37.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.642 0.734 . . . . 0.0 109.682 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.698 ' HE1' ' NE2' ' A' ' 26' ' ' GLN . 61.6 m95 -145.0 119.78 9.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.696 0.76 . . . . 0.0 109.129 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.666 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.4 pm0 -89.3 144.08 26.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.62 -0.675 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.664 HD22 ' N ' ' A' ' 31' ' ' THR . 0.6 OUTLIER -144.84 127.46 16.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.195 -0.941 . . . . 0.0 108.995 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.664 ' N ' HD22 ' A' ' 30' ' ' ASN . 0.1 OUTLIER -145.23 18.85 1.57 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.127 -0.983 . . . . 0.0 108.694 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.489 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 97.0 m-70 -68.39 -43.54 77.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.573 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -120.21 -134.05 0.31 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.745 -0.597 . . . . 0.0 109.43 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.9 p -84.71 -2.57 57.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 108.826 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 30' ' ' ASN . 45.4 mt -72.8 128.49 35.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 109.605 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -93.16 -57.93 2.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 109.664 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -149.67 150.72 32.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -141.5 155.8 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -170.66 -171.15 35.72 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.351 -1.404 . . . . 0.0 110.071 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.48 HD22 ' C ' ' A' ' 39' ' ' GLY . 3.9 mm? -114.09 146.14 40.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.91 -0.759 . . . . 0.0 109.601 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 22' ' ' ALA . 18.9 mt -117.23 124.16 48.38 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.59 0.709 . . . . 0.0 109.096 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' CD1' ' A' ' 25' ' ' ILE . . . -95.28 97.4 2.12 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 52.6 t0 -99.04 161.23 13.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.273 -1.134 . . . . 0.0 109.304 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.8 mt-10 -66.32 -18.55 65.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.2 p -93.73 -5.1 49.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.01 -144.53 12.71 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 pt -135.64 163.45 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.647 -0.913 . . . . 0.0 109.958 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 151.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.5 159.22 18.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -147.79 153.98 39.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.488 -1.383 . . . . 0.0 108.026 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -133.96 129.82 36.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.477 -0.764 . . . . 0.0 109.906 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -104.33 129.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.593 -0.692 . . . . 0.0 109.67 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -87.91 145.7 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -58.11 -38.22 76.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.496 -0.753 . . . . 0.0 109.309 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -59.51 -4.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 109.695 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.78 -27.91 24.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 108.879 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 55.17 52.96 10.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.627 -0.671 . . . . 0.0 110.244 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 mt -110.41 147.22 35.9 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.657 -0.652 . . . . 0.0 109.853 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.1 164.39 32.27 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.705 2.27 . . . . 0.0 112.648 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.4 mt -72.99 141.19 47.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.516 -0.74 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.9 mp -84.13 145.11 28.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.75 -0.594 . . . . 0.0 109.846 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -93.3 137.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.317 -0.864 . . . . 0.0 109.885 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.09 137.52 40.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.577 -0.702 . . . . 0.0 110.808 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.3 -7.21 72.14 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -106.11 162.21 13.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.366 -1.079 . . . . 0.0 110.689 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -100.96 142.58 32.23 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -134.79 152.2 51.57 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.97 0.89 . . . . 0.0 110.151 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HB2' HD23 ' A' ' 94' ' ' LEU . 49.1 tp -109.33 131.51 54.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.28 111.14 22.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.368 -0.833 . . . . 0.0 109.158 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 74.8 mtm180 -109.92 149.18 30.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.611 -0.681 . . . . 0.0 110.388 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 2.8 p 52.72 57.77 6.04 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.89 167.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.423 -0.798 . . . . 0.0 109.147 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.56 152.04 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.74 0.781 . . . . 0.0 109.718 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 132.84 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.769 -0.582 . . . . 0.0 109.553 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 147.78 16.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -90.51 101.19 13.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -1.134 . . . . 0.0 109.181 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.63 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 16.0 t80 -97.79 101.12 12.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 109.132 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.63 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 13.0 p30 40.25 -117.58 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.564 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 50.1 t0 -90.81 -18.07 25.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 77' ' ' TYR . 64.3 ttm-85 -100.0 154.46 18.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.169 -0.957 . . . . 0.0 110.532 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.79 151.17 19.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.103 -0.998 . . . . 0.0 108.78 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -145.41 151.5 38.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.987 -1.071 . . . . 0.0 109.02 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.45 121.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.934 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.62 127.79 53.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.0 133.84 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -133.76 -170.27 2.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 89' ' ' SER . 73.4 tttt -53.83 166.15 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.783 -0.573 . . . . 0.0 109.785 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.2 t-20 72.09 -19.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.679 . . . . 0.0 109.677 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 87' ' ' LYS . 16.4 p -76.69 162.81 27.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -0.95 . . . . 0.0 110.07 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.0 p -145.22 166.31 25.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.264 -0.897 . . . . 0.0 108.973 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.99 131.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.462 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -128.0 131.12 49.24 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.312 -0.867 . . . . 0.0 108.903 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -69.77 137.15 51.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 109.639 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -97.26 135.31 39.37 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.958 0.885 . . . . 0.0 110.192 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 m -82.35 -5.88 58.9 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -121.9 119.89 28.73 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.89 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 161.47 36.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.509 2.14 . . . . 0.0 112.128 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -98.19 152.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 101' ' ' GLY . 96.7 mt-10 -47.23 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.556 -0.715 . . . . 0.0 109.997 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 t 60.56 -72.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 99' ' ' GLU . . . -77.31 -80.35 0.66 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.422 ' CG ' ' H ' ' A' ' 103' ' ' GLU . 3.8 tp -151.9 -145.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -1.231 . . . . 0.0 109.983 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 102' ' ' LEU . 48.5 tp10 -97.57 107.91 20.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.742 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.0 m80 44.93 -163.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.905 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -65.4 -38.07 88.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 109.326 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 49.31 90.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.422 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.23 144.76 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.45 -43.71 89.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 56.1 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -53.27 152.78 7.7 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.545 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.18 177.01 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.58 2.187 . . . . 0.0 111.993 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.58 120.2 21.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.177 -0.952 . . . . 0.0 110.127 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.543 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.6 mm? -89.89 126.42 35.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.6 m -121.99 142.12 50.64 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -95.92 148.35 22.72 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.045 -1.034 . . . . 0.0 110.121 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.41 -43.61 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.197 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.91 -15.16 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.279 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.42 9.93 29.73 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 109.933 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.54 122.48 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.077 -1.015 . . . . 0.0 110.0 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.19 -0.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.304 -0.872 . . . . 0.0 109.749 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -131.73 134.29 45.72 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.32 -0.863 . . . . 0.0 109.081 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 57.0 p30 -90.07 159.01 17.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 0.0 109.881 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.4 20.69 79.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -98.47 147.02 25.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.343 -1.093 . . . . 0.0 109.706 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -97.82 135.13 40.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.418 -0.801 . . . . 0.0 109.592 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.432 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -157.39 169.02 25.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.111 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 71' ' ' SER . 11.3 m120 -132.41 136.96 47.12 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.674 ' C ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -159.67 178.84 9.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.021 -1.05 . . . . 0.0 110.461 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' N ' HD22 ' A' ' 20' ' ' LEU . 21.6 pttp -128.39 148.45 50.7 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.68 157.46 38.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.742 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -93.2 152.5 19.18 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.592 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.99 99.67 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 110.333 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 mm -73.35 -25.49 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.552 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 53.2 tt0 -166.63 157.85 12.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.0 -1.063 . . . . 0.0 109.702 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.912 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -127.66 153.32 46.61 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.542 -0.724 . . . . 0.0 110.071 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.552 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 44.0 m95 -144.28 123.06 12.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.284 -0.885 . . . . 0.0 109.231 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -68.38 140.26 55.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.513 -0.742 . . . . 0.0 109.455 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 10.8 p-10 -59.11 140.06 56.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.056 -1.028 . . . . 0.0 109.477 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.0 p -97.96 -0.88 43.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.0 108.856 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.536 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 99.4 m-70 -143.02 152.84 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.0 109.811 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' A' ' 34' ' ' SER . 17.2 pt-20 -57.64 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.486 -0.759 . . . . 0.0 110.172 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 33' ' ' GLU . 1.9 p 71.2 -55.15 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.469 -0.769 . . . . 0.0 110.034 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.5 mt -87.27 135.75 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.972 -1.08 . . . . 0.0 109.302 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 17.2 p -87.31 -58.52 2.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' N ' ' OG ' ' A' ' 36' ' ' SER . 50.7 tt0 -149.55 155.36 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.957 -1.09 . . . . 0.0 109.771 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 39' ' ' GLY . 53.9 t -137.95 160.92 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 38' ' ' VAL . . . 177.42 -162.75 30.9 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.881 -1.628 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.51 150.6 40.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.894 -0.768 . . . . 0.0 109.142 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.1 129.23 54.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.697 -0.627 . . . . 0.0 109.611 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.0 103.75 2.79 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -103.01 163.86 11.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.517 -0.99 . . . . 0.0 109.154 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' A' ' 99' ' ' GLU . 47.2 tp10 -69.41 -19.44 63.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -92.31 -10.87 36.77 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.941 -1.1 . . . . 0.0 110.14 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -150.29 21.87 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.7 pt -132.94 159.12 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.581 -0.952 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.8 tt -161.36 150.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.6 164.07 22.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 108.961 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -156.12 154.51 31.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.563 -1.336 . . . . 0.0 108.422 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 t -139.56 133.52 30.9 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.239 -0.913 . . . . 0.0 110.251 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.8 mt -105.27 128.7 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -96.64 147.75 23.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 0.0 110.335 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -67.06 -19.31 65.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.539 -0.725 . . . . 0.0 109.379 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -61.23 -33.26 73.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 109.842 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.34 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.047 . . . . 0.0 109.276 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.74 61.21 2.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.434 -0.791 . . . . 0.0 110.09 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.74 148.74 38.81 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.606 -0.684 . . . . 0.0 109.398 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.52 161.33 45.51 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.519 2.146 . . . . 0.0 112.189 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.19 143.63 50.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 110.364 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -85.15 148.43 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.573 -0.705 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -95.19 134.55 37.8 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.41 137.16 52.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.51 -12.84 68.81 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.26 158.39 15.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.877 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 p -94.92 143.74 26.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.32 152.55 51.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.816 0.817 . . . . 0.0 110.186 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.41 HD13 ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -100.33 130.84 46.48 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.41 ' H ' HD13 ' A' ' 68' ' ' LEU . 17.5 mt -109.01 105.26 14.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.513 ' NE ' ' OG ' ' A' ' 90' ' ' SER . 87.3 mtm-85 -107.68 133.04 52.67 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.665 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 1.1 m 70.81 59.37 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.116 -0.365 . . . . 0.0 110.76 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 m -112.86 160.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.346 -0.846 . . . . 0.0 109.456 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.45 151.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.499 0.666 . . . . 0.0 109.351 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.59 132.12 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.124 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' HA3' HE21 ' A' ' 84' ' ' GLN . . . -112.28 151.69 18.01 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' OE2' ' N ' ' A' ' 79' ' ' ASP . 10.8 tm-20 -98.76 93.15 5.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.129 -1.218 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -111.27 117.39 33.04 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.444 -0.785 . . . . 0.0 110.119 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 80' ' ' ARG . 20.0 t-20 55.57 54.36 8.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -0.818 . . . . 0.0 110.293 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.445 ' N ' ' OE2' ' A' ' 76' ' ' GLU . 91.2 m-20 56.35 -2.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.676 -0.64 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 78' ' ' ASN . 14.6 mmp_? -102.24 158.58 16.08 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.041 -1.037 . . . . 0.0 109.737 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.23 146.69 25.92 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.88 154.61 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.02 117.2 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.377 -0.827 . . . . 0.0 109.094 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.432 HE21 ' HA3' ' A' ' 75' ' ' GLY . 39.2 mt-30 -107.08 127.38 53.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.323 -0.861 . . . . 0.0 109.538 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.4 ' C ' HD22 ' A' ' 86' ' ' ASN . 22.0 t -93.6 124.59 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.697 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -152.55 -173.71 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 109.689 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 57.0 -152.64 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.54 0.686 . . . . 0.0 110.365 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 89' ' ' SER . 92.3 m-20 -83.58 27.18 0.63 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 88' ' ' ASN . 12.1 p -47.86 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.196 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.513 ' OG ' ' NE ' ' A' ' 70' ' ' ARG . 13.6 p -139.44 161.67 36.9 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.073 -1.017 . . . . 0.0 109.101 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.3 mt -140.85 132.87 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.187 -0.946 . . . . 0.0 109.272 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' CB ' HH12 ' A' ' 70' ' ' ARG . 83.8 tt0 -124.73 124.99 43.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.06 140.52 43.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 109.82 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.08 142.31 29.94 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.264 -0.898 . . . . 0.0 109.811 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.8 p -83.85 -3.82 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.589 -0.695 . . . . 0.0 109.773 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -109.88 133.01 21.09 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.429 -0.794 . . . . 0.0 109.307 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.77 155.9 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.848 1.699 . . . . 0.0 112.04 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -108.62 133.71 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 84.7 tt0 -88.79 124.0 33.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.87 -7.73 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.51 119.61 5.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -98.92 110.78 23.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -1.018 . . . . 0.0 108.75 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.08 140.92 57.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.679 -0.638 . . . . 0.0 110.265 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -59.38 -85.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.302 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -158.06 157.09 32.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.278 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -96.69 20.63 10.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.302 -0.874 . . . . 0.0 108.983 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -59.94 -41.48 91.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.578 -0.701 . . . . 0.0 109.811 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -67.6 127.69 33.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.573 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 78.3 m80 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.357 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mtp . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 46.08 57.21 16.39 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.764 -0.585 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HB2' HD22 ' A' ' 19' ' ' ASN . 57.1 Cg_endo -71.19 159.15 52.94 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 112.262 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.4 mp0 -81.36 111.54 17.82 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.348 -0.845 . . . . 0.0 109.56 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.4 mt -91.53 134.25 34.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.669 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -127.15 146.46 50.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.462 0.648 . . . . 0.0 109.381 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.35 147.71 22.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 110.072 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.36 -43.53 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.608 -0.682 . . . . 0.0 109.188 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 9' ' ' VAL . 14.3 p -65.61 -6.3 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.475 -0.765 . . . . 0.0 109.454 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -103.98 6.82 36.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -88.08 115.76 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 109.778 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.56 5.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 109.557 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -125.57 122.81 37.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.44 -0.788 . . . . 0.0 109.246 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 15' ' ' GLY . 2.3 t-20 -82.02 150.67 27.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.975 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.587 ' N ' ' ND2' ' A' ' 14' ' ' ASN . . . 76.93 19.33 77.71 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -96.32 144.11 26.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.481 -1.011 . . . . 0.0 110.095 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -102.28 130.23 48.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.557 -0.714 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.86 -176.26 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.848 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 3' ' ' PRO . 59.7 m-20 -122.96 146.93 47.17 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.1 tp -143.31 133.67 24.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.0 110.514 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -109.89 131.12 55.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.84 159.45 35.07 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.017 0.913 . . . . 0.0 110.883 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 17.5 ttmm -92.08 156.26 17.5 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.14 113.09 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.139 -0.976 . . . . 0.0 110.38 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 pt -90.4 -19.51 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.96 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -167.77 157.47 10.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.986 . . . . 0.0 109.707 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.498 ' N ' HE21 ' A' ' 63' ' ' GLN . 96.1 mt -135.39 159.93 40.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.595 -0.691 . . . . 0.0 109.98 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -144.72 118.14 9.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.508 -0.745 . . . . 0.0 109.435 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -72.86 132.76 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.53 -0.731 . . . . 0.0 109.664 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.481 HD22 ' CG2' ' A' ' 35' ' ' ILE . 53.2 t30 -120.03 125.73 49.05 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 108.943 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 33' ' ' GLU . 20.1 p -106.12 21.95 16.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.456 -0.777 . . . . 0.0 109.242 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 t-80 -68.98 13.68 0.1 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.491 -0.756 . . . . 0.0 109.384 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 31' ' ' THR . 95.6 mt-10 58.58 -68.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.076 0.465 . . . . 0.0 110.337 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 32' ' ' HIS . 48.9 m -51.56 -39.44 57.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 0.0 108.945 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.481 ' CG2' HD22 ' A' ' 30' ' ' ASN . 96.6 mt -105.37 140.94 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.679 0.752 . . . . 0.0 109.414 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 9.8 p -85.3 -57.16 3.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.658 -0.651 . . . . 0.0 109.911 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.502 ' N ' ' OG ' ' A' ' 36' ' ' SER . 17.4 pt20 -160.48 164.8 31.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.093 -1.005 . . . . 0.0 110.316 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.2 160.34 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.91 -165.76 31.07 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.169 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.34 145.73 49.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.925 -0.75 . . . . 0.0 109.531 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.42 130.58 55.93 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.35 101.33 2.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 44.3 t0 -104.86 162.69 13.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.56 -0.965 . . . . 0.0 109.445 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 13.5 tm-20 -70.3 -18.58 63.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.69 -0.631 . . . . 0.0 109.778 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.5 p -93.9 -9.74 36.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.074 -1.016 . . . . 0.0 109.334 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.93 -146.61 15.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.92 160.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.667 -0.902 . . . . 0.0 109.888 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -158.53 145.7 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 109.883 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -86.37 164.36 17.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.717 . . . . 0.0 109.992 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -154.29 156.82 37.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.696 -1.253 . . . . 0.0 108.48 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t -139.97 129.96 24.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 109.646 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -106.76 131.58 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.333 0.587 . . . . 0.0 109.68 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -90.91 144.07 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 110.362 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -59.63 -31.64 69.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.711 . . . . 0.0 109.406 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.87 -13.39 6.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -87.53 -30.3 20.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 108.938 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 55.3 55.84 7.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.557 -0.715 . . . . 0.0 110.242 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' A' ' 56' ' ' ALA . 8.8 mp -108.0 154.82 40.91 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.611 -0.681 . . . . 0.0 109.398 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.7 156.56 65.23 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.766 2.31 . . . . 0.0 112.528 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.96 144.28 48.95 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.751 0.786 . . . . 0.0 110.394 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -81.5 148.53 29.15 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.36 0.6 . . . . 0.0 109.936 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 98.3 mt-10 -101.35 136.03 41.86 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.802 0.81 . . . . 0.0 110.111 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.498 HE21 ' N ' ' A' ' 27' ' ' LEU . 97.5 mt-30 -71.77 134.55 46.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.523 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 93.89 -14.48 65.21 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.6 mp0 -95.43 158.41 15.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 110.65 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -90.63 141.98 28.22 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.41 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 35.2 m-85 -133.82 142.83 48.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.842 0.829 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.2 132.0 54.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.99 112.75 25.48 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.803 . . . . 0.0 109.312 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -109.54 140.45 43.31 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.578 0.704 . . . . 0.0 110.413 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 71' ' ' SER . 4.6 t 56.94 60.04 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.932 -0.48 . . . . 0.0 110.929 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.3 168.11 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.503 -0.748 . . . . 0.0 109.228 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 74' ' ' VAL . 11.5 p -128.08 160.33 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.426 0.632 . . . . 0.0 109.836 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 56.3 t -103.11 132.73 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.681 -0.637 . . . . 0.0 109.409 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.24 158.81 14.07 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -102.28 91.56 4.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.933 . . . . 0.0 109.392 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.46 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 88.0 t80 -101.37 119.74 39.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.818 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 80' ' ' ARG . 3.7 m120 52.68 43.08 31.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.763 -0.586 . . . . 0.0 110.657 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 68.99 -15.29 0.26 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.675 -0.641 . . . . 0.0 110.302 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 78' ' ' ASN . 79.9 mtp85 -88.04 159.91 18.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -89.76 135.52 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -143.33 153.7 43.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.172 -0.955 . . . . 0.0 109.332 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -97.2 123.32 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.403 -0.811 . . . . 0.0 108.861 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -108.89 124.47 50.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 0.0 109.366 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.9 132.53 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' LYS . 5.3 p30 -145.62 -178.89 6.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 62.0 tttm -40.91 161.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 74.76 -27.36 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 109.795 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 87' ' ' LYS . 23.2 t -79.92 166.01 22.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.923 . . . . 0.0 110.012 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.6 t -148.11 169.93 18.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 109.334 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.2 mt -144.48 136.01 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.455 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -126.06 127.59 46.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.45 -0.781 . . . . 0.0 109.189 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' C ' HD22 ' A' ' 94' ' ' LEU . 98.5 mttt -74.61 140.72 44.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.536 -0.728 . . . . 0.0 109.515 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.1 mm? -111.01 135.08 52.05 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.818 0.818 . . . . 0.0 110.175 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.2 m -85.66 9.67 15.55 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.23 92.47 39.93 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.455 -0.778 . . . . 0.0 109.19 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.12 153.25 21.77 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.761 2.308 . . . . 0.0 112.064 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.447 ' H ' ' HE2' ' A' ' 23' ' ' LYS . 96.7 mt -100.84 139.66 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 109.577 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.67 129.55 35.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.79 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.94 -12.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.04 -158.03 24.64 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 102' ' ' LEU . 39.5 tp 43.22 74.83 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.54 -0.976 . . . . 0.0 109.621 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.83 -11.04 43.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.72 -0.613 . . . . 0.0 109.937 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 106' ' ' HIS . 98.1 m-70 -63.79 -44.82 92.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.274 -0.892 . . . . 0.0 109.003 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.427 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 51.6 t-80 47.18 14.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 104' ' ' HIS . 12.6 t-80 -75.91 68.21 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -87.2 -9.13 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.66 -0.65 . . . . 0.0 109.856 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -79.99 -13.2 59.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.443 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.827 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mmm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.321 0.581 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 52.49 59.56 14.06 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.302 -0.874 . . . . 0.0 109.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.56 156.23 61.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.609 2.206 . . . . 0.0 112.121 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -81.89 121.99 27.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.437 HD23 HD22 ' A' ' 19' ' ' ASN . 56.9 mt -88.13 131.01 34.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.347 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 20' ' ' LEU . 85.4 m -124.99 138.71 54.22 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -95.66 152.77 18.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.276 -0.89 . . . . 0.0 109.814 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.1 mt -58.29 -44.35 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.548 -0.72 . . . . 0.0 109.361 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.94 -18.98 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 108.937 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 63.1 t0 -87.87 3.78 47.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.3 mt -85.6 120.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.047 -1.033 . . . . 0.0 109.678 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.2 p -138.47 -2.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.322 -0.861 . . . . 0.0 109.043 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 97.7 mt-10 -134.58 136.04 42.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.104 -0.997 . . . . 0.0 109.488 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -97.14 156.4 16.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.97 18.67 69.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 24.2 pt20 -103.36 159.49 15.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.446 -1.032 . . . . 0.0 109.71 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.24 135.42 46.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.69 -0.631 . . . . 0.0 109.642 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.29 177.36 11.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 109.796 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 16.1 t30 -133.46 138.16 46.05 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 6' ' ' THR . 57.4 tp -154.29 147.1 24.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.883 -1.136 . . . . 0.0 109.793 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -104.68 140.36 38.15 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . . . -152.27 161.05 43.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 111.236 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -103.82 153.92 20.18 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 t -93.14 102.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.067 -1.02 . . . . 0.0 110.597 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 pt -84.08 -23.8 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.596 ' CD ' ' HE1' ' A' ' 28' ' ' TRP . 47.5 tt0 -152.96 134.92 14.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.911 . . . . 0.0 108.918 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.3 tp -118.06 147.74 42.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.256 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.596 ' HE1' ' CD ' ' A' ' 26' ' ' GLN . 80.7 m95 -146.78 128.75 15.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 109.185 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -85.62 140.45 30.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.39 128.76 47.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 108.871 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.7 p -99.95 -5.09 28.8 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.225 -0.922 . . . . 0.0 109.081 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 33' ' ' GLU . 75.7 t60 -80.47 127.98 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.759 . . . . 0.0 109.252 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' O ' ' CD2' ' A' ' 32' ' ' HIS . 75.6 tt0 -51.76 167.6 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER 76.28 -47.16 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.546 -0.722 . . . . 0.0 109.414 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -97.12 134.4 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 52.3 p -88.0 -55.81 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.836 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.447 ' NE2' HD12 ' A' ' 52' ' ' ILE . 22.8 pt20 -158.23 165.87 33.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.014 . . . . 0.0 110.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.61 160.82 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.11 -166.59 34.26 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.194 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.74 146.77 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.857 . . . . 0.0 109.155 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.5 mt -109.16 125.22 51.96 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.84 99.43 2.43 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 22' ' ' ALA . 17.9 m-20 -105.52 164.52 11.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.552 -0.969 . . . . 0.0 109.479 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -70.48 -18.98 62.98 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.0 109.865 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -90.08 -10.51 44.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.106 . . . . 0.0 109.827 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.06 -147.87 18.33 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 48' ' ' ILE . 96.0 mt -134.73 155.81 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.597 -0.943 . . . . 0.0 109.48 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.45 ' N ' HG22 ' A' ' 47' ' ' ILE . 14.2 tt -154.53 148.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 109.795 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -88.22 154.42 20.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CB ' HG23 ' A' ' 83' ' ' VAL . 18.9 p90 -146.7 154.33 41.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.603 -1.31 . . . . 0.0 108.311 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.482 HG22 ' NE2' ' A' ' 84' ' ' GLN . 15.3 t -135.45 132.32 37.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.447 HD12 ' NE2' ' A' ' 37' ' ' GLN . 94.9 mt -102.77 128.7 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.573 -0.704 . . . . 0.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -83.96 142.68 30.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 110.454 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -60.8 -34.74 74.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -59.33 -9.59 2.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 109.764 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.33 -25.66 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -0.971 . . . . 0.0 108.825 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 42.47 47.3 4.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 110.066 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.55 165.45 14.34 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.03 147.65 89.16 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.321 2.014 . . . . 0.0 112.242 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.85 142.08 49.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.089 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.3 mp -80.24 143.89 33.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.52 -0.737 . . . . 0.0 109.525 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.79 131.99 43.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.164 -0.96 . . . . 0.0 109.307 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -70.07 134.45 48.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.0 110.477 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 -13.89 66.39 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -97.4 159.51 14.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -1.159 . . . . 0.0 110.796 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.7 m -93.26 146.73 23.49 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.271 0.558 . . . . 0.0 109.798 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -141.3 151.02 43.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.025 0.917 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.5 tp -106.3 132.53 52.23 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 58.3 mt -109.28 106.03 15.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -105.93 140.96 38.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.353 -0.842 . . . . 0.0 110.265 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.1 t 56.86 61.96 2.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.643 -0.66 . . . . 0.0 110.983 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.93 164.11 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.43 144.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.518 0.675 . . . . 0.0 109.637 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.9 t -94.09 134.27 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 151.54 18.04 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -97.4 95.86 7.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -1.155 . . . . 0.0 109.149 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.3 t80 -102.13 116.22 32.22 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.085 -1.009 . . . . 0.0 109.758 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.467 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 22.0 t-20 51.31 -126.7 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.591 -0.693 . . . . 0.0 110.44 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 56.8 t0 -95.85 -6.69 38.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.133 -0.98 . . . . 0.0 110.159 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' TYR . 44.8 ttm180 -114.83 146.67 40.79 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.809 0.814 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.73 158.2 21.87 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -141.71 156.96 45.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 108.886 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -103.0 123.5 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' NE2' HG22 ' A' ' 51' ' ' THR . 92.4 mm-40 -103.26 126.94 50.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.06 130.48 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 108.871 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.96 -166.83 1.67 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.629 0.728 . . . . 0.0 109.968 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -64.28 -41.93 96.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.666 -0.646 . . . . 0.0 110.14 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 88' ' ' ASN . 2.3 p30 -65.69 -11.78 48.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.998 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.1 t -86.34 162.44 18.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.461 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.6 m -135.24 157.96 45.57 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -138.98 130.31 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.056 -1.027 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.98 129.18 48.72 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.323 -0.86 . . . . 0.0 109.156 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' C ' HD22 ' A' ' 94' ' ' LEU . 78.3 tttt -77.36 138.67 39.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.423 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 93' ' ' LYS . 4.0 mm? -106.95 138.01 43.94 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.855 0.836 . . . . 0.0 109.981 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -83.16 2.25 36.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.817 -0.552 . . . . 0.0 109.512 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 96' ' ' GLU . 2.7 mp0 -103.5 129.71 24.91 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.189 -0.945 . . . . 0.0 109.796 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.64 146.87 30.92 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.872 1.715 . . . . 0.0 112.289 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -110.57 135.44 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.494 -0.754 . . . . 0.0 108.987 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -88.0 122.39 31.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 109.96 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.72 -4.16 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.43 122.64 4.95 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 73.5 mt -97.91 111.44 23.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -1.114 . . . . 0.0 109.088 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -76.82 -4.28 42.76 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.404 0.621 . . . . 0.0 109.668 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -148.7 164.86 33.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 108.852 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -123.78 163.95 20.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.521 -0.737 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -74.06 154.87 39.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.299 -0.876 . . . . 0.0 109.599 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -68.68 127.96 34.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.807 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -94.1 126.04 39.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 109.468 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.639 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.535 0.683 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 57.29 60.23 7.0 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.706 -0.621 . . . . 0.0 110.082 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 159.71 50.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.627 2.218 . . . . 0.0 112.206 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -81.65 118.16 22.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.864 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.568 ' CD2' HD22 ' A' ' 19' ' ' ASN . 47.3 mt -90.54 131.16 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.2 m -123.02 142.64 50.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.88 146.94 23.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.639 0.733 . . . . 0.0 110.402 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.2 mm -53.62 -46.02 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.421 -0.8 . . . . 0.0 109.597 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.82 -11.81 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.612 -0.68 . . . . 0.0 109.89 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.72 2.74 44.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -86.98 119.02 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 109.819 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -151.86 9.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.816 . . . . 0.0 109.459 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -127.35 123.11 35.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.555 -0.716 . . . . 0.0 109.283 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.38 152.02 23.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.438 -0.789 . . . . 0.0 110.057 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.73 79.17 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -98.06 145.2 26.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.092 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -99.17 129.6 45.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.516 -0.74 . . . . 0.0 109.481 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.21 -175.88 5.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.568 HD22 ' CD2' ' A' ' 5' ' ' LEU . 27.7 t30 -127.11 141.13 51.84 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.683 -0.636 . . . . 0.0 109.295 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.96 154.56 49.37 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.479 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -135.8 135.42 39.87 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.55 -173.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.169 0.985 . . . . 0.0 110.511 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.49 155.84 27.9 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.283 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.51 106.5 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.34 -24.0 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.568 -0.708 . . . . 0.0 109.284 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.62 ' HB3' HD21 ' A' ' 40' ' ' LEU . 10.3 tp-100 -161.26 151.41 17.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.043 -1.036 . . . . 0.0 109.529 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.889 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -140.96 163.85 31.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.467 -0.771 . . . . 0.0 109.961 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -145.37 111.14 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.802 0.81 . . . . 0.0 109.5 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.01 124.85 26.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.563 HD21 ' C ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -127.58 141.21 51.7 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -0.796 . . . . 0.0 108.886 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -116.13 29.93 7.66 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' SER . 76.8 m-70 -66.05 6.32 0.4 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 31' ' ' THR . 74.0 tt0 68.23 -54.9 0.52 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.178 0.513 . . . . 0.0 109.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' HIS . 40.6 t -60.5 -44.54 95.89 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.122 -0.987 . . . . 0.0 108.748 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.558 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.7 mt -110.94 142.81 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.514 0.673 . . . . 0.0 109.425 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.563 ' C ' HD21 ' A' ' 30' ' ' ASN . 46.9 t -93.25 -47.72 6.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.565 0.698 . . . . 0.0 109.96 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -155.05 156.51 36.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.37 141.1 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.665 ' C ' HD23 ' A' ' 40' ' ' LEU . . . -168.81 -154.09 8.73 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.291 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -136.88 153.09 50.85 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.794 -0.827 . . . . 0.0 109.322 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.02 132.12 54.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.64 0.733 . . . . 0.0 109.741 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.97 104.24 3.12 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 1.4 m-20 -103.73 162.68 12.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.654 -0.91 . . . . 0.0 109.375 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.598 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.9 mp0 -69.37 -15.35 63.29 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.707 -0.621 . . . . 0.0 109.826 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.5 p -97.0 -6.14 36.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.242 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.86 -147.11 17.28 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.227 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 pt -134.93 162.89 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.644 -0.916 . . . . 0.0 110.069 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -159.33 150.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.971 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.86 165.64 21.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.648 -0.658 . . . . 0.0 110.023 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 18.6 p90 -158.67 148.7 19.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.156 -0.965 . . . . 0.0 108.89 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -134.6 128.72 33.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.6 mt -105.45 128.44 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 109.414 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.62 143.01 27.22 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.755 0.788 . . . . 0.0 110.373 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 56' ' ' ALA . 39.5 tptt -60.45 -30.59 69.76 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.619 -0.675 . . . . 0.0 109.403 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -58.98 -3.22 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.838 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -97.14 -28.19 14.22 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.172 -0.955 . . . . 0.0 109.051 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 57' ' ' GLU . 55.2 mp0 48.97 54.7 10.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.21 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.1 mt -110.89 152.85 43.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.73 147.51 71.21 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.567 2.178 . . . . 0.0 112.709 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 mt -72.34 149.29 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.754 0.788 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -86.86 144.33 27.05 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.446 0.641 . . . . 0.0 110.115 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.88 139.56 31.14 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.884 0.849 . . . . 0.0 110.187 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -71.19 137.87 49.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.45 -0.781 . . . . 0.0 110.727 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.97 56.34 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -94.39 159.03 15.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 p -90.28 149.3 22.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.295 0.569 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -144.32 145.88 32.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.7 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 19' ' ' ASN . 36.5 tp -113.32 130.57 56.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.452 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 1.9 mp -119.45 113.64 21.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.63 -0.669 . . . . 0.0 109.502 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -105.92 151.53 24.46 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.76 58.64 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.553 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -112.3 165.07 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.535 -0.728 . . . . 0.0 109.459 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.87 147.58 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.676 0.75 . . . . 0.0 109.71 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.6 t -87.93 130.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.654 . . . . 0.0 109.67 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.9 147.44 16.31 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -96.81 103.26 15.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.451 -1.029 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' ARG . 71.2 t80 -101.58 107.62 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.737 0.78 . . . . 0.0 109.372 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.427 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 47.5 t30 39.69 -115.65 0.2 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.793 -0.567 . . . . 0.0 110.629 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.427 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 97.7 m-20 -93.61 -19.08 21.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.817 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' TYR . 84.8 mtt85 -97.41 159.54 14.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.25 -0.906 . . . . 0.0 110.353 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -110.88 153.19 25.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.619 -0.675 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -151.96 164.07 37.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 83' ' ' VAL . 17.0 m -102.91 126.91 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.95 128.77 53.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.325 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.8 t -103.59 134.29 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 87' ' ' LYS . 4.2 p30 -146.34 -174.4 4.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.87 0.843 . . . . 0.0 109.761 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 89' ' ' SER . 1.6 pptp? -44.34 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.899 -0.5 . . . . 0.0 109.896 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 t30 67.29 -27.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.676 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 87' ' ' LYS . 12.7 p -79.98 166.9 21.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.156 -0.965 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.8 p -141.14 160.42 40.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -139.38 132.3 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.593 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -128.76 130.16 46.68 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.609 0.719 . . . . 0.0 109.365 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.47 144.3 31.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.63 -0.668 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.33 145.24 46.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.704 0.764 . . . . 0.0 110.028 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -86.27 16.8 4.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -119.39 118.43 32.42 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.655 -0.653 . . . . 0.0 109.533 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.09 157.8 42.2 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.647 2.231 . . . . 0.0 112.376 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.3 mm -108.27 137.23 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.748 -0.595 . . . . 0.0 109.674 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.03 122.09 38.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.763 . . . . 0.0 109.663 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.62 80.61 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -119.31 19.32 9.98 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 104' ' ' HIS . 5.5 tp -62.18 -39.37 92.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.408 -1.054 . . . . 0.0 109.706 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.64 -13.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.717 -0.614 . . . . 0.0 110.015 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 102' ' ' LEU . 79.5 m80 -88.86 127.85 35.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 108.868 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 106' ' ' HIS . 46.6 p-80 -148.22 40.09 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 105' ' ' HIS . 85.7 t60 48.24 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.437 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -147.43 -55.12 0.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.51 -0.744 . . . . 0.0 109.441 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -154.54 139.83 17.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.583 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 63.4 m170 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.617 -179.873 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' C ' ' A' ' 2' ' ' GLU . 38.3 ttm . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 2.7 mp0 -32.08 96.1 0.09 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 CA-C-O 121.137 0.494 . . . . 0.0 110.369 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' N ' ' O ' ' A' ' 1' ' ' MET . 41.7 Cg_exo -55.26 141.11 81.53 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.43 2.086 . . . . 0.0 112.001 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -79.73 118.62 21.7 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.591 0.71 . . . . 0.0 109.687 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.2 mt -93.73 128.06 39.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.522 ' O ' HD13 ' A' ' 20' ' ' LEU . 14.8 t -129.6 152.69 48.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.557 0.694 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.18 135.1 34.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.341 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -50.97 -34.37 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.758 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.82 1.46 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.854 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -122.48 6.57 9.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.21 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 13' ' ' GLU . 27.7 mt -64.19 -52.42 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 11' ' ' ILE . 12.2 m 4.29 64.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 121.395 0.617 . . . . 0.0 111.383 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 11' ' ' ILE . 38.3 tp10 -174.09 109.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.732 0.777 . . . . 0.0 109.368 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p-10 -82.57 140.52 33.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.5 77.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -91.05 137.27 32.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -1.16 . . . . 0.0 110.049 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -100.01 129.72 46.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.524 -0.735 . . . . 0.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.99 -175.06 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.398 -0.814 . . . . 0.0 109.932 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 18' ' ' ALA . 88.0 m-20 -138.35 143.41 39.86 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.434 0.635 . . . . 0.0 109.629 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 6' ' ' THR . 62.2 tp -159.06 145.82 17.02 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.216 -0.928 . . . . 0.0 110.518 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -100.0 141.81 32.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.594 -0.692 . . . . 0.0 109.152 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.538 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . . . -154.73 159.07 40.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.853 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -97.8 150.42 21.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -89.31 101.9 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.551 -0.718 . . . . 0.0 110.754 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.45 -25.61 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -170.61 162.43 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.117 -0.989 . . . . 0.0 109.673 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.43 158.31 43.38 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.7 0.762 . . . . 0.0 110.144 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -148.61 127.94 13.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.437 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.628 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -95.17 131.39 41.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.522 -0.736 . . . . 0.0 109.918 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 3.3 p-10 -95.3 163.69 13.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.404 -0.81 . . . . 0.0 109.056 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.33 5.09 29.3 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.551 -0.718 . . . . 0.0 109.535 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 98.4 m-70 -96.25 139.4 32.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.86 -27.39 64.79 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.623 -0.673 . . . . 0.0 110.194 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 47.2 t -60.06 -46.22 90.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.205 -0.935 . . . . 0.0 108.807 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.595 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.8 mt -109.96 141.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.024 0.916 . . . . 0.0 109.75 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 37' ' ' GLN . 6.1 p -93.2 -56.62 2.89 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.096 -1.002 . . . . 0.0 109.832 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.515 ' N ' ' OG ' ' A' ' 36' ' ' SER . 80.1 mt-30 -150.01 158.61 44.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.952 -1.093 . . . . 0.0 110.542 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.67 141.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.85 -164.57 13.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.311 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.79 143.85 47.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.854 -0.792 . . . . 0.0 109.749 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.539 HD21 ' CE1' ' A' ' 50' ' ' PHE . 67.4 mt -112.85 128.89 56.57 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.69 0.757 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.01 99.02 2.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' A' ' 22' ' ' ALA . 47.8 m-20 -99.3 156.35 17.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.126 -1.22 . . . . 0.0 109.469 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 44' ' ' GLU . 13.8 pt-20 -68.96 -17.41 63.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.646 -0.659 . . . . 0.0 109.722 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 p -96.76 -11.74 24.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.285 -0.885 . . . . 0.0 109.076 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.84 -146.73 13.53 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.711 ' O ' HD12 ' A' ' 47' ' ' ILE . 2.5 pp -133.78 161.49 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.1 tt -161.97 143.9 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.756 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -97.37 148.74 22.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 110.172 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.539 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.9 p90 -138.6 160.03 40.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.945 -1.097 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 t -134.21 133.19 40.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.339 -0.851 . . . . 0.0 109.982 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.7 129.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.639 0.733 . . . . 0.0 109.656 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CE3' ' O ' ' A' ' 34' ' ' SER . 74.5 m95 -87.1 140.74 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 110.46 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -54.89 -23.63 19.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.57 -0.707 . . . . 0.0 109.539 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.33 -6.97 47.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.705 . . . . 0.0 109.673 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.584 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -86.96 -34.32 19.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.15 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 54.53 53.03 11.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 110.123 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.584 HD13 ' HB1' ' A' ' 56' ' ' ALA . 8.5 mp -105.19 155.46 37.73 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.533 -0.729 . . . . 0.0 109.39 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.06 156.03 65.01 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.774 2.316 . . . . 0.0 112.737 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.27 139.78 54.42 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.894 0.854 . . . . 0.0 110.684 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.4 mp -82.93 152.59 25.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.356 0.598 . . . . 0.0 110.113 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -104.31 133.3 49.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.727 0.775 . . . . 0.0 110.228 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -67.88 138.94 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.81 0.814 . . . . 0.0 110.622 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 -9.64 64.8 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -94.08 149.92 20.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.241 . . . . 0.0 110.471 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -89.2 147.56 24.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.45 0.643 . . . . 0.0 109.78 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -141.79 152.6 43.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.164 -0.96 . . . . 0.0 110.154 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HB2' HD21 ' A' ' 94' ' ' LEU . 38.9 tp -106.1 133.8 50.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.5 mt -110.38 109.65 20.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.393 -0.817 . . . . 0.0 109.648 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -113.66 142.69 45.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.75 0.786 . . . . 0.0 110.708 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t 57.06 58.04 4.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.115 0.483 . . . . 0.0 110.774 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.36 163.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.2 154.84 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.774 0.797 . . . . 0.0 109.953 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 83.5 t -95.34 130.1 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 109.851 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.54 151.05 18.96 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -91.29 96.15 10.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -1.028 . . . . 0.0 109.697 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.529 ' CD2' ' OD1' ' A' ' 78' ' ' ASN . 16.3 t80 -95.17 100.18 12.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' ' CD2' ' A' ' 77' ' ' TYR . 1.5 p-10 37.48 -110.52 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.402 0.62 . . . . 0.0 110.426 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -95.14 -20.93 18.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 109.868 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' TYR . 72.5 ttt180 -98.56 162.7 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.121 -0.987 . . . . 0.0 110.505 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -101.02 150.37 22.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.235 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -143.63 148.08 35.31 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.048 -1.032 . . . . 0.0 109.592 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.45 125.22 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 109.235 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.58 124.4 49.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.377 -0.827 . . . . 0.0 109.564 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.76 134.63 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -132.13 -167.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.889 0.852 . . . . 0.0 110.051 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.68 -41.69 98.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.661 -0.649 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.08 -22.72 67.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.195 -0.941 . . . . 0.0 109.605 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.7 m -80.23 163.99 23.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.937 . . . . 0.0 110.261 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 p -142.62 162.08 36.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 HD23 ' A' ' 58' ' ' LEU . 79.9 mt -141.56 134.1 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -130.7 135.27 47.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.329 -0.857 . . . . 0.0 109.339 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -71.26 136.45 47.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.702 . . . . 0.0 109.597 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 68' ' ' LEU . 98.2 mt -92.57 136.45 33.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.463 -0.773 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.9 t -74.99 -9.02 58.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.713 . . . . 0.0 109.78 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -118.92 137.27 24.84 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.769 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.9 159.15 38.32 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.668 2.245 . . . . 0.0 112.189 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.4 mt -110.11 131.53 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.687 . . . . 0.0 109.383 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.15 123.58 45.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.873 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.4 t -106.58 -15.46 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.85 77.59 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.24 -42.95 99.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -1.039 . . . . 0.0 109.82 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 48.88 65.87 1.25 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.642 0.734 . . . . 0.0 110.334 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.16 -59.67 4.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.41 -0.807 . . . . 0.0 109.001 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -173.32 76.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.539 -0.726 . . . . 0.0 109.228 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -157.24 119.17 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -93.21 -10.88 34.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.541 -0.725 . . . . 0.0 109.888 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -65.28 -40.53 94.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 56.1 t-80 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 2' ' ' GLU . 74.5 mtm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 1' ' ' MET . 46.2 mm-40 59.52 146.72 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.625 . . . . 0.0 110.157 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.64 157.97 58.76 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.391 2.061 . . . . 0.0 112.334 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.02 120.25 17.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.864 . . . . 0.0 109.74 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.5 mt -97.02 129.85 44.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -123.31 151.31 42.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -99.84 147.6 25.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.089 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 46' ' ' GLY . 5.0 pt -58.78 -43.0 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.517 -0.739 . . . . 0.0 109.369 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.8 -7.86 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.78 15.29 28.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.408 -0.808 . . . . 0.0 109.298 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.43 115.51 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.12 -0.987 . . . . 0.0 109.975 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.28 2.05 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 109.478 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -135.29 131.59 36.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.371 -0.831 . . . . 0.0 109.058 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -95.95 155.64 16.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.234 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.03 19.89 74.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -101.29 156.88 17.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.428 -1.042 . . . . 0.0 109.892 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -106.15 134.2 49.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -176.85 5.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.437 -0.79 . . . . 0.0 109.811 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 70' ' ' ARG . 9.9 m120 -120.37 135.0 55.17 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -136.62 138.03 40.74 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.962 -1.086 . . . . 0.0 110.174 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 34.0 ttpt -117.68 134.33 55.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.11 157.6 23.56 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.21 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 64' ' ' GLY . 51.6 tttp -96.53 163.35 13.07 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.05 97.17 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.321 -0.862 . . . . 0.0 110.942 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.7 pt -80.46 -27.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.877 . . . . 0.0 110.225 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -147.33 130.47 16.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -116.42 140.86 48.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.556 -0.715 . . . . 0.0 109.232 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -149.41 137.24 20.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.168 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -88.87 142.38 27.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.26 -0.9 . . . . 0.0 109.71 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.684 HD22 ' H ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -100.57 142.72 31.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.258 -0.901 . . . . 0.0 109.012 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.684 ' H ' HD22 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -118.01 19.74 13.53 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.445 -0.785 . . . . 0.0 109.037 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.489 ' C ' ' H ' ' A' ' 34' ' ' SER . 9.6 t60 -75.13 0.9 14.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' O ' ' CE ' ' A' ' 54' ' ' LYS . 74.1 tt0 66.65 -36.32 0.26 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.107 0.48 . . . . 0.0 110.013 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 32' ' ' HIS . 89.1 p -87.84 -6.13 58.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.845 -1.16 . . . . 0.0 108.863 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -124.36 149.7 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.536 0.684 . . . . 0.0 109.991 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.0 m -91.11 -54.1 4.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.502 -0.749 . . . . 0.0 109.607 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.41 ' CD ' HD12 ' A' ' 52' ' ' ILE . 13.9 pt20 -160.98 168.74 23.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 39' ' ' GLY . 94.7 t -146.91 156.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -179.67 -163.8 31.0 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.818 -1.658 . . . . 0.0 110.597 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.79 147.51 51.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.782 -0.834 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.489 HD11 ' CD1' ' A' ' 50' ' ' PHE . 4.9 mp -136.56 144.76 44.36 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.602 0.715 . . . . 0.0 109.806 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.493 ' O ' HG11 ' A' ' 100' ' ' VAL . . . -102.58 135.07 12.07 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' A' ' 44' ' ' GLU . 53.1 t0 -115.21 4.34 14.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.523 -0.986 . . . . 0.0 110.674 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.595 ' CB ' ' O ' ' A' ' 43' ' ' ASP . 65.1 tt0 100.75 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.515 1.052 . . . . 0.0 108.487 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -93.48 -3.56 52.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.153 . . . . 0.0 109.562 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' N ' HD11 ' A' ' 8' ' ' ILE . . . 155.47 -150.46 21.9 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.4 160.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.625 -0.927 . . . . 0.0 109.764 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tp -157.18 141.07 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.013 . . . . 0.0 109.526 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB3' HE22 ' A' ' 82' ' ' GLN . 14.6 ttmm -89.93 132.23 35.43 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -125.1 154.31 41.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.313 -0.867 . . . . 0.0 109.192 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -132.27 133.32 43.96 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 HD12 ' CD ' ' A' ' 37' ' ' GLN . 65.7 mt -100.69 122.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.304 -0.873 . . . . 0.0 109.79 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -80.41 149.57 30.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' CE ' ' O ' ' A' ' 33' ' ' GLU . 67.8 mttm -64.43 -34.71 78.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 109.71 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -59.67 -20.76 58.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 109.807 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.99 60.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.106 -0.996 . . . . 0.0 108.746 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 44.16 45.5 6.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.585 -0.697 . . . . 0.0 109.969 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.81 150.95 37.29 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.02 160.72 47.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.595 2.197 . . . . 0.0 112.296 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.87 134.87 48.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 110.109 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.2 mp -78.05 146.09 35.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.625 -0.672 . . . . 0.0 109.541 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -86.39 131.11 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -73.12 135.83 44.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.518 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . . . 88.73 5.02 75.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 78.0 mm-40 -113.69 157.54 22.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.413 -1.051 . . . . 0.0 110.896 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 m -85.9 141.79 29.31 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.33 0.585 . . . . 0.0 109.629 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -138.98 145.01 39.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.298 -0.876 . . . . 0.0 109.803 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.45 128.42 55.99 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mp -115.55 116.34 27.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.625 -0.672 . . . . 0.0 109.448 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' HA ' HD22 ' A' ' 19' ' ' ASN . 84.5 mtp180 -108.66 143.09 38.2 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.551 0.691 . . . . 0.0 110.432 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.9 p 60.57 57.51 2.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.366 0.603 . . . . 0.0 110.656 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.4 157.82 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.175 -0.953 . . . . 0.0 108.773 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.54 134.38 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.678 0.752 . . . . 0.0 109.211 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.09 135.82 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.532 -0.73 . . . . 0.0 109.649 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.76 ' H ' HE22 ' A' ' 84' ' ' GLN . . . -108.81 146.58 16.6 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.23 103.34 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.243 . . . . 0.0 109.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 80' ' ' ARG . 64.9 t80 -97.95 96.97 8.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.223 -0.923 . . . . 0.0 109.594 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.65 -119.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.645 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -91.21 -11.2 39.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 77' ' ' TYR . 89.1 mtm180 -111.15 161.12 16.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 110.115 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.38 153.87 18.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.414 HE22 ' HB3' ' A' ' 49' ' ' LYS . 88.0 mm-40 -140.32 153.94 46.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.146 -0.971 . . . . 0.0 109.133 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.76 113.81 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.241 -0.912 . . . . 0.0 108.582 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.76 HE22 ' H ' ' A' ' 75' ' ' GLY . 2.6 mp0 -103.05 134.98 45.58 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.317 -0.864 . . . . 0.0 109.325 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -102.92 129.42 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -121.36 -174.38 2.84 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.697 0.761 . . . . 0.0 110.047 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.68 -41.68 97.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.68 -0.638 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -65.59 -2.52 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.957 . . . . 0.0 109.767 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.4 m -89.82 161.28 16.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.2 t -132.99 151.86 52.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.97 128.32 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.901 -1.125 . . . . 0.0 109.086 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -129.44 135.92 49.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.081 -1.012 . . . . 0.0 109.135 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.2 tttp -79.6 129.78 34.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.33 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 93' ' ' LYS . 3.9 mm? -104.3 134.74 47.01 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.927 0.87 . . . . 0.0 109.982 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 m -81.81 -3.14 53.22 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -91.78 123.01 64.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.876 -1.14 . . . . 0.0 109.548 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.25 141.82 23.56 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.733 1.622 . . . . 0.0 112.422 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.01 141.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.46 -0.775 . . . . 0.0 109.177 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -48.38 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 0.0 109.223 -179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.493 HG11 ' O ' ' A' ' 42' ' ' GLY . 19.7 m 33.14 38.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.694 0.759 . . . . 0.0 110.287 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 99' ' ' GLU . . . 82.22 78.08 1.03 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 102' ' ' LEU . 4.1 tt -107.35 111.03 23.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.316 -1.108 . . . . 0.0 109.188 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.504 ' N ' HD23 ' A' ' 102' ' ' LEU . 44.8 tt0 40.5 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.745 -0.597 . . . . 0.0 110.688 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 102' ' ' LEU . 43.0 t-80 49.85 13.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.0 108.91 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' GLU . 30.9 m170 -59.91 -40.95 90.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -138.3 142.36 39.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.372 -0.83 . . . . 0.0 109.622 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.14 -43.55 91.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.859 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.402 ' H ' ' H ' ' A' ' 109' ' ' HIS . 84.2 t60 -150.93 -17.09 0.22 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.0 109.129 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.402 ' H ' ' H ' ' A' ' 108' ' ' HIS . 86.0 t60 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.309 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.613 0.72 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.62 59.2 1.19 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.728 -0.608 . . . . 0.0 109.995 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.62 158.14 51.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.493 2.128 . . . . 0.0 112.24 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -79.58 112.28 16.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.4 mt -89.89 129.61 36.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.0 109.691 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.6 m -123.88 139.87 53.54 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.421 0.629 . . . . 0.0 109.326 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.24 144.35 25.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.964 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 9' ' ' VAL . 9.5 pt -52.72 -41.7 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.626 -0.671 . . . . 0.0 109.686 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' N ' HG13 ' A' ' 8' ' ' ILE . 14.8 p -70.03 -11.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -96.59 6.44 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.65 119.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 109.968 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.92 6.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 16' ' ' GLN . 96.6 mt-10 -131.71 128.01 38.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.542 -0.724 . . . . 0.0 109.369 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.597 ' ND2' ' N ' ' A' ' 15' ' ' GLY . 2.3 t-20 -88.95 150.03 23.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.848 . . . . 0.0 109.924 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.597 ' N ' ' ND2' ' A' ' 14' ' ' ASN . . . 80.34 21.82 63.98 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 13' ' ' GLU . 4.9 pt20 -103.35 153.2 20.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.575 -0.956 . . . . 0.0 109.837 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -103.9 132.25 50.34 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.507 0.67 . . . . 0.0 109.446 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -160.32 178.87 9.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 109.863 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -120.66 144.98 47.89 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.1 tp -136.59 133.7 36.63 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.512 -0.742 . . . . 0.0 110.131 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -118.31 132.03 56.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.39 -173.21 0.87 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.176 0.989 . . . . 0.0 110.806 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.9 ptpt -118.19 155.82 29.82 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.438 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 95.8 t -90.06 105.75 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.471 -0.768 . . . . 0.0 110.158 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.449 ' C ' HE21 ' A' ' 63' ' ' GLN . 34.5 pt -73.19 -25.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.804 -0.56 . . . . 0.0 110.045 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -159.59 148.59 17.94 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.983 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.6 pt? -125.34 152.01 45.3 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.13 117.7 9.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 109.606 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 56.4 mp0 -94.75 125.45 39.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.623 -0.673 . . . . 0.0 109.386 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.427 HD21 HG21 ' A' ' 35' ' ' ILE . 31.5 p-10 -149.18 170.51 18.29 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 t -150.66 46.78 0.87 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 109.112 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -54.27 -37.36 64.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -167.26 -99.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.235 -0.916 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.3 p -87.38 -6.37 58.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.191 -0.943 . . . . 0.0 108.935 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 30' ' ' ASN . 94.4 mt -80.56 131.71 33.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 3.0 m -102.05 -46.32 4.9 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.513 0.673 . . . . 0.0 109.894 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -148.82 148.2 29.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.988 -1.07 . . . . 0.0 109.975 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.86 130.74 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.38 -166.93 15.12 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.15 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD21 ' NZ ' ' A' ' 49' ' ' LYS . 4.8 mp -135.31 150.48 50.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.866 -0.784 . . . . 0.0 109.734 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.7 mt -111.21 125.22 53.57 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 124.64 8.13 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.4 p-10 -125.73 -134.69 0.26 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.714 -0.874 . . . . 0.0 109.098 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 81.7 tt0 -119.8 -18.57 8.24 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 15.7 p -93.06 -11.06 33.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.97 -1.081 . . . . 0.0 109.473 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 151.65 -143.85 10.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.0 mt -141.54 158.11 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -1.09 . . . . 0.0 109.432 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -148.86 145.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 109.885 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.455 ' NZ ' HD21 ' A' ' 40' ' ' LEU . 67.9 mttm -92.01 127.36 37.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.023 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -122.87 152.76 40.44 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.3 m -131.24 133.44 45.45 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.426 0.631 . . . . 0.0 109.634 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.64 127.1 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -82.5 142.56 31.77 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.597 -0.689 . . . . 0.0 110.118 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' N ' ' OG ' ' A' ' 36' ' ' SER . 78.8 tttt -58.08 -37.32 74.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.541 -0.725 . . . . 0.0 109.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -6.11 1.23 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.449 -0.782 . . . . 0.0 109.828 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.62 18.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.285 -0.884 . . . . 0.0 109.158 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 46.33 51.95 11.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.643 -0.661 . . . . 0.0 109.889 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.4 mt -100.65 153.02 37.97 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.741 -0.599 . . . . 0.0 109.848 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.46 148.89 60.1 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.477 2.118 . . . . 0.0 112.779 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.6 140.12 51.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.512 -0.742 . . . . 0.0 110.379 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.3 mp -83.37 150.33 26.16 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.367 0.603 . . . . 0.0 109.964 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.2 128.2 45.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.449 HE21 ' C ' ' A' ' 25' ' ' ILE . 11.1 tm0? -66.71 137.99 57.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.662 -0.649 . . . . 0.0 110.712 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 86.74 -10.77 66.37 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -98.18 158.19 15.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.443 -1.033 . . . . 0.0 110.674 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.1 m -91.58 145.67 24.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -141.73 148.82 39.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 109.815 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 tp -110.32 128.76 55.71 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.83 118.05 31.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.531 -0.731 . . . . 0.0 109.728 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -114.86 145.01 42.63 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.692 0.758 . . . . 0.0 110.694 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 63.22 56.57 1.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 18' ' ' ALA . 19.0 m -110.73 161.97 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.512 -0.743 . . . . 0.0 109.381 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 148.43 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.581 0.705 . . . . 0.0 109.59 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 65.3 t -95.75 132.47 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.676 -0.64 . . . . 0.0 109.686 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.93 152.0 16.96 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -94.86 109.39 21.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.534 -0.98 . . . . 0.0 109.403 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.674 ' CB ' HE21 ' A' ' 82' ' ' GLN . 40.4 t80 -106.8 106.45 16.97 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.922 0.868 . . . . 0.0 109.483 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.4 m120 42.64 -118.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -93.07 -17.3 23.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.102 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 77' ' ' TYR . 95.7 mtt-85 -100.82 159.78 14.91 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.411 -0.805 . . . . 0.0 110.329 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -104.72 153.32 21.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.674 HE21 ' CB ' ' A' ' 77' ' ' TYR . 43.5 mt-30 -147.81 159.94 43.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.38 123.55 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.72 129.35 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -104.41 131.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -127.08 -170.46 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.673 0.749 . . . . 0.0 110.066 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.53 -45.14 91.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.907 -0.496 . . . . 0.0 110.181 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.18 -11.07 7.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 109.758 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.5 p -83.23 163.91 20.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.9 p -138.44 155.67 48.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -139.66 131.77 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 0.0 109.313 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -127.47 130.57 49.47 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -70.34 135.89 49.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.705 -0.622 . . . . 0.0 109.502 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.1 mt -96.92 134.36 40.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.505 -0.747 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.5 p -85.29 -6.34 59.26 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -107.12 130.52 22.74 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.567 -0.708 . . . . 0.0 109.57 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.25 147.39 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.478 2.119 . . . . 0.0 112.242 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.464 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.5 mt -110.27 131.67 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.6 mp0 -97.54 123.24 41.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 110.011 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 100' ' ' VAL . 94.8 t -84.57 -3.38 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.65 144.47 3.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.36 -0.83 57.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.46 -1.024 . . . . 0.0 109.177 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 51.13 -167.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -93.82 118.69 31.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -148.73 23.39 0.99 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.39 -0.819 . . . . 0.0 108.941 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.675 ' CD2' ' H ' ' A' ' 107' ' ' HIS . 84.7 t60 51.11 -117.17 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.366 -0.834 . . . . 0.0 109.718 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.675 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 50.3 t-80 -87.75 155.32 19.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.959 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -155.3 153.78 31.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.605 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.189 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -140.1 74.16 31.14 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.67 148.57 92.73 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.886 2.391 . . . . 0.0 112.017 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.03 115.43 18.7 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.12 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.9 mt -86.95 126.64 34.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.55 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.7 m -120.77 136.78 54.8 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.07 148.39 22.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.23 -43.3 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.528 0.68 . . . . 0.0 109.193 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.22 -13.39 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.429 -0.795 . . . . 0.0 109.535 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 53.2 t0 -95.58 5.52 51.29 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.159 -0.963 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 13' ' ' GLU . 3.7 mm -56.14 -72.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.142 -0.974 . . . . 0.0 109.185 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t 62.59 -32.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 11' ' ' ILE . 52.3 tp10 -145.54 147.6 32.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.883 -1.135 . . . . 0.0 108.987 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -101.48 173.11 6.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.56 0.695 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.43 21.85 79.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 13' ' ' GLU . 34.3 mt-30 -99.43 145.76 27.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.349 -1.089 . . . . 0.0 109.984 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -94.27 126.05 39.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.464 ' C ' HD22 ' A' ' 19' ' ' ASN . . . -162.28 -169.98 2.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -126.09 144.07 50.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.69 130.81 38.7 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.715 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -116.05 130.67 56.91 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.16 -173.67 1.14 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.23 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HZ1' ' HB ' ' A' ' 98' ' ' ILE . 3.3 ttmp? -114.26 148.89 36.72 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.831 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.08 123.71 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.203 -0.936 . . . . 0.0 110.239 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 pt -88.46 -20.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.432 -0.793 . . . . 0.0 110.45 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -164.91 154.82 13.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.723 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.7 mt -124.36 152.09 43.59 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.443 0.64 . . . . 0.0 110.021 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -137.33 104.92 5.53 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' HG2' HE21 ' A' ' 37' ' ' GLN . 96.9 mt-10 -87.71 131.91 34.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.743 -0.598 . . . . 0.0 109.695 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.596 HD21 ' C ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -111.71 -31.88 6.83 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m 63.27 6.73 2.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.504 -0.748 . . . . 0.0 109.32 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 35' ' ' ILE . 32.6 m-70 -74.19 150.53 40.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.99 -41.31 91.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 109.96 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 t -67.39 -54.06 23.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.096 -1.002 . . . . 0.0 109.624 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.537 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 69.8 mt -107.42 137.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.596 ' C ' HD21 ' A' ' 30' ' ' ASN . 9.1 p -90.93 -60.17 1.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.912 0.863 . . . . 0.0 110.437 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.537 ' N ' ' OG ' ' A' ' 36' ' ' SER . 81.3 mt-30 -146.67 155.34 42.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.864 -1.148 . . . . 0.0 109.964 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 39' ' ' GLY . 20.2 t -135.94 161.77 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' ' CE2' ' A' ' 50' ' ' PHE . . . 178.4 -168.17 39.16 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.058 -1.544 . . . . 0.0 109.939 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.08 149.88 52.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.764 -0.845 . . . . 0.0 109.583 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 mt -110.6 125.72 53.7 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.733 0.778 . . . . 0.0 108.992 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.93 101.2 2.75 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -105.05 164.02 12.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.678 -0.895 . . . . 0.0 109.293 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -71.49 -17.01 62.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.491 -0.756 . . . . 0.0 109.809 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.3 p -93.81 -10.85 32.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.086 -1.009 . . . . 0.0 109.571 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.61 -149.57 21.23 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 pt -132.98 156.16 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.944 . . . . 0.0 109.701 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -152.47 145.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.865 . . . . 0.0 109.397 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.612 ' H ' HH12 ' A' ' 80' ' ' ARG . 68.3 mttm -80.44 165.35 22.28 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.408 -0.807 . . . . 0.0 109.451 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CE2' ' C ' ' A' ' 39' ' ' GLY . 24.6 p90 -154.23 148.6 26.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.513 -1.367 . . . . 0.0 108.08 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.5 m -132.93 132.38 41.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.436 -0.79 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -105.7 127.56 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.491 -0.755 . . . . 0.0 109.38 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -83.76 140.3 32.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.66 -33.01 69.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.466 -0.771 . . . . 0.0 109.226 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -64.14 -6.43 6.54 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.79 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.58 -31.84 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 108.941 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 49.51 52.9 13.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.909 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 mt -101.96 153.93 37.67 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.36 -0.837 . . . . 0.0 109.87 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.71 149.65 31.67 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.145 1.896 . . . . 0.0 112.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt -67.0 138.29 57.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 0.0 110.27 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.8 mp -82.86 145.24 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 109.836 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -105.21 135.36 46.71 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.835 0.826 . . . . 0.0 109.998 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -74.78 146.64 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.022 0.915 . . . . 0.0 110.006 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.72 -11.1 42.11 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -97.81 150.14 21.58 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.102 -1.234 . . . . 0.0 110.507 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -84.16 143.8 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.364 0.602 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -142.14 150.26 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.843 . . . . 0.0 109.787 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.08 129.92 55.47 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.31 115.65 28.48 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.423 -0.798 . . . . 0.0 109.576 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -113.66 146.25 40.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.579 -0.701 . . . . 0.0 110.317 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.1 t 56.96 58.97 3.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.882 -0.511 . . . . 0.0 110.908 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.98 165.73 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.302 -0.873 . . . . 0.0 108.849 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 p -127.01 152.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.654 0.74 . . . . 0.0 109.591 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.15 132.08 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.649 -0.657 . . . . 0.0 109.536 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.12 156.24 15.71 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.44 118.17 36.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 109.032 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 84.5 t80 -135.46 117.89 15.77 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 80' ' ' ARG . 9.4 m120 52.73 55.75 8.58 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.774 . . . . 0.0 110.452 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 56.16 -4.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.68 -0.638 . . . . 0.0 110.808 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' H ' ' A' ' 49' ' ' LYS . 68.3 ttt-85 -102.02 131.91 48.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.093 -1.004 . . . . 0.0 109.598 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 11' ' ' ILE . 13.9 m-85 -78.15 146.3 35.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.488 -0.757 . . . . 0.0 109.233 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -147.32 162.6 38.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 0.0 109.613 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.94 119.77 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.442 -0.787 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -100.56 129.91 46.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.864 . . . . 0.0 109.043 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.56 132.39 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.045 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -125.49 -170.12 2.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.402 -0.811 . . . . 0.0 109.81 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -67.3 -25.42 66.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.654 -0.654 . . . . 0.0 110.102 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -80.72 -9.24 59.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.776 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 m -88.87 164.07 15.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 0.0 109.675 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.6 m -134.93 158.0 45.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.264 -0.897 . . . . 0.0 108.998 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.94 128.87 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.114 -0.991 . . . . 0.0 108.843 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.97 128.56 47.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.311 -0.868 . . . . 0.0 108.919 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.82 137.97 55.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 109.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.0 mt -103.2 134.37 46.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.848 . . . . 0.0 109.941 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.9 p -85.5 -2.01 57.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.617 -0.677 . . . . 0.0 109.548 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -109.66 127.53 27.0 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.368 -0.833 . . . . 0.0 109.692 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.55 151.0 41.35 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.121 1.881 . . . . 0.0 112.265 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.554 ' HB ' ' HZ1' ' A' ' 23' ' ' LYS . 96.6 mt -111.01 134.5 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -105.8 122.77 46.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.6 m -106.61 -6.56 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' LEU . . . -94.82 -164.94 35.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 102' ' ' LEU . 10.0 mp 41.61 67.47 0.55 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.478 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' HIS . 73.7 mm-40 -74.57 131.95 41.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.416 0.627 . . . . 0.0 110.323 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 49.19 -90.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 0.0 109.526 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' GLU . 80.3 m80 -137.92 -172.46 3.26 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.033 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -66.48 136.1 55.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.628 ' H ' ' CD2' ' A' ' 107' ' ' HIS . 7.1 p80 -80.06 145.11 32.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.4 -0.813 . . . . 0.0 110.051 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -81.03 145.09 31.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.697 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 tpp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.316 0.579 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.28 157.12 75.84 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.149 -0.969 . . . . 0.0 109.685 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 143.88 21.7 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.055 1.837 . . . . 0.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.469 ' N ' HD22 ' A' ' 19' ' ' ASN . 85.1 mt-30 -77.84 115.78 17.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.516 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.72 127.48 35.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.718 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.9 m -121.12 137.7 54.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -95.85 151.74 19.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.944 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.5 mm -55.96 -44.56 78.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.77 -18.24 23.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.562 -0.711 . . . . 0.0 109.222 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.28 -0.52 56.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.256 -0.903 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.23 118.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.169 -0.957 . . . . 0.0 109.796 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -142.88 -2.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.926 . . . . 0.0 109.192 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -134.8 140.52 45.93 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.094 -1.004 . . . . 0.0 109.505 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' A' ' 76' ' ' GLU . 39.4 p-10 -92.5 162.93 14.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.1 19.53 78.52 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -94.46 140.45 29.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -1.17 . . . . 0.0 109.682 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -96.48 128.26 43.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.626 -0.671 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.747 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.557 ' C ' HD22 ' A' ' 20' ' ' LEU . 58.9 m-20 -120.69 139.56 52.87 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD22 ' C ' ' A' ' 19' ' ' ASN . 4.4 mm? -116.84 146.68 42.74 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.087 -1.008 . . . . 0.0 109.71 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -138.42 125.33 21.16 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 -175.16 1.06 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.177 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -110.54 151.76 27.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.854 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.47 111.06 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.322 -0.861 . . . . 0.0 110.84 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.7 pt -89.22 -24.38 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.287 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -156.56 147.26 21.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 109.449 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 160.61 39.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.249 -0.907 . . . . 0.0 109.37 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.1 t90 -141.21 109.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 109.389 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.87 129.14 39.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.618 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -105.17 153.97 20.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.296 -0.877 . . . . 0.0 109.151 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.2 p -144.84 58.67 1.3 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.252 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.471 ' C ' ' H ' ' A' ' 34' ' ' SER . 76.3 t60 -124.49 17.73 8.89 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 55.52 2.93 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.776 -0.578 . . . . 0.0 110.66 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 32' ' ' HIS . 39.2 t -110.44 -49.02 3.09 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -108.16 140.73 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.684 -0.635 . . . . 0.0 109.524 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.416 ' OG ' ' C ' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -85.04 -58.32 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -151.98 152.01 31.92 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.258 -0.901 . . . . 0.0 109.871 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.87 133.01 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -161.27 -156.8 8.45 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.525 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.67 153.49 50.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.87 -0.782 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.46 128.7 55.35 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.8 97.84 2.35 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 53.8 t0 -101.37 159.86 14.91 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.423 -1.045 . . . . 0.0 109.421 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.3 mt-10 -68.99 -14.8 63.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.44 -0.788 . . . . 0.0 109.984 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -98.0 -7.03 30.73 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.155 -0.966 . . . . 0.0 109.577 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.61 -147.81 18.11 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.162 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 47' ' ' ILE . 2.1 pp -135.81 165.37 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.662 -0.905 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.5 tt -157.5 144.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.147 -0.97 . . . . 0.0 109.91 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -92.88 130.22 38.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -128.45 154.99 45.49 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.831 -1.168 . . . . 0.0 108.599 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.6 m -131.33 130.47 42.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.59 -0.694 . . . . 0.0 109.257 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.2 mt -100.06 129.62 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.332 -0.855 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.416 ' C ' ' OG ' ' A' ' 36' ' ' SER . 97.9 m95 -82.0 139.91 34.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 110.312 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 56' ' ' ALA . 64.5 tttm -59.63 -37.78 79.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -61.04 -2.04 0.54 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -85.07 -23.71 28.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.006 . . . . 0.0 108.779 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 53.85 48.28 21.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.475 -0.766 . . . . 0.0 109.9 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.1 mt -109.77 147.06 35.38 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.533 -0.729 . . . . 0.0 109.581 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 157.27 62.54 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.384 2.056 . . . . 0.0 112.648 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.74 147.39 43.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.054 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.7 mp -85.2 155.19 21.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.528 -0.733 . . . . 0.0 109.556 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 47.2 tp10 -100.47 136.73 39.9 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -71.34 138.6 49.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.405 -0.809 . . . . 0.0 110.488 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.16 -14.81 62.6 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -99.35 158.45 15.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.327 -1.102 . . . . 0.0 110.667 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -88.15 151.77 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.485 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 31.7 m-85 -142.9 143.72 32.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 109.561 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.3 tp -113.45 129.83 56.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.04 122.74 45.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.615 -0.678 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -116.86 151.99 35.41 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.477 0.656 . . . . 0.0 110.536 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m 56.93 54.97 6.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.89 -0.506 . . . . 0.0 110.788 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.21 164.6 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.243 -0.911 . . . . 0.0 108.853 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.51 147.27 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.564 0.697 . . . . 0.0 109.374 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.89 131.83 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.634 -0.666 . . . . 0.0 109.383 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.93 149.94 16.95 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 78' ' ' ASN . 5.5 tm-20 -92.08 100.2 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.034 -1.274 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' ARG . 52.8 t80 -95.18 103.61 15.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.93 . . . . 0.0 109.191 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' O ' ' OE2' ' A' ' 76' ' ' GLU . 99.3 m-20 40.25 -110.67 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 0.0 110.684 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -95.89 -19.65 19.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.099 -1.001 . . . . 0.0 110.383 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 77' ' ' TYR . 37.4 mmt180 -101.31 162.61 12.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.902 . . . . 0.0 110.006 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.37 152.25 21.81 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.426 ' NE2' ' CD1' ' A' ' 77' ' ' TYR . 27.5 mt-30 -142.06 157.81 44.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.16 123.7 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.434 -0.791 . . . . 0.0 109.111 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -104.8 126.64 52.08 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.453 -0.779 . . . . 0.0 109.545 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.74 134.93 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.39 -0.819 . . . . 0.0 109.162 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -129.29 -168.57 1.95 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.323 -0.86 . . . . 0.0 109.896 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.63 -41.63 98.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.521 -0.737 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.91 -20.07 66.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 109.735 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.0 m -81.21 163.88 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.777 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.5 m -137.44 162.27 34.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.31 -0.869 . . . . 0.0 108.923 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -138.85 130.19 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.015 -1.053 . . . . 0.0 108.834 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -130.08 134.71 47.55 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.211 -0.931 . . . . 0.0 109.013 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -75.57 139.54 42.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.532 -0.73 . . . . 0.0 109.902 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.07 141.74 28.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 109.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.8 t -85.05 -8.98 58.46 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.756 -0.59 . . . . 0.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -110.24 134.05 20.88 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.336 -0.852 . . . . 0.0 110.033 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 154.02 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.053 1.836 . . . . 0.0 112.155 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -111.64 133.41 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -87.65 123.0 32.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 109.663 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.7 t -108.65 -15.77 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.78 122.11 6.14 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.0 107.47 19.05 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.318 -1.107 . . . . 0.0 109.209 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.25 -3.66 40.91 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.769 -0.582 . . . . 0.0 109.72 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.3 m80 48.54 43.16 19.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 109.174 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -59.94 -44.57 94.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.503 -0.748 . . . . 0.0 109.409 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -150.81 163.44 38.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 109.341 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -138.15 45.92 2.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.385 -0.822 . . . . 0.0 109.34 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -63.87 -42.47 97.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.136 -0.977 . . . . 0.0 109.206 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.593 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -59.71 153.34 52.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.18 155.74 66.92 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.653 2.235 . . . . 0.0 112.093 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.74 115.66 20.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.95 131.43 35.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -123.57 142.08 51.38 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -93.28 149.86 20.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.073 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.25 -43.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.369 -0.832 . . . . 0.0 109.078 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 p -62.99 -5.7 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -102.02 6.25 41.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.372 -0.83 . . . . 0.0 109.322 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.74 112.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 109.551 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.6 m -149.74 4.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -132.91 130.47 39.68 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.362 -0.836 . . . . 0.0 109.078 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -88.15 160.06 17.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.193 -0.942 . . . . 0.0 110.359 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.52 20.68 72.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -94.29 138.57 32.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 109.996 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -94.85 126.69 40.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 109.386 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.37 -179.41 7.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.581 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -126.3 140.36 52.58 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.36 143.73 40.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.5 135.74 54.2 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.87 -173.69 1.01 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.183 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -111.09 150.99 28.6 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.863 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.14 97.34 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.086 -1.009 . . . . 0.0 109.932 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.7 tp -66.47 -32.59 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 121.092 -1.005 . . . . 0.0 110.529 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -147.35 129.7 15.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.287 -0.883 . . . . 0.0 109.535 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.78 147.59 41.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.598 -0.689 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -143.51 115.39 8.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.274 -0.891 . . . . 0.0 109.396 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.54 131.62 44.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.459 -0.776 . . . . 0.0 109.649 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.457 HD22 ' HB ' ' A' ' 35' ' ' ILE . 57.0 t30 -115.19 120.27 39.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.417 -0.802 . . . . 0.0 109.168 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 33' ' ' GLU . 69.3 p -110.99 8.25 21.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.486 -0.759 . . . . 0.0 109.1 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' GLU . 25.1 m-70 -58.87 -0.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tm-20 79.21 -51.49 0.43 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 35' ' ' ILE . 83.7 p -83.6 87.72 7.03 Favored 'General case' 0 C--O 1.201 -1.474 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 ' CB ' ' O ' ' A' ' 34' ' ' SER . 26.2 mt 124.87 137.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 C-N-CA 123.731 0.813 . . . . 0.0 109.218 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -81.72 -57.87 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.394 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -159.74 165.19 33.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 0.0 110.661 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.76 154.9 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.66 -155.38 17.36 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.393 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -136.01 155.2 50.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.911 -0.758 . . . . 0.0 109.541 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.35 127.8 55.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.8 105.89 3.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -112.95 167.99 10.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.923 . . . . 0.0 109.484 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -73.01 -17.33 61.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.597 -0.689 . . . . 0.0 109.947 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.8 p -93.17 -12.1 31.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.917 -1.114 . . . . 0.0 109.644 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.69 -148.56 19.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.676 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.3 pp -135.55 160.66 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.992 . . . . 0.0 109.55 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -153.77 147.56 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.189 -0.944 . . . . 0.0 109.76 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -81.07 163.64 23.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.232 -0.917 . . . . 0.0 109.189 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -160.6 150.94 18.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.483 -1.386 . . . . 0.0 108.265 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 t -138.42 133.1 32.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.36 -0.837 . . . . 0.0 109.47 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -105.2 129.77 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.677 -0.639 . . . . 0.0 109.467 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -81.98 139.3 34.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 110.686 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.35 -32.03 72.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.416 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -62.09 -10.4 10.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.85 -21.88 34.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 47.74 48.89 17.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.985 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt -103.71 152.27 38.9 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.404 -0.81 . . . . 0.0 109.8 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.42 146.5 41.27 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.077 1.851 . . . . 0.0 112.589 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.47 142.78 53.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.0 mp -82.63 143.32 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.514 -0.741 . . . . 0.0 109.667 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -93.41 132.04 38.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.28 -0.888 . . . . 0.0 109.755 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -69.26 139.11 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 110.746 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -11.97 59.56 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -96.06 158.51 15.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -1.109 . . . . 0.0 110.585 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.489 0.661 . . . . 0.0 109.836 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.11 148.78 38.9 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.936 0.874 . . . . 0.0 109.879 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.499 HD21 ' NE ' ' A' ' 70' ' ' ARG . 27.2 tp -107.16 131.41 54.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.9 mt -116.27 111.29 19.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.499 ' NE ' HD21 ' A' ' 68' ' ' LEU . 99.1 mtt180 -115.65 153.04 32.0 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.737 0.779 . . . . 0.0 110.556 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 5.2 p 50.46 56.58 7.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.867 -0.52 . . . . 0.0 110.67 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -112.83 167.26 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.98 152.72 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.6 0.714 . . . . 0.0 109.402 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.11 131.44 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.65 -0.656 . . . . 0.0 109.734 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.25 148.56 17.21 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -97.5 107.59 20.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.279 -1.13 . . . . 0.0 108.927 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ARG . 87.1 t80 -107.13 109.22 21.0 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.371 -0.83 . . . . 0.0 109.273 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.483 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 26.6 t-20 38.92 -116.8 0.2 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.623 -0.673 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.483 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 99.4 m-20 -92.81 -20.13 21.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 77' ' ' TYR . 3.6 mpt_? -96.12 162.22 13.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.84 153.89 25.94 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -149.77 161.87 41.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 109.167 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.17 128.14 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.87 124.35 49.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.484 -0.76 . . . . 0.0 109.356 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.7 t -98.4 133.51 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -123.27 -169.09 1.87 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 0.0 109.655 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -66.45 -38.81 88.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.761 -0.587 . . . . 0.0 109.924 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.55 -12.17 56.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.983 . . . . 0.0 109.902 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 t -87.75 166.66 14.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.4 m -134.82 156.03 49.59 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.29 -0.881 . . . . 0.0 108.829 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -139.12 130.88 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.094 -1.004 . . . . 0.0 108.981 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -127.22 127.91 45.21 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.28 -0.888 . . . . 0.0 108.917 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.58 141.92 44.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 0.0 109.25 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.27 142.2 37.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.402 ' OG ' ' OE2' ' A' ' 96' ' ' GLU . 94.5 p -88.2 3.18 50.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.616 -0.677 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 27.6 mp0 -105.99 133.72 20.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.291 -0.881 . . . . 0.0 109.687 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.51 148.29 37.49 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.089 1.86 . . . . 0.0 112.157 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.53 134.11 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 56.9 mp0 -88.79 120.93 30.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.095 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 t -91.52 80.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.58 87.92 0.28 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 102' ' ' LEU . 3.7 mm? 44.36 -98.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.525 -0.985 . . . . 0.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' HIS . 97.4 mt-10 -142.9 -67.27 0.37 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.465 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.8 t60 60.04 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' GLU . 97.8 m-70 -87.37 123.12 31.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -100.65 130.61 46.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.483 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 52.3 p-80 -59.85 -43.98 94.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.474 -0.766 . . . . 0.0 109.926 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.483 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 58.7 t-80 -149.24 156.61 42.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.736 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.492 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 36.7 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.068 -0.967 . . . . 0.0 109.709 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.401 0.62 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -166.15 57.78 0.47 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.214 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.14 161.09 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.749 2.3 . . . . 0.0 112.154 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.61 115.51 17.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.14 131.32 36.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.849 . . . . 0.0 109.438 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.3 m -124.68 141.06 52.37 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.88 151.75 19.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.3 mt -56.38 -45.84 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.229 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.7 -17.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.625 -0.672 . . . . 0.0 109.436 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -92.8 2.41 56.77 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.0 mt -86.21 121.23 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.045 -1.034 . . . . 0.0 109.861 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -147.9 6.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -137.56 135.42 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 76' ' ' GLU . 56.1 p30 -93.32 158.75 15.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.276 -0.89 . . . . 0.0 110.328 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.9 20.71 79.33 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -99.46 147.62 25.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -1.123 . . . . 0.0 110.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -97.49 126.91 43.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.94 -178.23 6.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.682 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.404 HD22 ' HG2' ' A' ' 70' ' ' ARG . 5.0 m120 -117.91 145.62 44.52 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.4 tp -134.24 127.86 32.72 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -114.88 130.21 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.11 170.78 11.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.122 0.963 . . . . 0.0 111.074 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -100.1 155.34 17.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.751 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.45 113.19 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.207 -0.933 . . . . 0.0 110.623 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.1 mt -100.51 -21.21 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -147.56 130.5 16.23 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.036 -1.04 . . . . 0.0 109.781 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.929 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.4 pt? -129.68 156.81 43.65 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.293 0.568 . . . . 0.0 109.812 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -144.5 110.5 5.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.98 117.8 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -102.52 137.76 40.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.269 -0.895 . . . . 0.0 109.176 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 33' ' ' GLU . 61.6 p -122.43 7.66 9.58 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.537 -0.727 . . . . 0.0 109.113 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -66.15 2.2 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 31' ' ' THR . 23.3 tp10 70.22 -47.57 0.63 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.706 -0.621 . . . . 0.0 110.023 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 t -60.05 -46.33 89.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.979 -1.076 . . . . 0.0 109.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt -107.8 135.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.435 -0.79 . . . . 0.0 109.485 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -82.52 -62.77 1.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.621 -0.674 . . . . 0.0 109.995 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -152.32 149.19 28.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.968 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.61 154.13 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.14 -159.63 22.68 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 tp -125.27 145.2 50.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.907 -0.76 . . . . 0.0 109.448 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.547 HD21 ' CE1' ' A' ' 50' ' ' PHE . 67.0 mt -108.48 128.68 55.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.514 -0.741 . . . . 0.0 109.201 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 97.83 2.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -103.32 164.31 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.97 . . . . 0.0 109.621 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.09 -20.22 62.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.602 -0.686 . . . . 0.0 110.104 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 p -90.12 -12.65 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 109.359 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.58 -148.97 20.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.425 ' N ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -132.02 159.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.672 -0.899 . . . . 0.0 109.666 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.42 141.69 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -88.36 144.68 26.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.547 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.5 p90 -141.27 158.63 43.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.73 -1.231 . . . . 0.0 108.49 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -135.03 137.57 43.09 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.514 0.674 . . . . 0.0 109.726 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.6 mt -106.33 129.68 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -86.39 142.94 28.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.376 -0.827 . . . . 0.0 110.378 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -61.93 -32.08 72.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.643 -0.66 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.5 -12.77 6.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.517 -0.739 . . . . 0.0 109.619 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.23 24.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.948 . . . . 0.0 108.939 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 49.13 52.91 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 109.815 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 mt -102.37 153.66 37.95 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.1 149.0 45.94 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 122.082 1.855 . . . . 0.0 112.72 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.5 mt -70.54 140.89 51.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.264 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.5 mp -82.97 145.04 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.709 -0.619 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 96.1 mt-10 -101.17 139.2 37.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.425 ' OE1' HD22 ' A' ' 27' ' ' LEU . 59.2 tt0 -76.58 138.27 40.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.644 -0.66 . . . . 0.0 110.726 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.02 -18.65 56.94 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 97.8 mt-10 -97.0 159.95 14.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.681 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 m -89.55 148.59 23.3 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.416 0.627 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.43 143.94 34.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.713 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 tp -109.45 130.44 55.5 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -113.33 122.17 46.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.502 -0.749 . . . . 0.0 109.831 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HG2' HD22 ' A' ' 19' ' ' ASN . 84.1 mtp180 -120.19 147.1 45.35 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.675 0.75 . . . . 0.0 110.426 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t 57.11 56.86 4.93 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.097 0.475 . . . . 0.0 110.751 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.56 166.03 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.81 143.26 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.602 0.715 . . . . 0.0 109.666 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.83 132.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.65 -0.656 . . . . 0.0 109.655 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.29 153.1 17.77 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.412 ' HB2' HD22 ' A' ' 14' ' ' ASN . 78.4 tt0 -95.71 110.44 22.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -1.147 . . . . 0.0 109.139 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 80' ' ' ARG . 75.4 t80 -103.84 109.73 21.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.145 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 43.75 -119.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.773 . . . . 0.0 110.438 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -94.01 -17.08 23.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.11 -0.994 . . . . 0.0 110.254 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 77' ' ' TYR . 78.4 ttt180 -102.56 144.13 31.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.38 153.27 37.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 0.0 108.955 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -143.82 152.05 40.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.991 -1.068 . . . . 0.0 109.011 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.89 122.27 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.86 128.67 53.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.448 -0.783 . . . . 0.0 109.414 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.11 133.11 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -136.94 -166.32 1.89 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 89' ' ' SER . 10.0 mtpm? -55.43 167.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.873 -0.517 . . . . 0.0 109.763 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 73.07 -23.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.413 -0.804 . . . . 0.0 109.614 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 87' ' ' LYS . 48.9 m -72.35 159.18 34.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.752 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.9 m -135.04 155.12 51.3 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.336 -0.852 . . . . 0.0 108.871 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -139.26 131.19 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.1 -1.0 . . . . 0.0 109.06 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -131.58 136.91 48.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.35 -0.844 . . . . 0.0 108.917 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -72.45 140.53 48.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.32 132.14 44.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.404 -0.81 . . . . 0.0 109.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.7 p -83.1 -4.77 58.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.661 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -115.53 93.66 37.42 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.78 . . . . 0.0 109.441 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.94 156.78 6.7 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.525 2.15 . . . . 0.0 112.208 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.7 147.85 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.05 -82.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.07 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t 61.09 60.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.33 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.54 32.38 27.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.8 tp -99.26 107.97 20.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -1.131 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 104' ' ' HIS . 74.2 tt0 -153.92 1.62 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 103' ' ' GLU . 96.5 m-70 53.09 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 109.357 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -136.06 135.88 39.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 109.206 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -77.77 146.35 35.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.677 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' HIS . 95.9 m-70 -75.73 144.75 41.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 107' ' ' HIS . 79.3 m80 49.42 -177.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.461 -0.775 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.697 -179.832 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mmm . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -165.0 58.19 0.57 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.4 156.06 62.48 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.673 2.249 . . . . 0.0 112.119 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.42 113.79 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.517 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.32 132.18 36.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.1 m -124.46 143.49 50.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.63 -0.668 . . . . 0.0 109.27 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -94.1 148.08 22.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.7 mt -57.24 -44.74 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 109.399 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.36 -12.31 13.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.565 -0.71 . . . . 0.0 109.385 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 53.7 t0 -97.31 4.89 50.67 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.2 mt -88.0 121.57 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.99 6.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.208 -0.933 . . . . 0.0 109.417 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -133.49 128.99 36.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.369 -0.832 . . . . 0.0 109.091 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -87.81 153.61 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.148 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.88 17.01 78.04 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -96.44 150.12 20.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.425 -1.044 . . . . 0.0 110.045 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -102.33 131.26 49.05 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.4 0.619 . . . . 0.0 109.481 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.63 179.24 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.745 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.578 ' C ' HD22 ' A' ' 20' ' ' LEU . 5.0 m-80 -117.15 131.12 56.95 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.578 HD22 ' C ' ' A' ' 19' ' ' ASN . 4.4 mm? -117.18 146.26 43.33 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.898 0.856 . . . . 0.0 110.352 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -136.08 131.47 34.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.54 -173.82 0.78 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.039 0.923 . . . . 0.0 111.041 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' CE ' ' H ' ' A' ' 98' ' ' ILE . 34.2 ttmt -111.85 150.98 29.62 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.943 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.4 t -86.39 95.02 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.21 -26.7 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.467 -0.77 . . . . 0.0 109.811 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -143.17 119.25 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.954 -1.091 . . . . 0.0 109.379 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD11 ' NE2' ' A' ' 37' ' ' GLN . 61.4 tp -109.3 143.63 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 0.0 109.18 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -140.26 107.28 5.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.61 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -73.01 116.93 14.12 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' OD1' ' ND1' ' A' ' 32' ' ' HIS . 48.9 t-20 -102.8 134.23 46.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.259 -0.901 . . . . 0.0 109.175 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.17 11.26 37.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -0.797 . . . . 0.0 108.905 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.465 ' ND1' ' OD1' ' A' ' 30' ' ' ASN . 24.3 m80 -79.4 147.4 32.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.34 -41.2 73.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.32 -0.862 . . . . 0.0 110.068 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 t -63.65 -51.47 65.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.313 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 32' ' ' HIS . 93.8 mt -106.58 133.7 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.677 0.751 . . . . 0.0 109.446 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 t -97.63 -50.06 4.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.813 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' NE2' HD11 ' A' ' 27' ' ' LEU . 48.2 tt0 -149.87 146.84 27.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 0.0 110.129 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.39 153.01 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.38 -161.58 23.87 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.275 -1.441 . . . . 0.0 109.925 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.76 146.53 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.021 -0.693 . . . . 0.0 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD21 ' CE1' ' A' ' 50' ' ' PHE . 70.3 mt -112.3 127.08 55.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.53 -0.731 . . . . 0.0 109.431 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.35 100.93 2.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -101.25 162.39 12.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.359 -1.083 . . . . 0.0 109.358 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -72.26 -21.93 61.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.601 -0.687 . . . . 0.0 109.893 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.9 p -93.92 -16.12 24.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.208 -0.933 . . . . 0.0 109.136 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.21 -156.98 29.26 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.014 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 47' ' ' ILE . 15.2 pt -137.98 163.18 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.531 -0.981 . . . . 0.0 109.93 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.2 tt -162.5 152.12 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.196 -0.94 . . . . 0.0 109.716 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -97.12 138.84 34.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CE1' HD21 ' A' ' 41' ' ' LEU . 4.4 p90 -131.49 156.16 46.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.058 -1.026 . . . . 0.0 108.933 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.8 m -131.59 132.28 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.472 0.653 . . . . 0.0 109.64 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.3 mt -98.47 128.23 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 109.699 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -85.0 143.73 28.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -0.792 . . . . 0.0 110.432 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.56 -35.36 74.09 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -58.97 -9.54 1.94 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.575 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.22 -28.13 24.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 108.889 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 45.9 49.99 11.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.639 . . . . 0.0 109.865 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.0 mt -102.78 153.22 38.37 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.614 -0.679 . . . . 0.0 109.739 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.78 149.91 47.89 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.357 2.038 . . . . 0.0 112.642 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.91 140.4 53.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.469 -0.77 . . . . 0.0 110.335 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -81.57 145.42 30.66 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.423 0.63 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 97.0 mt-10 -94.24 128.78 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 109.724 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 58.3 tt0 -68.5 135.45 51.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.592 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.83 -11.1 71.59 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.563 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.0 mp0 -99.4 162.38 13.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -1.123 . . . . 0.0 110.687 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 p -98.04 137.13 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -133.75 153.38 51.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.133 0.968 . . . . 0.0 110.08 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 tp -111.74 131.32 55.39 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.9 mt -111.9 120.86 43.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.471 -0.768 . . . . 0.0 109.533 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' O ' ' OG ' ' A' ' 71' ' ' SER . 83.0 mtp180 -117.75 151.37 37.43 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.578 0.704 . . . . 0.0 110.647 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.2 p 51.71 56.2 8.21 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.657 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.52 166.19 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.55 150.03 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.686 0.755 . . . . 0.0 109.888 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.45 132.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.622 -0.674 . . . . 0.0 109.442 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.75 150.2 16.85 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -88.02 99.7 12.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ARG . 76.2 t80 -98.1 100.71 12.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.251 -0.906 . . . . 0.0 109.225 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 44.7 -119.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 110.7 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 34.6 p-10 -93.65 -7.58 43.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -110.57 155.27 22.56 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.89 0.852 . . . . 0.0 110.184 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -95.95 153.45 17.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 108.848 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -144.11 159.43 42.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.129 -0.982 . . . . 0.0 109.203 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.41 126.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -103.13 126.75 50.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.432 -0.792 . . . . 0.0 109.148 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.03 132.24 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -127.01 -168.45 1.88 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.692 0.758 . . . . 0.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -65.2 -41.76 94.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.762 -0.587 . . . . 0.0 110.18 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -64.48 -12.2 41.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.413 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 37.8 t -83.86 164.03 19.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.8 m -136.5 157.59 46.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.327 -0.858 . . . . 0.0 109.044 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 61' ' ' LEU . 96.3 mt -134.96 128.24 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.267 -0.896 . . . . 0.0 109.226 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -129.76 133.12 46.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.467 ' C ' HD22 ' A' ' 94' ' ' LEU . 66.0 tttm -80.1 134.86 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' GLU . 4.0 mm? -107.64 -1.7 20.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.464 -0.772 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 14.3 t 47.28 15.77 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.269 -0.894 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 94' ' ' LEU . 6.9 tp10 -114.83 93.28 33.31 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 108.936 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.8 147.39 41.3 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.683 2.255 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.414 ' H ' ' CE ' ' A' ' 23' ' ' LYS . 29.8 mm -105.74 139.96 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.573 -0.704 . . . . 0.0 109.17 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -93.79 122.43 36.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.495 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.2 m -101.83 -5.48 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 103' ' ' GLU . . . 156.03 -94.26 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 103' ' ' GLU . 73.4 mt 56.04 5.48 0.17 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.481 -1.011 . . . . 0.0 109.312 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 101' ' ' GLY . 97.8 mt-10 44.21 -170.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.735 0.778 . . . . 0.0 110.751 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -152.97 127.5 9.35 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -154.6 24.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 108.875 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 47.2 77.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.475 -0.766 . . . . 0.0 109.293 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.49 139.64 38.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.61 -0.681 . . . . 0.0 110.037 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -73.2 139.02 45.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.677 -179.86 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -91.08 156.44 44.04 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.368 -0.833 . . . . 0.0 109.575 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.97 157.29 62.46 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.571 2.181 . . . . 0.0 111.971 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -81.56 117.96 22.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -87.77 128.67 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.442 ' O ' HD23 ' A' ' 20' ' ' LEU . 84.9 m -124.94 145.64 49.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -97.49 142.71 28.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 pt -52.94 -39.41 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 0.0 109.733 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.56 -12.19 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.504 -0.748 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -97.17 5.18 50.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.304 -0.873 . . . . 0.0 109.606 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.95 123.77 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.159 -0.963 . . . . 0.0 109.951 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.41 8.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -137.45 134.42 35.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.219 -0.926 . . . . 0.0 109.243 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.418 ' OD1' ' OE1' ' A' ' 76' ' ' GLU . 16.0 m120 -92.61 153.74 18.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.369 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.19 71.75 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -95.83 146.86 24.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.313 -1.11 . . . . 0.0 109.698 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.66 132.47 52.61 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.352 0.596 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.04 -175.16 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.398 -0.814 . . . . 0.0 109.848 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 27.3 t30 -119.48 140.53 50.31 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 6' ' ' THR . 14.8 mt -133.62 149.03 51.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.383 -0.823 . . . . 0.0 110.165 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -133.07 127.34 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.93 177.5 10.31 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.098 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -109.16 153.15 24.15 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.919 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.0 99.61 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.421 -0.799 . . . . 0.0 110.286 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.9 pt -79.51 -26.09 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -158.36 147.43 19.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.361 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.903 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -133.54 158.78 42.27 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.51 -0.744 . . . . 0.0 109.628 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -142.41 109.32 5.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -68.29 123.63 21.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.489 -0.757 . . . . 0.0 109.231 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.402 HD22 ' HB ' ' A' ' 35' ' ' ILE . 4.4 t30 -134.8 123.37 23.46 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.406 -0.809 . . . . 0.0 109.261 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -136.71 24.18 3.12 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.368 -0.833 . . . . 0.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.46 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.441 -0.787 . . . . 0.0 109.837 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -73.66 -110.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 109.443 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -116.02 10.85 15.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.402 ' HB ' HD22 ' A' ' 30' ' ' ASN . 89.8 mt -81.13 133.15 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 t -86.25 -57.43 3.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.991 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -151.41 154.95 37.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.187 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.35 139.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.69 -156.02 10.12 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.327 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.06 152.2 51.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.832 -0.805 . . . . 0.0 109.688 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.4 mt -110.75 131.64 54.88 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.33 99.15 2.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -100.34 160.78 14.06 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.452 -1.028 . . . . 0.0 109.46 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -69.98 -16.63 63.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.401 -0.812 . . . . 0.0 109.85 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.8 p -96.63 -11.72 24.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.213 -0.929 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.17 17.76 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.676 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.6 pp -132.82 162.35 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.964 . . . . 0.0 109.635 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.444 HD11 ' O ' ' A' ' 81' ' ' PHE . 7.2 tp -156.67 148.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.497 ' HZ1' ' NH1' ' A' ' 80' ' ' ARG . 63.1 mttp -81.53 164.13 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.603 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -157.01 148.07 21.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.64 -1.288 . . . . 0.0 108.543 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -136.42 131.88 34.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.216 -0.927 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.07 130.11 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.664 -0.648 . . . . 0.0 109.578 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -86.85 141.44 28.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 56' ' ' ALA . 12.6 mmtm -56.59 -35.3 68.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.54 -0.725 . . . . 0.0 109.068 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -59.4 -4.6 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.484 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -87.35 -31.08 20.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 108.909 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 51.22 50.62 18.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 110.089 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.82 152.38 42.29 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.765 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.2 148.34 41.02 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.173 1.915 . . . . 0.0 112.784 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.9 mt -68.32 144.65 54.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.479 -0.763 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -80.16 145.21 32.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -102.35 133.91 46.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.368 -0.833 . . . . 0.0 109.48 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.71 138.42 44.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.477 -0.764 . . . . 0.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.29 -8.15 79.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -106.04 157.32 17.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.417 -1.049 . . . . 0.0 110.493 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -89.1 147.4 24.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.861 -0.525 . . . . 0.0 109.619 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -140.52 145.75 37.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.819 0.819 . . . . 0.0 109.946 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -111.69 131.25 55.42 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 2.8 mp -117.75 115.85 25.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.516 -0.74 . . . . 0.0 109.51 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -109.59 149.12 30.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.52 -0.737 . . . . 0.0 110.597 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m 56.68 59.43 3.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.789 -0.569 . . . . 0.0 110.61 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.79 162.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.27 147.96 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.512 0.673 . . . . 0.0 109.473 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.36 127.81 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.22 156.79 15.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.508 ' OE1' ' CE2' ' A' ' 81' ' ' PHE . 49.6 tp10 -105.6 134.35 48.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -1.006 . . . . 0.0 108.816 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 79' ' ' ASP . 87.9 t80 -129.37 117.93 21.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.51 -0.744 . . . . 0.0 109.077 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' TYR . 95.0 m-20 39.65 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.707 -0.62 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 77' ' ' TYR . 37.3 p-10 -125.08 -17.61 5.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.309 -0.869 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.497 ' NH1' ' HZ1' ' A' ' 49' ' ' LYS . 96.8 mtt180 -93.25 155.43 17.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.969 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.508 ' CE2' ' OE1' ' A' ' 76' ' ' GLU . 96.0 m-85 -101.81 149.09 24.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.463 -0.773 . . . . 0.0 108.945 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -152.35 161.16 43.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.128 -0.983 . . . . 0.0 109.414 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -104.46 127.75 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.29 127.01 46.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.798 . . . . 0.0 109.596 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.59 133.15 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.368 -0.832 . . . . 0.0 109.07 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.433 ' N ' ' OG ' ' A' ' 89' ' ' SER . 78.8 m-20 -132.5 -166.16 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.825 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -62.36 -40.91 97.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -62.27 -32.31 73.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.552 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 86' ' ' ASN . 24.2 p -79.54 164.72 23.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.897 . . . . 0.0 110.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.4 t -139.54 166.92 23.28 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.468 -0.77 . . . . 0.0 109.111 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.2 mt -139.59 131.58 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.189 -0.944 . . . . 0.0 109.175 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -128.81 132.43 47.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.299 -0.876 . . . . 0.0 109.147 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.64 139.98 40.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.296 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -101.26 141.57 33.95 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.971 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -84.43 -1.75 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.556 -0.715 . . . . 0.0 109.681 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -114.04 131.4 23.19 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.433 -0.792 . . . . 0.0 109.692 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.43 152.91 49.81 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.998 1.799 . . . . 0.0 112.439 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.49 134.44 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.54 -0.725 . . . . 0.0 109.14 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -93.8 118.52 31.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.303 -0.873 . . . . 0.0 109.837 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.85 -31.2 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.3 104.23 0.66 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt 43.39 72.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.596 -0.943 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.03 128.37 35.81 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.452 0.644 . . . . 0.0 110.39 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 105' ' ' HIS . 45.5 t-80 -155.52 173.95 15.96 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 104' ' ' HIS . 97.9 m-70 -57.54 -157.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 109.515 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -76.28 -9.51 58.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.049 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -58.27 125.1 21.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.805 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -149.0 139.06 22.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.176 -0.952 . . . . 0.0 109.511 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.63 ' H ' ' CD2' ' A' ' 109' ' ' HIS . 6.3 p80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.613 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mmm . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.57 0.7 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 2.4 mt-10 -82.61 -49.4 0.81 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.279 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 74.4 Cg_endo -77.58 162.43 30.33 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.123 1.882 . . . . 0.0 112.28 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -76.72 118.5 19.41 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.303 -0.873 . . . . 0.0 109.35 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.8 mt -93.23 128.29 39.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -127.86 150.5 49.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -97.61 146.99 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.153 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.42 -42.3 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.795 . . . . 0.0 108.956 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.41 -8.97 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.558 -0.714 . . . . 0.0 109.407 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 57.9 t0 -100.18 4.46 44.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.254 -0.904 . . . . 0.0 109.176 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -87.56 118.95 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 109.67 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.55 6.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 14' ' ' ASN . 8.0 tm-20 -131.09 129.34 41.76 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.407 -0.808 . . . . 0.0 109.137 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.429 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 52.7 p30 -88.04 150.63 23.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.284 -0.885 . . . . 0.0 110.289 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.85 16.33 79.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -93.07 144.46 25.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.364 -1.08 . . . . 0.0 109.938 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.82 129.69 45.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.695 . . . . 0.0 109.565 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.71 -179.42 7.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.384 -0.822 . . . . 0.0 109.876 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 71' ' ' SER . 77.2 m-20 -140.09 145.48 37.69 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.453 -0.779 . . . . 0.0 109.157 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -159.96 158.57 30.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -100.57 139.69 35.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.044 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 41' ' ' LEU . . . -153.26 157.51 40.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -103.06 153.89 19.81 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.1 110.45 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.098 -1.001 . . . . 0.0 110.132 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 pt -91.5 -21.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 110.143 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' NE2' HE22 ' A' ' 63' ' ' GLN . 67.8 tp60 -162.76 153.03 16.41 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.08 -1.013 . . . . 0.0 109.422 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.528 ' N ' HE21 ' A' ' 63' ' ' GLN . 91.5 mt -132.06 157.11 45.0 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.572 0.701 . . . . 0.0 109.909 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' VAL . 46.1 m95 -144.55 118.94 9.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.218 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.14 128.17 34.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.6 141.68 35.99 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.317 -0.864 . . . . 0.0 109.122 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 33' ' ' GLU . 70.8 p -120.83 11.59 11.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.461 -0.775 . . . . 0.0 109.142 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -62.62 10.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.509 -0.744 . . . . 0.0 109.377 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.616 ' H ' ' C ' ' A' ' 31' ' ' THR . 96.8 mt-10 56.44 16.1 2.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 110.703 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.6 t -131.74 -32.71 1.45 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.384 -0.823 . . . . 0.0 108.935 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.41 138.62 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.799 0.809 . . . . 0.0 109.432 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -81.69 -65.1 1.05 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.547 0.689 . . . . 0.0 109.914 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -149.55 153.24 36.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.011 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 28' ' ' TRP . 3.0 t -137.91 163.75 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.55 33.55 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.1 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -126.96 146.81 50.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.973 -0.722 . . . . 0.0 109.123 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 58.1 mt -109.92 129.41 55.66 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.79 101.74 2.8 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -107.01 165.0 11.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.597 -0.943 . . . . 0.0 109.458 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.96 -18.78 62.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.52 -0.738 . . . . 0.0 109.847 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 p -91.66 -11.56 36.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.095 -1.003 . . . . 0.0 109.391 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.25 -146.61 15.89 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.56 151.1 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.691 -0.888 . . . . 0.0 109.636 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tp -146.48 138.06 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.477 -0.765 . . . . 0.0 109.655 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -83.28 152.52 25.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.382 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.11 154.67 41.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.574 -1.329 . . . . 0.0 107.864 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.3 m -132.19 131.06 41.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.637 -0.664 . . . . 0.0 109.743 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -103.71 128.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -89.41 144.02 26.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HZ3' ' HA ' ' A' ' 33' ' ' GLU . 53.8 mtmt -58.22 -34.36 70.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -58.84 -5.7 0.65 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -89.07 -33.41 17.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 108.719 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 49.81 50.25 18.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.597 -0.689 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD13 ' HB1' ' A' ' 56' ' ' ALA . 5.8 mp -102.85 163.11 18.2 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.551 -0.718 . . . . 0.0 109.671 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.79 150.09 84.73 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.577 2.185 . . . . 0.0 112.325 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.5 mt -72.35 142.82 48.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 110.308 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -84.35 149.52 25.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.668 . . . . 0.0 109.723 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 57.0 mp0 -110.14 142.39 41.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.964 0.888 . . . . 0.0 109.593 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.528 HE21 ' N ' ' A' ' 27' ' ' LEU . 99.5 mt-30 -74.56 137.58 42.49 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.541 0.686 . . . . 0.0 110.794 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.49 -14.91 64.4 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.06 155.01 16.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 0.0 110.832 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.468 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 5.7 p -93.39 158.79 15.55 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.489 ' HE2' ' HZ3' ' A' ' 93' ' ' LYS . 90.1 m-85 -149.8 149.28 30.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -103.66 131.73 50.56 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 68' ' ' LEU . 77.0 mt -105.43 107.5 18.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -110.15 139.39 45.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.463 0.649 . . . . 0.0 110.252 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 25.2 t 55.25 59.11 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.88 -0.512 . . . . 0.0 110.908 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 m -112.42 165.57 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.34 -0.85 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.78 153.99 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.623 0.725 . . . . 0.0 109.759 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.03 131.28 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.756 -0.59 . . . . 0.0 109.709 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.47 148.13 17.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -93.29 100.19 12.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -1.166 . . . . 0.0 109.229 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' ARG . 73.5 t80 -101.49 105.2 16.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.4 t30 40.57 -117.13 0.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.527 -0.733 . . . . 0.0 110.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.63 -18.35 23.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.284 -0.885 . . . . 0.0 110.18 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' TYR . 96.4 mtt-85 -99.29 162.78 12.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.255 -0.903 . . . . 0.0 110.056 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.48 153.0 24.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.23 163.13 36.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 0.0 109.124 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.62 125.89 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -106.08 126.19 51.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.381 -0.824 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 t -97.17 135.2 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -130.95 -169.41 2.16 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.479 -0.763 . . . . 0.0 109.747 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.53 -39.45 94.46 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.649 -0.657 . . . . 0.0 110.224 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -68.0 -19.63 64.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.794 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.57 166.24 17.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -0.843 . . . . 0.0 110.019 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -145.08 164.29 31.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.228 -0.92 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.9 mt -149.4 139.72 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -133.61 143.24 48.5 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.468 -0.77 . . . . 0.0 109.583 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 68.1 mttm -72.81 140.68 47.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.502 -0.749 . . . . 0.0 109.766 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt -111.64 147.72 34.89 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.634 0.73 . . . . 0.0 109.996 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -95.75 6.07 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.0 109.783 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.56 92.08 43.09 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.427 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.09 160.46 8.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.821 2.348 . . . . 0.0 112.117 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.81 139.2 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.552 -0.717 . . . . 0.0 109.55 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 101' ' ' GLY . 48.7 tp10 -71.19 126.58 29.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -0.809 . . . . 0.0 109.641 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.2 2.45 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.424 ' O ' ' OE2' ' A' ' 99' ' ' GLU . . . -151.14 106.22 0.3 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.442 ' CD2' ' H ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -89.43 102.23 14.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.333 -1.098 . . . . 0.0 109.239 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 57.2 mp0 -46.54 98.68 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.493 0.663 . . . . 0.0 110.583 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -65.89 -41.88 90.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.817 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 107' ' ' HIS . 81.7 t60 -150.11 -56.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.422 -0.799 . . . . 0.0 109.113 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 46.02 -91.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.43 -0.794 . . . . 0.0 109.845 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' HIS . 85.1 t60 -153.08 69.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.196 -0.94 . . . . 0.0 109.36 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -66.3 -43.43 86.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.91 . . . . 0.0 109.489 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.18 -179.977 . . . . . . . . 0 0 . 1 stop_ save_